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Abstract 
 
Longitudinal Growth of Mammalian Bones: A Possible Role for Membrane 
Transporter in Mediating Chondrocyte Hypertrophy 
 
Long bone lengthening occurs at the growth plate (GP) by well-regulated 
chondrocyte proliferation, hypertrophy and terminal matrix deposition. GP 
chondrocyte (GPC) hypertrophy has been implicated to be the main determinant of 
bone growth rate; however the mechanism is poorly understood. The work of this 
thesis examined some of the cellular process that drives the chondrocyte swelling 
or hypertrophy particularly in a mammalian post natal GPs using living in situ GPC 
and fixed GP tissues.  
 Confocal scanning microscopy (CLSM) was used to determine living in situ 
GPC volume and dimension changes in proliferative zone (PZ) through to 
hypertrophic zone (HZ) chondrocytes of different GPs of various bones. While PZ 
cells showed similar volumes and dimensions, HZ cells varied in different GPs, 
even within the same long bone but at opposite ends. However, the hypertrophic 
cell volume measured at a single post natal age (day 7) was independent of the 
corresponding bone length. This could reflect a complex interplay between local 
and systemic factors in different GPs, which occurs throughout the active phase of 
bone growth. 
 Maintaining GPC morphology was critical in studying GPC hypertrophy 
using fixed tissues. This work highlighted a problem caused by conventional 
fixative solutions, which caused up to 44% hypertrophic GPC shrinkage following 
GP fixation. This artifact appeared to be associated with the hyperosmotic nature of 
the fixatives used and could be abolished by adjusting the fixative osmolarity close 
to physiological level (280 mOsm), or could be significantly reduced by bisecting 
bone tissues prior to tissue fixation.  
 This thesis proposed roles for plasma membrane transporter(s) in mediating 
GPC hypertrophy. This hypothesis was tested by examining roles of sodium-
Abstract 
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hydrogen exchanger (NHE) and anion exchanger (AE) in GPC hypertrophy using 
an ex vivo bone growth inhibition model. Inhibition of bone growth by inhibitors of 
NHE (EIPA) and AE (DIDS) respectively was shown to be dose-dependent. The 
histology of bones demonstrated that the late HZ width was significantly reduced 
in GPs treated with EIPA or DIDS. Although in situ GPC volumes in the PZ and 
HZ were not notably different in DIDS-treated GP, the cell volumes in both zones 
were significantly reduced by EIPA treatment. Fluorescence 
immunohistochemistry revealed distinctive cellular localisations of NHE1 and AE2 
in the PZ and early HZ. These results suggest a possible role of AE in mediating 
GPC volume increase in PZ chondrocytes and those in the early stages of cell 
hypertrophy, whereas NHE could possibly maintain intracellular pH of GPC 
throughout all GP zones.  
 This thesis has characterized various changes in volume and dimensions of 
living in situ GPC from PZ through to HZ of different GPs of postnatal rats. This 
work emphasized the importance of fixative osmolarity in order to accurately 
preserve the normal volume/morphology of cells within tissues. Most importantly, 
this thesis confirmed a potential role of the plasma membrane transporters, AE and 
NHE in GPC hypertrophy of growing bones.  
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Preface 
How does bone grow longer?  
Bone growth is generated by a process, which is composed of a finely 
balanced cycle of cartilage growth, matrix formation and cartilage calcification, 
which occurs during phase of skeletal development. This process takes place at 
regions of a specialised cartilage, the epiphyseal growth plate, involving the 
activities of chondrocytes. The predominant cell type in the growth plates of long 
bones undergo proliferation, enlargement, maturation and subsequently cell death 
during the process (Wilsman et al., 1996b). 
Chondrocyte enlargement or hypertrophy at the later stage of the cell’s 
differentiation is of significant importance for longitudinal bone growth as it has 
been implicated as the main determinant of the rate of the bone elongation (Breur 
et al., 1991; Wilsman et al., 1996b). Hitherto, however, an understanding of the 
underlying mechanism(s) involved in the growth plate hypertrophy is still lacking. 
This knowledge is crucial in the research of some growth plate disorders and their 
subsequent treatment (Breur et al., 1992; de Luca, 2006). 
The present work explores the question what is/ are the mechanisms 
responsible for growth plate chondrocyte hypertrophy. This is achieved by 
examining living in situ and fixed growth plate chondrocytes and furthermore by 
studying the fundamental cellular process involved in chondrocyte enlargement.  
1.1 Thesis Overview 
This work comprises four main related study projects. The general aim and 
hypothesis of the work and the projects undertaken are described at the end of this 
chapter. The general methods employed to achieve them are described in chapter 
two, whereas the specific methods used in each project are given in the respective 
project results chapters:  
• Characterization performed on in situ living chondrocyte hypertrophy in 
various growth plates of post natal rats are detailed in chapter three.  
• Experiments examining the importance of fixative osmolarity for 
maintaining growth plate chondrocyte morphology in growth plate tissue 
preservation are given in chapter four.  
  Chapter 1: Introduction 
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• Results derived from sodium-hydrogen exchanger (NHE) and anion 
exchanger (AE) inhibition using ex vivo bone culture are presented in 
chapter five.  
• The changes to NHE1 and AE2 expression levels with growth plate 
chondrocyte hypertrophy using the immunofluorescence technique is the 
subject of chapter six.  
• Finally, the findings of chapter three to six are summarized and discussed in 
chapter seven.  
The following section in this chapter is a synopsis of relevant background 
theory. It outlines: (i) introduction to skeletal bone development, (ii) introduction to 
epiphyseal growth plate, (iii) longitudinal bone growth, (iv) the clinical importance 
of bone growth and pertinent disorders, (v) relevant previous research findings ((a) 
growth plate cell hypertrophy and longitudinal bone growth (b) growth rate and 
differential growth, (c) regulatory volume transporters and chondrocyte 
enlargement) and (vi) experimental models used to study skeletal bone 
development. 
1.2 Skeletal Bone Development 
Embryonic bone formation occurs through two distinct processes. 
Intramembranous growth results in the formation of flat bones-such as the cranium, 
mandible, and scapula, whereas the process of endochondral growth (Figure 1.1) 
accounts for the formation of long bones-such as the tibia, femur and humerus, 
bones of the extremities, and those parts of the axial skeleton that bear weight, e.g. 
vertebrae (Farquharson, 2003; Clarke, 2008). Longitudinal and radial growth 
occurs during childhood and adolescence. In addition, bone modelling and 
remodelling occur constantly during life to help the bone to adapt to changing 
biomechanical forces, as well as to remove old, microdamaged bone and replace it 
with new, mechanically stronger bone (Clarke, 2008). Therefore, modelling and 
remodelling are two important biological mechanisms that determine the strength 
of the bone (Frost and Schonau, 2000). 
In the main, bones grow in two directions: through a cartilage template to 
increase its length (longitudinal or endochondral growth), and through the 
  Chapter 1: Introduction 
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formation of new bone on the outer surfaces of existing bone to increase its width 
(appositional growth; Farquharson, 2003; Figure 1.2 and 1.3).  
1.2.1 Intramembranous Bone Formation  
During intramembranous bone formation, mesenchymal cells proliferate within a 
highly vascularised area of the embryonic connective tissue, forming early cell 
condensations within which cells differentiate directly into osteoblasts. These cells 
synthesize a woven bone matrix, while mesenchymal cells at the periphery 
continue to differentiate into osteoblasts. Blood vessels are incorporated between 
the woven bone trabeculae and form the hematopoietic bone marrow (Sims and 
Baron, 2000). Clearly, during the process there is no intervention of a cartilage 
precusor or concomitant resorption of cartilage and deposition of bone on a spicule 
(remnant of the cartilage resorption) of calcified matrix as occurs in endochondral 
bone formation (Ross and Reith, 1985).  
 
1.2.2 Endochondral Bone Formation 
Most bones develop through a process known as endochondral ossification, the 
initial stage of which is the formation of a cartilage anlage. During foetal 
development and postnatal growth, this anlage is gradually replaced by bone. 
Cartilage anlages are formed through condensation of mesenchymal cells, followed 
by their differentiation into chondrocytes and secretion of typical cartilage 
extracellular matrix components (Fig. 1.1). The cartilage anlage once formed is 
invaded first at its centre and later at each end by a mixture of cells that establish 
the primary and secondary (respectively) centres of ossification. These centres of 
ossification gradually encroach on the remaining cartilage, ultimately replacing it 
(except at the articular surfaces, where a thick cartilage layer forms the articular 
surfaces) by the time skeletal maturity is achieved. The importance of the cartilage 
model lies not only in its provision of a mechanically stable template or scaffold 
for bone formation, but also in its role as the source of longitudinal bone growth 
(Mackie et al., 2008) by a finely balanced cycle of cartilage growth with matrix 
formation and calcification of cartilage (Gerber et al., 1999). 
 As bones continue to develop, so-called secondary ossification centres are 
established (Fig. 1.1). In the long bones of the limb, the secondary centres of 
ossification are separated from the primary centre of ossification by a distinct 
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group of chondrocytes that continue to proliferate and responsible for the 
longitudinal growth. This cartilage is referred to as the growth plate, as it forms a 
distinct region of cells (plate) between the bone of the secondary ossification centre 
and the primary spongiosa (Kronenberg, 2003). In the adult bone, the metaphyseal 
and epiphyseal bone fuse to each other by the formation of boney bridges, leading 
to the growth plate closure (Mackie et al., 2008). 
 
1.2.3 Bone Modelling 
Modelling is the process by which bones change their overall shape and size in 
response to physiological influences or mechanical forces, leading to gradual 
adjustment of the skeleton to the forces that it encounters by following Wolff’s 
law1. Modelling enables long bones to increase in diameter, to change shape and 
develop a marrow cavity, to widen or change axis by removal or addition of bone 
to the appropriate surfaces. This process is achieved through bone formation by 
osteoblasts at some sites (e.g. periosteal apposition) and through bone destruction 
by osteoclasts at other sites (e.g. endosteal resorption; Fig. 1.3). However, during 
bone modelling, bone formation and resorption are not tightly coupled (Clarke, 
2008). It is most active during childhood and adolescence, and continues 
throughout adult life, but is less frequent than remodelling in adults (Kobayashi et 
al., 2003). 
 
1.2.4 Bone Remodelling 
Remodelling is the process by which bone is renewed to maintain bone strength 
and mineral homeostasis (bone turnover). Remodelling involves continuous 
removal of discrete packets of old bone, replacement of these packets with newly 
synthesized proteinaceous matrix, and subsequent mineralization of the matrix to 
form new bone. The remodelling process resorbs old bone and forms new bone to 
prevent accumulation of bone microdamage. Remodelling begins before birth and 
continues until death. The bone remodelling unit is composed of a tightly coupled 
group of osteoclasts and osteoblasts that sequentially carry out resorption of old  
                                                 
1 A law (developed by Julius Wolf, 1836-1902) stating that bone adapts its external shape and internal structure 
in response to the mechanical forces it is required to support (Prendergast and Huiskes, 1995; Villemure and 
Stokes, 2009).  
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Figure 1.1 Endochondral bone development. Schematic diagram showing the 
initial stages of endochondral ossification. Bone development begins with 
mesenchymal condensation to form a cartilage model (anlage) of the bone to be 
formed. Following chondrocyte hypertrophy and matrix mineralization, osteoclast 
activity and vascularization result in formation of the primary and then secondary 
ossification centers. In mature adult bones, the growth plate is fully resorbed so that 
one marrow cavity extends the full length of the bone (after Sims and Baron, 
2000). 
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Figure 1.2 A diagrammatic representation of the mechanism of growth plate 
cell enlargement and longitudinal bone growth. An index cell (shaded) is 
pictured during longitudinal growth of the epiphyseal growth plate. As longitudinal 
growth proceeds, the index cell remains in a constant position while the growth 
plate undergoes its developmental changes. After Hochberg (2002). 
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Figure 1.3 Bone growth, modelling and remodelling. Diagram showing surfaces 
on which bone is deposited and resorbed to account for the remodelling that takes 
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bone and formation of new bone (Clarke, 2008). The remodelling cycle is 
composed of four sequential phases: i) activation, ii) bone resorption, iii) reversal, 
and finally iv) bone formation. Remodelling sites develop mostly in a random 
manner but are also targeted to areas that require repair through the actions of the 
osteocyte (Burr, 2002; Clarke, 2008). Both modelling and remodelling processes 
are induced by mechanical loads (Ehrlich and Lanyon, 2002), predominantly from 
muscle- and gravity-derived forces (Beck, 2009). 
 
1.2.5 General Bone Classification and Basic Structure 
The four general categories of bones are long bones, short bones, flat bones, and 
irregular bones. Long bones include the clavicles, humeri, radii, ulnae, metacarpals, 
femurs, tibiae, fibulae, metatarsals, and phalanges. Short bones include the carpal 
and tarsal bones; and sesamoid bones such as patellae. Flat bones include the skull, 
mandible, scapulae, sternum, and ribs. Irregular bones include the vertebrae, 
sacrum, coccyx, and hyoid bone (see Appendix 1 for overview diagram of these 
bones in a rat skeleton). Flat bones form by membranous bone formation, whereas 
long bones are formed by a combination of endochondral and membranous bone 
formation (Clarke, 2008). 
The long bones are composed of a hollow shaft, or diaphysis; flared, cone-
shaped metaphyses below the growth plates, and rounded epiphyses above the 
growth plates. The diaphysis is composed primarily of dense cortical bone, whereas 
the metaphysis and epiphysis are composed of trabecular meshwork bone 
surrounded by a relatively thin shell of dense cortical bone (Clarke, 2008). Bone 
tissue contains hydroxyapatite and various extracellular proteins, producing bone 
matrix (Vaughan, 1981; Marks et al., 1988).  
Osteoblasts develop from mesenchymal stem cells. Many stimulatory 
factors are known to activate osteoblast differentiation. Mature osteoblasts 
synthesize bone matrix and may further differentiate into osteocytes (Sims and 
Baron, 2000; Clarke, 2008). Osteocytes maintain structural bone integrity and 
allow bone to adapt to mechanical and chemical stimulus (Knothe Tate et al., 
2004). Osteoclasts are derived from haematopoietic stem cells. A number of 
transcription and growth factors have been identified to be essential for osteoclast 
differentiation and function (Crockett et al., 2011). Finally, there is a complex 
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interaction between osteoblasts and osteoclasts. Bone resorption begins with 
attachment of osteoclasts to the bone surface. Following this, osteoclasts undergo 
specific morphological changes. The process of bone resorption starts by acid  
dissolution of hydroxyapatite. After that, osteoclasts start to breakdown the organic 
matrix by the production of proteases (Blair et al., 2002; Crockett et al., 2011).  
1.3 The Growth Plate 
The previous section has emphasised the central role of the growth plate in 
longitudinal bone growth. This section describes in greater detail the morphology 
and function of the growth cartilage.  
 
1.3.1 General Morphology  
At the macroscopic level the skeleton appears to be a static organ whereas in reality 
it is an extremely dynamic organ (Khosla et al., 2008), and this is exemplified by 
the growth plate chondrocyte differentiation process (Figure 1.4). While often 
considered a simple structure, the growth plate, or physis, of an endochondral bone 
is a complex composite of cells that appears to vary from species to species and 
even among different bones within the same species. This variability is not well 
recognized, but is important for understanding specific diseases of bone growth in 
children, and the selection of appropriate animal models of such diseases (Ogden 
and Rosenberg, 1988). However, all growth plates have a common role in the 
endochondral ossification process as discussed earlier. The primary function of the 
growth plate is the longitudinal growth of bones although it also contributes 
significantly to circumferential expansion of the bone through the peripheral zone 
of Ranvier (Speer, 1982; Langenskiold, 1998). The growth plate can be divided 
into a series of anatomical zones that distinguish unique morphological and 
biochemical stages during the process of chondrocyte differentiation (Ballock and 
O’Keefe, 2003)(Fig. 1.5). 
 
1.3.2 Growth Plate Chondrocyte  
1.3.2.1 The Cell 
Chondrocytes, the characteristic cell of cartilage tissue, are easily recognized 
histologically. They have a specific shape and orientation (Buckwalter et al., 1985; 
Figure 1.5) embedded in the cavities of the extracellular matrix; the lacunae. The  
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Figure 1.4 Different zones of the growth plate (physis). (a) X-ray film of the 
proximal tibia of a  young male showing the growth plate location (arrow head), (b) 
schematic of bisected proximal tibial bone to show the gross appearance of a 
growth plate, (c) diagram of differentiating chondrocyte zones in the growth plate 
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Figure 1.5 A histological section highlighting the different cellular zones of the 
growth plate. Light microscopic appearance of growth plate showing part of 
reserve, proliferative, hypertrophic and provisional calcification zones, together 
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Figure 1.6 Microscopic image of hypertrophic growth plate chondrocytes. 
Left: A high power (2500x magnification) light microscopic view of hypertrophic 
chondrocytes from a proximal tibia of 7-day-old rat growth plate histological 
section fixed in 1.3% glutaraldehyde (GA) with 0.5% ruthenium hexamine 
trichloride (RHT) and stained with 0.1% Toluidine Blue O. Right: A projection of 
sequential confocal images of a rat growth plate showing fluorescently labeled 
(calcein) living in situ hypertrophic chondrocytes in proximal tibia. Bar=20 µm. 
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lacunae are completely filled by chondrocytes with the cell membranes directly 
attached to the proteoglycan-rich pericellular matrix along the whole lacunae 
surface (Hunziker et al, 1983; Oi and Utsumi, 1980; Figure 1.8). 
Identification of chondrocytes, in practice, often depends on recognizing their 
synthetic and secretory products such as collagen type II and the proteoglycan 
aggrecan. Typical chondrocytes are ovoid cells ranging in maximum diameter from 
10 µm in articular cartilage to about 30 µm in other hyaline cartilage (Stockwell, 
1978; Figure 1.6). With the electron microscope (ultrastructural level), the 
chondrocyte is seen to contain numerous profiles of rough-surfaced endoplasmic 
reticulum (rER), a large Golgi, secretory granules, vesicles, intermediate filaments, 
microtubules, and actin microfilaments, with the nucleus is eccentrically located. 
The large amount of rER and the extensive Golgi area indicative of a cell actively 
engaged in the production of cartilage matrix (Ross and Reith, 1985; Figures 1.7 & 
1.8). Mitochondria are common in young cells but rarer in old cells (later in the 
maturation stage), and glycogen and lipid are common inclusions. The chondrocyte 
is unique in its ability to synthesize greater amounts of chondroitin sulphate 
proteoglycans and collagen than almost any other cell type (Vaughan, 1981). 
Chondrocytes also express a characteristic genetic program driven by SOX9 and 
other transcription factors (Kronenberg, 2003). 
Two morphologically distinct types of chondrocytes coexisting in zones of 
proliferation and hypertrophy and are termed ‘light’ and ‘dark’ chondrocytes 
(Ahmed et al., 2007). Light chondrocytes are usually oval or round cells with a few 
thin cytoplasmic processes extending into the surrounding matrix; the cytoplasm 
contains sparse endoplasmic reticulum and an inconspicuous Golgi region. Dark 
chondrocytes are of an irregular shape with numerous dense cytoplasmic processes 
and vesicles budding from the cell surface; the cytoplasm contains well developed 
endoplasmic reticulum and a prominent Golgi zone consisting of numerous 
vacuoles filled with fibrillar material (Ahmed et al., 2007b). 
 
1.3.2.2 Plasma Membrane and Membrane Transporters 
The plasma membrane is a selectively permeable barrier between the cytoplasm 
and the extracellular environment (Figures 1.9 & 1.10). Its permeability properties 
ensure that essential molecules such as glucose, amino acids, and lipids readily 
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enter the cell, metabolic intermediates remain in the cell, and waste compounds 
leave the cell. The selective permeability of the plasma membrane, together with 
the roles of intracellular buffers and membrane transporters allows the cell to 
maintain a constant internal environment (Lodish et al., 1995).  
 A plasma membrane which is composed of a phospholipid alone is only 
slightly permeable to water (e.g. through aquaporin water channels; Verkman and 
Mitra, 2000) and is essentially impermeable to most water-soluble molecules, such 
as glucose, nucleosides, and amino acids, and to ions such as hydrogen, sodium, 
calcium, and potassium (Figure 1.10). Proteins spanning the phospholipid bilayer 
are required to transport such molecules and ions across all cellular membranes. 
Because different cell types have different requirements for these low-molecular-
weight compounds, the plasma membrane of each cell type contains a specific set 
of transport proteins that allow only certain ions or molecules to cross, as does the 
membrane surrounding each type of subcellular organelle. Figure 1.11 illustrates 
three major types of membrane transport proteins (Lodish et al., 1995). 
 
1.3.2.3 Chondron 
Chondrocytes encapsulate themselves in basket-like networks of fine fibrils of 
elaborate structure, each termed a chondron. These may be isolated intact and are 
found to contain one or several chondrocytes. Chondrons appear to be 
compression-resistant, meshwork that dampens mechanical, osmotic and physico-
chemical changes induced by dynamic loading. Their long axes are oriented 
parallel to the lines of force operating in situ (Muir, 1995). Immunolocalisation 
experiments show that chondrons contain several constituents, including types II, 
VI, and IX collagens (Muir, 1995). 
 
1.3.3 Chondrocyte Differentiation Zones 
The growth plate can be divided into various zones according to their morphology 
and function (Figures 1.4 & 1.5). Immediately next to the secondary ossification 
centre is the RZ (reserve zone), and adjacent to this are the proliferation and then 
the hypertrophic zones. The zone of growth is concerned with both longitudinal 
and diametric (latitudinal) expansion of a bone. It is the area where cellular 
addition and mitosis occur (Ogden and Rosenberg, 1988). The hypertrophic zone is  
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Figure 1.7 Ultra microscopic image of proliferative chondrocytes. Electron 
micrograph of proliferative chondrocytes from rat growth plate cartilage (35-day-
old; proximal tibia). Tissue was processed by high pressure freezing, freeze 
substitution, and low temperature embedding. Bar = 2µm. N, nucleus; G, Golgi; 
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Figure 1.8 Ultra microscopic image of a hypertrophic chondrocyte. Electron 
micrograph of a hypertrophic chondrocyte after standard RHT fixation. The cell 
membrane (M) is intact and attached to the pericellular matrix (P) along the whole 
surface. No lacunar space visible between the cell membrane surface and the 
pericellular wall, which will be evident in case of artefactual shrinkage of the 
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Figure 1.9 Cell membrane structure. (A) Electron micrograph of a human red-
cell plasma membrane. Cell membranes are 6 to 10 nm thick, too thin to be seen 
without the aid of an electron microscope. In an electron micrograph a membrane 
appears as ‘railroad track’ appearance at the cell surface - two dark lines separated 
by a light interspace. The dark lines correspond to the polar regions of the proteins 
and lipids, whereas the light interspace corresponds to the nonpolar regions of these 
molecules. (B) Arrangement of the proteins and lipids in the membrane. (C) 
Arrangement of integral and peripheral membrane proteins in association with a 
bimolecular layer of phospholipids. Dark-green areas indicate the polar regions of 
integral membrane proteins. After Vander et al. (1994).  
(C) 
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Figure 1.10 Plasma membrane phospholipid bilayer permeability.  A pure 
phospholipid bilayer is permeable to small hydrophobic molecules and small 
uncharged polar molecules. It is slightly permeable to water and impermeable to 
ions and to large uncharged polar molecules. When a small phospholipid bilayer 
separates two aqueous compartments, membrane permeability can be easily 
determined by adding a small amount of radioactive materials to one compartment 
and measuring its rate of appearance in the other compartment. After Lodish et al. 
(1995). 
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Figure 1.11 Membrane transport proteins. Schematic diagrams illustrating 
action of membrane transport proteins. (a) The three major types of transport 
proteins. Pumps utilize the energy of hydrolysis of a phosphoanhyride bond in ATP 
to power movement of specific ions (red circles) against their electrochemical 
gradient. (Gradients are indicated by triangles with the tip pointing towards lower 
concentration and/ or electrical potentials). Channels catalyze movement of 
specific ions (or water) down their electrochemical gradient. Transporters, which 
fall into three groups, facilitate movement of specific small molecules, such as 
glucose and amino acids (black circles) or of ions, such as Na+ and H+. (b) The 
three groups of transporters. Uniporters (also shown in part [a]) transport a single 
type of molecule down its concentration gradient. The movement of one molecule 
against its concentration gradient (black circles), driven by movement of one or 
more ions down an electrochemical gradient (red circles) is catalyzed by 
symporters and antiporters. These cotransport proteins differ in the relative 
direction of movement of the transported molecule and cotransported ion. After 
Lodish et al. (1995).  
) 
  Chapter 1: Introduction 
                                                                                                         Page  21  
sometimes subdivided into zones of maturation and provisional calcification 
(Revell, 1986). The easy identification of cells at each maturational stage in this 
lineage cascade makes the study of chondrocyte cell biology in vivo much easier 
than, say, that for osteoblasts or osteoclasts (Loveridge, 1999). 
1.3.3.1 Reserve Zone 
An alternative name given to the reserve zone is the ‘resting zone’, even though the 
cells at this level are not resting (Revell, 1986). They are spherical in shape and are 
present singly or in pairs. They are separated by more extracellular matrix than in 
other zones, and contain glycogen, more lipid and less alkaline, acid phosphatase 
and other enzymes than in the other zones (Kuhlman, 1960; Brighton et al., 1973). 
The chondrocytes show little or no proliferative activity, and the function of the RZ 
has not been clearly defined. Although commonly accepted that it serves as 
precursors for the flat proliferating columnar chondrocytes (Kronenberg, 2003), 
there was no direct evidence to support the idea that it provides a source of 
chondrocytes for the rest of the growth plate (Revell, 1986). However, growth plate 
organ culture studies showed recruitment of cells from the RZ to the proliferating 
zone under stimulation of certain hormone, e.g. thyroid hormone (1.4.2.1.2). In 
addition, a more recent study suggested that RZ cartilage makes important 
contributions to endochondral bone formation at the growth plate: i) contains stem-
like cells that give rise to clones of proliferative chondrocytes, ii) produces a 
growth plate-orienting factor (GPOF), a morphogen that directs the alignment of 
the proliferative clones into columns parallel to the long axis of the bone, and iii) 
may also produce a morphogen that inhibits terminal differentiation of nearby 
proliferative zone chondrocytes and thus may be partially responsible for the 
organization of the growth plate into distinct zones of proliferation and hypertrophy 
(Abad et al., 2002).  
The RZ cells are intimately associated with the epiphyseal blood vessels 
that supply this region. These small arterioles and capillaries may also be 
instrumental in providing undifferentiated cells from the perivascular regions that 
are subsequently added to the pool of RZ chondrocytes. Additional cells are also 
elaborated peripherally through a specialized area of the perichondrium, the zone 
of Ranvier (Ogden and Rosenberg, 1988). 
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With age, the growth plate undergoes programmed senescence, where 
longitudinal bone growth slows down and eventually stops. This process has been 
associated with the decrease in RZ chondrocytes proliferative capacity due to the 
loss of cell DNA methylation. This event could serve as a fundamental biological 
mechanism that determines the overall adult size of the organism (Nilsson et al., 
2005). 
1.3.3.2 Proliferation Zone 
The proliferative zone contains flattened cells arranged in longitudinal 
columns (Figures 1.4 & 1.5). The cells contain glycogen and have been shown by 
electron microscopy to have large amounts of endoplasmic reticulum which 
increases 3-fold from the beginning to the bottom of this zone (Brighton et al., 
1973; Fig. 1.7). Autoradiographic studies of tritiated thymidine incorporation have 
shown that the cartilage cells in the proliferative zone are the only ones that divide 
(Kember 1960). It is the topmost cell of each column which acts as the source of 
those lower down. Proliferation of cartilage cells is responsible for the increase in 
bone length but the cartilage columns themselves do not increase in length, being 
converted at their metaphyseal ends into bone (Revell, 1986) at the same rate as 
new cell production. In this zone of growth active cell division occurs principally 
in a longitudinal direction and leads to cell column formation (Ogden and 
Rosenberg, 1988).  
 
1.3.3.3 Hypertrophic Zone 
The next functional area is the zone of cartilage formation. Following proliferation, 
chondrocytes pass through a transition stage in which they are known as 
‘prehypertrophic’ chondrocytes (Mackie et al., 2008). These cells then undergo 
hypertrophy, a reflection of their increased metabolic activity (Ogden and 
Rosenberg, 1988), increasing their volume dramatically, at the same time 
remodeling old, and secreting new extracellular matrix, which eventually becomes 
mineralized (Mackie et al., 2008).  
 The flattened chondrocytes on the metaphyseal side of the cartilage 
columns are changed into large spherical cells in the hypertrophic zone (Figure 
1.8). The cells increase in size by twofold to seventyfold within this zone (Farnum 
et. al., 2008) in different growth plates, and lower down the cells lose the 
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intracytoplasmic glycogen which is present in the upper half of the hypertrophic 
zone (Brighton et al., 1969). There is a twofold to fivefold increase in the mean 
cellular surface area of rough endoplasmic reticulum, the Golgi membranes, and 
the mean cellular mitochondrial volume, which reflects a high metabolic activity of 
hypertrophic cells (Hunziker et al., 1987b). 
The hypertrophic chondrocyte, simply through its increase in size, is the 
principal engine of bone growth, and is also a master regulatory cell. Hypertrophic 
chondrocytes direct the mineralization of their surrounding matrix, attract blood 
vessels through the production of factors such notably vascular endothelial growth 
factor (VEGF), and attract chondroclasts (closely related or identical to osteoclasts, 
which are cells of the macrophage lineage that digest matrix) and direct adjacent 
perichondrial cells to become osteoblasts, which secrete a characteristic matrix and 
form the bone collar (Kronenberg, 2003). 
The last part of this zone is involved with cartilage transformation. The 
cartilaginous matrix (chondroid) is sufficiently calcified to allow vascular invasion 
by the metaphyseal sinusoidal loops. These vessels invade the hypertrophic cell 
columns by a breakdown of the transverse septa and provide cellular components 
for initial bone formation from the perivascular tissue. The osteoblasts elaborate 
osteoid matrix directly on the preformed longitudinal chondroid septa. This tissue 
is mineralized and forms the primary spongiosa (Ogden and Rosenberg; 1988) 
There is also progressively increasing vacuolation of the cells which is 
extensive at the bottom of the zone, where there is fragmentation of the cell 
membranes and of the nuclear envelope (Brighton 1978). Electron microscopy has 
demonstrated the presence of electron-dense granules in the mitochondria of 
growth plate chondrocytes, and these granules have been shown to contain calcium 
and phosphorus by X-ray spectroscopy (Sutfin et al., 1971). Chondrocytes at this 
level contain higher concentrations of lysosomal enzymes than at any other 
chondrocytes in the growth plate, which suggests that probably bring about 
degradation of of proteoglycans (Revell, 1986).  
The initial calcification which takes place in the growth plate occurs only in 
the longitudinal septa of the matrix. The septum becomes calcified by the growth 
and confluence of crystals in the bottom of the hypertrophic zone, hence is 
frequently called ‘the zone of provisional calcification’. Matrix vesicles are small 
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membrane limited extracellular structures distinguishable at the ultra structural 
level and produced by the chondrocytes. They occur in greatest concentration in the 
hypertrophic zone (Anderson 1969) and are considered to play a central role in the 
process of mineralization.  
 
1.3.3.4 Chondrocyte Death 
The fate of terminally differentiated hypertrophic chondrocyte is unclear. It is 
accepted however, that in order to compensate for the rapid chondrocyte 
proliferation and hypertrophy rates, the differentiated chondrocyte must be 
removed to maintain the steady-state thickness of the growth plate (Farquharson, 
2003). In growing rats it has been calculated that eight hypertrophic chondrocytes 
(including their associated matrices) are eliminated from each column of cells 
every day (Hunziker et al., 1987b). 
Hypertrophic chondrocytes then die, and as they do so, the transverse septa 
of cartilage matrix surrounding them are broken down, leaving vertical septa 
largely intact and allowing entry of the invading cells of the ossification front: 
blood vessels, osteoclasts (multinucleate bone-resorbing cells), and precursors of 
osteoblasts (bone-forming cells) and bone marrow cells (Mackie et al., 2008). The 
cartilage matrix left behind provides a scaffold for osteoblasts that invade the 
cartilage template along with blood vessels and lay down a true bone matrix within 
the primary spongiosa (Ogden and Rosenberg; 1988; Kronenberg, 2003). 
 The process by which hypertrophic chondrocytes die is currently the subject 
of debate. Many authors have described these cells as dying by apoptosis (as 
reviewed by Gibson, 1998; Adams & Shapiro, 2002), the programmed cell death 
that plays an important role in physiological cell removal, in particular during 
foetal development (Aigner, 2002). Apoptosis is characterized by distinctive 
morphological features, including intense condensation of chromatin into 
geometric shapes, and fragmentation of the nucleus and cytoplasm into membrane-
bound apoptotic bodies (Kerr et al., 1972). Many of the papers describing apoptosis 
of hypertrophic chondrocytes have done so on the basis of detection of DNA strand 
breaks or other molecular features known to be associated with apoptosis, rather 
than on the basis of the definitive morphology (Adams & Shapiro, 2002; Gibson, 
1998). On the basis of early ultrastructural studies and recent observations, 
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however, in a number of publications it has been argued strongly that the process 
by which hypertrophic chondrocytes die is morphologically distinct from apoptosis 
(Roach and Clarke, 1999, 2000; Colnot et al., 2001; Roach et al., 2004). Roach et 
al. (2004) proposed the term ‘chondroptosis’ to refer the non-classical apoptosis of 
chondrocyte, which results in ultimate self-destruction of the cell without the 
requirement of phagocytosis - therefore may be more advantageous for 
chondrocytes that are isolated within their lacunae.  
 Shapiro et al (2005) have put forward the hypothesis that hypertrophic 
chondrocytes die by autophagic cell death. Ahmed et al. (2007) have demonstrated 
that light and dark hypertrophic chondrocytes die by cell type-specific (non-
apoptotic) processes. Light cells appear to disintegrate within their cell membrane, 
whereas dark cells undergo progressive extrusion of cytoplasm into the 
extracellular space; for both cell types, nuclear condensation is late and irregular 
(Mackie et al., 2008). 
 
1.3.4 Extracellular Matrix 
Chondrocytes secrete an extracellular matrix that is composed mainly of collagen 
types II, IX and XI, with type X collagen specific to the hypertrophic zone. Non-
collagenous proteins also exist and include proteoglycans such as aggrecan and 
perlecan; cartilage oligomeric matrix protein (matrilins-1) and matrilins-3 (Aszodi 
et al., 2000; White and Wallis, 2001).  
 Although the matrix of articular, structural (such as nasal and costal 
cartilage), and growth plate cartilage appears histologically similar, the function of 
these different types of cartilage is quite dissimilar. Physeal cartilage serves a 
structural function as well as being responsible for bone growth through the 
process of endochondral ossification. Generally all types of cartilage matrix are 
comprised of approximately 50% water and 25% each proteoglycan and collagen 
(Sussman, 1998). However, matrix of hyaline cartilage that serves as the 
epiphyseal growth plate, or presents at the articular bone surface shows high degree 
of hydration, where 60-78 percent of the net weight is water (Ross and Reith, 
1985). The proteoglycan of cartilage exists as large aggregates that form a gel with 
water and gives cartilage its unique physical consistency. Proteoglycans exert a 
swelling pressure that is constantly restrained by the collagen network in which 
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they are entrapped (Muir, 1978). Most of the collagen is organised in a network of 
fibrils that provides additional structural stability to the cartilaginous matrix (van 
der Rest and Garrone, 1991; Figure.1.12).  
 Type II collagen is the major structural collagen in cartilage and comprises 
80% and 90% of the collagen therein. This collagen is distributed evenly 
throughout cartilage as collagen fibrils. Type IX collagen is an unusual disulphide-
linked collagen that has a proteoglycan-like domain and it is speculated that it may 
play a role in collagen-proteoglycan interactions (Sussman, 1998). Type X collagen 
appears to be unique to cartilage just prior to ossification and is found in the growth 
plate, foetal preosseus cartilage and fracture callus (Sussman, 1998). This 
distribution indicates that it has a significant role in the process of endochondral 
ossification. Grant et al. (1985) have demonstrated that this collagen is not 
synthesised in structural cartilage, and in the growth plate is only synthesised in 
significant quantities in the hypertrophic zones. Type XI collagen is a constituent 
of all cartilage fibrils and has been isolated and characterized by its unique 
solubility characteristics (Mendler et al., 1989). 
All of the matrix components of the growth plate including the collagens 
are synthesised by chondrocytes therein, and all chondrocytes are capable of 
synthesising any or all to these collagen types as well as the proteoglycans 
(Sussman, 1998).  
 What is the role of the extracellular matrix? Most certainly, the ability of 
chondrocytes to enlarge requires changes to occur in the composition and 
organization of the surrounding matrix. Matrix changes in the hypertrophic cell 
zone that have been investigated as possible mechanisms to promote and control an 
increase in cellular volume include the removal of calcium, increased degradation 
of proteoglycans, increased activity of collagenase, and decreased collagen content 
(Campo, 1988; Dean et al., 1992). 
 As chondrocytes increase in volume, the cell enlargement has to be 
constrained or otherwise regulated. Without such active regulation the initially 
flattened chondrocytes of the proliferative zone would become spherically shaped 
chondrocytes, and in normal growth plates, this is not the case. In normal animals, 
vertical hypertrophic chondrocyte expansion is at least five times that of horizontal 
expansion, leading to the conclusion that one of the roles of the cartilaginous 
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Figure 1.12 The extracellular environment of chondrocytes. The high numbers 
of fixed negative charges on the keratan sulphate (KS) and chondroitin sulphate 
(CS) of glycosaminoglycan (GAG) chains attracts mobile cations and leaves out 
mobile anions from the extracellular matrix of articular chondrocytes. After 
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matrix is to constrain the increase in cellular volume, directing expansion of the 
vertical diameters at the expense of the horizontal diameters (Breur et al., 1992). 
In addition, the extracellular matrix also has a significant impact on 
chondrocyte differentiation within the growth plate. For example, proteoglycans 
play an essential role in the binding and presentation of important signalling 
molecules such as fibroblast growth factor (FGFs) and Indian hedgehog (Ihh) to 
their receptors (White and Wallis, 2001). 
 
1.3.5 Ossification Groove and Perichondrial Ring  
The details of the structure of the growth plate given above are reasonably well 
recognised. The peripheral structures in this region are less so. The periphery of the 
growth plates is encircled by a wedge-shape groove of cells termed the ossification 
groove of Ranvier and a band of fibrous tissue and bone known as the 
perichondrial ring (Figure 1.4).  
 The ossification groove contains oval cells, which are considered to pass 
from the groove into the cartilage at the level of the RZ. It is thought that the 
function of the groove is to contribute chondrocytes to the growth plate for its 
increased diameter (Tonna 1961) by chondroblast precursors via appositional 
chondrogenesis (Shapiro et al. 1977).  
 The perichondrial ring is a dense fibrous band encircling the growth plate at 
the level of the bone-cartilage junction. It is continuous at one end with the group 
of fibroblasts and collagen fibres of the ossification groove and at the other end 
with the periosteum and metaphyseal subperiosteal bone. The perichondrial ring 
provides a mechanical support for the otherwise weak bone-cartilage junction of 
the growth plate (Shapiro et al. 1977)  
 
1.3.6 Chondro-osseous Junction and Metaphysis 
The metaphysis begins immediately distal to the last intact transverse septa at the 
bottom of the cartilage cell columns. The upper part of the metaphysis immediately 
adjacent to the growth plate shows the presence of small vessels invading the 
calcified cartilage. Plum and oval-shaped active osteoblasts are present in the upper 
part of this region and within a few cells show evidence of forming bone within 
and upon the calcified cartilage. The area of vascularised calcified cartilage is 
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sometimes termed the primary spongiosum while the area in which there is bone 
formed on the cartilage template is the secondary spongiosum (Revell, 1986).  
The initially formed woven bone of this region is replaced by lamellar bone 
in the process of internal remodelling. Osteoclasts/ chondroclasts are present within 
the metaphysis, resorbing both calcified cartilage and the lamellar bone in the 
remodelling process. They are also present at the perisoteal surface of the 
metaphysis, where they are responsible for the external remodelling which results 
in the narrowing of the bone at the diaphyseal region (Revell, 1986). The 
differentiating osteoblasts use the remnants of cartilage matrix after removal by 
osteoclasts as a scaffold for the deposition of bone matrix (Mackie et al., 2008). 
 
1.4 Longitudinal Bone Growth 
 
1.4.1 The Longitudinal Growth Process 
The mechanisms of long bone growth are similar across many animal species. They 
are, however, major variations in the growth rate between similar bones of different 
species, bones of an individual animal and the two growing regions (growth plates) 
of the same bone (Farquharson, 2003).  
Endochondral ossification of the embryonic cartilaginous model of most 
bones contributes to longitudinal growth (Mackie et al., 2008). Bone lengthening, 
particularly rapid during foetal life, is driven primarily by the rate of production of 
hypertrophic chondrocytes from these proliferating chondrocytes (Kronenberg, 
2003). 
During this process, the epiphyseal growth plate undergoes morphogenesis. 
A region of resting chondrocytes differentiates into a zone of proliferating 
chondrocytes that then hypertrophies and finally undergoes cell death, while being 
replaced by bone. The net result is lengthening of the bone, while the thickness of 
the growth plate remains relatively constant. Such a sequence of events relies on 
the precise coupling of chondrogenesis (cartilage production) with osteogenesis 
(bone formation). During this process, blood vessel invasion from the metaphysis 
coincides with mineralization of the extracellular matrix (ECM), apoptosis of 
hypertrophic chondrocytes, ECM degradation and bone formation (Gerber et al., 
1999; Blair et al., 2002). The sequential changes in chondrocyte dynamics are 
tightly regulated by both systemic factors and locally (autocrine/ paracrine) 
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secreted factors, which act on receptors to affect intracellular signalling and 
activation of chondrocyte-selective transcription factors (Mackie et al., 2008).  
 
1.4.2 The Regulatory Process  
Longitudinal growth of long bones depends on the precise coordination, both 
temporally and spatially, of a multitude of processes (Roach et al., 2003). Overall 
longitudinal bone growth is governed by a complex network of endocrine signals, 
including growth hormone (GH), insulin-like growth factor I (IGF-I), 
glucocorticoid (GC), thyroid hormone, sex steroids, vitamin D, and leptin. Many of 
these signals regulate growth plate function, both by acting locally on growth plate 
chondrocytes and also indirectly by modulating other endocrine signals in the 
network. Some of the local effects of hormones are mediated by changes in 
paracrine factors that control chondrocyte proliferation and differentiation. Many 
human skeletal growth disorders are caused by abnormalities in the endocrine 
regulation of the growth plate (Nilsson et al., 2005). 
 
1.4.2.1 Systemic (Hormonal) Regulation  
The major systemic hormones that regulate longitudinal bone growth during 
childhood are GH and IGF-I, thyroid hormone (T3 and T4), and GC, whereas 
during puberty the sex steroids (androgens and oestrogens) contribute a great deal 
to this process (van der Eerden et al., 2003).  
 
1.4.2.1.1 GH-IGF-I System 
There are two possible mechanisms that explain the dependent functions between 
GH and IGF-I axis on bone growth. First, GH stimulates growth at the epiphysis by 
systemically derived liver IGF-I, and second, besides that GH acts on RZ 
precursors of the GP to stimulate the differentiation of chondrocytes and then 
amplifies local IGF-I synthesis, which, in turn, induces the clonal expansion of 
chondrocyte columns and hypertrophy in an autocrine/ paracrine manner (Ahmed 
and Farquharson, 2010).  
 The relative contributions of GH and IGF-I to pre- and postnatal bone 
growth have been examined through growth analysis of various transgenic mouse 
lines (Baker et al., 1993; Lupu et al. 2001). Before birth, IGF-I and -II are believed 
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to be the key regulators of growth, and largely independent of GH (Woods et al., 
1996). After birth, GH is an important modulator of longitudinal bone growth and 
appears, together with IGF-I, the central player of the hypothalamus-pituitary-
growth plate axis. GH secretion from the pituitary is tightly controlled by the 
activity of GHRH (stimulator) and somatostatin (inhibitor), which are released by 
the hypothalamus (van der Eerden et al., 2003).  
 In brief, IGF-I signalling is considered to be GH independent at prenatal 
age, whereas IGF-I is partly or fully GH dependent for post natal bone growth. 
However, the possibility of GH and IGF-I have both independent and common 
functions (Lupu et al. 2001, Wu et al. 2009) could not be ruled out and this was 
especially predominant in the GP chondrocytes (Lupu et al. 2001). 
 Prepubertal growth is primarily regulated by GH and IGF-I, with important 
contributions from GC and thyroid hormone (Siebler et al., 2001). 
1.4.2.1.2 Thyroid Hormone 
Besides GH, T3 and, to a lesser extent, its precursor T4 are crucial for normal bone 
maturation (Stevens and Williams, 1999). Both congenital hypothyroidism and T3 
deficiency are associated with severe growth retardation in rodents and humans. 
Hyperthyroidism causes an increased growth velocity in children but also leads to 
premature growth plate fusion and short stature (van der Eerden et al., 2003). 
T3 functions to stimulate the recruitment of cells to the proliferating zone 
from the germinal (reserve) zone and facilitate the differentiation of growth plate 
chondrocytes in embryonic avian cartilage organ culture, and in rat mandibular 
condyle and femur organ cultures (Burch and Wyk, 1987; Wakita et al., 1998). 
Recent data have confirmed that T4 induces the expression of both type II and X 
collagen, the activity of the differentiation marker alkaline phosphatase, and 
chondrocyte hypertrophy (Okubo and Reddi, 2003). Besides influencing GH 
secretion, thyroid hormones have been shown to interact with the GH-IGF-I 
pathway at the level of the growth plate. In short, thyroid hormones act through 
chondrocytes bearing thyroid hormone receptors to modulate growth plate 
proliferation, differentiation, and vascular invasion. Part of these effects appear to 
be mediated by modulating local GH and/or IGF-I actions (van der Eerden et al., 
2003). 
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1.4.2.1.3. Glucocorticoids 
Various clinical conditions, such as juvenile rheumatoid arthritis, chronic asthma, 
and post renal transplantation, require prolonged GC therapy, leading among other 
phenomena to decreased bone volume and growth retardation. Dexamethasone, a 
synthetic GC inhibits chondrocyte proliferation and matrix synthesis, suggesting 
that GC is a potent negative regulator of chondrogenesis (van der Eerden et al., 
2003).  
A few studies have localized the GC receptor (GR) in rat bone cells, 
including chondrocytes (van der Eerden et al., 2003), and in human growth plates, 
especially in hypertrophic chondrocytes, suggesting direct effects of GC on the 
growth plate (Abu et al., 2000). GR was demonstrated in the proliferating and 
hypertrophic zone of rat growth plates, and treatment with high doses of 
corticosterone in rats resulted in a reduced growth plate width in long bones, 
concomitant with growth retardation (Siverstrini et al., 2000). These findings are 
most likely explained by reduced chondrocyte proliferation, in combination with 
increased apoptosis in terminal hypertrophic chondrocytes (Chrysis et al., 2003). 
GC has also been shown to suppress growth by impairing the IGF system. GC 
treatment significantly decreased the number of growth plate chondrocytes 
expressing IGF-I, which could contribute to the GC-induced growth retardation 
(Smink et al., 2003).  
GC is also capable of modulating (local) thyroid hormone levels (Miura et 
al., 2002). Apparently, GC causes growth retardation, not only through direct 
effects via the GR but also by interference with other growth-modulating pathways. 
 
1.4.2.1.4 Oestrogens 
It has long been established that sex steroids are important for longitudinal growth, 
especially during puberty (van der Eerden et al., 2003). Previous studied have led 
to the assumption that in both males and females, oestrogen is the main 
determinant for the puberty-associated phenomena related to longitudinal growth 
and bone quality (Juul, 2001). Oestrogen is also the principal driver of growth plate 
closure in both genders (Weise et al., 2001). Disruptive mutations of the genes for 
the ER in males and females have been shown to cause the delay in the GP fusion 
(Smith et al., 1994; Carani et al., 1997). The presence of ER in prepubertal children 
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re-emphasises the essential role of oestrogen in skeletal maturation process 
(Egerbacher et al., 2002). In addition, immunofluorescent study showed the ER 
was detected in matured GP age in species that shows GP fusion at puberty such as 




The androgen receptor (AR) has been localized to hypertrophic chondrocytes of the 
human tibiae (Abu et al., 1997). AR mRNA and protein were also expressed in the 
tibial growth plate of the rat (van der Eerden et al., 2002). The differences in 
subcellular AR expression between males and females around sexual maturation 
suggests a role for testosterone in establishing sex differences in longitudinal 
growth during sexual maturation, which account for some skeletal differences 
between males and females (van der Eerden et al., 2003). 
 
1.4.2.1.6. Vitamin D 
In growing mammals, vitamin D deficiency produces a constellation of skeletal 
abnormalities known as rickets, a classic metabolic bone disease of humans and 
animals (Dittmer and Thompson, 2010). The width of the hypertrophic zone of the 
growth plate is increased and mineralization is defective in mice lacking the 
vitamin D receptor. In these mice there is decreased apoptosis of hypertrophic 
chondrocytes at the metaphyseal ends of the columns and delayed invasion by 
blood vessels and bone cells (Donohue and Demay, 2002)  
 The growth plate effects of vitamin D may be mediated primarily through 
the vitamin D receptor expressed in intestinal epithelial cells, leading to increased 
calcium and phosphate absorption from the intestinal lumen. Vitamin D 
metabolites, however, may also act directly on the growth plate. 24R,25-
dihydroxycholecalciferol (24,25(OH)2D3) injected directly into rachitic chick 
growth plates resulted in healing (Lidor et al., 1987). In vitro, the 24,25-
dihydroxyvitamin D3 stimulates differentiation but decreases proliferation in RZ 
cells, while 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) decreases proliferation in 
reserve and proliferative zones (Boyan et al., 2002). 
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1.4.2.1.7. Leptin 
Leptin, a protein secreted primarily by white adipose tissue, regulates food intake 
and body weight. Because circulating leptin levels are increased in obesity, it has 
been hypothesized that leptin might contribute to the robust linear growth that 
occurs in obese children, despite low GH levels (Vignolo et al., 1988). 
Consistent with this hypothesis, leptin deficiency in mice impairs 
longitudinal bone growth, while treatment of these mice with leptin injections 
increased the rate of bone growth (Steppan et al., 2000). In organ cultures of 
mandibular condyle, a model of endochondral ossification, chondrocytes were 
found to contain specifiic binding sites for leptin (Maor et al., 2002), and leptin, at 
high concentrations, was found to stimulate chondrocyte proliferation and 
differentiation as well as IGF-I-receptor expression. The presence of the leptin 
receptor was also reported in primary cultures of rabbit chondrocytes (Nakajima et 
al., 2003). Taken together, these lines of evidence suggest that leptin may have a 
direct effect on chondrocytes in addition to its indirect effects, exerted through its 
ability to regulate appetite, energy metabolism, and endocrine systems.  
The systemic regulators of longitudinal bone growth are summarized in Figure 
1.13. 
 
1.4.2.2 Local Regulation  
The most important locally acting growth factors influencing longitudinal growth 
are Indian hedgehog (Ihh), parathyroid hormone-related peptide (PTHrP), 
Fibroblast growth factors (FGFs), bone morphogenetic proteins (BMPs), and 
vascular endothelial growth factor (VEGF)(van der Eerden et al., 2003). The 
summary of the local regulators of longitudinal bone growth are shown in Figure 
1.14. IGF-I as described above acts in a systemic manner through synthesis in the 
liver under GH stimulation. However, IGF-I also has local effects on most tissues 
including the growth plate and bone growth (Isgaard et al., 1986; Mushtaq et al., 
2004; Stratikopoulos et al., 2008). 
 
1.4.2.2.1 Indian Hedgehog  
Ihh belongs to the family of hedgehog proteins, which are morphogens that play 
crucial roles in embryonic patterning and development. Ihh is expressed by 
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prehypertrophic chondrocytes of chicken and mouse foetal long bones (Vortkamp 
et al., 1998). Ihh has been recognized as a regulator of the pace of chondrocyte 
differentiation. Ihh acts as a coordinator of endochondral ossification, regulating 
chondrocyte proliferation and differentiation and osteoblast differentiation, and 
coupling chondrogenesis to osteogenesis (Karp et al., 2000). Chondrocyte 
proliferation is maintained via the Ihh/PTHrP feedback loop (see section 1.4.2.2.2 
below) and any interference with this loop results in stunted patterns of bone 
growth (Wallis, 1996). 
 
1.4.2.2.2 PTH-related Peptide 
PTHrP pharmacological actions are closely similar to those of parathyroid (PTH). 
PTH and PTHrP bind to the same receptor (PTH/PTHrP-R), however a second 
receptor has been identified that binds only PTH (Segre et al., 1997). The crucial 
role of PTHrP and the PTH/PTHrP receptor in embryonic bone formation and 
longitudinal growth was recognized in a number of studies (van der Eerdeen et al., 
2003). PTHrP is expressed abundantly in the embryonic periarticular 
perichondrium in mouse (Karperien et al., 1996). Its receptor at that stage is 
detected in late proliferating and early hypertrophic chondrocytes (Karperien et al., 
1994). 
 The natural functions of PTHrP are best illustrated by PTHrP(-/-) mutant 
mice. These mice die at birth, and they manifest abnormalities in their 
endochondral bone development that all can be attributed to accelerated bone 
differentiation. In these growth plates, the zone of proliferating cells is markedly 
reduced, the onset of cell hypertrophy, matrix mineralization, and chondrocyte 
apoptosis is more advanced compared with wild–type mice. This observation 
suggests that PTH/PTHrP-R mediates the actions of PTHrP during chondrocyte 
differentiation and PTH/PTHrP receptor must respond to more than just foetal 
PTHrP during early development (Segre et al., 1997). 
 PTHrP together with Ihh form a feedback loop that regulates the pace of 
cartilage differentiation (Figure 1.14). During bone growth, chondrocytes 
differentiate from proliferating chondrocytes through an intermediate 
prehypertrophic cell type to become hypertrophic chondrocytes. Prehypertrophic 
chondrocytes express both PTH/PTHrP-R and Ihh. PTH/PTHrP-R is expressed in 
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cells just before the onset of Ihh expression. A target of the secreted Ihh signal is 
the perichondrium, which responds by directly or indirectly increasing expression 
of PTHrP in the periarticular perichondrium. PTHrP then signals through the 
PTH/PTHrP receptor in the prehypertrophic cells and prevents differentiation to the 
prehypertrophic phenotype. When the prehypertrophic chondrocytes have fully 
differentiated into hypertrophic cells, Ihh expression ceases. The reduction in Ihh 
expression attenuates the negative feedback loop and allows new cells to initiate 
the differentiation pathway. The level of Ihh produced by the prehypertrophic 
chondrocytes, therefore, reflects the number of cells committed to the hypertrophic 
pathway, providing a mechanism for regulating the rate of chondrocyte 
hypertrophy (Segre et al., 1997). 
 
1.4.2.2.3 Fibroblast Growth Factors 
The family of FGFs constitutes at least 22 members that interact with at least four 
receptors (FGFR) and are major regulators of embryonic bone development (Ornitz 
and Itoh, 2001; Ornitz and Marie, 2002). Unique expression patterns of FGFRs 
have been identified in the growth plate. Both FGF-1 and -2 as well as FGF 
receptors, FGFR-1, -2, and -3, are expressed in chondrocytes (Jingushi et al., 1995; 
Leach et al., 1997; Hamada et al., 1999).  
FGFR3 is expressed in the epiphyseal growth plate and is most highly 
expressed by proliferating and prehypertrophic chondrocyte. This expression 
pattern suggests a direct role for FGFR3 in regulating chondrocyte proliferation 
and possibly differentiation. In contrast, FGFR1 is prominently expressed in 
hypertrophic chondrocytes (Delezoide et al., 1998), suggesting a role for FGFR1 in 
maintaining the hypertrophic phenotype of these cells (cell survival), in regulating 
the production of unique extracellular matrix products of hypertrophic 
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Figure 1.13 The endocrine signals that regulates longitudinal bone growth. 
Arrows indicate direct action on the growth plate and indirect action by modulating 
other endocrine signals. + = Stimulatory effect; – = inhibitory effect. After Nilsson 
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Figure 1.14 The local regulation of longitudinal bone growth. Interaction of Ihh, 
PTHrP, BMP, and FGF signaling in modulating chondrocyte proliferation and 
differentiation during prenatal endochondral bone formation. Ihh is expressed by 
chondrocytes making the transition from a proliferating into a hypertrophic 
phenotype. Expression of Ihh at this stage is up-regulated by BMPs but inhibited 
by FGFs. Ihh activates adjacent chondrocytes and diffuses toward the lateral 
perichondrium, where it can bind to its receptor patched. Via an as yet unknown 
mechanism, PTHrP production is stimulated in the periarticular perichondrium. 
Then, PTHrP diffuses toward the prehypertrophic zone, which expresses high 
levels of PTH/PTHrP receptors and inhibits the differentiation of proliferating 
chondrocytes to cells capable of synthesizing Ihh. Besides modulating chondrocyte 
differentiation, Ihh also stimulates chondrocyte proliferation, both directly and 
indirectly (through BMP signaling). FGFs are able to inhibit chondrocyte 
proliferation independently of the two stimulatory pathways. BMP signaling 
inhibits terminal differentiation of chondrocytes, a process that FGFs can promote. 
The balance between BMP and FGF signaling seems to be crucial in regulating 
proliferation, Ihh expression, and terminal differentiation of chondrocytes. After 
van der Eerdeen et al. (2003). 
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1.4.2.2.4 Bone Morphogenetic Proteins/ Transforming Growth Factor  
The family of BMPs is comprised of at least 15 members, which are all part of the 
TGF superfamily. BMPs were originally identified as stimulators of bone 
formation but are now recognized as important regulators of growth, 
differentiation, and morphogenesis during embryology (Reddi, 2001). Within the 
developing limb cartilage elements, BMP2, -4, and -7 have been detected in the 
perichondrium, whereas BMP6 was found in prehypertrophic and hypertrophic 
chondrocytes (Lyons et al., 1989; Lyons et al., 1990; Jones et al., 1991; Macias et 
al., 1997; Haaijman et al., 1999; Grimsrud et al., 1999). In addition, BMP7 was 
detected in chick sternal prehypertrophic and murine metatarsal proliferating 
chondrocytes (Haaijman et al., 1999; Grimsrud et al., 1999). 
 
1.4.2.2.5 Vascular Endothelial Growth Factor 
VEGF is a chemoattractant for endothelial cells and is one of the most important 
growth factors for endothelial cells (Ferrara and Davis-Smyth, 1997). Hypertrophic 
chondrocytes in the epiphyseal growth plate express VEGF. VEGF is an essential 
coordinator of chondrocyte death, chondroclast function, extracellular matrix 
remodelling, angiogenesis and bone formation at the growth plate (Gerber et al., 
1999). 
 
1.4.2.3 Systemic and Paracrine Regulatory Interactions 
There is an increasing body of evidence suggesting interactions between endocrine 
and local factors within the growth plate to control bone growth. Receptors for GH, 
T3/T4, GC, oestrogens, and androgens have all been localised to growth plates in 
various species, indicating that most hormones can have direct effects on processes 
in the growth plate after birth. These actions maybe either direct or act via the 
expression of locally acting growth factors, such as Ihh, PTHrP, BMPs, FGFs, and 
VEGF (van der Eerden et al., 2003). 
 
1.5 Clinical importance of Growth Plate: Longitudinal Bone Growth 
Disorders 
From the review above it is clear that longitudinal bone growth is dependent upon 
normal growth plate function and endochondral ossification; regulated by a 
complex interaction of molecular signals acting systemically as well as locally 
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within the growth plate. This network is often dysregulated during chronic illnesses 
and this results in impaired chondrogenesis and, in turn, growth failure (De Luca, 
2006).  
Mutations in the genes are involved in the regulation of various stages of 
the chondrocyte proliferation and differentiation process have also been implicated 
in human growth plate disorders, resulting in skeletal dysplasias and short stature. 
For example, mutations involving most of the ECM encoding genes have been 
shown to cause heritable disorders of skeletal morphology and growth, a family 
disorders called “chondrodysplasias” (Aszodi et al., 2000). In addition, 
abnormalities of collagen have been demonstrated to be responsible for aberrations 
of growth in certain hereditary chondrodystrophies, and it is likely that many, if not 
all, of these heritable disorders will ultimately be described on the basis of their 
underlying biochemical defect (Sussman, 1998). To date, there are over three 
hundred well defined disorders of skeletal growth and development. 
Achondroplasia and osteogenesis imperfecta are among the most common skeletal 
dysplasias, while others are less common (Phornphutkul and Gruppuso, 2009). 
Primary growth arrest can also be caused by direct physical injury to the 
epiphyseal growth plate such as physeal fracture, deleterious effects of 
chemotherapy, certain types of infection (particularly meningococcal septicaemia), 
neurological disease, burns, juvenile chronic arthritis, uraemia, intoxication 
(vitamins A, C, D and heavy metals)  as well as endocrine disease and malnutrition 
(Bush et al 2008a). 
Skeletal problems within the livestock industry also have a great potential 
impact on both welfare and economic issues (Loveridge, 1999). In particular, 
poultry production (meat type and egg laying birds) has a long association with 
skeletal problems which pose a major animal welfare issue (Fleming et al., 2006) 
and represent a substantial direct cost to the poultry industry (Bennett et al., 1999) 
due to economic loss from culling, death or carcass condemnations and 
downgrading at slaughter (Riddell, 1980; Robinson et al., 1992; Thorp, 1994). In 
the US alone, skeletal deformities cost the broiler industry an estimated $120 
million per year (Cook, 2000). 
Whatever the aetiological inputs that brings about these skeletal growth 
disorders, the ultimate effect on the activity of the growth plate and structural 
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integrity must be controlled by the component cells and the signals which they 
receive. Hence, a better understanding of chondrocytes and their mechanisms of 
growth regulation will help to determine the causes of disease or malfunction of the 
growth plate (Bush et al., 2008a). However, our understanding of the cell biology 
of the growth plate, its regulation under normal conditions, and how these can be 
influenced in clinical practice is still at an elementary stage (Bush et al., 2008a). 
In order to understand pathophysiology changes of the aforementioned 
growth plate disorders, the knowledge of normal growth plate cellular 
mechanism(s) essential for longitudinal bone growth is needed. In particular, a 
focus on new insights into the normal process which underpin the cell enlargement 
of growth-plate chondrocytes, will allow us to develop a more biologically oriented 
approach to address problems associated with growth plate disorders and the 
control of endochondral ossification in the future. 
 
1.6 Growth Plate Chondrocyte Hypertrophy and Longitudinal Bone 
Growth 
Growth can be defined as hypertrophy or hyperplasia at the tissue or cellular level 
(Goss, 1978). Cell hypertrophy usually refers to an increase in cell size and volume 
associated with an increase in organelles (Buckwalter et al., 1986). Hyperplasia 
refers to an increased number of a certain type of cells in a given organ or tissue 
than is ordinarily observed (Ouyang et al., 2011). Both cellular mechanisms are 
active in the growth plate (Van Sickle, 1985). A study of the growth plate of the rat 
proximal tibia showed the volume of the growth plate chondrocyte (GPC) 
increased up to 10-fold from proliferative (~1790µm3) to hypertrophic zone 
(~17400µm3) (Hunziker et al., 1987b).  
The rate of longitudinal bone growth is controlled at several levels. Namely 
the number of proliferative and hypertrophic zone cells, the rate of division of 
proliferative chondrocytes, chondrocyte ECM synthesis, the rate of volume 
increase of the hypertrophic zone cells and the final volume attained by these cells 
(Thorngren and Hansson, 1973; Hunziker, 1994; Wilsman et al. 1996b). In the 
proximal tibial growth plate of a 4-week old rat, 9% of growth was contributed by 
proliferation, 32% by matrix synthesis, and 59% by chondrocyte enlargement 
(Wilsman et al. 1996b; Figure 1.15). The cell volume increases at the later stage of  
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Figure 1.15 Differential growth by growth plates. Relative contributions to daily 
total elongation at the chondro-osseous junction are shown by longitudinal growth 
rate of the proximal and distal of radial and tibial growth plates of 28-day-old rats. 
The elongation fractions contributed by the hypertrophic and proliferative zones of 
the growth plates, via cell duplication, matrix synthesis and cell enlargement are also 
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GPC differentiation has also been shown to be the main determinant of the rate of 
bone elongation in proximal and distal radial and tibia growth plates of rat and 
swine (Breur et al., 1991). 
 
1.7. Regulatory Volume Transporters and Chondrocyte Enlargement 
The role of membrane transporters is indispensable in virtually all cellular 
functions of normal and pathological processes. Their roles, amongst others, 
involve acid-base homeostasis, ionic conductance, pH and cell volume regulation, 
cell growth and proliferation, intestinal absorption, cell death, and gene expression 
(Mahnensmith and Aronson; 1985; Seifter and Aronson, 1986; Yannoukakos et al., 
1994; Orlowski and Grinstein, 1997; Khaled et al., 1999; de Congilani et al., 2001; 
Alrefai et al., 2001; Nakamura, et al., 2005; Zachos, et al, 2005; Bernardo et al., 
2006; Malo and Fliegel, 2006). 
Cell volume regulation is one of the most fundamental homeostatic 
mechanisms and essential for normal cellular function. At the same time, however, 
many physiological mechanisms are associated with regulatory changes in cell size 
(Stuzin and Hoffmann, 2006). The necessity to rapidly regulate volume after 
shrinkage or swelling is obvious in cells from lower organisms, which are 
continually exposed to osmotic stress. Yet, in mammals, where osmolarity of the 
internal milieu is carefully regulated, cells also exhibit rapid volume regulatory 
responses (O’Neill, 1999).  
Volume-regulatory pathways in mammalian cells are not merely a vestige 
that has no significant physiological role. Mammalian cells are still subject to 
volume changes, despite a relatively constant osmolarity. Furthermore, even if cell 
volume were not threatened, mechanisms are still needed to alter cell volume, such 
as during hypertrophy and atrophy, apoptosis, and differentiation. Thus mammalian 
cells clearly require volume-regulatory mechanisms, despite their relatively 
isosmotic existence. Although the principal volume regulatory transporters have 
been identified and characterized, their activation by changes in cell volume is 
poorly understood and their physiological role is largely unexplored (O’Neill, 
1999). 
To avoid excessive alterations to cell volume, cells have developed and 
utilize a multitude of volume regulatory mechanisms including transport across the 
cell membrane and metabolism. These mechanisms are triggered by minute 
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alterations of cell volume. They not only serve to readjust cell volume but 
profoundly modify a wide variety of cellular functions. Thus cell volume is an 
integral element within the cellular machinery regulating cellular performance 
(Lang et al., 1998). 
The cells ability to extrude Cl- (coupled with extrusion of Na+ by the Na+-
K+ pump) appears to be the principal mechanism that maintains steady-state cell 
volume. However, additional mechanisms required by cells to correct acute 
deviations in their volume are termed regulatory volume increase (RVI) and 
regulatory volume decrease (RVD) adaptations and occur through activation of 
specific transporters in the plasma membrane that mediate net fluxes of osmotically 
active ions and molecules and therefore water (O’Neill, 1999). 
Clearly, cell volume regulation is under a tight and dynamic control and 
abnormal cell volume regulation will ultimately lead to severe cellular dysfunction, 
including alterations in cell proliferation and cell death (Stuzin and Hoffmann, 
2006). Figure 1.16 provides an overview of various membrane transporters 
involved in cell volume regulation. 
Articular and growth plate chondrocytes share at least one feature in 
common. They lie isolated and embedded within a matrix, which has no capillary 
blood supply and the cells are nourished by dissolved substances diffusing through 
the intercellular substance (cartilage matrix) that surrounds them (Vaughan, 1981; 
Wilkins et al., 2000; Serrat et al., 2009). Therefore, chondrocytes, must possess 
effective membrane transport systems to counter this limitation and other related 
shortcomings caused by their remoteness from the vasculature. Cellular volume, 
pH and [Ca2+] control are three parameters which are highly relevant in the context 
of the extracellular environment experienced by these cells (Wilkins et al., 2000). 
Cell volume regulatory function in articular chondrocyte is particularly important 
because they are constantly experiencing changes in their osmotic environment at 
least in two circumstances (Hall et al., 1996a): (a) during static loading, when fluid 
expression raises the hydrostatic pressure of the interstitial fluid (Urban, 1994) and 
(b) in the initial stages of osteoarthrosis, when tissue swelling is the first detectable 
change of the disease process (Stockwell, 1991). Therefore the cellular volume 
homeostasis via cell membrane transport systems is fundamental to the 
maintenance of the articular cartilage integrity in general. 
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 Regulatory transport systems involved in the articular chondrocyte cellular 
volume control have been reviewed by Hall et al. (1996a) and Wilkins et al. 
(2000). Volume regulatory functions of chondrocytes have been demonstrated and 
measured in living porcine articular chondrocytes explants (Errington and Hall, 
1995; Errington et al., 1997) using confocal microscopy. A study on freshly 
isolated bovine articular chondrocytes suggested that the cells possess volume 
regulatory capacity (Hall, 1995), and despite the rigid nature of cartilage, in situ 
articular chondrocytes were osmotically sensitive within the extracellular matrix. In 
addition, the chondrocytes also possess a variety K+ transport pathways sensitive to 
cell volume that are similar to those found in other cell types (Hall et al., 1996b). 
The RVD capacity has been shown in in situ bovine articular chondrocytes and the 
RVD function remained intact in the isolated cells (Bush and Hall, 2001a; Hall and 
Bush, 2001). The main pathway involved in RVD in chondrocytes appears to be a 
volume-activated 'osmolyte' channel, which has some of the characteristics of 
similar channels in other cell types (Hall et al., 1996a; Figure 1.16). 
The RVI function was also shown in both the isolated and in situ  bovine 
articular chondrocytes (Bush and Hall, 2001b), but in only limited capacity with a 
possible role of the cytoskeletal integrity in regulating the RVI activity, which 
appears to be mediated principally by the Na+-K+-2Cl- cotransporter (Kerrigan et 
al., 2006). In short, the Na+/K+ pump and Na+-K+-2Cl- cotransporter are specific 
transporters which play a key role in articular chondrocyte ion transport and hence 
in the regulation of intracellular ionic/osmotic composition (Hall et al., 1996a,b). 
In the growth plate, chondrocyte volume increase is a crucial event during 
endochondral ossification and bone lengthening (Wilsman et al., 1996). 
Morphometric analyses of electron micrographs on adult mice tibial GPs showed 
that GPC enlargement process was primarily the swelling of the cytoplasm and 
nucleus although the synthesis of organelles also contributes to the cell 
enlargement (Buckwalter et al., 1986). The increase in the chondrocyte volume 
was reasonably achieved by transportation of fluid following active solute 
movement across the plasma membrane into the intracellular space (Hunziker et 
al., 1987b). 
However, based on searches of the relevant topics documented in current 
literatures hitherto, our knowledge of the growth plate cellular volume regulatory  
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Figure 1.16 Transporters involved in cell volume regulation. The arrows show 
the usual direction of net flow, but many of the transporters (Na, K, 2Cl 
cotransporter; K-Cl cotransporter; K channels) operate in either direction 
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transporters is meagre. Transport of metabolites and regulation of pHi also remain 
largely uncharacterized for the growth plate chondrocyte. 
 
Contrary to RVI volume recovery after cell shrinkage that returns a cell to 
its original volume, the growth plate chondrocytes require a coordinated and 
continual volume increase as they progress from proliferative chondrocyte (PZC) 
to terminal hypertrophic chondrocyte (HZC) phenotypes. Increased activity of 
membrane transporters may be able to drive the persistent cell enlargement (Bush 
et al., 2010). In addition, the membrane transporters which normally prevent cell 
swelling are essentially suppressed; otherwise the increase in volume will be 
compromised (Bush et al., 2006a). 
An increase in the cell volume can be explained by classical “hypertrophy” 
(see section 1.6) and/or by “swelling” mechanisms (Bush et al., 2008a, b; 
Buckwalter et al., 1986). A study by Buckwalter et al. (1986) suggested that 
hypertrophic chondrocyte formation was primarily caused by swelling mechanism. 
Cell swelling involves cytoplasmic and nuclear enlargement via accumulation of 
fluid in the cell (Buckwalter et al., 1986). However, an osmotic sensitivity study 
showed no difference between the osmotic sensitivity of PZC and HZC, suggesting 
a ‘‘hypertrophic’’ rather than ‘‘swelling’’ mechanism being responsible for cell 
volume increase (Bush et al., 2008b). In other words, the total volume increase is 
not predominantly brought about by swelling but instead by an increase in non-
osmotically active cellular ‘‘dry matter’’. This suggests that cell volume increase 
by hypertrophy has a greater role in cell enlargement than swelling, and is a main 
mechanism responsible for growth plate chondrocyte volume increase and hence 
bone elongation (Bush et al., 2008a, b). 
However, hypertrophy demands an increased movement of osmotically 
inactive structures (e.g., amino acids, simple sugars, etc.) into the cell but before 
the amino acids are synthesised into proteins they must act as osmolytes and exert a 
transient swelling pressure. Therefore, transport of the components may cause a 
transient osmotic gradient inducing cell swelling, which may be important in the 
last stages of cell differentiation. Thus we cannot rule out that cell swelling acts as 
the driving force for cell volume increase that is followed by cell consolidation 
through the production of ‘‘dry matter’’ (Bush et al., 2008a, b). 
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Interestingly, both mechanisms of cell volume increase require an increase 
in the activity of plasma membrane transporters given that there has to be a net 
intracellular accumulation of osmolytes for swelling or hypertrophy to occur. 
Indeed, a study analysing mRNA showed that a number of candidate transporter 
required for swelling and hypertrophy mediated mechanisms of cell volume 
increase were more highly expressed in hypertrophic chondrocytes than in those 
found in the proliferative zone (Wang et al., 2004). Figure 1.17 shows a schematic 
model outlining a possible role for membrane transporters in mediating the growth-
plate chondrocyte volume increase. 
1.8 Growth Rate and Differential Bone Growth 
Differential growth is the phenomenon whereby each growth plate at different ages 
in an individual’s life, may elongate at different rates by a factor of 3 to 7. Even the 
same phenomenon can be observed in the two growth plates at opposite ends of the 
same bone (Wilsman et al., 1996b, 2008). For example, proximal and distal growth 
plates in both radius and tibia of the rat foetus elongated at similar rates; however, 
at 28 days of age, bone elongation due to proximal and distal growth plates in both 
bones was markedly different (Wilsman et al., 2008).  
A study by Wilsman et al. (1996b) using a set of eight independent 
variables suggested that differential growth was best depicted as a complex 
interplay among cellular division, matrix synthesis, and cellular enlargement during 
hypertrophy (Figure 1.15). This study confirmed the importance of cellular 
hypertrophy during elongation and the locally mediated regulatory systems 
controlling growth-plate activity. 
Differential growth is primarily associated with differences in hypertrophic 
cell volume manifested when growth deceleration occurs (Figure 1.18). This study 
also illustrates that differential growth is superimposed on systemic regulators that 
affect all growth plates simultaneously. The most dramatic illustration of this is the 
sharp decline in growth velocity in all four growth plates that occurs perinatally 
(Wilsman et al., 2008). 
 As has been discussed earlier, volume increase and cellular shape changes 
during hypertrophy may be regulated at the level of individual growth plates and 
that both are significant in understanding differential growth of long bones.  
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Figure 1.17 Diagram of a model to describe chondrocyte enlargement in the 
growth plate, encompassing both classical hypertrophy and swelling. If a cell is 
considered to be composed of osmotically-inactive (black) and osmotically-active 
(white) fractions, for ‘dry’ cell matter (i.e. proteins) and fluid respectively, then the 
proportion of chondrocyte enlargement due to hypertrophy and swelling can be 
represented. The intracellular accumulation of both organic (e.g. amino acids and 
simple sugars) and inorganic (e.g. K+, Na+, and CI-) osmolytes through membrane-
transport proteins will create an osmotic gradient which water is obliged to follow 
thereby driving cell swelling. Accumulated amino acids can then be used in the 
synthesis of protein, contributing to the total ‘dry’ cell matter, and increasing cell 
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Figure 1.18 Changes in hypertrophic chondrocyte volumes and growth 
velocity over a course of study period. The changing pattern in cellular volumes 
of the postnatal adolescent period of Long-Evans rat pups, parallels changes in 
growth velocity during the same period in four different growth plates (the 
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Wilsman et al. (1996a) demonstrated that chondrocytes in the proliferating zone of 
different growth plates have significantly different cell cycle times that regulated 
primarily through different G1 phase duration. This study suggests that, in addition 
to systemic controls of chondrocyte proliferation, local controls may modulate rates 
of proliferation of individual growth plates and thus may be another locally 
mediated regulator of differential growth.  
When considering bone growth rate as the variable of interest in differential 
growth, at any one time in any one growth plate, regulation of the kinetics of 
proliferation and regulation of the kinetics of hypertrophy occur simultaneously. 
Regulations of either the kinetics of proliferation or hypertrophy or both determine 
the final growth rate. It is also useful to consider the differential role of locally 
produced factors that to influence growth plate chondrocytes in regulating cell 
production, hypertrophic chondrocyte volume, cell shape, and integrating these 
cellular activities across these regulatory gates (Wilsman et al., 2008). 
 
1.9 Models for the Study of Bone Growth and Skeletal Development 
Techniques used to study bone growth, development and modelling in children, 
adolescents and adults are restricted to non-invasive methods (Pedersen, 1982; 
Salle et al., 2002; Bailey et al 2003; Kjar, 1974; Guadalupe-Grau, 2009; Yamamah 
et al., 2010). These techniques include fetal growth measurement using ultrasound, 
skeletal maturity evaluation using X-ray, and cross-sectional investigation 
including sports participation and dual-energy x-ray absorptiometry (DXA) 
measurement. However, the study of endochondral ossification and bone 
remodelling requires the use of appropriate experimental models as outlined below. 
 
1.9.1 In Vivo Model  
In vivo bone research has the potential to gain insight into growth and 
development, systemic response to varied cytokines, growth factors, and fracture 
repair of bone (Davies et al., 2006). No in vitro cell culture system is able to 
produce loading that simulates the in vivo situation and currently very few ex vivo 
systems are able to approach such physiological loading (Pearce et al., 2007). 
However, there are a few disadvantages of using this experimental model. Models 
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of this kind are expensive, requiring large numbers of animals, and it can be 
difficult to obtain discrete data due to systemic influences (Smith et al., 2010). 
There is also inter-species, inter-site and inter-individual variability. Therefore 
caution is required when extrapolating data obtained from one model to other 
models and to the situation in vivo (Davies et al., 2006).  
1.9.1.1 Embryo  
The foetal animal model has been used to study the morphology of normal and 
abnormal bone development in different species such as chick (Sawad et al., 2009), 
rodent (Efting et al., 2004), ovine (Barbera et al., 1995) and bovine (Kan and 
Cruess, 1987). 
1.9.1.2 Postnatal 
Post natal animal model are widely used in a number of studies using various 
animal species such as chicken (Glimcher et al., 1980; Kocamis et al., 1999), rabbit 
(Rivas & Shapiro, 2002), rat, bat (Farnum et. al., 2008) and deer antler (Kierdorf et 
al. 2009). They were used to cover a broad scope of studies, which included 
collagen chemistry of healing bone, growth performance with administration of 
growth hormone, histological events in long bone formation, growth plate 
chondrocyte performance in longitudinal bone growth and mammalian tissue 
regeneration. 
1.9.1.3 Genetic Manipulation: Transgenic and knock-out animals 
Although various animals are used to investigate human skeletal biology, the 
mouse stands out because has been documented with a good understanding of 
molecular manipulation. Manipulation of the mouse genome has become an 
extremely powerful tool to define molecular mechanisms responsible for the 
morphogenesis and growth of the vertebrate skeleton (Horton, 2003). 
Two strategies are used to change mouse genes namely transgenesis 
(injection of functional DNA pieces into single-cell embryos, that are expressed 
during subsequent embryonic development and postnatal life; Palmiter and 
Brinster, 1985) and targeted mutagenesis or gene targeting (introducing direct 
changes in endogenous genes of the mouse genome at the chromosomal locus; 
Cheah and Behringer, 2001). Mice with both alleles at a gene locus that are 
inactivated are referred to as knockout mice (Horton, 2003). For example 
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progesterone and GHR knock out mice have been used to study the effects of these 
ligands on bone growth and turnover (Sims et al., 2000; Rickard et al., 2008).  
 
1.9.1.4 Other In Vivo Experimental Models 
1.9.1.4.1 Models of Induced Bone Formation 
Although there are dissimilarities between human and avian bone development 
(Leach and Gay, 1987), the avian model has been valuable in understanding human 
skeletal defects. For example, chickens were the primary model used to define 
nutrients necessary for normal long-bone growth (Cook, 2000). Ectopic bone 
formation has been studied by subcutaneous implantation of bone cells 
impregnated construct in vivo (Mai et al., 2006). Bone and cartilage formation in 
intraperitoneal diffusion chamber transplants have been used to test the osteogenic 
potential of both non-human and human cell sources (Johnson et al., 1988; 
Krebsbach et al. 1999).  
The effects of mechanical loading on bone formation have been studied 
using nonsurgical methods in mouse (Lee et al., 2002; Gross et al., 2002) and rat 
(Torrence et al., 1994; Turner and Forwood, 1994; Hsieh and Turner, 2001; Ertem 
et al., 2008). Other studies involved non-union bone treatment canine model 
(Heckman et al., 1991) and calvarial bone formation model in mouse (Izbicka et 
al., 1997).  
1.9.1.4.2 Models of Longitudinal Bone Growth 
Surgical and non-surgical approaches are used in animal model. Rodents are most 
commonly used (Buckwalter et al., 1985; Wilsman et al., 1996a & b, 2008). 
Rabbits are used as an alternative animal model to rodents (Wilson-Macdonald et 
al., 1990) since the age of growth plate closure in rodents e.g. rats is longer than 
human in relation to their lifespan (Martin et al., 2003). Whereas in humans an 
obvious growth spurt occurs during puberty and GP fusion at the end of it, rodents 
do not clearly demonstrate these phenomena during sexual maturation (van der 
Eerden et al., 2003; Vico and Vanacker, 2010). The effects of mechanical loading 
on bone growth has been studied using surgical intervention methods in chicken 
(Rubin and Lanyon, 1984), calf, sheep, rabbit and rats (Stokes et al., 1996, 2002, 
2007; Stokes, 2002).  
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1.9.1.4.3 Models of Growth Plate Nutrient Transport 
Serrat et al. (2009) used in vivo multiphoton imaging technique to quantitatively 
measure solute transport in tibial growth plates of mice. These analytical methods 
are a substantial advancement over traditional approaches to bone and cartilage 
imaging and important for elucidating the role of nutrient transport in natural and 
experimental models of growth plate dysfunction, particularly chondrodysplasias 
with known defects in components and structure of the ECM.  
1.9.2 In Vitro System 
As discussed earlier, the use of in vivo systems are to study mechanisms of bone 
growth in any detail are compromised by the complexity of the regulatory networks 
that operate in the whole animal. In addition these systems are subjected to various 
levels of factors such as loading over the bone or cartilage, growth rate and ageing 
which complicate interpretation. For this reason, the in vitro model systems are 
widely used and copious literature has documented work studies using these 
methods. The advantage of using in vitro models is that experimental replicates can 
be virtually identical, making statistical analysis and quantification easier. In 
addition, a great number of molecular and biochemical tools are currently available 
for these systems (Davies et al., 2006). 
In vitro bone research has three main branches: i) Cell culture – the growth 
of isolated cells no longer organised into complex tissues as in vivo. Cells are 
harvested from tissue either mechanically or through enzyme digestion and 
propagated in a cell suspension or attached to a surface as a monolayer. ii) Tissue 
culture – the maintenance of tissue fragments, not necessarily preserving tissue 
architecture. iii) Organ culture – the maintenance or growth of tissue, or organs (in 
whole or in part), which may allow differentiation and preservation of architecture 
and function (Davies et al., 2006). Different examples of the various in vitro 
systems used are outlined below. 
1.9.2.1 Primary Cells 
Cells have been isolated from chick growth plates (Farquharson et al., 1995) and 
bovine metacarpal epiphysis (Hutchison et al., 2007), and can be fractionated into 
distinct populations (PZC and HZC) by means of Ficoll or Percoll density gradients 
(Trippel et al., 1980; Warner et al., 1983; Oberbauer and Peng, 1995). Percoll 
density gradient techniques have been used widely to examine growth plate 
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chondrocytes of varying maturation (Carey & Xia Liu, 1995; Farquharson et al., 
1999, 2000, 2001; Min et al., 2002). Monolayer and suspension cultures of primary 
chondrocytes have been prepared from 21 day old rat tibia growth plate (Robson et 
al., 2000), equine articular cartilage (Wilkins et al., 2003; Ahmed et al., 2007), 
rabbit and mouse chostochondral cartilage (Kato and Gospodarowicz, 1985; 
Yamakawa et al., 2008; Fukai et al., 2010), and bovine articular cartilage (Hall et 
al., 1996b; Hall, 1999; Bush and Hall, 2001a, b; Simpkin et al., 2007). Other 
sources of chondrocytes include those from the tip of xiphoid process of postnatal 
(11d) or adult (250 g body weight) rats, and 12 and 17-day chick embryo (Schmid 
and Conrad, 1982; Ishizaki et al., 1994). Ichinose et al. (2005) used MSCs from 
human bone marrow as an in vitro differentiation model to study chondrogenesis. 
Human articular chondrocytes are also now available commercially (Akagi et al., 
2009). 
There are some drawbacks in using isolated cells. This technique cannot 
reproduce the chondrocyte in situ environment and the environment of culture 
media into which cells are liberated during digestion is arguably unphysiological 
(Hall et al., 1996a). The primary cell isolation process involves laborious digestion 
steps (Wilkins et al., 2000). Harsh enzymatic digestion (Glade et al., 1991) which 
the cells are subjected to was reported to destroy cell membrane proteins (Glant 
and Mikecz, 1986). There is also evidence that some chondrocyte parameters, such 
as regulatory volume responses, reset to match the environment of the isolation 
medium (Hall, 1995; Bush et al., 2001a). The chondrocyte phenotype is also 
unstable and may undergo subsequent phenotypic drift and dedifferentiation 
following their isolation, which could be due to dissociation of cells from their 
three dimensional geometry and their propagation on a two dimensional substrate 
(Benya and Shaffer, 1982; Davies et al., 2006). 
1.9.2.2 Cell Line  
Clearly, cultures of primary chondrocytes for studying chondrocyte cellular 
physiology are notoriously difficult to handle. An alternative is the use of 
chondrocytic cell lines: human chondrocyte-like cell line, HCS-2/8 (Takigawa et 
al., 1989; Saas et al., 2004; Chagin et al., 2006) and C-20yA4 (Browning and 
Wilkins, 2004), TC6 derived from articular cartilage (Mataga et al., 1996) or 
MCC-2, -5, -35 from costal cartilage of transgenic mice (Akagi et al., 2009), and  
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Figure 1.19 Chondrocyte-like murine ATDC5 cell line. Intact monolayer cells 
(a, b, c) and cell suspensions (d, e, f) stained with CMFDA (5 µg/ml) are shown. 
Cell suspensions were made from monolayer cells through trypsinization using 
0.05% (v/v) Trypsin-EDTA solution. CLSM (Zeiss Axiovert-inverted microscopy 
for panel a and c; and upright Zeiss Axioskop LSM 510 for panel b, d, e, f and g) 
was used to acquire the fluorescence images. Increase in size of a number of cells 
was observed from day 0 to day 42 post confluence. Cells were visualized using a 
Plan-Neofluar x10/0.3NA lens (Zeiss Axiovert) or Achroplan x63/0.95 NA ceramic 
water-dipping lens (Zeiss Axioskop) at day 0 (a, b, and d); day 42 (c and f); and 
day 21 (e) post confluence. g. Fluoresbrite®YG Microparticles 10 µm 
(Polyscience, Inc.), fluorescent latex spheres, are shown for size comparison. 
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ATDC5 from murine teratocarcinoma stem cells (Atsumi et al., 1990; Shukunami 
et al., 1997; Musthtaq et al., 2002; MacRae et al., 2006a, b; Takayama and 
Mizumachi, 2010; Figure 1.19).  
Although cell lines offer an easily available, plentiful and reproducible 
source of chondrocytes, they have a number of disadvantages over primary cells. 
Immortalized chondrocyte cell lines appear to proliferate greatly and show less 
expression of genes of matrix synthesis and turnover (Saas et al., 2004), thus their 
properties reflect only an approximation of the true chondrocytes. 
Despite all these limitations, a combination of studies using in situ 
chondrocytes in cartilage explants (section 1.9.4.3), isolated primary chondrocytes 
and cultured cell lines has provided valuable fundamental information about 
chondrocyte properties and function (Wilkins et al., 2000). 
1.9.2.3 In Situ Cells in Tissue Explants 
The visualisation of living cells within their ECM has been revolutionised by 
advances in confocal laser scanning microscopy. Many studies have been 
performed using living in situ chondrocytes model. In this technique the cartilage 
explants are freshly obtained and the chondrocytes left intact within the cartilage 
matrix for examination (Errington and Hall, 1995; Errington et al., 1997; Bush et 
al, 2001a, b, 2005a, b, 2006a, 2007; Kerrigan et al., 2006, 2008; Amin et al., 2009; 
Amini et al., 2010).  
 Using these models, the survivability and three- or four-dimensional 
morphological changes of cartilage in situ could be quantified at both tissue and 
cellular levels when the cartilage explants were subjected to various conditions 
such extracellular medium osmotic perturbation, Ca2+ treatment, and mechanical 
loading (Bush et al, 2001a, b, 2005a, b, 2006a, 2007; Kerrigan et al., 2006, 2008; 
Amini et al., 2010). This approach offers the possibility of obtaining new insights 
into the fundamental process of cellular regulatory capacity for example, without 
the perturbations arising from cell isolation. 
1.9.2.4 Tissue or Organ Culture (Ex Vivo) 
Ex vivo models have significant advantages, as the cells and tissue are able to be 
cultured in the same spatial arrangement as would be found in the in vivo situation, 
while systemic influences, which often hinder in vivo work, are removed (Smith et 
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al., 2010). The regulation of limb growth, and the signals involved in chondrocyte 
proliferation, maturation, and hypertrophy can be studied using these model 
systems (Di Nino et al., 2002). Organ cultures taken from embryos of certain ages 
can be used for evaluating the local effect of various agents simultaneously, in a 
system where cellular interactions are intact (Chen and Klein, 1978; Chagin et al., 
2006). A role of a membrane transporter in GPC volume increase, and catch up 
bone growth of post dexamethasone treatment have been demonstrated using post 
natal rat bone culture (Bush et al., 2010; Chagin et al., 2010). The use of 
metatarsals from 18-day-old embryonic mice is well established and used in a 
number of studies (Mushtaq et al., 2004; MacRae et al., 2006a, b). Bovine cartilage 
tissue culture was used to study proteoglycans metabolism under influence of 
transforming growth factor β (Morales and Roberts, 1988). 
A novel ex vivo mechanically loading culture system for 3D cancellous 
bone tissue has been developed to overcome some of the limitations discussed 
above for both cell culture and organ culture. The loading and media diffusion is 
believed to be more physiological than current organ culture techniques (Davies et 
al., 2006). However this technique is limited to culture preparation of trabecular 
bone explants. 
In spite of being widely used, there are number of limitations of the tissue 
and organ culture systems. Biochemical and molecular techniques in organ cultures 
are limited because the multi-cellular population makes determination of specific 
biochemical pathways attributed to a specific cell difficult. Organ cultures have a 
short lifespan, as they often undergo central necrosis due to vascular occlusion and 
rate-limiting mass transfer. The loss of the vascular system has implications in 
limiting the size of organ sample that can be harvested, since cells in culture 
depend upon diffusion of nutrients and metabolites as well as for the removal of 
waste (Davies et al., 2006).  
The above sections have given an overview of the relevant background 
literature reviews related to the scope of this work.  The thesis aim/ hypothesis and 
the outline of the relevant projects undertaken are discussed below.  
1.10 The Aim of Study and General Hypothesis  
The general aim of this thesis was to investigate the following hypothesis: Plasma 
membrane transporter(s) have a role in growth plate chondrocytes enlargement 
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that contributes significantly to the rate of longitudinal bone growth. In order to 
test this hypothesis, four main projects were undertaken:  
(1) Characterization of in situ living chondrocyte hypertrophy in various growth 
plates of post natal rats and their contribution to the bone length  
(2) Investigation of the effect of fixative osmolarity in maintaining morphology of 
growth plate chondrocytes when using conventional fixative solutions 
(3) Examination of the role of sodium–hydrogen and anion exchangers in 
longitudinal bone growth  
(4) Study on changes to sodium/ hydrogen (NHE1) and anion exchanger (AE2) 
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2.1 Materials 
2.1.1 Equipments 
(see Appendix 2)  
2.1.2 Biochemicals and Solutions 
Unless otherwise stated, all biochemicals and solutions were purchased from 
Sigma-Aldrich, Poole, U.K.  
Buffer Solutions 
Phosphate buffered saline (PBS) 
A 200 ml PBS solution was prepared by dissolving a 5g PBS tablet (Invitrogen, 
U.K.) with 200 ml of distilled water. This buffer contains 10 mM phosphate, 150 
mM sodium chloride, pH 7.3 to 7.5. 
 
Sodium cacodylate (pH 7.4) 
Prepared by diluting sodium cacodylate trihydrate powder (assay, approx. 98%) in 
distilled water; and the pH was corrected to 7.4 by addition of HCl. 
 
Tris-EDTA-T80 HIAR buffer  
10 mM Tris Base; 1 mM ethylenediaminetetraacetic acid (EDTA); 0.05% Tween 
80, pH 9.0 was prepared as 1L stock solution by adding 1.21g Tris Base and 0.37 g 
of EDTA in 1L distilled water. The solution pH was adjusted to 9.0 with hydrogen 
chloride (HCl) before 0.5 ml of Tween 80 being mixed into the solution.  
 
Bone Rudiment Culture Media 
Dissection media (290-305 mOsm)  
PBS solutions with: 
7.5% (v/v) alpha modified essential medium (Invitrogen Ltd., Paisley, UK) 
2% (w/v) bovine serum albumin V.  
 
Standard culture media (postnatal rats) 
α-MEM supplemented with: 
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1 mM Na2 glycerol bi-phosphate  
0.2% (w/v) bovine serum albumin (BSA), Fraction V  
5mg.ml-1 L-ascorbic acid  
1% (v/v) Pens/Strep (for a final concentration of 100 I.U./ ml penicillin and 100 
µg/ ml streptomycin).  
 
Standard culture media (embryonic mice) (Mushtaq et al., 2004). 
α-MEM supplemented with: 
1 mM Na2 glycerol bi-phosphate 
0.2% (w/v) BSA, Fraction V,  
0.05 mg.ml-1 L-ascorbic acid phosphate 
0.05 mg.ml-1 gentamicin 
1.25µg.ml-1 fungizone (amphotericin B)  
 
Growth Plate Fixatives  
1.3% (v/v) glutaraldehyde with 0.5% w/v ruthenium hexamine trichloride (RHT)  
4% (w/v) paraformaldehyde (PFA), prepared from PFA powder (assay, 95%) in 
0.01M phosphate buffer (pH 7.4).  
Histological Slide Mounting Medium 
FluoroSaveTM  (Calbiochem, Nottingham, U.K.) 
Di-N-Butyl Phthalate in Xylen (DPX)  
 
Histological Staining 
0.1% (w/v) toluidine blue O in PBS buffer (pH 5.5)  
Hematoxylin and Eosin (as described by Drury and Wallington, 1980)  
Fluorescent Dyes 
Vital cytoplasmic dyes 
Chloromethylfluorescein diacetate (CMFDA, CellTrackerTM Green) and calcein 
AM were both purchased from Invitrogen, Paisley, U.K. were prepared in dimethyl 
sulphoxide (DMSO) as 1 mM-stock and used at 5µM in tissue medium. 
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Nucleic acid stain 
Propidium iodide (PI) was prepared as an aqueous 1 mM-stock solution and used at 
5µM in tissue medium. 
Pharmacological Agents 
AE inhibitor solution 
4,4-diidothiocyano-2,2-stilbenedisulfonate (DIDS) was prepared fresh as a 0.1M 
stock solution in 0.1 M potassium bicarbonate.  
 
NHE inhibitor solution 
5-(N-Ethyl-N-isopropyl) amiloride (EIPA) was prepared as a 120 mM stock 
solution in DMSO.  
2.1.3 Animals and Growth Plate Preparation 
Growth plates were obtained from 7- day-old Sprague-Dawley rat pups (7-day-old; 
P7) and 18-day-old fetal (E18) Swiss mice were dissected fresh and prepared for 
immediate image scanning, or further processed for later use in histology and 
immunohistochemistry. The bones with intact GP were dissected and temporarily 
placed in dissection medium. The P7 rats were humanely killed for other 
experiments following U.K. The post natal 7-day-old rat bones were chosen since 
at this age the bone mineralisation was found minimum and the histological section 
preparation could be performed by avoiding the possible immuno-comprimising 
bone decalcification step.  Home Office guidelines, whereas the experimental 
protocol for E18 mice was approved by Roslin Institute’s Animal Users Committee 
and the maintenance of the animals was in accordance to Home Office guidelines 
for the care and use of laboratory animals. 
2.2 Tissue Culture (Ex vivo) Technique 
2.2.1 Seven-day-old Post Natal Rat Metatarsals 
Metatarsal rudiments mainly from the middle three with intact growth plate 
cartilage were dissected and temporarily placed in bone dissection media. The 
overall length of the metatarsal rudiments was measured before being cultured 
individually in 1 ml standard culture media supplemented with different 
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concentrations of treatment drugs. The vehicle-alone control was prepared by 
adding the standard culture media with the vehicle without their corresponding 
drugs. All the bone rudiments were maintained at 37o C (CO2 5%: air 95%; pH 7.4) 
for 24 hrs, before the second bone length measurement was taken. 
 
2.2.2 Eighteen-day-old Embryonic Mouse Metatarsals 
Middle three metatarsals were aseptically dissected under dissecting microscope 
(Figure 5.2B). All the bones were pooled together before being cultured 
individually in each well of a 24-multi-well plate. At least six bone rudiments were 
assigned to each treatment groups. Each culture well contained 300 µl of a standard 
culture medium with the different treatments, and placed at 37o C in a humidified 
atmosphere of 95% air / 5% CO2 for up to 11 days. In all experiments, the medium 
was changed every second/third day.  
2.3 Tissue Processing 
2.3.1 GP Fixation 
Bones were fixed in 4% (v/v) paraformaldehyde (PFA) overnight, and stored at 4oC 
in PBS in preparation of microscopy or 2% glutaraldehyde (GA) with 0.7% 
Ruthenium Hexammine Trichloride (RHT), where appropriate. 
2.3.2 GP Histological Preparation 
The bones were fixed overnight before being dehydrated through a graded series of 
ethanol solutions. After the dehydration, the bones were embedded in paraffin wax 
using a standard procedure (Kiernan, 1999) and cut into longitudinal 10 µm serial 
sections using a microtome (Reichert-Jung Microtome 2050 Supercut, Arnsberg, 
Germany). The sections were then mounted on poly-l-lysine-coated microscope 
slides (PolysineTM, VWR International, Leicestershire, UK) and dried overnight.  
2.3.3 Histological Staining 
2.3.3.1 Toluidine Blue O  
After de-paraffinisation with xylene and rehydration with a series of ethanol 
solutions (100%, 90%, 75%), the sections were stained with 0.1% toluidine blue O 
in PBS (pH 5.5; 30secs at room temperature) using the technique adapted from 
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Bancroft and Cook, 1994. The section slides were then rinsed briefly in distilled 
water and allowed to air dry prior to mounting in FluoroSaveTM with cover slips. 
2.3.3.1 Hematoxylin and Eosin  
Hematoxylin and eosin procedure used was as described by Drury and Wallington 
(1980). Briefly, the dewaxed and rehydrated slides as previously described 
(2.3.3.1) were immersed in haematoxylin for 2-5 mins, washed with running tap 
water for 5 mins, immersed in eosin for 2 mins then washed again in running tap 
water for 5 minutes. Afterward, the sections were dehydrated in 70%, 95%, and 
two changes of 100% ethanol (60 seconds in each change). Then the slides were 
cleared in xylene before being mounted with DPX mountant. 
 
2.3.4 Fluorescent Staining  
2.3.4.1 Living In Situ Growth Plate Chondrocytes 
Bones were washed, sagitally bisected (see Figure 4.6(A)) and then exposed to 
fluorescent dyes e.g. CMFDA or calcein AM (5 µM), and/ or PI (5 µM) for 30-60 
mins at 37o C. CMFDA or calcein was used to label the viable cells as they are 
permeable to intact live cell membrane and produces a membrane-impermeant 
fluorescent product once reacted with intracellular esterase that stains the 
cytoplasm of viable cells green. On the other hand, PI is only capable of crossing 
plasma membrane of dying/ dead cells and stains the nuclei of the dead cells red 
(Gatti et al., 1998; Amin et al., 2008).  
 
2.3.4.2 Fluorescent Immunohistochemistry 
Fluorescent immunohistochemstry (FIHC) was performed after pretreatment 
procedures being applied to the GP histological sections. Each GP section per 
histological slide was marked by a small hydrophobic circle drawn around the 
tissue sections using a PAP pen (Liquid Blocker, Daido Sangyo, Tokyo) to keep 
the Ab pooled in a small droplet and avoid any mixture between the Ab or serum 
applied in adjacent sections. One of the 3-4 sections per slide was designated to be 
a negative control while the other 2-3 underwent normal staining. Non-specific Ag 
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sites were blocked using goat serum (1:5 dilution) on all sections at RT. Goat 
serum was replaced after 30 mins by specific 1o antibodies under investigation. 
Optimal dilution of the 1o Ab, the concentration that gives the optimal specific 
staining with the least amount of background staining (Renshaw, 2007) was 
determined by titration test using series of different titres of the 1o Ab. For the 
negative control section, the primary Ab was omitted and replaced with the serum 
from the species that the secondary antibody was generated. Slides were then 
incubated overnight at 4° C (or for 2 hrs at 37° C) in a humidity chamber. 
Afterwards, slides were washed 3 times with PBS for 5 mins each before being 
incubated with a FITC (fluorescein isothiocyanate )-tagged 2o Ab at 37° C for 1hr. 
Sections were again washed 3 times with PBS for 5 mins each. Then, cover slips 
were mounted using FluorSave™ and left to dry for 3 hrs at 4°C in tinfoil wrap 
prior to imaging using a CLSM.  
 
2.4 Cell Imaging 
2.4.1 Histological imaging  
Images of P7 rat growth plates were taken using the transmitted light detector of an 
upright confocal laser scanning microscope fitted with a x10 dry objective lens. For 
E18 mouse metatarsals, the bone histological sections were examined under a Leica 
DMR microscope which connected to a Leica DFC 490 digital camera. Image 
acquisition was performed with the Leica application suite (LAS, Peterborough, 
U.K.) software in conjunction with the use of the microscope and digital camera. 
2.4.2 Confocal Laser Scanning Microscopy  
An upright Zeiss Axioskop LSM 510 CLSM (Carl Zeiss Ltd., Welwyn Garden 
City, Herts., U.K.) was used to acquire fluorescent images of in situ GPC. Cells 
were visualized using a Plan-Neofluar x10 dry objective (numerical aperture (NA) 
= 0.3) for low power overviews and an Achroplan x63 ceramic water-dipping lens 
(NA=0.95) for high power views. Intracellular calcein (Exc/Em = 495/ 517 nm) or 
CMFDA (Exc/Em = 488/ 517 nm) was excited using an Argon laser (488 nm) and 
emitted fluorescence detected using a 500-550 nm band pass filter; whereas nucleic 
acids bound PI (Exc/Em = 536/ 617 nm) was excited using a He-Ne laser (543 nm) 
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and emitted fluorescence detected using a 560 nm long pass filter. The confocal 
detection pinhole was set at 1.00 Airy Unit. Laser power and detector sensitivity 
were adjusted to provide optimum image quality. The scanning speed was typically 
0.6Hz with 2 frame integration of a 512x512 pixel image, with serial 1µm z-step 
optical sections (see Bush & Hall, 2001a & b; Bush et al., 2007 for further details).  
2.5 Data Handling and Analysis 
2.5.1 Proliferative and Hypertrophic Growth Plate Zones Definition  
Projections of adjacent high magnification image stacks were ‘stitched’ together to 
produce a montage encompassing the GP from proliferative to hypertrophic zones 
(Figure 3.1A). To determine the beginning and terminal point of the GP, GPC 
zones must be first clearly defined. We used several subjective criteria based on the 
cell size and organization as previously described by other groups. Briefly, 
chondrocytes within the PZ (between the reserve and HZ) appeared to be 
ellipsoidal and arranged with at least 3 cells per group (Buckwalter et al., 1985). 
The cells in the HZ (between zone of proliferation and calcification) were larger 
and rounded in shape defined by the cell height being one-half than the cell’s width 
(Farnum and Wilsman, 1986).  
 Whilst great care was taken to be consistent, there was inevitable variation 
in the angle of bone bisection, and GP from differing positions are of different 
length. Consequently the position of cell within GPs has to be normalized for 
comparisons to be made. The high power GP image montages were divided into 
eight equidistant sections (S1 to S8) from the proximal edge of the proliferative 
(S1) to the distal edge of the hypertrophic zone (S8) (Figure 3.1B). This could be 
performed in all GPs in the present study in spite of various GP lengths. Eight 
sections gave sufficient sensitivity to allow changes in chondrocytic cell parameters 
to be detected along the GP zones (Breur et al., 1994) and at the same time permit a 
statistically adequate number of cells to be measured within each section. Therefore 
comparative analysis on the cellular parameters could be made between 
corresponding sections from different GP sections (Bush et al., 2008b).  
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2.5.2 In situ Growth Plate Cell Volume and Surface Area Measurement 
Volume analysis was performed using high performance 3D imaging software 
(Volocity®, Improvision, Coventry, U.K.) on scanned CLSM images using the 
calibrated cell volume method as previously described (Bush and Hall, 2001a). 
Briefly, cells and beads were individually selected as regions of interests (ROIs), 
and a 40% baseline threshold (BT) of the fluorescent intensity from the three-
dimensional cell image was determined before the volume was calculated. This BT 
value was found to return accurate object volumes over a wide range of calibration 
beads used (Bush and Hall, 2001a). 
2.6 Statistical Analysis 
Data were expressed as means ± S.E.M. obtained from a minimum of 3 bones from 
separate animals (n) and (N) GPC cells at each condition with the data shown as 
(n[N]). Statistical significance between two groups was evaluated using two-tailed 
Student’s unpaired t-tests, with the P value considered significant when P<0.05. 
The statistical significance of differences between treatments was ascertained using 
a one way and two way ANOVA for repeated measures, followed by a post hoc 
multiple comparisons analysis of pairwise differences between treatments using the 
Holm-Sidak method. Linear and non-linear relationships ware determined using 
Regression Wizard analytical application of SigmaPlot® (11.0). All other statistical 
tests were also performed using SigmaPlot® (11.0) statistical software (Systat 
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3.1 Introduction 
All growth plates exhibit a cascade of cell differentiation from the proliferative 
through to the hypertrophic zones. Different bones grow at different rates and 
ultimately achieve different lengths (Wilsman et al., 2008). The growth plate 
chondrocyte (GPC) volume increase at the later stage of GPC differentiation has 
been shown to be the main determinant of the rate of bone elongation in proximal 
and distal radial and tibia growth plates of hooded rat and Yucatan swine (Breur et 
al., 1991). In a previous study on proximal tibia of rat growth plates, the volume of 
the GPC has been shown to increase up to 10-fold from proliferative (~1790 µm3) 
to hypertrophic zone (~17400 µm3) (Hunziker et al., 1987b).  However, as different 
growth plates elongated at different rates at a given time point (Wilsman et al., 
2008), it was not clear whether the increase in cell volume and rate of longitudinal 
growth contribute to the final bone length. A comparison of the same bones from 
the laboratory mouse (Mus musculus) and big brown bat (Eptesicus fuscus) 
suggested longer bone length was correlated with and early attainment of final 
hypertrophic cell volume (Farnum et al., 2008). 
 In order to understand further this differential growth phenomenon, the 
present study examined the profile of in situ living GPC volume increase in 
different growth plates from one animal species at one age (7-day-old Sprague 
Dawley rats) using CLSM. The present study examined the contribution of GP 
hypertrophic cell volume as the main differential GP variable determining the 
overall length of the corresponding growth plates and bones. Chondrocyte 
performance and kinetic studies have previously been undertaken using a 
stereological approach on fixed GP tissues (Buckwalter et al., 1985; Hunziker et 
al., 1987b; Breur et al., 1991; Kuhn et al., 1996; Noonan et al., 1998; Wilsman et 
al., 1996b; Wilsman et al., 2008). A stereologically approach requires an optimal 
chemical fixation as the cell’s morphology is prone to alter during the fixation 
process (Hunziker et al., 1983; see Chapter 4). The present study utilized living, 
unfixed, in situ chondrocytes which were minimally perturbed and therefore were 
as close as possible to their natural physiological morphology. The use of CLSM 
offers an alternative way of visualizing and studying living, in situ GP cells 
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through calibrated, quantitative measurement of cell volume and dimensions whilst 
excluding any preceding fixation steps.  
This study also expanded on previous work by examining GPs of long, 
short and flat bones, incorporating both load and non-load bearing bones. Thereby 
examining if different bone shapes (in particular the bone length) or load bearing 
function has any effect on GPC differentiation and hypertrophic cell size. Earlier 
studies have also shown the important contribution of the chondrocytic shape 
change especially in the direction of bone growth to bone lengthening growth 
(Farnum et al., 2008). While the Farnum et al. (2008) study looked at the GPC 
shape changes in the digital bone GP of the laboratory mouse and big brown bat 
using stereological approaches, this present study measured the same parameters on 
in situ living GP cells of two different long bones (tibia and radius) of the same 
species (P7 laboratory rat). The quantitative and physiological understanding of 
how bone growth is regulated in response to mechanical loading is still lacking 
(Villemure and Stokes, 2009). However a few studies have reported significant 
effects of mechanical loading on endochondral bone growth at the tissue and 
cellular level when growth plates were subjected to compressive and distractive 
mechanical force (Stokes et al., 2002; Stokes et al., 2007 Cancel et al., 2009; 
Amini et al., 2010). Therefore, it is important to know how load bearing under 
normal physiological condition alters chondrocyte differentiation and hypertrophy 
and contributes, if any, to the longitudinal bone growth. 
It is well recognized that there is a positive association between the GPC 
hypertrophy and the rate of longitudinal bone growth (Breur et al., 1991; Kuhn et 
al., 1996; Wilsman et al., 1996b). In this study this observation has been extended 
by examining the link between the GPC hypertrophy and final bone length. In 
previous studies the rate of longitudinal bone growth was determined by the 
measurement of new bone formation in a single GP within 24 hrs by the use of 
fluorescing labeling agent such as oxytetracycline or calcein (Hunziker et al., 
1987b; Kuhn et al., 1996; Wilsman et al., 2008). Although informative, this 
experimental approach might not truly represent the total bone growth rate 
considering there are possible cumulative contributions of new bone formations 
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from two GPs of opposite cartilaginous ends of a same bone to make up the overall 
bone length increase. Therefore, in the present study the relationship between the 
GPC hypertrophy with longitudinal bone growth with reference to the final length 
of the respective bone has been examined.  
In view of the possible dynamic regulation and control of cell volume 
increase that is present in the GP throughout the period of active longitudinal bone 
growth, it is likely that that the contribution of the GP hypertrophic cell volume to 
the overall length of the corresponding bone could not be directly exhibited at a 
single moment in time during bone lengthening. Therefore in the present study, this 
hypothesis was tested by measuring the in situ chondrocyte hypertrophy in 
different living growth plates of rats at a single time point (7-day-old) and 
examining the relationship between the chondrocyte hypertrophy and the 
corresponding final bone lengths at this given post natal age. 
 
3.2 Materials and Methods 
3.2.1 Animals and Growth Plate Preparation  
Twenty-one Sprague-Dawley rats (7-day-old; P7) were prepared as described 
previously (2.1.3). Tibiae, radii, femora, humeri, metatarsi, metacarpi, pelvic ilia 
and rib bones were dissected and temporarily placed in dissection medium (293 
mOsm). At least three bones with intact GP were obtained from three (n=3) 
different animals.  
Bones were categorized based on gross morphology (Bannister et al., 1995; 
Lever and Heinemann, 1980) namely: long bones (humerus, femur, tibia and 
radius), cuboid or short bones (metacarpus and metatarsus); and flat bones (pelvic 
ilium and rib). The long and cuboid bones were weight-bearing, whereas the flat 
bones were non-weight bearing (this was based mainly on observation in the older 
animals which are more physically active). The GPs studied were the proximal and 
distal of femur and tibia, proximal humerus and radius, distal metatarsus and 
metacarpus, pelvic iliac crest and rib cartilage beginning from the costochondral 
junction. 
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For the imaging of in situ living growth plate chondrocytes, surrounding 
soft tissue was carefully dissected away before the bones were cut sagittally to 
reveal the growth plate (Appendix (A)). Bone dissection was performed using a 
fresh scalpel blade (No.11) to minimize cell death by blunt injury (Huntley et al., 
2005). After bisection the bones were immediately incubated in calcein AM (5µM 
in dissection medium) at 37o C for 30 min. The bones were then attached to  the 
base of  a 35x10 mm sterile tissue culture dish (Cellstar®, Greiner Bio One, U.K.) 
using cyanoacrylate super glue (Loctite®, Cheshire) at a point distant to that being 
imaged with the cut surface of the growth plate facing upwards. At all times, tissue 
was kept under dissection medium to prevent dehydration. CLSM imaging was 
performed within 6 hrs of the animal being sacrificed.  
3.2.2 Confocal Laser Scanning Microscopy  
An upright Zeiss Axioskop LSM 510 (Carl Zeiss Ltd., Welwyn Garden City, 
Herts., U.K.) CLSM was used to acquire fluorescent images of in situ GPC using 
the protocol that has been described previously (2.4.2). A series of adjacent high 
power image stacks were obtained from the osteochondral junction to the early 
proliferative zone cells at the cartilagenous end.  
3.2.3 Determination of Proliferative and Hypertrophic Growth Plate 
Zones  
Projections of adjacent high magnification image stacks were ‘stitched’ together to 
produce a montage encompassing the GP from proliferative to hypertrophic zones 
(Figure 3.1A). The proliferative and hypertrophic GP zones were determined using 
subjective criteria that have been described earlier (2.5.1). 
3.2.4 In Situ Cell Count, Density, Volume, Surface Area, and Cell 
Dimensions Measurement 
Three dimensional volume images were observed using high performance 3D 
imaging software (Volocity®) on CLSM image stacks. Cell numbers were counted 
by eye from each GP zone. Only whole cells which were entirely within the 3D 
image volume were counted and used to determine cell density.  
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Figure 3.1 Overview of in situ living rat GPC as observed using CLSM and the 
evaluation of the GPC dimensional parameters. (A) Growth plate of P7 rat as 
observed under x10 objective dry lens of a confocal microscope. Series of regions 
of interest (ROI; series of square area) were identified and observed further under 
high power lens (x63 water-dipping lens, figure B). (B) The collated series of 
higher power magnification images provides a whole length high magnification 
view of the GP. (C) The constructed 3D cell image of a hypertrophic GPC and (D) 
proliferative GPC using Volocity® software which allows the measurement of the 
cell volume (see Materials and Methods). The inset of figure C and D shows the 
range of fluorescence intensity of a single chondrocyte cell image after the 
threshold correction, as a function of the voxels (three-dimensional pixel) of the 
cell image.  Constructed 3D images of in situ chondrocytes (e.g. proliferative (E) 
and hypertrophic (F) GP zone cells) could be viewed from various angles and 
planes using 3D opacity mode (interactive rendered 3D image visualization mode) 
of the software for general evaluation of the cell shape and orientation. 
Measurement of the cell length, width and depth was determined using LSM Image 
Browser (G). AC, articular cartilage; SOC, secondary ossification centre; MB, 




E.                                                F.                                               G. 
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 The quantification of in situ chondrocytes volume and surface area was as 
described in General Materials and Methods (2.5.2). The cell dimensions were 
measured using LSM image browser (Zeiss LSM Image Browser Software, Carl 
Zeiss Microlmaging GmbH, Germany) (Figure 3.1G). Cell length and width 
dimensions were determined by inspecting individual optical sections. The greatest 
length (measured along the axis of longitudinal bone growth) and width 
(perpendicular to the length in the same place as the bisected bone cut surface) 
were measured. Cell depth was measured through adjacent optical sections, 
perpendicular to both length and width (Bush et al., 2007).  
3.2.5 Growth Plate and Bone Length Measurement 
Growth plate length was determined based on the length of the GP as seen on the 
‘stitched’ high-magnified GP images obtained from CLSM imaging as explained 
above. The GP beginning and terminal points were determined using a method that 
has been described in 2.5.1. The bone length was measured directly by eye using a 
rule graduated to 0.5 mm on the cleanly dissected whole bone tissue. 
Measurements were performed on each bone from at least three different animals. 
3.3 Results  
3.3.1 In Situ Living GPC as Observed Using CLSM 
To visualize GP zones from different GPs this section describes the appearance of 
in situ living GPC as observed in various GPs.  The length and width of the growth 
plates could conveniently be observed under a lower power magnification using 
x10 objective (Figure 3.1A). Using this live (i.e. unfixed) cell fluorescent labeling 
technique, an increase in the size of GPC from proliferative zone (PZ) to 
hypertrophic zone (HZ) was visualized in all growth plates (Figure 3.2A-E). Rib 
growth plates demonstrated the longest growth plate (Figure 3.2B). At day 7 
postnatal, the secondary ossification centre could be clearly observed at the centre 
of the proximal radius bone cartilage where the GP differentiation cascade started 
immediately distal to the ossification centre (Figure 3.2C). The pelvic iliac crest 
GP showed variable length from the distal osteochondral junction to the proximal 
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edge of the GP because of its curved-shape which was atypical compared to the 
other GPs studied (Figure 3.2E).  
 Using higher power magnification, more detailed information of the shape 
and volume of individual living GPC in situ could be identified. To obtain the 
detailed morphology of  in situ  GPC the full length of the GP tissue (Figure 3.2F-
L), a series of high magnification images (x63 objective) were collated and 
‘stitched’ together before being divided into eight equidistant sections (Figure 
3.1B, see Materials & Methods). Besides providing useful information of the in situ 
arrangement and orientation of the GPC along the GP differentiation cascade, this 
method also allowed any trends in the dimensions of cell to be studied along the 
GP. The classical ellipsoidal appearance of PZ cells and the rounded shaped of the 
larger HZ cells as seen in fixed GP tissue (Buckwalter et al., 1986; Farnum and 
Wilsman, 1986) were observed in live in situ GPC. There was a clear variation in 
the arrangement of the GPCs along the GP among different GPs. For instance the 
organization of the GPC and a number of cells grouped together in columns 
particularly at the early stage of differentiation was most noticeable in the distal 
metacarpus GP (Figure 3.2L) compared to the other GPs. 
 Using Volocity®, the 3-dimensional image of individual GPC or groups of in 
situ living GPC could be constructed (Figures 3.1C and D). The insets show the 
fluorescent intensity recorded from the cell as a function of the image voxels after 
40% baseline threshold adjustment to give more accurate volume measurement of 
the cell (see Materials and Methods). Figure 3.1E and 1F demonstrated the detailed 
shape and arrangement of GPC in HZ and PZ respectively and their orientation 
with the surroundings cells. Having acquired 3D images from the CLSM with the 
LSM browser software it was possible to determine cellular length, depth and 
width measurements of individual GPC (Figure 3.1G and Table 3.2). The result 
highlights the variability of GPC shape and orientation along the GP in different 
bones as the cells increase in size from PZ to HZ in all GPs.  
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Figure 3.2 Comparative morphology of living in situ chondrocytes within 
different growth plates. Projected images (reconstructed three-dimensional 
images) of GP sections and chondrocytes from various living growth plates of 7-
day-old rat pup as observed in situ. Panels A, B, C, D & E show low power views 
of GP (x10 objective lens) from proximal tibia, rib, proximal radius, metatarsus and 
pelvic iliac crest respectively.  Bar = 100 µm for all panels. The lower panels 
demonstrate the higher power magnification views (x63 water-dipping objective) 
of the GP from proliferative to hypertrophic zones (F. proximal tibia, G. distal 
tibia, H. distal femur, I. rib,  J. pelvic iliac crest, K. distal metatarsus and L. distal 
metacarpus). RZ, resting zone; PF, proliferative zone; HZ, hypertrophic zone; 
SOC, secondary ossification centre ; MB, mineralized bone. Bar = 20 µm.  
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3.3.2 Profile of Chondrocyte Volume Increase along GP Sections 
(Proliferative to Hypertrophic Zones) In GPC of Various Bones 
Given the variation in the gross appearance of the GPC along the various GPs, the 
change in the GPC size by determining the profile of the GPC volume increase 
along the GP was then quantified. Figures 3.1, 3.4 and 3.5 demonstrate the 
variation in GPC volume increase along the GP sections in different GP, plotted 
from the proliferative through the hypertrophic zones (GP section 1 (S1) to GP 
section 8 (S8)).  
(i) Long bones. For the GPC volume of the distal and proximal tibia, there was a 
dramatic increase of GPC volume from S4 to S7 and S4 to S8 respectively (Figure 
3.3A and B). For distal tibia, the volume of HZ cells (S7-S8) was significantly 
higher than the volume of GPC at S1-S5 (P<0.05). For proximal tibia the volume 
of HZ cells (S8) was significantly higher than the volume of GP cells in S1-S6 
(unpaired Student’s t-test; P<0.05) and for S7 the GPC volume was significantly 
higher than in S1-S3 for the distal tibia GP (P<0.05). One way analysis of variance 
analysis (ANOVA) performed on the GPC volume data along the GP sections 
showed a significant volume increase (P<0.001) along the sections of both GPs. It 
was also noted that in distal tibia GP, the GPC surface area per volume generally 
decreased as the GPC volume increased along the PZ to HZ GP sections (S3-S7). 
For proximal radius, the volume increase from S1 to S8 was less remarkable. The 
GPC volume in the early PZ (S1-S3) was not significantly different although it 
appeared slightly higher than in the mid sections of the GP (S4-S5; Figure 3.3C). 
However, the HZ cell volume (in S8) was significantly higher than the GPC in S3-
S6 (unpaired Student’s t-test; P<0.05). There was a significant overall volume 
trend along the proximal radius GP (one way ANOVA; P<0.001). For femur, the 
distal and proximal GP showed obvious GPC volume increase from S5-S8 (Figure 
3.4A and B) and the GPC volume increase was significant along the GP (one way 
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Figure 3.3 GPC volume change from the proliferative to hypertrophic zones of 
three long bone growth plates (proximal & distal tibia, and proximal radius). 
The profile of the GPC volume changes along the proliferative and hypertrophic 
zones in (A) distal tibia, (B) proximal tibia and (C) proximal radius of P7 rats. 
Each showed a different profile in GPC volume increase. In panel B the change in 
the volume changes along the GP was plotted together with the change in the 
surface area per unit volume (broken line) that demonstrates the decrease in the 
surface area-volume ratio as the cell volume increased. (Data are given as means ± 
S.E.M; from 3 different animals with in total of 146, 177, and 249 cells measured 
from distal tibial, proximal tibial and proximal radial GP respectively). *Significant 
difference from the cell volume at S8; §significant difference from the cell volume 
at S7 (unpaired Student’s t-test, P<0.05); **one way ANOVA, P<0.05. 
 
was also observed in proximal humerus GP (one way ANOVA; P=0.007; Figure 
3.4C).  (ii) Short bones. Distal metacarpal and metatarsal GP appeared to show a 
GPC volume increase from S5-S8 (Figure 3.5A). A one way ANOVA test showed 
significant GPC volume changes along the GP section in both GPs (P<0.01).  
(iii) Flat bones. The pelvic iliac crest GP showed a significant GPC volume 
increase from S1 to S8 (one way ANOVA; P=0.006), and was particularly notable 
from S6-S8 (Figure 3.5B). For the rib, the increase of the GPC volume took place 
from S1 to S4; followed by a more dramatic change from S4-S8. The HZ cell (S7-
8) volume was significantly higher than the GPC volume at S1-S4 (unpaired 
Student’s t-test; P<0.05) and the trend along the GP sections were significant when 
tested with one way ANOVA (P<0.001).  
 The variety of GPC volume increase profiles in different bones could 
suggest the possibility of a different rate of cell hypertrophy along the length of the 
GP. To examine this, the ratio of the GPC volume changes along different GP 
zones (the slope value of GPC volume versus GP sections plot) was determined. 
Since the linear relationship between the GPC volume and GP sections among 
different GPs was found to have a wide range in the coefficient of determination 
value (r2=0.333 to 0.872), the data plots were converted to semi- logarithmic plot to 
give better fit of the data to the linear relationship plot (r2=0.872 to 0.993), hence 
make them more comparable. Since apparent GPC volume increase started to be 
observed from S4 to S8 in all GPs (Figure 3.3, 3.4, and 3.5), only GPC volume 
along these sections were studied. Log10-transformed GPC volume data along S4- 
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Figure 3.4 GPC volume increase from the proliferative to hypertrophic zones 
of three long bone GPs (proximal humerus and proximal & distal femur).  The 
profile of the GPC volume changes along the proliferative and hypertrophic zones 
in (A) distal femur, (B) proximal femur and (C) proximal humerus (Data are given 
as means ± S.E.M; from 3[76], 3[72], and 3[80] of distal femoral, proximal femoral 
and humeral GP respectively). *Significant difference from the cell volume at S8; 
§significant difference from the cell volume at S7 (unpaired Student’s t-test, 
P<0.05); **one way ANOVA, P<0.05. 
 
S8 in all GPs showed linear relationship when tested with linear regression test 
(coefficient of determination, r2 = 0.70 to 0.99). The following semi-logarithmic 
plot slope values were presented as means ± SEM. Distal femur GP showed the 
highest slope (0.283 ± 0.014). This was followed by proximal femur, proximal 
humerus, distal metacarpus and proximal tibia (0.248 ± 0.032, 0.223 ± 0.022, 0.210 
± 0.024 and 0.207 ± 0.024 respectively). Pelvis ilium, distal tibia and distal 
metatarsal each showed slope value of 0.199 ± 0.039, 0.177 ± 0.029 and 0.158 ± 
0.027 respectively. Proximal radius and rib GP each showed the lowest slope value 
(0.150 ± 0.033 and 0.105 ± 0.039 respectively). Regression test analysis performed 
on the slope value data with the HZ cell volume of the corresponding GPs (Table 
3.1) suggests there was a  good contribution of the plot slope value to the HZ cell 
volume (r2=0.569; data not shown). The results in this section show it is possible to 
measure the volume of in situ living GPC along the GP using the method described 
earlier. Overall, the results suggested that the GPC volume profile along the GP 
sections did not relate to the type of bone or GP location, and the different HZ cell 
volume produced was contributed to some extent by the ratio of the GPC volume 
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Figure 3.5 GPC volume increase from proliferative to hypertrophic zones of 
short bone and flat bone GPs. Profile of GPC volume changes along the GP in 
(A) distal metatarsal and metacarpal (short bones), (B) pelvic iliac crest and rib 
(flat bone) GP. The data are given as means ± S.E.M; from 3[120], 3[109], 3[146], 
and 3[281] for distal metatarsal, distal metacarpal, pelvic iliac crest and rib bone 
GP respectively). *Significant difference from the cell volume at S8; §significant 
difference from the cell volume at S7 (unpaired Student’s t-test, P<0.05); **one 
way ANOVA, P<0.05. 
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Figure 3.6. Semilogarithmic plot that shows log10-transformed GPC volume 
data along S4-S8. The linear relationship between the GPC volume and GP 
sections among different growth plates was determined using linear regression test: 
(A) distal femur, (B) proximal tibia and (C) proximal radius. (Data are given as 
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3.3.3 Hypertrophic GPC Volume Increase in Different GPs  
In order to determine the absolute GPC volume increase and total cell swelling 
from PZ to HZ, the GPC volume at the beginning and end of the GPC 
differentiation cascade (S1-S2 and S8) among the GPs of the long, short and flat 
bones was compared (Table 3.1). 
(i) Long bones. Among the long bones, distal femur GP showed the largest final 
HZ cell volume (17909 ± 4874 µm3 (3[9])). This was a 1772 ± 543 % higher 
volume compared to PZ cells (1179 ± 195 µm3 (3[18])), of the same GP. The 
proximal GP of the same long bone showed an increase of 846 ± 287 % cell 
volume from the PZ cells (808 ± 287 µm3 (3[18])) to HZ cells (7533 ± 2264 µm3 
(3[9])). The distal tibia GP showed 655 ± 68 % higher cell volumes for PZ cells 
(1184 ± 81µm3 (3[42])) in comparison to HZ cells (8510 ± 586 µm3 (3[11])). On 
the other hand, the proximal tibia showed 1114 ± 488 % increase in volume from 
the PZ cells (1372 ± 463 µm3 (3[62])) to HZ cells (11817 ± 1139 µm3 (3[17])). 
Proximal humerus GPC volume in PZ increased from 1517 ± 428 µm3 (3[124]) to 
12284 ± 4585 µm3 (3[7]) of HZ cells which was 849 ± 474% % increase. Proximal 
radius GP showed the smallest GPC volume change from PZ (1399 ± 92 µm3 
(3[57])) to HZ (3342 ± 508 µm3 (3[9])) by showing only 134 ± 25 % cell swelling. 
(ii) Short and flat bones. For the short bones, the metacarpal GP had 466 ± 137% 
volume increase from the PZ cell (811 ± 164 µm3 (3[22])) to HZ cell (4850 ± 1504 
µm3 (3[14])). The metatarsal GP had 727 ± 259 % volume increase from the PZ 
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Table 3.1 
 
Bone Growth plate  Mean 
volume of 
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844 ± 242 
 















855 ± 341 
 
0.199 ± 0.039 
 
Table 3.1 Chondrocyte growth plate volume increase from PZ to HZ in 
different bones and locations. The mean volume of GPC in the PZ (S1-S2) and 
HZ (S8) zones of GPs are shown.  The GPC swelling (%) is shown as the percent 
increase of volume from the PZ cell volume. Data are given as (n[N]) are presented 
as means ± S.E.M. *Significantly different from the corresponding GP HZ cell; 
**significant difference from distal femur GPC swelling; ¥significant difference 
from proximal tibia GP HZ cells; #significant difference from distal femur HZ cells 
(unpaired Student’s t-test, P<0.05). 
 
that the non-weight bearing GP such as proximal femur (greater trochanteric GP), 
rib and pelvic ilium GP showed consistently higher GPC swelling (about 8-fold 
increase in all the GPs). However the highest GPC swelling was observed in long 
bones (e.g. distal femur and proximal tibia GP). 
 There was no significant difference in PZ cell volume between all different 
GPs (unpaired Student’s t-test; P>0.05). Generally, the mean PZ cell volume in all 
GPs was within a range of 808 to 1517 µm3 (1101 ± 451 µm3 (SD)).  
However, there was a range of final volumes of HZ cells among different 
GPs. For instance the proximal tibia GP HZ cell volume was significantly different 
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from the proximal radius, distal metacarpus and distal metatarsus GPs (P<0.05); 
but was not significantly different from the rest of GPs studied (Table 3.1). In 
general, the highest HZ cell volumes (>11,000 µm3) were observed in long bone 
GPs such as proximal tibia, distal femur and proximal humerus.  However, another 
long bone GP, namely the proximal radius showed the lowest HZ cell volume. Flat 
bone GPs showed slightly higher HZ cell volumes compared to the short bones 
although the difference was not significant (P>0.05). 
The HZ cell volume in almost all GPs were significantly higher than their 
corresponding PZ cell volume (P<0.05; Table 3.1). The exceptions were for distal 
metacarpus and pelvic ilium GP, which the HZ cell volume were not significantly 
different than the PZ cell volume although appeared higher (P<0.05). The 
relatively higher HZ cell volume was particularly evident for proximal and distal 
tibia GP (P<0.001 and P=0.001 respectively). Yet, there was no significant 
difference in the GPC swelling from PZ to HZ among different GPs (P>0.05) 
except the GPC swelling in proximal radius GP and distal femur GP, which was 
significantly different (P<0.05). The data in this section demonstrate while the 
GPC shared almost the same cell volume at the start of the GPC differentiation (i.e. 
PZ), the final volume reached at the end of the GP differentiation cascade varied 
markedly among different GPs and even from GPs of opposite cartilaginous end of 
the same bone. 
3.3.4 Dimensional Changes of Chondrocytes along the Growth Plate 
of Two Different Bones 
Given the variation in the final GPC volume among different GPs, the changes in 
GPC dimensions and properties of two different long bones was then compared. 
Figure 3.7 and 3.8 demonstrate the chondrocytic properties and dimension 
parameters (cell surface area, cell length, width and depth) and cell properties (i.e. 
cell density) between proximal tibia and proximal radius along the GP. These two 
bones were used as they are both long load-bearing bones but with different length 
and HZ cell volume (Table 3.1).  
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Figure 3.7 Comparative trends in the change of cell density and cell surface 
area between proximal tibia and radius GPC along growth plate sections. Data 
are given as means ± S.E.M; from 3[223] and 3[143] for proximal tibia and 
proximal radius GP respectively). *Significant difference from the cell volume at 
S8; §significant difference from the cell volume at S7 (unpaired Student’s t-test, 
P<0.05); **one way ANOVA, P<0.05. 
 
 Figure 3.7A and C show the changes in cell density, and Figure 3.7B and D 
show the changes in cell surface area in both GPs. There was initially a slight 
increase in the density of cells (S1-S5) and then constant decrease (S5-S8) along 
the GP zones in proximal tibia GP (Figure 3.7A). The GPC density in S8 was 
significantly lower from the density in S1 and S3 (unpaired Student’s t-test; 
P<0.05). One-way ANOVA analysis showed a decreasing trend in the volume 
along the GP (P=0.027).  For proximal radius GP, the cell density initially 
increased from S1-S3, almost reached a plateau from S3-S6, and then declined 
abruptly from S6-S8. However there was no significant difference in cell density 
within the S1-S7 (unpaired Student’s t-test; P>0.05) although the cell density was 
significantly reduced in S8 compared to the density in S1-S2 and S4-S7 (P<0.05). 
The overall GPC density decrease along the proximal radius GP was only just 
significant (one-way ANOVA; P=0.043; Figure 3.7C). Generally the proximal GP 
showed higher cell density compared to the proximal radius GP in each 
corresponding GP sections. The highest difference was observed at the S1 (~3-fold 
difference). 
 There was a significant progressive increase in GPC surface area from PZ 
to HZ in proximal tibia GP (one-way ANOVA; P<0.001; Figure 3.7B). However, 
the GPC surface area of the proximal radius gradually decreased from S1-S6, 
before a sudden increase at S6-S8 (Figure 3.7D). The GPC surface area trend along 
the GP was also statistically significant (P<0.001). It was noted that the cell surface 
area over S6 to S8 in proximal radius was much smaller compared to the cell 
surface area over the same GP sections in proximal tibia GP (~2 to 3-fold smaller). 
In both GPs the final GPC surface area in S8 was significantly higher in 
comparison to the cell surface area in the other sections (unpaired Student’s t-test; 
P<0.05).  
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Table 3.2 A comparison between the dimensions of chondrocytes in PZ and 
HZ cells as measured in two different P7 rat long bones. This table shows the 
mean volume of various chondrocytic performance parameters in the PZ and HZ 
zones of proximal tibial and radial GPs.  Data are given as (n[N]) are presented as 
means ± S.E.M. *Significantly different from the corresponding HZ cells; 
**significantly different from distal femur GPC swelling; ¥significantly different 
from HZ of proximal radius GP; #significantly different from PZ of proximal radius 
GP (unpaired Student’s t-test, P<0.05). 
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 Table 3.2 presents the absolute value of the cell surface area, cell surface 
area-volume ratio and cell density from PZ (S1-S2) and HZ (S8) cells in proximal 
tibia and radius GP. The GPC surface area in PZ of both GPs was significantly 
higher than in the HZ (unpaired Student’s t-test; P=0.002 and P<0.001 
respectively). Similarly, the GPC density in PZ of both GPs was significantly 
higher than in the HZ (unpaired Student’s t-test; P=0.011 and P=0.016 
respectively). It was also shown that the GPC density in PZ of proximal tibia was 
significantly higher than in PZ of the radius GP (unpaired Student’s t-test; 
P=0.041). However the GPC density in the HZ between both GPs was not 
significantly different (P=0.230). This result shows significant increase in the cell 
surface area and conversely decreased in the cell density towards the later stage of 
GP differentiation in both GPs.  
 Figure 3.8 shows the trends in cell shape changes along the GP sections in 
proximal tibia and radius. Cell dimensions were measured based on the cell length, 
width and depth as described in the Materials and Methods. Proximal tibia GP 
demonstrated clear GPC shape changes in all the three dimensional parameters as 
the PZ cells transformed to HZ cells along the GP sections (Figure 3.8A, B and C). 
One-way ANOVA test showed significant trends in the shape changes along the 
GP (P<0.001, P=0.002 and P<0.001 for cell length, width and depth measurements 
respectively). However, the increase in cell length for proximal radius GP only 
appeared to begin from S6-S8 (Figure 3.8D). The final cell length at S8 was 
significantly higher than in other sections (S1-S7) while cell length in S7 was 
significantly higher than in S3-S5 (unpaired Student’s t-test; P<0.05). Similar 
trends could be seen for the cell width changes (Figure 3.8E). The GPC width in S8 
was significantly higher than in S1-S6 (unpaired Student’s t-test; P<0.05; one-way 
ANOVA; P<0.001).  For the proximal radius GPC depth (Figure 3.8F) there was 
no significant difference in the cell depth observed along the GP.  
 Comparison of the absolute value of the dimensions of the cells (length, 
width and depth) between the PZ (S1-S2) and HZ (S8) cells is given in Table 3.2. 
The GPC of proximal tibia GP showed significant increases in its length, width and 
depth as it reached the HZ from the PZ (P=0.002, P=0.006 and P=0.003  
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Figure 3.8 Comparison of changes in cell dimension between proximal tibia 
and radius GPC along GP sections. This graph demonstrates there was gradual 
increase in dimensions of GPC from PZ to HZ in proximal tibia GP. Data are given 
as means ± S.E.M; from 3[223] and 3[143] for proximal tibia and proximal radius 
GP respectively). *Significant difference from the cell volume at S8; §significant 
difference from the cell volume at S7 (unpaired Student’s t-test, P<0.05); **one 
way ANOVA, P<0.05. 
 
respectively; unpaired Student’s t-test from 3 animals and in total 223 cells 
measured  from  both PZ or HZ). The HZ cell length, width and depth increased by 
2.9, 1.70 and 1.75-fold from the PZ cells. For proximal radius GP, although the cell 
shape appeared to show changes in all directions as PZ cells were transformed to 
HZ cells, only the cell length and width increased significantly (P=0.003 and 
P=0.001 respectively (3[143])). The HZ cell length, width and depth increased by 
1.8, 2.0 and 1.1-fold from the PZC.  It was also found that the final HZ cell length, 
width and depth in proximal tibia GP were significantly higher than in proximal 
radius GP (P=0.004, P=0.008 and P=0.001 respectively). On the other hand, there 
was no significant difference in PZ cell shape and size between both GPs. The 
results in this section generally associated the increase in the final GP HZ cell 
volume and surface area with the increase in the cell length, width or depth. The 
HZ cells in the longer bones were also found to show preferentially higher increase 
in the cell length than in cell width and depth.  
3.3.5 Relationship of GPC Volume Increase, HZ Cell Volume, Growth 
Plate Length and the Total Bone Length 
After taking into consideration all the above results, the relationship between the 
chondrocytic parameters and GP and total bone length which is a result of 
accumulative chondrocyte performance was then investigated.  
 In Figure 3.9A, two GP chondrocytic parameters namely GPC volume 
increase and hypertrophic GPC volume were plotted against bone length of the 
corresponding bone (of P7 rats). GPC volume increase was shown as a % 
difference in volume between the PZ (S1-S2) and HZ (S8) cells (see Table 3.1). To 
examine any relationship between the chondrocytic parameters and the length of 
the various bones, linear regressions were plotted through data points that  
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Figure 3.9 Relationship between chondrocytic parameters changes, GP length 
and the total bone length. (A) The regression plot exhibits the linear relationship 
between GPC swellings and HZ cell volumes from PZ to HZ with the total bone 
length. (B) Proximal and distal GP length linear relationship with the total bone 
length was shown. Filled pattern = proximal GP length; non-filled pattern = distal 
GP length. (C) Regression plot of HZC volumes with the corresponding GP length 
was shown. Filled pattern = proximal GP HZ cell volume; non-filled pattern = 
distal GP HZ cell volume. Data are given as means ± S.E.M; from 3 separate 
animals (see Table 3.1) for all chondrocytic parameters and each GP and bone 
length. mc = metacarpal, mt = metatarsal, r = radius, fmr = femur, hmrs = humerus, 
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comprised the data from proximal and/ or distal GP. This showed a poor 
relationship between GPC HZ cell volume with the bone length (r2=0.394). 
Furthermore no relationship could be seen between GPC swelling from PZ to HZ, 
with bone length (r2=0.151). Figure 3.9B demonstrates the relationship between the 
GP lengths with the corresponding bone length. There was a good relationship (r2= 
0.829) between the proximal GP length and the bone length. However, the distal 
GP length showed a weak relationship with the length of the corresponding bone 
(r2=0.357). Figure 3.9C displays the hypertrophic GPC volume as plotted with the 
corresponding GP length. Linear regression test showed no association between the 
increase in the GP length with the volume of the hypertrophic GPC (r2=0.066). 
Further regression test analysis on the same data suggested the GPC swelling and 
HZ cell volume showed no significant contribution to the length of the 
corresponding bone. Likewise, the HZ volume exhibited no influence to the length 
of corresponding GP (r2 = 0.019). On the other hand, the length of proximal GP 
contributed significantly to the bone length (r2= 0.829); however, the distal GP 
length gave only very small influence to the bone length (r2=0.357). In general, this 
finding suggests that although there was a relationship between the GP length and 
the bone length, no clear relationship was observed between the HZ cell volume 
and the corresponding GP and bone length.  
3.4 Discussion  
This study highlights the differential growth among various growth plates of 
postnatal rats, which signify the complex regulatory mechanism involved in the 
longitudinal bone growth. Using the CLSM method, it was found that all in situ 
living GPs exhibited the cell differentiation cascade along the GP. The proliferative 
cell volume in all GPs was not significantly different; however the final 
hypertrophic GPC volume at the end of the differentiation cascade in different GPs 
was markedly varied depending on the bone under investigation. The hypertrophic 
GPC volume to some extent was influenced by the rate of hypertrophic cell 
formation along the GP. However there was no obvious relationship between the 
hypertrophic GPC volumes with the resulted bone length. 
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 Conventional histological methods on fixed tissue to study GP cells has 
commonly been used by many workers (Buckwalter et al., 1985; Buckwalter et al., 
1986; Hunziker et al., 1987b; Breur et al., 1991; Breur et al., 1994; Kuhn et al., 
1996; Noonan et al., 1998; Wilsman et al., 1996b; Wilsman et al., 2008). The use 
of the CLSM technique to study in situ living GP cells as in the present study has a 
number of advantages over the histological methods.  The in situ living cells could 
be visualized following labeling with calcein circumventing tissue processing steps 
which could potentially cause the alteration of the original morphology of the cells. 
Among these steps was the fixation of the GP tissue using conventional fixatives 
which was shown to cause significant shrinkage artifact to the GP cells due to their 
high osmolarity (see Chapter 4). Three dimensional morphology of the individual 
cell or the orientation of a group of cells could be viewed and examined using the 
CLSM imaging software. Using a calibrated quantification method (Bush and Hall, 
2001b), accurate volume measurement and other dimensional parameters could be 
performed on the 3-dimensional images of the proliferative cells through to the 
hypertrophic cells permitting the measurement of the volume changes along the 
GP. 
However as a note of caution, as the preparation of the tissue warranted the 
bisection of the bone to allow the fluorescence dye to be loaded into the cells, some 
cell death induced by the cut could not be avoided as what has been observed at the 
edge of articular cartilage cut where the nuclei of dead cells seen stained red by 
propidium iodide (Huntley et al., 2005). In this respect, it was noticed that the 
bigger the size of the cells the more the cells susceptible to the traumatic cell death 
(unpublished observation). The release of internal pressures upon bisecting the 
bone could also potentially lead to the changes the in vivo properties of the 
chondrocytes (Guilak and Mow, 2000). To minimize all these artefactual 
consequences, relatively deeper (>20 µm) optical planes were selected during the 
cell imaging to exclude any cut-induced dead cells or intact cells that exposed to 
the cut surface.  Possible GPC change (e.g. volume) over the period of 
measurement could be minimized by keeping the GP section under medium at all 
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times at 37o C until use; and keeping the imaging time as short as possible (~25 min 
per sample). 
 It was also noticed during the present experiments, some terminal large 
hypertrophic GPC that survived the cut injury and were close to the mineralized 
area tended to be stained poorly by calcein, and inevitably had to be excluded given 
that the poor quality image produced. The reason for this poor staining was not 
clear but could be for two different reasons. First, the terminal hypertrophic GPCs 
were mainly of the GPC cells undergoing degeneration and apoptosis (Farnum and 
Wilsman, 1989), in which might have relatively reduced levels of the esterases 
which metabolise the non-fluorescent dye molecules into fluorescent by-product 
upon entering the cell cytoplasm. Smaller GPC could take some time to die as 
shown by the slow deterioration of fluorescent staining intensity. Second, the 
terminal hypertrophic GPCs are metabolically active (Cowell et al., 1987; Farnum 
et al., 1990; Hunziker et al., 1987b) so can rapidly break down intracellular 
fluorescent molecules reducing the fluorescent intensity staining of hypertrophic 
cells if the imaging could only take place after several hours following the staining. 
If it was because of the first reason, it would not affect the validity of the data 
obtained but instead facilitated the exclusion of the dying cells from the present 
data acquisition and analysis. On the other hand, if it was due the second reason, 
the imaging of relatively larger hypertrophic GPCs had to be performed soon after 
calcein being loaded (after 1/2 to 1 hrs) to ensure decent quality of the fluorescent 
GPCs images could be obtained for later analysis before the fluorescence faded. 
Having taken this into account, scatter ranges were noted in the mean GP 
hypertrophic cell volume (S7-S8) in some GPs (Figure 3.4A, 4B, 4C and 5A). The 
possible explanation of this was the GPC within the HZ of the bone GPs showed 
wider range of cell volume than the other GP zones and could imply an important 
physiological property of the GP at the HZ. The physiological variation was 
especially observed in the HZ of proximal femur, distal femur, proximal humerus 
and pelvic ilium GPs.  
 The GPC along the GP displayed the profile of volume increase, which 
corresponded to the cascade of cell differentiation in the GP. The GPC volume 
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measurement demonstrated various profile of volume increase from PZ through to 
HZ, which appeared to be independent of the type of bones, GP locations 
(proximally or distally located) and load function (load-bearing bone or non-
bearing).  This was in line with the different GPC hypertrophy displayed by 
different GP. The GPC hypertrophy in the present work were determined by 
measuring two relevant parameters namely the GPC swelling and the HZ cell 
volume. The GPC swelling allowed us to determine the total volume increase in the 
PZ cell that gave rise to the final HZ cell volume, regardless of the rate of the cell 
transformation from proliferative to hypertrophic cell along the GP. The total cell 
volume increase ranged from around 2-18 fold increase. Since there was no 
significant difference in PZ cell volume among different GPs, the difference in the 
GPC swelling and HZ cell volume among different GPs implied a difference in the 
chondrocytic performance along the GPC differentiation cascade. When the rate of 
GPC hypertrophy over the GP section (S4-S8) was examined, which was 
represented by the slope of the semi-logarithmic volume increase plot, it appeared 
to have a good influence in determination of the HZ cell volume (r2=0.569; data not 
shown). This suggests that relatively higher HZ cell volume produced if the GPC is 
transformed swiftly towards the hypertrophic cell during the proliferative – 
hypertrophic cell differentiation process. General comparison among different GPs 
using the above-mentioned chondrocytic parameters showed the proximal tibia GP 
exhibited relatively high GPC swelling, large hypertrophic cell mean volume and 
high rate of the cell hypertrophy conversion from proliferative cell across the GP 
zones. Therefore it appeared that this GP was the most suitable GP to be used as a 
model for studying GP chondrocytic performance in P7 rat in future.  
In the present study the relationship between the GP lengths with the post 
natal bone length was examined. As shown in the results, the proximal and distal 
GP length showed distinct contribution to the bone length (r2=0.829 and r2=0.357 
respectively). However, the length of the GP was independent of the HZ cell 
volumes. The data showed that there was no clear relationship between the HZ cell 
volumes or rates of hypertrophy to the bone length which could be associated with 
the end result of longitudinal bone growth performance. This experiment was 
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repeated in older animals (10-month-old rats), and showed the same result of a lack 
relationship between the HZ cell volume with the adult bone length (data not 
shown). One possible explanation for this is that different growth plates even from 
the opposite cartilaginous ends of the same bone elongates at different rates at a 
given time point. This phenomenon of differential growth has been linked to the 
different hypertrophic GPC volume manifested by different GP at a given point of 
time (Wilsman et al., 1996b). Nevertheless, the net effect of the cell hypertrophy 
against the final bone length might not be seen at a single time point as in the 
present study. The involvement of other chondrocytic factors therefore, such as 
growth plate cell division and bone matrix deposition (Hunziker et al., 1987b; 
Wilsman et al., 2008) could not be ruled out to play some important roles in 
influencing the bone longitudinal growth at some stages. However the relative 
contributions of each could differ in GPs growing at different rates. Generally, 
cellular enlargement during hypertrophy is relatively more important in faster 
growing bone, whereas matrix synthesis makes a more important contribution in 
those growth plates that have slower growth rates (Wilsman et al., 1996b). At the 
same time, the regulation for GPC hypertrophy must be tightly coupled with the 
controls for proliferation, as the regulation of kinetics of either proliferation or 
hypertrophy or both determine the final growth velocity of each different bone 
(Wilsman et al., 2008).  
Those results allude to the importance of locally mediated regulatory 
controls of GP elongation (Wilsman et al., 1996a), that could tailor the need of 
individual bone accordingly which has a specific final bone length as the end 
product (see Figure 3.10 for comparison of different bone length increases in 
various bones of rats from day 7 to week 40 of age). This is the complement to 
systemic control systems such as hormones, growth factors and nutrient status 
(Hunziker et al., 1994; Loveridge, 1993; Nilsson et al., 2005), which 
simultaneously controls the overall regulation of chondrocytic performance in all 
GPs. However, there was no clear evidence that the load bearing factor inherited by 
certain GP played any role in the differential growth phenomenon as shown in the 
present results. The relative contributions of the three factors (cell proliferation,  
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Figure 3.10 Comparison of bone lengths between P7 and 40-week-old rats. The 
lengths of various bones were measured from Sprague Dawley rats at two different 
ages. The differences in length (%) between the two age groups, which represent 
the bone length increase between the two periods, are shown on top of each 
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cell hypertrophy and matrix deposition) to bone elongation in the postnatal animal 
have been quantitatively evaluated previously using stereological estimation 
method (Hunziker, 1987b; Wilsman et al., 2008; Wilsman et al., 1996b). The 
previous results suggested the importance of other factors than HZ cell volume to 
the bone lengthening growth in some bones. Future experiment could be designed 
to study the topic using the living in vivo GPC model (as used in the present study) 
since multiple chondrocytic variables could be directly quantified using this 
method and no longer based on mathematical models as in the previous reports.  
An interesting question that arises when observing the variety in GPC volume 
increase and the HZ cell volume between opposite GPs of the same bone (i.e. 
proximal and distal ends) is whether the cumulative performance produced between 
the two GPs is tightly controlled in order to finally produce a specific final 
shape and length of the respective bone.  Does any perturbation in one GP trigger 
compensatory consequence in the other GP of the same bone? To answer this 
question, the analytical approach in the present study, which measured the GPC 
volume increase and HZ cell volume among different GPs individually should be 
optimized by also looking at the cumulative effect of the studied chondrocytic 
variables from the two opposite GPs of the same bone to the final bone length. The 
contributions of the chondrocytic variables studied in the present work (i.e. GPC 
volume increase, HZ cell volume, GP length) to the final bone length could be 
different if the cumulative effect of the variables could be taken into account in the 
quantitative analysis. 
The results also point out the different shape and orientation among 
different GPs as the cells differentiated from PZ to HZ. It was noted that as the 
GPC volume increases towards the hypertrophic zone, the length, width and depth 
of the cell were also increased. It was also found that based on the comparison 
between two long bones with clearly different length (tibia and radius), GPC in the 
longer bone demonstrated preferential GPC length increase over the width and 
depth than the shorter bone. As shown in the present study, the GPC volume 
increase of proximal tibia GP was followed by 2.9-fold increase in the GPC length 
as compared to 1.8-fold increase for proximal radius GP. The previous study has 
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shown this GPC preferential growth character in digital bone GP of two other 
mammalian namely laboratory rat and big brown bat (Farnum et al., 2008) and it 
seemed the GPC length increase in the direction of the bone growth is the 
important feature of GPC hypertrophy that could confer the key contribution to the 
longitudinal bone growth. The preferential linear dimensional increases of GPC at a 
single direction instead of equally in all directions as the volume increases could 
imply the involvement of complex control of the cell morphology, possibly 
intracellular cyto-skeletal elements (Iscru et al., 2008) and intracellular 
microtubules to the final GPC shape modulation (Farquharson et al., 1999). 
 The GPC hypertrophy has been postulated to some extent to involve the 
transporters of the GPC plasma membrane (Bush et al., 2010) in mediating the cell 
swelling or hypertrophy during GPC differentiation. In view of the present 
findings, it would be interesting to know how GPC volume was regulated 
differently at different time points throughout the phase of longitudinal bone 
growth. If plasma membrane transporters have important roles in the GPC 
hypertrophy, it is then intriguing to know whether membrane transporter(s) is 
expressed at different time at a particular zone of GPC differentiation cascade 
during the active phase of the bone growth.  
In conclusion, the results of the present study underline the significant 
phenomenon of differential growth among different growth plates. All postnatal 
GPs showed cell differentiation cascade manifested by GPC volume increase and 
change in the cell shape particularly the cell length. However, different GPs had 
distinct postnatal GPC volume increase and HZ cell volume. In addition, there was 
no apparent relationship between the post natal GPC hypertrophy with bone length, 
which suggests the overall bone length could not possibly be determined by a 
change in HZ cell volume at a single time point (e.g. day-7 post natal) but instead 
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4.1 Introduction 
The accurate study of the morphology of living cells as they appear within tissues 
is difficult but fundamental for an understanding of normal cell biology, and the 
changes that occur in disease states.  Accordingly a vast amount of research has 
been performed on chemically-fixed cells and tissues, with the intention of 
retaining the fine morphology and constituents of living in situ cells so that they 
can be studied without the complications of deleterious changes to cell metabolism 
and loss of viability during the investigation (see Hopwood, 1985). In addition, 
tissue fixation should protect against cell autolysis, attack by bacteria, and changes 
to cell volume and shape especially during subsequent preparative treatment 
(Baker, 1960) when tissue dehydration is frequently performed. Thus, fixative 
solutions should serve to stabilize the specimen and protect it from rigorous 
physical tissue processing and staining as required for study (Hopwood, 1969). The 
particular research emphasis of this chapter has been on the cellular mechanisms 
underlying the structure and function of the mammalian growth plate. There has 
been extensive study on chemically-fixed growth plates, and particular interest in 
the remarkable increase in chondrocyte volume which is a major determinant of 
bone growth (Buckwalter et al., 1986). The large volumes of growth plate 
chondrocytes (typically ranging from 1,000 to 10,000 µm3; Bush et al., 2008b) 
potentially makes them extremely sensitive to osmotic artifacts during fixation. 
Para-formaldehyde (PFA) and glutaraldehyde (GA) and their combinations 
have long been used as fixative solutions (Fox et al., 1985; Hopwood, 1969) to 
retain tissue and cell properties (Kiernan, 1999; Renshaw, 2007). Examples of 
these aldehyde preparations used conventionally are (a) 4% (w/v) PFA (Fox et al., 
1985; Hosoya et al., 2005; solution A, Table 4.1 which has the same formaldehyde 
concentration (4%) as 10% Formalin (Kiernan, 1999)), (b) 2% (w/v) GA & RHT 
(ruthenium hexamine trichloride) combined with 2% (w/v) PFA (Farnum et al., 
2002; solution B, Table 4.1) and (c) 2% GA (w/v) with 0.7% (w/v) RHT (Hunziker 
et al., 1983; solution C see Table 4.1). Although the fixative properties have been 
widely known, less appreciated is the fact that the osmolarity of these solutions is 
markedly greater than that of typical physiological extracellular solutions (Table 
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4.1). The osmolarity of the fixative solutions and their effects on cell and tissue 
morphology have received relatively little attention recently – indeed often appear 
ignored – despite the fact that there are studies in the literature highlighting this 
issue. For example, Schultz and Karlsson (1965) observed that hypertonic fixative 
solutions perfused into the central nervous system caused cellular shrinkage and 
increased extracellular spaces, whereas isotonic (300-320 mOsm) and hypotonic 
fixatives could result in cell swelling. Mathieu et al., (1978) have reported the 
importance of both the concentration of GA and the molarity of the vehicle used for 
the fixative solution for the preservation of lung tissue. Even with these early 
studies, there are recent examples of investigators using hyper-osmolar fixative 
solutions (Farnum  et al., 2002) but little if any comment on the morphology of the 
fixed cells which frequently appear shrunken/distorted (Buckwalter  et al., 1985; 
Erben, 1997; Hosoya  et al., 2005; Kouri  et al., 1996; Lee  et al., 1996; Ross  and  
Reith, 1985; Sanchez  et al., 2000; Van Der Eerden  et al., 2000) and no attempt at 
quantification of the shrinkage artifact. The present study, therefore (a) re-visited 
this issue to emphasize the importance of osmotic correction to fixative solutions in 
order to retain cell morphology and (b) provide quantitative data on the extent of 
cell shrinkage and specifically report on the influence of fixative osmolarity on 
connective tissue cells.  
During preliminary experiments when we were attempting to optimize the 
chemical fixation protocols for mammalian growth plates to permit a detailed 
morphological study of hypertrophic zone chondrocytes, we noticed that their 
appearance in histological sections obtained from whole bones fixed with 
conventional fixatives was markedly different compared to sagittally sectioned 
bones fixed using exactly the same methods. The morphology of the cells in the 
whole bone fixed samples appeared considerably mis-shapen and shrunken, 
whereas in the bisected bone morphology was relatively normal. From our previous 
studies on the shape/volume of chondrocytes exposed to osmotic challenge (Bush 
& Hall, 2001b) we suspected that an artifact of the relatively high osmotic pressure 
of the fixative solution could be responsible.  
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Thus, in the present study, using standard fixative solutions which are widely 
used in the histological preparation of tissues, experiments were undertaken to 
quantify the osmotic shrinkage effect on hypertrophic growth plate chondrocytes. 
The present data show that a shrinkage artifact is particularly marked when whole 
bones were chemically fixed, and significantly reduced when bones are sagittally 
bisected prior to fixation. The present findings also demonstrate that adjusting the 
fixative solution to an osmolarity close to that of typical extracellular solutions 
(approx. 280 mOsm; (solution D, Table 4.1) abolishes the artifact. 
4.2 Materials and Methods 
4.2.1 Animals and Growth Plate Preparation 
The tibia of each limb with intact proximal GP from twenty-five Sprague-Dawley 
rats (7-day-old; P7) was prepared as described previously (2.1.3). 
For the preparation of samples for histology, fifty tibias from 25 animals 
were used and placed in fixative solutions of differing composition as follows: (a) 
conventional fixative solutions (Table 4.1), (b) fixatives with GA concentration 
maintained constant, but with osmolarity similar to that used for conventional 
fixative solutions (Table 4.2), and (c) fixatives with various concentrations of GA 
but with osmolarity maintained at approx. 550 mOsm (Table 4.3). The growth 
plates were fixed for 24 hrs at room temperature for subsequent paraffin-
embedding for histological sectioning. For group (a) three intact tibias and 3 
bisected tibias were fixed in each fixative solution, whereas in group (b) and (c), 
three and five intact tibias were used in each fixative solution respectively. 
For the preparation of growth plates for the analysis of in situ growth plate 
chondrocyte (GPC) volume, 15 tibias from 8 rat pups were used. They were 
grouped into two: (i) five bones maintained intact, and (ii) ten bones that were 
bisected sagittally (Figure 4.6(A)). Both groups of bones were incubated with 
either CMFDA-green for 60 mins (if the bones were subsequently fixed) or calcein 
AM (for non-fixed bones). Then, all bones from group (i) and four bones from 
group (ii) were fixed in solution A. The other three bones from group (ii) were 
fixed in osmotically-corrected fixative solution (solution D, Table 4.1). All the 
bones were fixed for 24 hrs at room temperature. The remaining 3 bones in group  
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Table 4.1 Composition of fixative solutions used in the study. Fixative solutions 
were prepared as described in the references cited which reported the morphology 
of growth plate chondrocytes following fixation. For solution A, distilled water was 
used instead of cacodylate buffer. Fixative solution D was prepared by diluting 
solution C with distilled water. [Concentrations are given as % (v/v) for GA= 
glutaraldehyde and PFA= paraformaldehyde, and as % (w/v) for RHT= ruthenium 
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Fixative Solution Cacodylate 




280 0.7% RHT + 1% GA 50 6.76 273 ± 13 
480 0.7% RHT + 1% GA 50 6.60 467 ± 28 
640 0.7% RHT + 1% GA 50 6.55 637 ± 20 
1200 0.7% RHT + 1% GA 50 6.49 1141 ± 116 
 
Table 4.2 Modified fixative solutions with constant concentrations of GA and 
RHT, but with osmolarity varied using NaCl. Fixative solutions were prepared 
with the constituents at the concentrations indicated (see Materials and Methods), 
with the osmolarities and pH of the resulting solutions as shown. Concentrations 
are given as % (w/v) for RHT, and % (v/v) for GA. Data expressed as means ± 















0.5GA 0.7% RHT + GA 0.5 50 6.81 543 ± 1 
1GA 0.7% RHT + GA 1.0 50 6.73 542 ± 4 
2GA 0.7% RHT + GA 2.0 50 6.72 556 ± 18 
4GA 0.7% RHT + GA 4.0 50 6.35 577 ± 11 
 
Table 4.3 Modified fixative solutions with varying GA concentration, but with 
similar final osmolarity. Fixative solutions were prepared with the constituents 
including different GA concentrations (% v/v) as indicated (see Materials and 
Methods), with the osmolarities of the resulting solutions as shown. Concentrations of 
RHT are given as % (v/v). Data expressed as means ± S.E.M from at least 3 
independent determinations. 
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(ii) were maintained unfixed for in situ living cell imaging. The osmolarity of all 
solutions was determined using a freezing point micro-osmometer (Model 3300, 
Vitech Scientific Ltd., Partridge Green, U.K.) with solid NaCl or distilled water 
added to adjust the osmolarity to the required range. The pH of all solutions was 
measured at room temperature using a SevenEasyTM pH meter (Mettler Toledo, 
UK) with the pH of fixative solutions altered as required by adding either HCl or 
NaOH. 
 
4.2.2 Histology of the Growth Plate 
Bones were embedded in paraffin wax using a standard procedure as described in 
2.3.2. The sections were then mounted on poly-l-lysine-coated microscope slides 
(PolysineTM, VWR International, Leicestershire, UK) and dried overnight. After 
removing paraffin, the sections were stained with 0.1% (w/v) Toluidine blue O (see 
2.3.3.1). 
4.2.3 Measurement of Growth Plate Chondrocyte Shrinkage 
Histological sections of fixed hypertrophic GPC stained with 0.1% Toluidine blue 
O were observed under an x63 (oil-immersion) objective lens. Several histological 
views of chondrocytes within sections S5 and S6 of the hypertrophic zone (see 
details in the section In situ volume measurement (below), and Figure 4.1(A)) were 
randomly selected and the images recorded using a mounted digital camera 
(Coolpix 4500, Nikon, Japan) with Coolpix MDC2 Relay lens (MXA 2900, Nikon, 
Japan). The captured images were then transferred to a computer for further image 
analysis. Java-based scientific image processing software (ImageJ, NIH, Bethesda, 
Maryland, U.S.A.) was then used to measure the cell shrinkage from the images of 
the histological sections.  
In order to determine the extent of chondrocyte shrinkage it was necessary 
to identify the area of individual chondrocytes and that of their lacuna – i.e. the 
‘cavity’ in which the cell resided. It was in fact relatively straightforward to do this 
as the outermost edge of the cell area stained distinctly with Toluidine blue O, and 
the perimeter of the corresponding lacuna was identified as the edge of the 
extracellular matrix that demarcated the border between the stained area of the 
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matrix and the ‘space’ of the lacuna which was relatively unstained. It was noted 
that the area of the lacuna could only be observed if there was cell shrinkage. For 
each group of treatments, 4 fields of view from each image were selected and up to 
11 cells and their corresponding lacunae randomly taken for area measurement. 
The area of each cell and that of its associated lacuna were selected by outlining 
their perimeters using the freehand selection tool (see Figure 4.2A), panel a). The 
total area of the cell and its lacuna were then determined using the ‘analyze’ and 
‘measure’ toolbar in the software. Cell shrinkage was calculated as {100 – [(cell 
area/lacuna area) x 100]} and expressed as a percentage of the initial volume (see 
Fig. 4.2A(a)). When the cell and its corresponding lacuna shared the same 
perimeter, the value of cell shrinkage was defined as zero as defined above. 
4.2.4 Confocal Laser Scanning microscopy 
An upright Zeiss Axioskop LSM 510 CLSM was used to acquire fluorescent 
images of in situ hypertrophic growth plate chondrocytes using the protocol that 
has been described previously (2.4.2). 
 
4.2.5 In situ Volume Measurement 
Whole growth plates imaged from the proliferative to hypertrophic zones were 
divided into eight equal parts and labeled S1 to S8 (Figure 4.1(A)). This was done 
so that a comparative analysis could be made between corresponding sections from 
different individuals (see 2.5.1). Since the greatest number of hypertrophic cells 
that was consistently found to be intact was in the sections S5 and S6, the in situ 
growth plate cell volume analysis was performed only at these sections. 
Chondrocytes in S7-S8 often appeared to be in poor condition, possibly as a result 
of cutting trauma during the preparation of the tissue (Huntley et al., 2005; Amin et 
al., 2008). Volume analysis was performed using high performance 3D imaging 
software (Volocity®) on scanned CLSM images using the calibrated cell volume 
method as previously described (2.5.2).  
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4.3 Results 
4.3.1 Volume and Morphology of Rat Growth Plate Chondrocytes 
Initially, to determine live cell volumes and the morphology of in situ, unfixed 
chondrocytes, in situ growth plate chondrocytes were labelled with calcein as 
shown (Fig. 4.1). Imaging of the fluorescently-labelled in situ living growth plate 
chondrocytes demonstrated a clear increase in the size of GPC from the 
proliferative through to hypertrophic zones (Fig. 4.1(a)). Chondrocytes within the 
proliferative zone (between the reserve and hypertrophic zone) appeared ellipsoidal 
and usually arranged in columns of at least three to eight cells. In the hypertrophic 
zone (between the proliferative zone and the zone of calcification) the cells were 
larger and frequently more rounded although there were cells with a height greater 
than half of the cell’s width (Buckwalter et al., 1985; Farnum and Wilsman, 1986). 
In accordance with the visual appearance of chondrocytes along the growth 
plate, the quantified volume of in situ cells increased although it was clearly not a 
linear process as there was a relatively poor fit to a linear regression (correlation 
coefficient r2 = 0.793). The volume increase was initially gradual through to S5, 
but then became more rapid from S5-S8 similar to an exponential growth 
relationship (Fig. 4.1(b)). When the volume data were transformed to log10 and 
plotted semi-logarithmically (see inset to Fig. 4.1(b)) there was a much better fit to 
the data (r2 = 0.955) supporting the notion of a logarithmic increase in chondrocyte 
volume associated with hypertrophy. In the present study, a focus was made on 
chondrocytes within these latter sections of the growth plate. Although the 
shrinkage artifact was apparent in the smaller cells, it was very difficult to quantify 
the phenomenon. It was found that using our imaging methods (see Materials and 
Methods) the distinction between the perimeter of the lacuna and the cell edges of 
smaller (shrunken) cells was difficult to determine accurately, resulting in large 
variations. Therefore, the phenomenon was studied only on chondrocytes in the 
hypertrophic zone to ensure accurate measurements, and the cells within S5-S6 
were chosen because an adequate number of intact cells from these segments could 
consistently be observed. 
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Figure 4.1. Overview of the rat growth plate, and division of in situ living rat 
chondrocytes (GPC) into sections from proliferative to hypertrophic zones. 
Living chondrocytes in a bisected proximal tibia of a 7-day-old rat pup were 
labeled with calcein AM, and sequential CLSM images taken with a x63 water-
dipping objective (see Materials and Methods). Panel (A) demonstrates the 
projected image of a section of the growth plate showing the increase in 
chondrocyte volume from proliferative to hypertrophic zone. The zones were 
divided into eight equal sections (labeled S1-S8) from early proliferative zone to 
late hypertrophic zone. Panel (B) shows the changes in the volume along the 
growth plate sections as measured using Volocity® software on living in situ 
growth plate chondrocyte images captured with CLSM. Also shown is an inset 
where the same data points were transformed to log10. (Data shown are means ± 
S.E.M. or S.D. as appropriate, with n = 2 for S1-S4 and S7-S8, and n = 3 for S5-S6; 
and at least N=15 cells measured at each section). 
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4.3.2 Measurement of Cell Shrinkage 
The accuracy of the method used for assessing chondrocyte shrinkage in 
histological sections as described in Materials & Methods (Fig. 4.2A(a)) was 
initially determined by measuring the area of GPC cells that had distinct and well-
defined perimeters. The cell measurement was made independently using the free-
hand selection tool on the same cell twice and the difference between the two 
readings compared. The mean difference between the two measurements was 
2.7±1.9 % (mean ± S.D., for 11 cells) indicating the measurement method had an 
appropriate level of accuracy.  
4.3.3 Morphology of Growth Plate Chondrocytes Fixed Using 
Conventional Solutions 
An ideal fixative should successfully preserve tissue for subsequent staining 
procedures, but it is important to accurately retain the original morphology of the 
living cells in the tissue, free from artifacts occurring during the fixation process. 
To demonstrate the morphology of GPC fixed with conventional fixatives (Farnum 
et al., 2002; Hosoya  et al., 2005; Hunziker  et al., 1983), we used three standard 
and widely-used solutions (Table 4.1). These fixative solutions were all hyper-
osmotic (Table 4.1), and therefore for comparison an iso-osmotic fixative with 
osmolarity adjusted to close to that of typical extracellular physiological solutions 
(280 mOsm; Table 4.1), was also included.  
 In whole (non-bisected) bone samples, fixed and processed as described for 
histology (see Materials and Methods), there was a clear cell shrinkage artifact 
observed in tissue fixed with the three conventional fixatives (solutions A, B & C; 
Table 4.1; Fig. 4.2A(a-c)). Among the three fixatives, chondrocyte shrinkage 
assessed visually was most marked for solutions A and B and least for solution C 
(Fig. 4.2A(c,d)). When osmotically corrected solution D (~280 mOsm) was used, 
no apparent cell shrinkage was observed (Fig. 4.2A(d)). Quantitatively, solution A 
caused the highest cell shrinkage (44 ± 3 % (3[44])), followed by tissue fixed in 
solution B (31 ± 4% (3[44]), then cells in solution C 17 ± 5% (3[44]) and finally 
for the osmotically-corrected fixative solution D, there was no measurable cell  
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Figure 4.2A. Conventional fixatives cause considerable shrinkage of 
hypertrophic growth plate chondrocytes when applied to whole (intact) bones. 
Intact proximal tibias of 7-day-old rat pups were fixed using various standard 
fixative solutions (Table 4.1) and sections prepared and stained with 0.1% 
Toluidine blue O (see Materials and Methods). The method used to calculate the 
extent of chondrocyte shrinkage was illustrated in panel a. The thick white line was 
drawn free-hand around the perimeter of the lacuna and the black broken line drawn 
around the membrane edge of its resident chondrocyte (see details in Materials and 
Methods). The gap between the cells and the border of the lacuna is illustrated by 
double headed arrows. Cell shrinkage was observed in all conventional fixatives 
(panels a - c) but not when the osmolarity of the fixative was adjusted to a 
‘physiological’ osmolarity (panel d). For pooled data see Figure 4.3. The scale bar 
of 20µm in this and the following Figure applied to all panels.  
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shrinkage (5.5 ± 0.8% (3[44])). When analysing the extent of the shrinkage from 
solutions A to D (lowering osmolarity, Table 4.1), there was a significantly 
decreasing trend (one-way ANOVA test; p = 0.010) however only the shrinkage for 
cells in solutions A and B were significantly different (unpaired Student’s t-test, 
p<0.05) from the osmotically-corrected fixative solution D. Note that although 
shrunken cells were routinely observed microscopically in cells fixed in solution C 
(Fig. 4.2A(c)) the pooled data did not show a significant difference and this was 
mainly because of the range in the magnitude of the shrinkage effect.  
In bisected bones (Fig. 4.2B), microscopic inspection showed clearly that 
the extent of the chondrocyte shrinking artifact was considerably reduced with the 
four fixatives when compared to the cells within fixed whole bones (Fig. 4.2A(a-
d)). When the shrinkage was quantified (Fig. 4.3B), the same decreasing trend in 
cell shrinkage with the four fixatives was also observed and the trend significant 
over the whole range (one-way ANOVA test; p = 0.024). The absolute level of 
shrinkage and the trend with decreasing osmolarity, was less compared to the data 
for intact bones (Fig. 4.3A). When the data sets for intact and bisected bones over 
the range of fixatives were compared using a two-way ANOVA, the difference was 
significant (p=0.004). In solution A cell shrinkage in bisected bones was 22 ± 
2.6%, which was significantly less than the shrinkage of chondrocytes fixed in 
intact tibias (p = 0.030). Fixative solution B caused 17 ± 1.4% (3[44]) shrinkage 
whereas solution C caused 9 ± 0.4% (3[44]) cell shrinkage and these values were 
less than for intact bones but did not reach the level of significance (p> 0.05). Cell 
shrinkage in the iso-osmotic fixative solution D for GPC in bisected bones was 
only 4 ± 0.4% (3[44]; Fig. 4.3) and this was not significantly different from the 
data in intact bones (see above). These results showed that the shrinkage artifact 
was considerably reduced if the bones were bisected prior to fixation, and with 
osmotic correction, there was no shrinkage artifact of GPC in either intact or 
bisected bones. 
As noted in Table 4.1, the pH of the fixatives varied over the range 5.67 to 
7.11, which was the result of different types and concentration of fixative agents 
and buffer concentration. A further experiment to examine whether pH contributed  
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Figure 4.2B. Reduced cell shrinkage in GPC of sagittally-bisected bones 
following fixation. Bisected sections prepared and stained with 0.1% Toluidine 
blue O (see Materials and Methods). With these bisected bones the extent of cell 
shrinkage was markedly less compared to the intact bones (Figure 4.2A) and 
shrunken chondrocytes were only occasionally observed as illustrated by the double 
headed arrows (panel a). The morphology of chondrocytes within the three other 






Chapter 4: Shrinkage Artifact with Conventional Fixatives 








Figure 4.3A. Growth plate chondrocyte shrinkage in histological sections from 
intact bones fixed in four different solutions. Cell shrinkage of in situ 
chondrocytes fixed in solutions A (1148 ± 2 mOsm), B (1135 ± 32 mOsm), C (420 
± 20 mOsm)or D (270 ± 10 mOsm) (for composition see Table 4.1) in intact tibias 
from 7 day-old rats were measured as described (see Materials and Methods). Data 
in this and the subsequent Figure were from at least (3[44]) for each condition. In 
this and the following Figure, P values for unpaired Student’s t-tests are shown. 
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Figure 4.3B. Growth plate chondrocyte shrinkage in histological sections from 
bisected bones fixed in four different solutions. Cell shrinkage of in situ 
chondrocytes fixed in solutions A (1148 ± 2 mOsm), B (1135 ± 32 mOsm), C (420 
± 20 mOsm)or D (270 ± 10 mOsm) (Table 4.1) in sagitally-bisected tibias from 7 
day-old rats were measured as described (see Materials and Methods). A single 
asterisk (*) denoted a significant difference when the two-way ANOVA tested the 
trend of cell shrinkage between intact and bisected bones in various fixative 
solutions. A double asterisk (**) denoted a significant difference compared to the 
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significantly to the quality of tissue preservation was conducted. Two pH values 
(i.e. 5.6 and 7.2) were tested using the same fixative solution (solution D) to fix 
two groups of growth plate tissue from proximal tibia of P7 rats (n=3). Using the 
same method to quantify the cell shrinkage as described previously, the result 
showed that at pH 5.7 there was 8 ± 0.6 % (mean ± S.E.M.) cell shrinkage, whereas 
at pH 7.2 there was 7 ± 1.5 % of cell shrinkage. These were not significantly 
different (p<0.05) and so we concluded that pH over this range had a negligible 
effect on cell shrinkage compared to the osmolarity of the fixative solutions. 
4.3.4 Fixation of GPC Using Different Concentrations and Osmolarities 
of Glutaraldehyde (GA) Solution 
To test whether the osmolarity or concentration of fixative was responsible for the 
shrinkage artefact, whole bones were immersed in solutions with varying 
osmolarity (273-1141 mOsm) and standard fixative concentrations (GA 1%, RHT 
0.7%; Table 4.2), or in solutions varying fixative concentration (GA 0.5-4%) whilst 
maintaining osmolarity relatively constant (555± 8 mOsm; Table 4.3). At the 
lowest osmolarity (273 ± 13 mOsm), cell shrinkage was minimal (13 ± 0.6% 
(3[44])), but as it was raised, there was a progressive and significant increase 
(ANOVA, p<0.001) in the extent of cell shrinkage (Fig. 4.4(A)). At the highest 
osmolarity studied (1141 mOsm) cell shrinkage was 52 ± 1.6% (3[44]) and 
significantly greater (unpaired Student’s t-Test, p<0.001 for both) than the 
shrinkage observed in 273 and 467 mOsm solutions. When the GA concentration 
was varied over the range 0.5 to 4%, but with the osmolarity of all solutions 
maintained constant, the shrinkage of GPC fixed in intact bones with 1%, 2% and 
4% GA was 15 ± 2.4%, 12 ± 0.5%, and 16 ± 2.1% respectively, and not 
significantly different (p>0.05; data from at least (5[44]); Fig. 4.4(B)). It was 
notable that GA at 0.5% showed slightly higher cell shrinkage (25 ± 4.1% (5[44])) 
compared to 1% GA, but this was not significantly different from the lowest cell 
shrinkage produced by GA at 2% (p > 0.05). The morphology of a noticeable 
number of these cells was abnormal, suggesting that they were not properly fixed, 
and thus it was possible that the cells were susceptible to the post-fixation  
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Figure 4.4A. Chondrocyte shrinkage increased with elevated osmolarity of the 
fixative solution. Whole bones were fixed in solutions composed of 1% GA and 
0.7% RHT, with osmolarity varied over the range 273 to 1141 mOsm by the 
addition of NaCl (see Table 4.2). Shrinkage of GPC was determined as described 
(see Materials and Methods, and Fig. 4.2(A(a))). Data were from at least 3 animals 
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Figure 4.4B. There was no difference in cell shrinkage with an increase of 
fixative concentration if osmolarity was kept constant. Whole bones were fixed 
in fixative solutions with the GA concentration varied over the range 0.5 to 4%, but 
with the osmolarity maintained constant at ~550 mOsm (see Table 4.3 for 
composition of solutions). Shrinkage of GPC was determined as described (see 
Materials and Methods, and Fig. 4.2(A(a)). There was no significant difference 
between any pairs of data (Student’s unpaired t-test). Data were from at least 
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dehydration protocols (unpublished observations).Taken together, these data 
suggest that the shrinkage and morphological changes of GPC fixed using standard 
solutions could be accounted for by the osmolarity of the fixative solutions and not 
by the concentration of the fixative. 
4.3.5 In situ Growth Plate Chondrocyte Volume Following Fixation in 
Solution A in Intact and Bisected Bones 
The volume of in situ GPC within intact or sagittally-bisected bones and fixed 
under various conditions was also assessed using another method.  Solution A was 
chosen as it had the highest osmolarity among the different conventional fixative 
solutions used in the present study and has been used previously in the study of 
growth plate chondrocytes (see Table 4.1). Images of fluorescently-labelled in situ 
chondrocytes taken by Clhands howeverSM showed the majority of cells with 
abnormal shrunken morphology in intact bone fixed with this solution (Fig. 4.5(a)). 
When the bone was sagitally bisected and then fixed using the same solution, the 
proportion of shrunken chondrocytes was markedly less (Fig. 4.5(b)), and similarly 
when these bones were fixed in the osmotically-corrected solution (solution D, 
Table 4.1) there were almost no shrunken cells observed (Fig. 4.5(c)) with the cells 
appearing morphologically normal. The volume of GPC fixed in the intact bone 
was only 40% of those fixed in the bisected bone (Table 4.4; unpaired t-Test: p = 
0.016, n=5). For comparison, GPCs volume of living non-fixed bone and of 
bisected bone fixed in solution D was not significantly different from the GPC 
volume of bisected bone fixed in solution A (unpaired t-Tests, p>0.05). However, 
the GPC fixed in solution A showed no significant volume decrease than the GPC 
fixed in solution D and non-fixed GPC as expected due to cell shrinkage, as shown 
previously (Figure 4.3B). The reason for this was not immediately obvious, 
although it should be noted that the errors associated with the measurement of in 
situ GPC volume were relatively large (Table 4.4). In summary, the reduction in 
cell volume was significantly greater for GPC within intact bones compared to 
bisected bones when fixed in a conventional fixative solution (Table 4.4).  
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Figure 4.5 Reduced volume and altered morphology of in situ GPC fixed 
within intact bone compared to those within bisected bones. Panels (a-c) 
showed the typical appearance of fluorescently (CMFDA-green)-labeled 
chondrocytes within intact (panel a) or bisected (panels b, c) bones, and fixed under 
the various conditions indicated. The shrinkage of some cells was observed in the 
fixed in situ cells (examples indicated with white arrows, panels a and b) but not in 
the osmotically-corrected fixative solution D (panel c). Panel (d) shows the 
appearance of unfixed (i.e. living) in situ hypertrophic GPCs labeled with calcein. 
All images were taken by CLSM using a x63 water-dipping objective. Cell volume 
measurements were performed as described (see Materials and Methods) with 
pooled data given in Table 4.4. Details of the composition of fixative solutions are 
given in Table 4.1. Scale bar = 20 µm. 
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Nature of the 
bone specimen 




Intact PFA 4% (solution A) 1698 ± 166* 
Bisected PFA 4% (solution A) 4064 ± 571 
Bisected GA 1.3% + RHT 0.5% (solution D) 3389 ± 659 
Bisected No fixative 3411 ± 1148 
 
Table 4.4 Reduction of in situ GPC volume in fixed intact bones compared to 
bisected bones. CMFDA-labeled in situ chondrocytes were fixed under the 
conditions shown (see Figure 4.5), their volume determined as described (see 
Materials and Methods) and the pooled data presented. Data (as means ± S.E.M.) 
are from n = 5 animals with 5-29 chondrocytes measured from each animal. 
*Denotes a significant difference (Student’s unpaired t-test) between the data for 
the intact bone and the three other solutions. 
 
4.4 Discussion 
This study demonstrated that the osmolarity of fixative solutions was of critical 
importance for maintaining the normal morphology of in situ hypertrophic 
chondrocytes within the mammalian growth plate following chemical fixation. The 
shrinkage artifact evident when using conventional fixatives, was abolished when 
the osmolarity of the medium was reduced to close to that of normal physiological 
solutions or markedly reduced when the bones were sagitally bisected prior to 
fixation. These results raise important issues in relation to the accurate preservation 
of cell morphology by these widely-used chemical fixative solutions.  
 The first point to consider is the identification of a fixative concentration 
that ensured proper fixation of the cells/tissue without the osmolarity being too 
high to cause a shrinkage artifact and the present data suggest that solution D was 
optimal (Table 4.1; Fig. 4.3). This osmolarity would be close to that normally 
present in physiological extracellular solutions meaning that the osmolarity of the 
cells within the extracellular matrix of the growth plate would similarly be optimal 
for normal chondrocyte morphology. (Note however that the exact extracellular 
osmolarity around the GPC will most likely be higher due to the presence of 
glycosaminoglycans present in the extracellular matrix (Urban et al., 1993)). A 
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lower concentration of GA (0.5%) produced what appeared to be a shrinkage 
artifact (Fig. 4.4B) but although individual shrunken cells were present on visual 
examination, statistical analysis of pooled data showed this was not significant. 
However we would caution against using such a low concentration as the fine 
appearance of the cells suggested that there were cells that were not properly fixed, 
resulting in morphological changes/distortions during post-fixation protocols 
(unpublished observations). Previous studies have, however, successfully utilized 
low fixative concentrations. For example Maunsbach (1966) investigating the 
kidney and Hopwood (1967) studying the brain noted that GA was an effective 
fixative down to 0.25% (Hopwood, 1967; Maunsbach, 1966). It is possible that low 
fixative concentrations could be used successfully in these studies because of the 
different physical nature of hard tissues compared to soft tissues, as in the latter the 
diffusion rate and thus penetration of the fixative would be expected to be 
considerably greater. The present findings were in general agreement with a 
previous report that identified the importance of fixative osmolarity to produce 
correct soft tissue preservation. Mathieu et al., (1978) reported both the GA 
percentage and molarity of the fixative vehicle were of importance for the 
preservation of lung tissue. In this study, they noted the shrinkage was induced by 
the osmolarity of buffer and fixative combined, as evidenced by shape changes of 
erythrocytes in capillaries and small vessels of the trachea, and a reduction in the 
air-blood tissue barrier of the trachea with different fixative osmolarities. Higher 
fixative concentrations (e.g. 2-4% GA) could of course be used for some 
applications where cell shrinkage is not a concern (e.g. for tissue perfusion fixation 
(Santoreneos et al., 1998) or biomaterial fixation (Nuss et al., 2006)), but clearly 
the results from the present study emphasize the importance of researchers being 
aware of the potential for an osmotic shrinkage artifact to cell shape.  
In the present study RHT (ruthenium hexamine trichloride) was included in 
most of the fixative solutions (Table 4.1). Hunziker et al., (1982) have proposed 
that this cationic dye stabilized the GPC plasma membrane within the lacuna by 
establishing electrostatic cross-linkage between anionic components within the 
plasma membrane and the proteoglycans of the pericellular matrix which surrounds 
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chondrocytes. They suggested that this could prevent the rupture or detachment of 
the plasma membrane from the pericellular matrix when conventional aldehyde 
solution was used simultaneously (Hunziker et al., 1982; 1987a, 1992b) (Fixative 
solution B and C; Table 4.1). In our hands however, the presence of RHT could not 
prevent the shrinkage artifact (see Fig. 4.3). Thus, although the % shrinkage was 
not significantly different from the osmotically-corrected fixative solution (solution 
D) it was still clearly greater than the solution B & C. In addition, 
abnormal/shrunken cells were routinely observed (Fig. 4.2A(c)) as also reported in 
the original Hunziker et al., (1982) study. Therefore, although it is possible that 
RHT does protect against the shrinkage effect to some extent by stabilizing the cell 
membrane against the pericellular matrix, it appears that osmotic correction is the 
preferred procedure to eliminate the artefact (Fig. 4.3) and the presence of any 
abnormal cells (Fig. 4.2A(d)). 
The nature of the chemical fixative is also an issue of importance as there is 
not one fixative suitable for all applications. For example, GA has been associated 
with antigen masking due to its excessive and aggressive cross-linking of proteins, 
and is therefore normally considered unsuitable for tissues intended for 
immunochemical staining (Renshaw, 2007). GA is usually used as a mixture with 
PFA (termed Karnovsky’s fixative; (Karnovsky, 1965) so as to take advantage of 
the latter which has rapid tissue penetration although the fixation rate is not as 
rapid as that of GA (Kiernan, 1999). Therefore, PFA (4%) alone probably gives the 
best compromise between good cytological preservation and immunolocalisation, 
while at the same time maintaining antigen masking to a minimum. However, as it 
is a fixative solution with high osmolarity (Table 4.1), tissues should be bisected 
beforehand to maximize rapid fixative access to limit undesirable cell shrinkage 
artifacts although it should be noted that they were still clearly apparent (Fig. 
4.2B(a)) and still significant (~20% shrinkage, Fig. 4.3).  
 The finding that the shrinkage artifact was significantly reduced in bisected 
compared to whole bones, strongly suggested that the rate of penetration of the 
fixative compared to the osmotic changes to chondrocytes resulting from the high 
osmolarity of the fixative solutions are important. In the whole bone, the large 
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shrinkage artifact suggested that osmotically-induced cell shrinkage occurred 
before the tissue was fixed. Thus when the bone was placed in the fixative solution, 
water movement out of the bones to the hyper-osmolar fixative solution occurred 
rapidly, and before the fixative fully penetrated the bone/cartilage matrix to fix the 
cells throughout the sample. Dempster (1960) has shown that fixatives obeyed the 
diffusion laws, that is, the depth penetrated (d) was proportional to the square root 
of time and the coefficient of diffusibility of the fixative, which was specific for 
each fixative. As the diffusion is directly proportional to the concentration gradient 
based on Fick’s Law (Mehrer, 2007), the diffusibility of the fixative molecules 
(PFA, FA, GA) through the extracellular matrix of the tissue will undoubtedly be 
less than that for water molecules because of their different molecular shape and 
molecular weight. Thus, the diffusibility of the fixatives will be markedly less than 
that of water, leading to a greater shrinkage effect in thicker and denser tissues such 
as bone/cartilage, compared to ‘soft’ tissues such as brain and kidney (see Figure 
4.6(B) that illustrates the comparative diffusion rate of fixative and water into the 
bone tissue). For thick tissues where preservation of cell morphology deep in the 
tissue is of importance, osmotic adjustment with lower fixation concentrations and 
longer fixation times would be advisable. Most workers set the fixation period 
using conventional fixatives of between 1- 4 hrs, or even longer (Hopwood, 1969). 
The optimum time will depend on several factors including the physical properties 
of the tissue (e.g. bone/cartilage vs brain) concentration of the fixative and 
thickness of tissue sections. Higher fixative concentrations require shorter fixation 
times (Monis et al., 1965) whereas thicker blocks and harder tissues will 
necessitate longer fixation times as the penetration of the fixative will be slower.  
The present results demonstrated that the shrinkage artifact could also be 
significantly reduced - although not abolished - when the bone was bisected before 
being fixed in standard (high osmolarity) fixative solutions (Fig. 4.3). Bone 
bisection would markedly reduce the physical obstacles and diffusional distances 
thereby providing a more direct and far more rapid exposure of the GPC that were 
being visualized to the fixative solutions. The rate of fixation would thus be much 
more rapid compared to GPC within intact bone (Figure 4.6(B)), although the fact  
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Figure 4.6 A-Schematic illustration of intact and bisected bones; B- The rate of 
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that the shrinkage artifact was still present indicated that despite the increased 
access provided to the fixative, significant cell shrinkage still occurred before the 
tissue was effectively fixed (Fig. 4.3). However, the drawback with bone bisection 
as a manoeuvre to reduce the fixation artifact would be that it could cause physical 
trauma/death to the cells at the cut edge (Huntley et al., 2005) and unless care was 
taken with imaging protocols by optically sectioning deeper into the tissue, the 
damaged surface cells would be the ones that are visualized. Bone bisection would 
also release internal (physiological) pressures within the bone and result in the 
loss/damage to matrix constituents (loss of proteoglycans, damage to the 
collagenous network, altered ionic/osmotic environment) potentially leading to 
changes to the in vivo properties (volume/morphology) of chondrocytes prior to 
fixation (Guilak  and  Mow, 2000).  
The present measurements of cell shrinkage by a histological method (Fig. 
4.2A, B; Fig. 4.3) were supported to some extent by volume analysis of 
fluorescently-labeled living in situ GPC images taken by CLSM (Figure 4.5 and 
Table 4.4). Although the latter technique was more time-consuming, it served as a 
useful additional and direct measure of cell volume to confirm the cell shrinkage 
due to hyper-osmolar fixatives.  The results from this method clearly showed the 
reduction in the cell volume of chondrocytes fixed with PFA (4%) in intact bone 
compared to bisected bone (Table 4.4). However we would have expected that in 
parallel with the histological shrinkage measurements (Fig. 4.3A & B), the volume 
of cells within the bisected bone samples would not have been reduced in the PFA 
solution to the same extent as cells fixed with the osmotically-corrected fixative 
solution. At present no explanation could be given for this finding, but it was noted 
in the present study that the volume method was not as sensitive for detecting the 
chondrocyte shrinkage compared to the histological method.  
Both of these approaches provided us with more accurate quantitative 
measurements of the cell shrinkage artifact, compared to previous indirect methods 
e.g. counting the number of cell nuclei per unit area of tissue (Fox et al., 1985). 
Previous studies had suggested fixation artifacts arose from subsequent steps in 
tissue processing e.g. during ethanol-induced dehydration and embedding 
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(Hopwood, 1969). However the present data suggest that before it is possible to 
determine these secondary artifacts resulting from further preparation of tissue for 
histological analysis, it is essential that as far as possible the fixed tissue was as 
close as possible to its native state by abolishing the osmotic shrinkage artifact 
reported here.  
In summary, the present study demonstrated that the high osmolarity of 
conventional fixatives caused a shrinkage artifact to chondrocytes within the 
hypertrophic zone of the mammalian growth plate. This was particularly noticeable 
when whole bones were fixed, but was still present when the bones were bisected 
prior to fixation. This problem could be avoided by adjusting the osmolarity of the 
fixatives to the osmotic pressure of normal extracellular fluids (~280 mOsm). In 
conclusion, in order to preserve the normal volume/morphology of cells within 
tissue samples, careful consideration should be given to the osmotic pressure of the 
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5.1 Introduction 
Longitudinal bone growth occurs by endochondral ossification in which cartilage is 
first formed, calcified and then replaced by bone tissue. Central to this process is 
the growth plate (GP), in which chondrocytes undergo proliferation, hypertrophy 
and extra-cellular matrix secretion (Gerber et al., 1999; Olsen et al., 2000; Mackie 
et al., 2008). The hypertrophic differentiation has a significant contribution to 
longitudinal growth as the chondrocyte height can increase by 6 to 10-fold during 
the terminal stage of hypertrophy (Hunziker et al., 1994). This contributes up to 
60% of the overall longitudinal growth of rats (Wilsman et al., 1996b). Until now 
the mechanism(s) that regulates the GP hypertrophy has received relatively little 
attention. However one possible mechanism has been proposed to involve the 
plasma membrane transporters (Bush et al., 2008b; Bush et al., 2010).  
The existence of both anion exchanger (AE) and sodium-hydrogen 
exchanger (NHE) has been described in virtually all tissues and cells (Wakabayashi 
et al., 1997; Romero et al., 2004). These transporters are always coupled 
functionally to sustain the normal physiological cellular milieu (Hofmann and 
Simonsen, 1989; Jiang et al., 1997, Lang et al., 1998; Alrefai et al., 2000). AEs, 
which exchange chloride for bicarbonate (Boron, 2001), are vital for several 
physiological processes including the carbon dioxide (CO2) carriage from the 
systemic capillaries  to the pulmonary capillaries, the secretion or  resorption of 
acid-base equivalents by a range of epithelia (e.g., NaHCO3 reabsorption by the 
kidney, HCl secretion by the stomach), NaCl reabsorption by certain epithelia (e.g. 
ileum, proximal colon), and the regulation of intracellular pH in nearly every cell 
of the body (Romero et al., 2004). It was also shown to have a possible role in cell 
volume regulation albeit not in all type of cells (Alper, 1991; Guizouarn et al., 
2001).  For NHE, it mediates transmembrane exchange of sodium for hydrogen 
(Malo & Fliegel, 2006), and specifically plays a critical role in cellular homeostatic 
processes by maintaining intracellular pH, Na+ concentration, and cell volume 
(Mahnensmith & Aronson, 1985; Seifter & Aronson, 1986). NHE is also involved 
in cell growth, proliferation and differentiation (Shrode et al., 1997; Wang et al., 
1997), which implicates the transporter as being an important player in normal 
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developmental processes. NHE is also thought to be involved in cell apoptosis 
(Khaled et al., 2001; Reshkin et al., 2003; Wu et al., 2004). 
Given the broad range of vital roles played by the transporters in other cell 
types and tissues, it is perhaps surprising that relatively little is known about their 
exact role in growth plate chondrocyte. It is interesting to speculate their function 
in mediating transport of osmolytes and water into the cell through the osmotic 
gradient as normally occurs during regulatory volume increase (RVI) (Lang et al., 
1998; Waldeggar et al, 1998), which contribute  to the net chondrocyte cell 
enlargement by swelling and hypertrophy (Bush et al., 2008b). 
Microarray analysis of the adult rat GP showed higher expression of a 
number of plasma membrane transporters in the hypertrophic zone (HZ) compared 
to the proliferative zone (PZ), which included the NKCC, GLAST and AE (Wang 
et al., 2004; Bush et al., 2006b; Bush et al., 2010). This raises the question of 
whether the increased expression reflects their specific roles in chondrocyte 
hypertrophy. A previous study has suggested a possible role for NKCC and AE in 
growth plate chondrocyte (GPC) hypertrophy and longitudinal bone growth (Bush 
et al., 2010). In this study, using a specific NKCC inhibitor (bumetanide), P7 rat 
metatarsal bone growth was significantly inhibited by 30% after 24 hrs culture. In 
the presence of the AE inhibitor, DIDS (4,4-diidothiocyano-2,2-
stilbenedisulfonate) bone lengthening was further reduced by up to 80%. This 
finding suggests the possibility that more than one membrane transporters is 
involved in regulating the rate of longitudinal bone growth.  
To expand the previous work that has suggested a role for NKCC1 in GPC 
volume increase (Bush et al., 2010), the present study examined the role of AE and 
NHE in regulating the rate of longitudinal bone growth by studying the effects of 
their inhibitors namely DIDS and EIPA (5-(N-Ethyl-N-isopropyl) amiloride) 
respectively (Figure 5.1; Vigne et al., 1984; Cabantchik & Greger, 1992; Shen et 
al., 2002). The study was undertaken to test the hypothesis that AE or NHE have 
functional roles in GPC hypertrophy and consequently longitudinal bone growth, 
and this function would be impaired to some extent should the normal activity of 
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the transporters be inhibited. In the present study, histological examination on the 




Figure 5.1 Schematic of AE and NHE transport activity.  Adapted from 
Kunzelmann and Mall (2001); Seidler et al. (2001). An AE subfamily (Anion 
exchanger 1) and two NHE isoforms, NHE 2 or 3 (NHE 2/3) are indicated. The 
inhibitors of these systems are also shown.  DIDS, 4,4’-diisothiocyano-2,2’-
stilbenedisulfonate; EIPA, isopropylamiloride.  
 
height of the HZ as a result of the AE and NHE inhibition (Bush et al., 2010). The 
HZ cell volume of in situ GPC treated with the inhibitors was also examined to 
determine the effect of the drugs on cell enlargement. Cell viability tests on living 
in situ GPC of post natal rat metatarsals were also conducted after the drug 
treatment to rule out bone growth cessation caused by possible cytotoxic effect of 
the inhibitors. To further confirm this, the cell density in the HZ was also studied to 
ensure no significant decrease in the HZ cell numbers following treatment with the 
inhibitors.  Micro-computed tomography (micro-CT) was also undertaken to 
examine if the effect of the drugs on the bone growth lengthening might be 
influenced by changes in the physical bone morphometry. The ex vivo experiment 
was repeated in foetal mouse metatarsals to allow observation of the DIDS and 
EIPA effects on longitudinal bone growth beyond 24 hrs period and to study the 
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difference in bone growth response to the drugs in foetal compared to postnatal GP, 
and between 2 species namely mice and rats. 
5.2 Materials and Methods 
5.2.1 Animals and Growth Plate Tissue Preparation  
5.2.1.1 Seven-day-old Post Natal Rat Metatarsals  
Metatarsals from forty-nine P7 Sprague-Dawley rats were prepared using the 
method that has been described in 2.2.1. For inhibitor dose-response curve 
experiments, whole metatarsal rudiments from n=40 animals with intact growth 
plate cartilage were dissected and temporarily placed in bone dissection media. The 
overall length of the metatarsal rudiments was measured as described below (5.2.2) 
before being cultured individually in 1 ml standard culture media supplemented 
with different concentrations of DIDS or EIPA (Figure 5.2). For DIDS inhibition 
experiments, 24 metatarsal bone rudiments were pooled from four animals, and 4 
bones from different animals were each cultured in five different final 
concentrations of DIDS (50, 100, 250, 500 and 1000 µM). For EIPA inhibition 
study, a minimum of 8 bone rudiments pooled from 36 separate animals were 
cultured in each 7 different final concentrations of EIPA (28, 56, 111, 222, 444, 
888, and 1333 µM). The vehicle-alone control was prepared by adding the standard 
culture media with the vehicle without the inhibitor (potassium bicarbonate for 
DIDS; and DMSO for EIPA). All the bone rudiments were maintained at 37o C 
(CO2 5%: air 95%; pH 7.4) for 24 hrs, before the second bone length measurement 
was taken. 
For histological analysis, 6 metatarsal rudiments from 6 different animals 
were cultured in each of four treatment groups namely 250 µM DIDS, 444 µM 
EIPA and their controls. Bone rudiments were maintained at 37o C for 24 hrs as 
mentioned above, and then fixed (see below) for paraffin wax embedding (see 
below). These concentrations of inhibitors were chosen because these were the 
minimal concentration of the inhibitors that were found to give maximum growth 
inhibition to the whole metatarsal rudiment culture (see Results; Figure 5.3). 
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Figure 5.2 Ex vivo rat and mouse metatarsal bone culture.  (A) The P7 
rudiment bones were individually cultured in 24-well plate with bone culture 
medium with or without the DIDS and EIPA inhibitors and incubated for 24 hrs 
(left). The right figure is the close-up image of an individual bone culture from the 
24-well plate. The bone measurement was performed initially at 0 hrs and repeated 
24 hrs later (see the Materials & Methods). (B) The mice foetal rudiment bones 
were collected E18 mice (left upper panel) and the middle three metatarsals from 
the hind limbs were isolated (a single mid-metatarsal is shown within the rectangle, 
upper left panel) and pooled together (lower panel) before individually cultured in 
24-well plate with bone culture medium with or without the presence of the DIDS 
and EIPA and incubated for 7 days (see the Materials & Methods). 
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For in situ GPC volume analysis, 18 metatarsal rudiments from 6 rat pups 
were used. At least three bones from different animals were each cultured in 
medium supplemented with inhibitors with final concentrations of (i) 0 µM DIDS 
(vehicle alone), (ii) 250 µM DIDS, (iii) 0 µM EIPA (vehicle alone), and (iv) 444 
µM EIPA. All the bone rudiments were maintained at 37o C for 24 hrs as described 
above. Bones were then washed in fresh culture media before being bisected 
sagitally, and incubated with the CMFDA, 5µM for 60 mins. Then, they were fixed 
in 4% (v/v) paraformaldehyde (PFA) overnight, and stored at 4oC in PBS until 
analysed using a CLSM. 
For in situ GPC viability test, at least three bones from each different 
treatment group as described for the GPC volume analysis above were prepared. 
After 24 hrs incubation at 37o C, bones were washed, sagitally bisected and then 
exposed to CMFDA or calcein AM (5 µM) concomitantly with PI (5 µM) for 60 
mins. CMFDA or calcein was used to label the viable cells, whereas PI the dead 
cells (see 2.3.4). The region of interest (ROI; Figure 5.4) incorporating the 
proliferative and the hypertrophic zones of the GP was viewed under low power 
CLSM lens (x10 dry objectives). Cell viability was evaluated qualitatively by 
comparing the distribution of dead over the live cells within the ROI between 
treatment groups. 
For the micro-CT analysis, 16 metatarsal rudiments from 4 rat pups were 
used. Four bones from 4 separate animals were cultured in each of 4 different 
medium treatments as described for the GPC volume analysis experiment above. 
After 24 hrs, the bones were fixed in 70 % ethanol until analysed. 
5.2.1.2 Eighteen-Day-Old Embryonic Mouse Metatarsals.  
The experimental protocol was described in 2.2.2. The middle three metatarsals 
were aseptically dissected under a dissecting microscope from up to ten 18-day-old 
embryonic Swiss mice (E18; Figure 5.2(B)). All the bones were pooled together 
before being cultured individually in each well of a 24-multi-well plate. Six bone 
rudiments were assigned to each treatment groups: (i) 0 µM DIDS (vehicle alone), 
(i) 100 µM DIDS, (ii) 250 µM DIDS, (iii) 0 µM EIPA (vehicle alone), and (iv) 200 
µM EIPA. Membrane transporter inhibitors (EIPA or DIDS, where appropriate) 
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were added to the cultured bones. Each culture well contained 300 µl of a standard 
culture medium with the different treatments, and placed at 37o C in a humidified 
atmosphere of 95% air / 5% CO2 for up to 11days. In all experiments, the medium 
was changed every second/third day. For histology, a total of 2 bones from DIDS 
control, 3 bones from 250 µM DIDS and 4 bones from the rest of treatment groups 
above, were fixed at d 11 and prepared for histological examination as described 
later. 
5.2.2 Measurement of Whole Metatarsal Rudiment Length  
For P7 rat metatarsals, images (640x480 pixels) of rudiments were acquired 
immediately after dissection and after 24 hrs in the presence or absence of 
DIDS/EIPA, using an eyepiece camera (DCM 35 350K Pixel Digital Eyepiece 
Camera, Brunel Microscopes, U.K.) fitted to a dissecting stereomicroscope (Wild 
M3, Switzerland). An image of a rule was acquired to provide calibration, and bone 
lengths were measured using ImageJ software (National Institutes of Health, 
Bethesda, Maryland, U.S.A.).  
 For E18 mouse metatarsals, the bone rudiment length was taken using a 
digital camera (COHU, San Diego, CA) attached to an Eclipse T300 inverted 
microscope (Nikon, Surrey, UK) on day 0, 3, 5, 7 and 11. The total lengths of the 
bones were determined using Image Tool (Image Tool version 3.00, University of 
Texas Health Life Science Centre, San Antonio, Texas). All results are expressed 
as a percentage change from the length at day 0, which was regarded as baseline to 
demonstrate the rate of growth over time.  
5.2.3 Histology of the Growth Plate 
The metatarsals were fixed overnight with GA (1.3% v/v with 0.5% w/v RHT) or 
PFA (4% w/v in 0.01M phosphate buffer; pH 7.4). The histological sections were 
prepared as described in 2.3.2. For P7 rats, the sections were stained with 0.1% 
toluidine blue O, whereas for E18 mice with Hematoxylin and Eosin (see 2.3.3). 
E18 mouse metatarsal bone histological sections were examined under a 
Leica DMR microscope (Peterbrough, U.K.) which connected to a Leica DFC 490 
digital camera (Peterbrough, U.K.). Image acquisition and analysis was performed 
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with the Leica application suite (LAS, Peterbrough, U.K.) software in conjunction 
with the use of the microscope and digital camera. Histological evaluation of the 
sections under high magnification views was made based on identification of 
various zones of chondrocyte differentiation in foetal mouse metatarsals as 
previously reported (Van Bezooijen et al., 2002). P7 rat metatarsal histological 
sections were examined using CLSM (see 5.2.4 below). 
 
5.2.4 Measurement of Growth Plate Length and Cell Density 
Images of distal growth plates were taken using the transmitted light detector of an 
upright confocal laser scanning microscope (Zeiss LSM510, U.K.) fitted with a x10 
dry objective lens. To determine the beginning and terminal points of the GP, 
several subjective criteria based on the cell size and organization were used as 
described in 2.5.1. The GP length and the late HZ height were then identified and 
measured using an established procedure that has been described previously (Bush 
et al., 2010). Briefly, three zones were identified by eye and marked by drawing a 
horizontal freehand line along the top of the proliferating cells border, the clear 
demarcation of cell enlargement between proliferative and hypertrophic regions, 
and the zone of mineralization at the base of the hypertrophic zone.  Another 
straight line was drawn vertically at right angles along the mid GP section (Zeiss 
LSM Image Browser Software, Carl Zeiss Microlmaging GmbH, Germany) (see 
Fig. 5.6).  The GP length was determined from the distance between the two points 
where the vertical and horizontal lines met most proximally and distally using 
ImageJ software (National Institutes of Health, Bethesda, Maryland, U.S.A.). The 
late HZ height was determined from the distance between the two points the lines 
met at the PZ-HZ cell enlargement regions proximally and the zone of 
mineralization distally. The total number of cells within the late hypertrophic zone 
was counted by eye and the surface area of the zone was selected using freehand 
selection and measured using ImageJ. The cell density was determined based on 
the total cell numbers counted over the measured area of the late HZ (cells/mm2). 
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5.2.5 Confocal Laser Scanning Microscopy 
An upright Zeiss Axioskop LSM 510 CLSM was used to acquire fluorescent 
images of in situ proliferative and hypertrophic growth plate chondrocytes. The 
same protocol as described in 2.4.2 was used. 
5.2.6 In Situ Cell Volume Measurement 
Whole growth plates imaged from the proliferative to hypertrophic zones were 
divided into eight equal parts and labeled S1 to S8 (see 2.5.1) and volume analysis 
was performed on scanned CLSM images using the previously described method 
(2.5.2).  
5.2.7 Micro-CT Analysis 
The micro-tomography was performed using established method as has been 
previously reported (Idris et al., 2009). Briefly, the metatarsal bone rudiments were 
scanned (300 slices directly distal of the growth plate) using SkyScan 1172 
instrument (Kontich, Belgium) set at 60 kV and 167 µA, at a resolution of 4.9 µm. 
The images were reconstructed using the SkyScan NRecon program and analyzed 
using SkyScan CTAn software (Aartselaar, Belgium).  
 
5.3 Results  
5.3.1 DIDS and EIPA Treatment in P7 Rat Metatarsal Bone Culture (24 
hrs) 
5.3.1.1 DIDS and EIPA Dose–Response Curve 
In order to study the roles of AE and NHE on bone lengthening, the effects of the 
inhibition of the membrane transport systems by DIDS or EIPA was studied.  
The mean increase in bone length from the overall baseline length in the 
control medium was 6.2 ± 1.3% (n=4) over 24 hrs. Exposure to DIDS (0-1 mM) for 
24 hrs resulted in dose dependent reduction of bone lengthening (Figure 5.3(A)). 
The rate of reduction was most dramatic in 50 µM DIDS solution, bone 
lengthening reduced to 1.9 ± 0.9% (n=4), and all [DIDS] tested resulted in a 
significant reduction in longitudinal growth (unpaired Student’s t-Test; P<0.05; 
n=4). A DIDS concentration of 250 µM appeared to provide maximal inhibition  
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Figure 5.3 The inhibitory effect of the DIDS and NHE EIPA on rat metatarsal 
bone rudiment growth.  A. Five different final concentrations of DIDS were used 
in the dose-response curve experiment (see the Materials and Methods). Each data 
point contains results from four metatarsals (n=4) from four different animals 
which were cultured for 24 hrs in the presence/ absence of the drugs at the 
concentration as shown. The mean bone increase was measured as described in 
Materials and Methods. There was a dose dependent relationship for DIDS 
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inhibition, individual points were significantly different from control (contains no 
DIDS) with all the other DIDS concentrations (§P<0.05; unpaired Student’s t-test). 
B. The effect of metatarsal mean bone increase in response to the increasing EIPA 
concentrations is shown. Each data point contains a number of metatarsals (n) each 
pooled from different individual animals which were cultured in the presence/ 
absence of EIPA in the shown concentration for 24 hrs and measured (see 
Materials and Methods). There was a dose dependent relationship for EIPA 
inhibition, and some individual points were shown as significantly different 
(unpaired Student’s t-test; P<0.05) from control (no EIPA) and from lower 
concentration treatment groups when the indicated data point was compared to A 
control, B 28 µM, a 56 µM, b 111 µM and c 222 µM. Data expressed as means ± 
S.E.M. 
 
and was therefore used for the remaining studies. Figure 5.3(B) illustrates the effect 
of EIPA (0-1.3 mM) on metatarsal bone longitudinal growth. The mean control 
bone length increase after 24 hrs was 7.9 ± 0.5% (n=36). A one way ANOVA 
study demonstrated a significant trend of overall bone longitudinal growth decrease 
as the DIDS concentrations increased (P<0.001). Post-hoc pairwise (vs control) 
comparison analysis (Holm-Sidak method) showed a significant overall bone 
lengthening difference from the control (P<0.05).  
EIPA resulted in a dose dependent decrease in bone lengthening, but only 
becoming significantly reduced at an [EIPA] of 111µM and above (unpaired  
Student’s t-Test; P<0.05; at least n=8). Whilst an EIPA concentration of 1.3 mM 
showed the maximum reduction of bone lengthening (1.4 ± 0.3%), 444 µM was the 
lowest concentration that produced the optimal reduction of bone lengthening and 
was therefore used in the later experiments. The effective concentration of EIPA 
which resulted in a 50% inhibition (EC50) was approximately 250 µM. A one way 
ANOVA study showed a significant trend reflecting overall bone growth decrease 
as the EIPA concentrations increased (P<0.001). Post-hoc multiple comparison 
analysis against the control (0 mM)(Holm-Sidak method) showed a significant 
bone lengthening difference in 111, 222, 444, 888, and 1333 µM EIPA-treated 
groups (P<0.05). 
This result showed dose-response relationship between the DIDS or EIPA 
to the bone lengthening growth and the DIDS effective at lower concentrations 
compared with EIPA.  
Chapter 5: NHE and AE in Bone Growth 
                                                                                                        Page  149 
5.3.1.2 Viability of the GPC after Treatment with DIDS and EIPA  
DIDS and EIPA could potentially induce cell cytotoxicity or cell death in some 
cells (Lieu et al., 2008; Park et al., 2009). This could consequently impair the bone 
lengthening growth and give a false indication that the decrease in bone growth is a 
result of the inhibition of their respective transport system by the drugs. To rule out 
this, a cell viability test was undertaken on the GPC after the 24 hrs treatment with 
250 µM DIDS or 444 µM EIPA. Bisected metatarsal bones were incubated in 
CMFDA or calcein AM concomitantly with the PI to examine and compare the 
ratio of dead: living in situ cells (see Materials and Methods). Figure 5.4 shows 
viable intact CMFDA-labelled cells could be observed in all bones after 24 hrs 
incubation in the drugs. Although DIDS control bone appeared to reveal more PI-
stained cells than the other groups in the Figure 5.4, the overall examination on the 
rest of the GP sections showed no clear difference in dead cell ratio over live cells 
observed between the treatment group (250 µM DIDS or 444 µM EIPA) and the 
controls. This suggested that the reduction in the bone growth was likely not to be 
associated with cytotoxic or apoptotic induced effects of the inhibitors. 
5.3.1.3 Gross Morphology of the Bones Post Treatment 
There was no obvious difference in the gross appearance and morphology of rat 
metatarsal bone after 24 hrs treatment in DIDS compared to the control (Figure 
5.5(A & B) far left respectively). However, EIPA-treated bones showed that the 
diaphyseal zone looked paler in colour (Figure 5.5(D) far left) when compared to 
the control (Figure 5.5(C) far left) after 24 hrs. This raised question of whether 
EIPA caused any changes to the morphometric properties of the treated bones and 
this was studied in the following section. 
5.3.1.4 Three-Dimensional Morphometric Parameters Analysis of the 
Treated Bones 
To examine whether the morphological changes observed in EIPA-treated 
metatarsal involved changes in bone mineralization particularly at the diaphyseal 
region, micro-CT scanning was undertaken to evaluate the three-dimensional 
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Figure 5.4 DIDS or EIPA caused no apparent effects on the GPC viability.  P7 
rat metatarsal bones were bisected and incubated in CMFDA fluorescent dyes and 
PI, fixed and then viewed using low power objective lens of confocal microscope 
following 24 hrs treatment with the DIDS (250 µM)  and EIPA (444 µM). The 
similar ROI (proximal GP) was identified in all bones, and the cells viability were 
determined by whether the cells were positively stained by the CMFDA or calcein 
AM (live cells) or PI (dead cells): A. DIDS control, B. DIDS-treated, C. EIPA 
control, D. EIPA-treated. HZ, hypertrophic zone; PZ, proliferative zone  Scale bar 
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morphometry of the bone specimens after the EIPA treatment. For a comparison, 
the micro-CT scanning on DIDS-treated bones and the controls were also 
undertaken. Figure 5.5(A-D) (middle and far right), showed the 3-D reconstructed 
micro-CT images of the metatarsal bones as viewed at upright-lateral (middle) and 
ventral-dorsal (right). No clear differences (unpaired Student’s t-test; P>0.05) in 
three dimensional structural changes were observed between the different treatment 
groups. All metatarsals showed the absence of mineralization in the trabecular 
bones of the diaphyseal area as shown by hollow bone shaft. The diaphyseal 
cortical bone thickness between treatment groups and controls showed no clear 
difference. In addition to the visual assessment of the bone microarchitecture, 
analysis was made on the following morphotomographic determinations: (i) bone 
density (grayscale index), (ii) tissue volume (µm3), (iii) bone volume (µm3),  (iv) 
percent of bone volume (%),v. bone surface/ volume ratio (x10-3 µm-1), (vi) 
trabecular thickness (µm), (vii) trabecular separation (µm), (viii) trabecular number 
(µm-1), (ix) degree of anisotropy (DA), and (x) total porosity (%). The results of the 
analysis were tabulated in Table 1 and revealed no significant difference in the 
effect of DIDS or EIPA to the bone morphometric parameters. 
5.3.1.5 Histological Measurement of the GP Length and Late HZ Height 
Following Treatment 
Having recorded the dose-response relationship between the DIDS or EIPA with ex 
vivo bone longitudinal growth (Figure 5.3), the histological changes were then 
examined. Emphasis was placed on the GP HZ cells, as the size of these cells are 
the key determinant to the rate of longitudinal bone growth (Wilsman et al, 1996b). 
The total length of the GP, the height of the late HZ and the cell density in the late 
HZ were measured (see Materials and Methods; Figure 5.6). Table 5.2 shows the 
histological analysis results of the metatarsals cultured in the presence or absence 
of DIDS (250 µM) or EIPA (444 µM). There was no significant difference in the 
total growth plate length between the control and DIDS treated group (657 ± 99µm 
and 670 ± 76µm respectively; unpaired Student’s t-Test; P>0.05; n=4 to 6). 
Similarly there was no significant difference in the total growth plate length 
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between the non-treated and EIPA-treated group (683 ± 99µm and 668 ± 68µm 
respectively; P>0.05). The height of the HZ in the control was also not 
significantly different from the DIDS-treated GP (144 ± 18µm and 116 ± 11µm 
respectively; P>0.05). Likewise, there was no significant difference between the 
height of the HZ in the control as compared to the DIDS-treated GP (147 ± 19µm 
and 117 ± 19µm respectively; P>0.05).  However, when HZ height was expressed 
as a percentage of the total GP length, the relative HZ height in the DIDS and 
EIPA-treated groups (17.5 ± 0.7% and 17.3 ± 1.5%  respectively) were found to be 
significantly different compared to the controls (22.6 ± 1.8% and   21.9 ± 1.1%; 
unpaired Student’s t-Test; P<0.05; n=4 to 6). This result reveals the effect of DIDS 
and EIPA on the HZ heights over the GP length, which possibly implies the 
perturbation of normal GPC hypertrophy in the presence of the drugs. 
5.3.1.6 Histological Measurement of the Cell Density 
The reduction in the size of the late HZ height over the total GP length was 
possibly as a result of changes in GPC size (e.g. caused by perturbation of normal 
cell enlargement) or the cell numbers (e.g. caused by cell death possibly associated 
with cytotoxic effect of the drugs). To further investigate this, the cell density in 
the HZ was measured. The result presented here (Table 5.2) showed no difference 
in number of GPC in the HZ of the DIDS and EIPA-treated metatarsals (4404 ± 
884 cells/mm2 and 4019 ± 1300 cells/mm2 respectively) as compared to the 
controls (4383 ± 25 cells/mm2 and 4007 ± 1316 cells/mm2; unpaired Student’s t-
Test; P>0.05; n=3). This suggests that the transport protein inhibitors used did not 
cause significant hypertrophic GPC death, and confirms the finding from the 
viability assessments, which showed no evidence of direct effect of the inhibitors 
on the viability of living in situ GPC after 24 hrs culture period.  
5.3.1.7 Effect of the GP and EIPA to the GPC Volume  
Having established that the effect of the DIDS and EIPA was non-cytotoxic to the 
GPC, further examination of the effect of DIDS and EIPA inhibition on in situ 
GPC volume was made using CLSM technique. The reduction in cell enlargement 
should be detectable by volume measurement if the drugs inhibited normal cell  
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Figure 5.5 Gross morphology and three-dimensional micro-CT images of 
metatarsal bones after DIDS or EIPA treatment.  The far left images show the 
gross morphology of the bones before and after 24 hrs culture in each indicated 
treatment group: A. DIDS control, B. DIDS treated (250 µM), C. EIPA control, D. 
EIPA treated (444 µM). The middle and far right images showed the corresponding 
reconstructed three-dimensional micro-CT images after 24 hrs as viewed at two 
different angles: upright-lateral (middle) and ventral-dorsal (right). Scale bar = 2.5 
mm in all gross morphology images and 0.2 mm in all the reconstructed 3-D micro-
CT images.  
 
enlargement. In these experiments, volume analysis was performed at the PZ (S1-
P2) and the HZ (S7-S8; see Materials and Methods). Using a high power objective 
lens, no clear difference was observed in the appearance of the GPC treated with 
DIDS and the control (Figure 5.7 (A & B)). However there was a clear difference 
between the EIPA-treated GP and the control cell size (Figure 5.7 (C & D)). 
Volume analysis was also performed on the GPC in the PZ and HZ from the 
metatarsal bones of each treatment group (Table 5.3). The result showed the mean 
volume of the control cells in PZ (609 ± 46µm3; 6[29]) was not significantly 
different from DIDS-treated (572 ± 71µm3; 3[25]); unpaired Student’s t-Test; 
P>0.05). Likewise, the mean volume of the control cells in HZ (1880 ± 230µm3 
6[44]) was not significantly different from the mean GPC volume in DIDS-treated  
GP (2660 ± 419 µm3; 3[27]; P>0.05). On the other hand, there was significant 
difference between the mean volume of the control cells in PZ and HZ (761 ± 50 
µm3 (6[33]); and 2044 ± 219 µm3 (6[38]) respectively) and the volume of the 
respective EIPA-treated cells in PZ (211 ± 26 µm3; 3[15]) and HZ (586 ± 54 µm3; 
3[19]); unpaired Student’s t-Test; P<0.05; n=3 to 6). Taken together, these data 
suggest that the DIDS treatment resulted in no significant changes to the size of the 
PZ cells and HZ cells whereas EIPA treatment resulted in a significant reduction in 










































Table 5.1 Micro-CT bone mineral and morphometric analysis of metatarsal bones after DIDS or EIPA treatment. The metatarsals were 
from four P7 rats (n=4) that were cultured for 24 hrs in the absence/ presence of DIDS or EIPA at the indicated concentrations. Ten 
morphometric parameters were measured using SkyScan CTAn software from the reconstructed three-dimensional bone images acquired using 
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7.54 ± 0.35 
 
 
1.69 ± 0.62 
 
 
22 ± 1 
 
 
65 ± 3 
 
 




232 ± 12 
 
 
4.6 ± 0.1 
 
 
1.60 ± 0.24 
 
 
77.6 ± 4 
 
 












1.79 ± 0.89 
 
 
18 ± 4 
 
 
64 ± 1 
 
 
49 ± 1 
 
 
285 ± 60 
 
 
3.7 ± 0.8 
 
 





EIPA [444] 103 ± 2 8.04 ± 0.43 1.74 ± 0.88 22 ± 0 64 ± 1 49 ± 2 222 ± 11 4.4 ± 0.1 2.12 ± 0.28 81.8 ± 
4.0 
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Figure 5.6 The total percentage height of the late hypertrophic GP zone 
decreased significantly in the presence of DIDS or EIPA. P7 rat metatarsal 
bones were fixed; sections prepared and stained with 0.1% Toluidine blue O 
following 24 hrs treatment with 250 µM DIDS or 444 µM EIPA. Using light 
microscopy the proximal GP was located and the late GP hypertrophic zone cells 
(LHC) were identified by eye in between the beginning of the late hypertrophic 
zone cells and the mineralized bone (MB) at the bottom (between the 2 horizontal 
lines). The vertical black line at the mid GP section and between the two horizontal 
lines indicates the average height of late hypertrophic GP zone in DIDS and EIPA-
treated bones (B & D), and the controls (A & C). The straight black and white 
vertical line at the mid GP section were used to determine the total length of the GP 
as defined in the Materials and Methods. PC, proliferating zone cells; EHC, early 
hypertrophic zone cells. Scale bar =100 µm in all panels. 
 
5.3.2 DIDS and EIPA Treatment in E18 Mouse Metatarsal Bone Culture  
Having found the inhibitory effect of DIDS and EIPA on the post natal bone 
growth, the investigation was extended to foetal bones. Foetal mouse metatarsal 
bone cultures were treated with either DIDS or EIPA for seven days as described in 
Materials and Methods. 
5.3.2.1 Foetal Metatarsal Gross Morphological Changes  
Preliminary results (data not shown) showed clear abnormal gross morphology 
changes following treatment with 250 µM of DIDS. Therefore, a lower DIDS 
concentration (100 µM) was also used in the present study in order to compare the 
effect between the two different concentrations on bone morphology and 
particularly on bone lengthening growth. For EIPA, a preliminary experiment using 
250 µM (as had been used in postnatal rat metatarsals) resulted in total bone growth 
arrest and poor bone morphology following 72 hrs of treatment. This raised 
concerns about possible cytotoxic effects incurred by the inhibitor at the given dose 
(250 µM; data not shown).  Therefore slightly lower EIPA concentration (200 µM) 
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Table 5.2 The effect of DIDS and EIPA on growth plate zone height and cell 
density. Distal metatarsals from three to six P7 rats were cultured for 24 hrs in the 
absence/ presence of DIDS or EIPA at the concentrations indicated. Bones were 
fixed, prepared, and visualized as described in Materials and Methods. There was 
significant reduction in height (%) of hypertrophic zone from the total height of the 
growth plate in DIDS or EIPA-treated bones. However the average height of growth 
plates and hypertrophic zone between control and treated bones were not 
significantly different. Hypertrophic zone cell density of treated bones also showed 
no significant difference from the control. * denotes significantly different from the 
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Figure 5.7 In situ GPC volume evaluation post 24 hrs of DIDS (250 µM) or 
EIPA (444 µM) treatment.  Bisected bones as described in Figure 5.5 were then 
examined under high power magnification on the confocal microscope. The ROI 
was selected at PZ and HZ of the GP and the images were recorded for further cell 
volume analysis (see Materials and Methods). All the panels shown here 
demonstrate the HZ cells of the GP from different treatment groups: A. DIDS 
control B. DIDS-treated, C. EIPA control, and D. EIPA-treated. Scale bar = 20 µm 
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Table 5.3 The effect of EIPA and DIDS on growth plate chondrocyte volume. 
Distal metatarsals from three to six P7 rats were cultured for 24 hrs in the absence/ 
presence of DIDS or EIPA at the concentrations indicated. Bones were bisected, 
loaded with fluorescent dye (CMFDA), fixed and visualized using CLSM 
technique as described in Materials and Methods. Data are given as means ± 
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Figure 5.8 (panels A, D, G, J, M and P) shows the image of gross 
morphology of the intact foetal metatarsals at d 3 post treatment, as visualized and 
recorded using a digital camera (see Materials and Methods). No clear gross 
change to morphology was observed between the 100 µM DIDS treatment group 
(panel D) and the control (panel A) where the mineralized and non-mineralized 
zones looked similar. However, besides the straight bone shape formation (panel 
G) some bones in the 250 µM DIDS treatment groups also showed some degree of 
peculiar (crooked) bone deformity (panel J). For EIPA treated bones (panel P), 
there were no obvious changes in shape of the mineralized and non-mineralized 
zones compared to the control culture (panel M).  
5.3.2.2 Longitudinal Bone Growth Measurement  
 As shown in Figure 5.9, at d 3 of E18 bone culture, 250 µM DIDS showed a 
significantly higher growth rate (59.54 ± 3.67 %; unpaired Student’s t-test; n=4) 
than the control (40.32 ± 1.64%; P=0.002; n=4) and the 100 µM DIDS treated 
bones (47.50 ± 2.37%; P=0.023; n=4). DIDS at a concentration of 100 µM also had 
a significantly higher growth rate compared to control bones (P=0.034). The 
difference in growth rate noted in the 100 µM DIDS treated bones at d 3 was not 
seen at any other time points examined.  At d 5 culture, the 250 µM DIDS caused a 
further significant increase in growth rate (76.61 ± 5.41%) compared to the control 
(56.51 ± 3.39%; P=0.013) and 100 µM DIDS treated bone (54.86 ± 2.32%; 
P=0.008). At d 7, 250 µM DIDS caused a further increase in growth rate (80.08 ± 
3.97 %) and this was significantly different from the control (63.32 ± 3.88%; 
P=0.013) and 100 µM DIDS treated bone (61.79 ± 2.56%; P=0.004). At d 11, the 
mean bone increase of the 250 µM DIDS-treated bones (81.82 ± 4.08%) remained 
significantly higher than the control (65.46 ± 2.72%; P=0.009) and 100 µM DIDS-
treated bones (66.98 ± 3.06%; P=0.017). It should be noted that the control and 100 
µM DIDS-treated bones grew almost identically between 3 and 11 days of culture. 
The overall effect of 250 µM DIDS treatment on the bone growth rate compared to 
the control and 100 µM DIDS was significantly different (two way ANOVA, P 
<0.001). 
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The results also demonstrated that at d 3, 5, 7 and 11, the bones treated with 
200 µM EIPA (n=4) showed generally less than a 3 % increase in growth rate 
suggesting that growth rate was, at best, negligible. On the other hand, the EIPA 
control demonstrated progressive increase in bone growth during the same 
durations (27.25 ± 2.97% to 55.65 ± 3.93%, from d 3 to 11). The growth rate of the 
200 µM EIPA treated bones was significantly much lower than the growth of the 
EIPA control during these periods (P<0.0001, n=4). At d 11 however, the EIPA 
control bone had a growth rate very similar to that of the DIDS control (no 
significant difference between the two; P>0.05). 
When comparing the changes in the growth rate of the same treatment 
groups at different time points, the mean growth rate of the DIDS control bones 
was significantly higher at d 5, 7, and 11 compared to d 3 (P=0.003, 0.001 and 
0.0001 respectively). For 100 µM DIDS-treated bones, the growth rate at d 11 and 
7 was significantly greater than at d 3 (P=0.001 and 0.002 respectively). The 100 
µM DIDS-treated bones at d 11 was also had a significant higher growth rate than 
at d 5 (P=0.01). For the 250 µM DIDS-treated bones, the growth rate reached at d 
11 was significantly higher than at d 3 (P=0.002). Likewise, the growth rate at d 7 
and d 5 was significantly higher than at d 3 (P=0.004 and 0.03 respectively). For 
EIPA, the control showed significant growth rate at d 11 compared to d 3 and 5 
(P=0.0002 and 0.002 respectively). At d 7, the EIPA control demonstrated 
significantly higher growth rate than at d 3 (P=0.005). For 200 µM EIPA-treated 
bones, the growth rate at d 11 was significantly higher than at d 3, 5 and 7 
(P=0.0002, 0.002 and 0.02 respectively). The bone growth rate was also 
significantly higher in d 7 compared to d 3 (P=0.005).   
It should be noted that the increase in growth rate of EIPA control bones was 
significantly less than the growth rate of the DIDS control bones (P≤0.005) on d 3, 
5 and 7 of culture which could suggest a possible adverse effect of the 1% DMSO 
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Figure 5.8 Gross morphology and histological staining of foetal mouse 
metatarsals cultured in the absence or presence of DIDS and EIPA.  Eighteen-
day-old foetal mouse metatarsals were cultured for seven days in the absence (A-C) 
or presence of DIDS (100 and 250 µM; D-F and G-L respectively); or in the 
absence (M-O) or presence of EIPA (200 µM; P-R). Panels A, D, G, J, M and P 
show the gross morphology of the intact foetal metatarsals at day 3 culture. Panels 
B, E, H, K, N and Q demonstrate the histological sections of the foetal metatarsals 
after day 5 culture (fixed in 4% PFA and stained for Haematoxylin and Eosin). 
Higher magnification views of the respective histological sections are shown in 
panels C, F, I, L, O and R; with four different zones of chondrocyte differentiation 
are shown: rc, resting chondrocytes; pc, proliferating chondrocytes; ehc, 
unmineralized early hypertrophic chondrocytes; lhc, mineralized late hypertrophic 
chondrocytes.  
 
that was used as the solvent for the EIPA. However it was clear that EIPA 
completely inhibited longitudinal growth when compared to the EIPA control. 
These results suggest clear differences between the inhibitory effects of DIDS and 
EIPA on foetal mouse bone growth. DIDS at both given concentrations 
significantly stimulated bone growth, whereas EIPA significantly inhibit it over 11-
day bone culture period. 
5.3.2.3. Foetal Metatarsal GP Histological Changes  
To examine further the cause of the contrasting effects of DIDS and EIPA on the 
bone lengthening, histology was performed on the GP from the d 5 post treatment 
bone sections.  Lower magnification views showed the overall bone shapes at d 5 
in all treatment groups (Figure 5.8 panels B, E, H, K, N) and demonstrated no clear 
changes from those at d 3 as described earlier. An exception was in the EIPA-
treated bone (Figure 5.8 (Q)) that showed relatively smaller bone size.  
The sections were analysed at higher magnification where the various zones of 
chondrocyte differentiation were identified (see Materials and Methods). At lower 
DIDS concentration (100 µM), there was an increase in the proliferative 
chondrocytes (PC) and reduction in the early un-mineralized hypertrophic 
chondrocytes (EHC) (Figure 5.8 (F)) as compared to the control (Figure 5.8 (C)). 
At higher concentration (250 µM), the cell differentiation (i.e. proliferation and 
hypertrophy) appeared to be non-uniform along the GP. The PC zone was generally 
reduced whereas the resting chondrocytes (RZ) and EHC zone length were 
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variable, with both a slight increase and a slight decrease observed (see Figure 5.8 
(I & L)). The late mineralized hypertrophic chondrocytes (LHC) zone appeared 
became relatively longer than in the control and the 100 µM DIDS groups. For 
EIPA, there was a complete elimination of the EHC zone (Figure 5.8 (R)). The PC 
zone increased as compared to the control (Figure 5.8 (O)). These histological 
findings demonstrate irregular changes in the foetal metatarsal GPC differentiation 
pattern as a consequence of DIDS or EIPA treatment. 
5.4 Discussion  
This study identifies a possible role of AE and NHE in postnatal bone longitudinal 
growth as shown by dose-response relationship of the inhibitors to the two 
transporters namely DIDS and EIPA respectively with the bone lengthening.  The 
results show that both NHE and AE are implicated in the GPC enlargement 
mechanism. However, prenatal bone growth in the presence of the AE inhibitor 
DIDS exhibited the opposite effect, with bone lengthening stimulated. 
5.4.1 The Specificity of DIDS and EIPA Effects 
DIDS was used as it has recognized inhibitory effects on the AEs (Cabantchik & 
Greger 1992), whereas EIPA (an amiloride analogue) was found to potentially 
produce full inhibition on NHE activities up to 140 times more than amiloride itself 
(Vigne et al., 1984). The inhibition of bone growth in P7 rat metatarsals by DIDS 
and EIPA was shown to be dose-dependent, where the optimal concentration that 
produced the maximum inhibition effect was approximately 250 µM for DIDS and 
444 µM for EIPA as estimated from the dose-response curve (Figure 5.3).  
 The effects of DIDS and EIPA have been studied previously in 
various cell types. For DIDS, it has been found to provide protection against 
apoptosis in cardiomyocytes (100-250 µM; Wang et al., 2005 Okada et al., 2006, 
Liu et al., 2008), N1E 115 cells (clonal mouse neuroblastoma)(250 µM; O’Reilly et 
al., 2002), MDCK cells (renal epithelial cell line) (10-500 µM; Araki et al., 2002), 
human adenocarcinoma KB cells (100 µM; Ise et al., 2005); and HeLa cells and 
U937 (human monocytic cell)  (500µM; Wang et al., 2005). It also has been shown 
to inhibit cell proliferation and induce cell apoptosis in hepatocellular carcinoma  
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Figure 5.9 Effect of DIDS (100 and 250 µM) and EIPA (200 µM) on foetal 
metatarsal bone growth. Each data point contains results from four metatarsals 
(n=4) from at least 10 foetuses of 18-day old that were pooled together in a same 
dish. Each bone was cultured individually in 24-well plate for 7 days in the 
presence/ absence of the drugs in the concentration shown and measured as 
described in Materials and Methods. The mean bone increase (% change in bone 
length from the baseline) was significantly different (unpaired Student’s t-test) 
when the indicated data point was compared to a DIDS control at the same time 
point (P≤0.034), b 100 µM DIDS at the same time point (P≤0.023), c EIPA control 
at the same time point  (P< 0.0001), ф 250 µM DIDS at d 3 (P≤0.029), ¥ 100 µM 
DIDS at d 3 (P≤0.002), ¶ 100 µM DIDS at d 5 (P<0.011), § DIDS control at d 3 
(P≤0.004), δ EIPA control at  d 3 (P≤0.005), Ω EIPA control at d 5 (P≤0.002), and  
# EIPA control at d 7 (P≤0.021). Data expressed as means ± S.E.M.  
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cells (400-1000 µM; Liu et al., 2008). Besides AE, DIDS also inhibit some 
bicarbonate-transporter family members of HCO3
- transporters namely the Na+-
coupled HCO3
- transporters such as NBC1 (Romero et al., 2004). NBC1 could be 
found ubiquitously in many tissue such as in the basolateral membranes of renal 
proximal tubule, pancreatic ducts, and epididymis, as well as in astrocytes and 
neurons in several regions of the brain, several tissues within the eye, and blood 
vessels and intercalated disks within the heart (Romero et al., 2004). Even though, 
it has been suggested has a role in cell pH regulation (Bernardo et al., 2006), 
contrary to AE this system has no coupling function with NHE (Alrefai et al., 
2000), which was also associated with other roles in cellular mechanisms such as 
volume regulation (Alper, 1991). 
For EIPA, at 10 µM it induced total NHE inhibition in MCF-7 (human 
breast cancer cells) and CNE-1 (nasoparyngeal carcinoma) cells. However when 
this was coupled with heating factor (43oC, 2 hrs) it induced cell cytotoxicity (Li 
and Liu, 1997). It was also reported that at 1µM it substantially reduced myocardial 
infarct size in isolated rabbit hearts when it was administered either prior to or after 
the onset of ischemia (Sato et al., 1997). Besides that, EIPA at 5-1000 µM could 
induce cell apoptosis through the inhibition of intracellular alkalinization (Khaled 
et al., 2001; Wu et al., 2004). However since some of these were cancer cells, the 
signaling pathway may not represent a typical mechanism in healthy cells (Malo 
and Fliegel, 2006). Na+ channel (found in electrically high resistance epithelia) is 
another transport system besides NHE that sensitive to EIPA. However compared 
to Na+ channel, NHE is found in many different cellular preparations and seems to 
function in cell proliferation and differentiation (Shrode et al., 1997), volume 
regulation and intracellular pH regulation (Seifter & Aronson, 1986), which related 
to cellular events involving GPC. In addition, this exchange pathway becomes 
operational usually after some external stimuli and to inhibit the system much 
higher concentrations of amiloride are required than those required for the Na+ 
entry pathway (Beno, 1982). 
These observations serve to provide general overview of the effects of 
DIDS and EIPA in various cells, which seems varies depending to dose and the 
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type of cells studied. Therefore, the present study on ex vivo GPC undertook 
several methods including histology and in situ cell viability test and volume 
analysis in order to identify the relevant effect of the agents on the GP that could 
specifically explain the growth retardation.  
The concentration of DIDS used in the present ex vivo study was within the 
range of concentrations used previously in the culture of other cells (O’Reilly et al., 
2002; Araki et al., 2002; Ise et al., 2005; Wang et al., 2005; Okada et al., 2006; Liu 
et al., 2008). However for EIPA, a relatively much higher concentration was 
needed to give optimal effects in the present study than what was reported 
previously in other cell types (Li and Liu, 1997; Sato et al., 1997; Khaled et al., 
2001; Wu et al., 2004; Malo and Fliegel, 2006). Considering the P7 rat metatarsal 
bones were relatively small and have less amount of calcification (Table 5.2) 
serving as barriers between the culture media containing the drug and the 
chondrocytes, it was reasonable to expect that the concentration range needed was 
not much different from the one used in in vitro.  This was the case with DIDS in 
the present ex vivo study. However, the higher concentration required for EIPA 
could be due to the presence of competitive inhibitors for EIPA which reduced the 
EIPA binding to the target protein receptors. A possible factor that could act as 
competitive inhibitor was the increase in the extracellular Na+ ion (Vigne, 1984; 
Kleyman and Cragoe, 1988). DMSO, the solvent for EIPA, has been shown to 
induce leakage of Na+ ion from other cells (Santos et al., 2002). Other sensible 
explanation is the negatively charged dense GP cartilage, due to the presence of 
proteoglycans (Ng et al., 2002; Ng et al., 2003) caused electrostatic repulsion of 
negatively polar EIPA compound (Kleyman and Cragoe, 1988). This resulted in a 
decrease of the drug concentration upon reaching the target tissue and subsequently 
reduced the EIPA binding. 
The relatively much higher concentration of EIPA than the dose used 
previously in other cell types (Li and Liu 1997; Sato et al., 1997) could potentially 
expose the cells to toxicity that in turn could adversely affect bone growth. To rule 
this out, an in situ viability test and histology was performed on the GPC after 
incubation with the EIPA. No clear difference in the appearance of dead cells over 
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live cells was observed in treated bones compared to the control bones after 24 hrs 
incubation of the in situ GPC (Figure 5.4). The intact CMFDA-labelled cells could 
be observed across the GP in all bones exposed to the drugs. However, as a note of 
caution the in situ viability cell test in the present study could only serve as a 
general qualitative cell viability evaluation of the bone tissues.  No attempt to 
further quantify cell viability was made since it would not have offered extra 
evidence; the process of bisecting these delicate bones causes significant cell death 
over and above that due to cytotoxicity of any drug. This is especially true for the 
largest cells, those in the early and late HZ, being most affected by this cutting 
artifact. Therefore further assessment was undertaken using histological 
examination described earlier. The histology results support the in situ qualitative 
viability observations, showing no significant changes in the density of HZ cells in 
the presence of the inhibitors (Table 5.3). This implies that any drug toxic effect 
was limited and that any affect was through the inhibition of HZ cell volume 
increase.  
The in situ GPC culture model used in this study better mimics the 
physiological milieu of the GPC than the use of cells in monolayer culture. 
However exposing the entire bones to the drugs could also trigger responses from 
cells other than those in zones of the growth plate. For example, it has been 
reported that DIDS can block completely the sulphate transport activity of DTDST 
(diastrophic dysplasia sulphate transporter) that speculated to play a role in 
endochondral bone formation, at a concentration of 1 mM (Satoh et al., 1998). 
Even though the present study did not rule out an effect of DIDS on epiphyseal 
matrix sulphated proteoglycans synthesis activity (critically affected in the absence 
of DTDST), the histology results narrowed down the possible effect of DIDS to a 
decrease in GPC hypertrophy. In addition, the microCT results do not suggest any 
significant effects of DIDS on the bone morphometric parameters. 
It was also interesting to know if 250 µM DIDS used in the current post 
natal bone growth study could induce protection against cell apoptosis in GPC as 
reported in various other cell types cells (Araki et al., 2002; O’Reilly et al., 2002; 
Ise et al., 2005; Wang et al., 2005; Okada et al., 2006 and Liu et al., 2008). In bone 
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growth, cell apoptosis is considered to be an important mechanism to remove the 
terminally mature hypertrophic chondrocytes in order to match the rate of 
chondrocyte proliferation, and transform the composite chondroid bone into 
mineralized bone which has relatively superior mechanical, physical and structural 
properties (Adams and Shapiro 2002; Shapiro, 2005). It is also one of the key 
factors in the bone formation process by initiating the recruitment of the bone cell 
precursors and blood vessel formation at the terminal HZ (Gibson, 1998). How 
significant the effect of DIDS on the apoptosis of the HZ cells at the terminal HZ 
was not specifically studied in the present work but if apoptosis was inhibited a 
relatively longer HZ would be expected as the number hypertrophic chondrocytes 
progressively increased. The present results showed the HZ height over the GP 
length of DIDS-treated GP of postnatal rats was found significantly lower than in 
the control (Table 5.2). It can be reasoned from this observation that DIDS at the 
given dose used in the postnatal rat metatarsal study inhibited bone growth most 
likely through the inhibition of HZ cell volume increase and not through the 
blocking of the apoptosis of terminal HZ cells. This was further supported by the 
evidence of no changes in the cell numbers, which suggest that the rate of apoptosis 
is not affected by DIDS.  
As could be noted in the result (Figure 5.3) there was no significant 
difference in bone growth between the DIDS and EIPA controls of post natal rat 
metatarsals after 24 hrs treatment. On the other hand, the DIDS and EIPA controls 
showed marked difference in the bone growth of foetal mouse metatarsals during d 
3 to 7 incubation periods (Figure 5.9). The EIPA control that contained only the 
vehicle solution of the drug showed significantly lower growth rate compared to 
the DIDS control during the duration of culture. This suggested at exposure of 1% 
(v/v) of DMSO used as the solvent (vehicle) for EIPA in the current study could 
adversely effect the normal bone growth of foetal metatarsals. A toxic effect of 
DMSO has been reported previously in post natal rat cochlear organotypic cultures 
and how this could be minimized if the concentration of DMSO used was between 
0.1-0.25% (Qi, 2008). However for the present study, since all the EIPA 
experiments were run in parallel with the control groups that contained DMSO 
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alone, the result clearly demonstrated the significant net effect on the bone 
lengthening was EIPA-dependent (Figure 5.9). 
The Micro-CT results reveal no difference in the three-dimensional bone 
morphometry between treated bones and the controls (Table 1), which suggests that 
the paler colour appearance seen grossly in EIPA-treated bones (Figure 5.5(D) far 
left) compared to the control (Figure 5.5(C) far left) was not as the result of 
changes in the bone mineralization and architecture. However the actual cause for 
these gross morphological changes was not clearly identified but could be due to 
the effect of the drug on bone marrow. The three-dimensional micro-CT 
morphometry on Sprague Dawley rat metatarsal bones have not been reported 
previously to the best of my knowledge. However almost all the present 
morphometric parameter results showed approximately the same range values as 
have been reported in male Wistar rat tibia (4-week-old; Bielohuby et al., 2010), 
Wistar rat femoral diaphysis (53 to 56-day-old; Freeman et al., 2008) and C57BL/6 
mouse distal femur metaphysis (10-week-old; Gudberg et al., 2004).  
5.4.2 Possible AE and NHE Roles in Bone Longitudinal Growth  
The current hypothesis suggests that the AE and NHE have roles in GPC 
hypertrophy and consequently in longitudinal bone growth. This hypothesis fits 
well with the present finding and demonstrates the dose-response relationship 
between DIDS or EIPA to the inhibition of postnatal bone growth. The results 
indicate that 250 µM DIDS or 444 µM EIPA inhibited ~97% and 64% of 
longitudinal bone growth in P7 rat metatarsals, respectively. Both drugs caused a 
significant decrease in the height of the hypertrophic zone over the total GP length.  
The decrease in the height of the GP HZ over the GP length suggests that 
the inhibition of the transporters have direct effects on GPC hypertrophy, probably 
through the inhibition of normal cell regulatory volume mechanism. In this 
experiment, all bones in this experiment were fixed in fixative solution of 1.3% GA 
with 0.5% RHT, with the osmolarity was adjusted to the osmotic pressure of 
normal extracellular fluids (Chapter 4) to avoid fixative-induced cell artefact 
shrinkages having bias towards the decrease of the HZ height over the GP length. 
To examine this further, the post treatment in situ GPC volume of the DIDS and 
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EIPA treated bones was measured at PZ and HZ of the GP. The results showed a 
marked decrease in GPC volume in the PZ and HZ of EIPA-treated bones but no 
significant volume changes were observed in DIDS-treated bones.   
The HZ cell height has been shown to be significantly higher than in the PZ 
cell due to preferential increase in cell height over the cell width and depth in 
normal HZ chondrocytes (Farnum et al., 2008). This fact could explain why the 
effect of EIPA on the HZ cell volume subsequently caused a significant decrease in 
the GP HZ height over the GP length (Table 5.2), although GPC volume decrease 
was observed in both the PZ and HZ (Table 5.3). 
It was interesting to find that the effect of EIPA on GPC volume was across 
the PZ and HZ (Figure 5.4 & 5.7; Table 5.3). Related to this, there is accumulating 
evidence suggesting that the inhibition of NHE leads to cell death possibly by an 
apoptotic process (Khaled et al., 2001, Reshkin et al., 2003; Wu et al., 2004). The 
NHE inhibition could have caused cell death in at least two possible ways. First, it 
induces apoptotic volume decrease (AVD), a hallmark of apoptotic mechanism that 
could be simply referred as abnormal RVI as the decrease of cell volume takes 
place under hypotonic condition (Okada and Maeno, 2001; Okada et al., 2001). 
Second, it causes the loss maintenance of the normal intracellular pH (pHi), which 
has been suggested to lead to the apoptotic cell death (Matsuyama et al., 2000; 
Khaled et al., 2001; Lagadic-Gossmann et al., 2004). Even though no clear 
indication that the GPCs were dying or in a process of apoptosis (Figure 5.4 & 5.7), 
the effect of EIPA at a concentration of 444 µM on GPCs volume was evident 
(Table 5.3). Therefore, it cannot be ruled out that the NHE function in GPC could 
be critically important in regulation of GPC survival as has been observed in other 
cells (Schelling and Jawdeh, 2008). The NHE role in regulating cells viability  
could be achieved by enhancing the Na+ entry as a part of RVI-mediated defense 
against AVD (Okada and Maeno, 2001; Okada et al., 2001; Okada et al., 2006). 
When cells are induced to shrink, RVI is coordinated by activation of NHE and, in 
some cells, the AE and NKCC (Lang et al., 1998). The net effect is Na+, K+ and Cl- 
and H2O influx, which leads to cell volume re-expansion (Schelling and Jawdeh, 
2008) and consequently prevents the progression of AVD.  
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While it was clear from the current findings that the reduction of the HZ 
height in EIPA treated bone was partly due to a decrease in hypertrophic GPC 
volume, the reduction in the HZ height of the DIDS-treated bones could be 
explained differently.  The AE could have a critical role in the initial stage of PZ 
cell transformation into HZ cells during PZ-HZ cell differentiation. Inhibition of 
the AE by DIDS could plausibly delay the transformation rate of PZ cells into HZ 
cells. As the transformation rate from the proliferative to hypertrophic GPC could 
contribute to the final HZ volume (unpublished data/ Chapter 4 of this thesis), the 
delay in the transformation would affect the final HZ cell volume and consequently 
the HZ height. Nevertheless, this could not rule out a more extensive effect of 
DIDS on the majority of the GP cells e.g. by disruption of AE intracellular pH 
regulation function (Romero et al., 2004). How ever this would not prevent 
terminally differentiated HZ from progressing to apoptotic process. This plausible 
broader effect of DIDS would explain the almost total inhibition of bone 
lengthening, the maintenance of HZC volume, and the decrease in % HZ height. 
This finding also highlights the possibility that the AE was not the main plasma 
membrane transporter system involved in mediating the GPC volume increase at 
the later stage of the hypertrophy. The main role could be taken up by other 
membrane transport system, which was not affected by the inhibition of the AE 
function and could also be able to compensate perturbed functions of other 
membrane transporters at the earlier HZ. A good candidate for this is Na+/K+/2Cl- 
co-transporter (NKCC), which has previously been shown to demonstrate cellular 
localisation in GP HZ and increase in mRNA expression of the cells (Bush et al., 
2010). In addition, a reduction in bone growth by 35% was observed when the 
NKCC activity was blocked by its specific inhibitor, bumetanide (Bush et al., 
2010).  
5.4.3 Response of Foetal Mouse and Postnatal Rat Bone Growth to 
DIDS and EIPA 
The present results indicate the markedly different effects of the drugs at 
different development stages (prenatal and postnatal) as well as in two different 
species. Even though different species (mouse and rat) were used at the different 
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time points, it is interesting to find that EIPA caused ~100% inhibition of bone 
lengthening in prenatal (E18) mouse GPs, whereas DIDS generated a significant 
~50% increase in bone length compared to the control (Figure 5.9). The growth 
promoting effects of DIDS on the prenatal bones was contradictory with it 
inhibition effects on postnatal bones (Figure 5.3), which caused a ~97% reduction 
in longitudinal bone growth. The growth-promoting effect of DIDS was noted at d 
3 at a concentration of 100 µM; and at d 3, 5, 7 and 11 bone cultures at a 
concentration of 250 µM (Figure 5.9). Microscopic examination and histology 
revealed that at a concentration of 250 µM, the DIDS induced bone deformity 
(crooked bones) (Figure 5.8(J)). This was in contrast to that observed in P7 rat 
metatarsals 24 hrs bone culture. At lower concentrations (100 µM) DIDS caused 
the increase in the proliferative cells and reduction in the early non-mineralized 
hypertrophic cells. In higher concentration (250 µM), there was irregular cell 
differentiation particularly at the proliferative and hypertrophic zones along the GP 
which could contribute to the deformed bone formation in some of DIDS-treated 
bones. The late mineralized hypertrophic cells zone appeared to increase probably 
due to the effect of apoptosis inhibition in the HZ cells as discussed earlier. 
However the histological observation was based on general qualitative evaluation 
of the histological sections, since the very tiny sections made it impossible to 
produce sufficient and decent quality histological sections for quantitative and 
statistical analysis of different zone of GPC differentiations. Nevertheless, this 
result highlights the different effect of DIDS at different stage of GP development 
(i.e. foetal vs postnatal animals); or at different days of bone culture (24, 72 or 120 
hrs); or at different DIDS concentration used. For EIPA, the inhibitor demonstrated 
the consistent longitudinal bone growth inhibition in both E18 mouse and P7 rat 
metatarsals. Gross examination on the EIPA treated mouse foetal metatarsals 
showed the relatively smaller bone size than the control, whereas the histology 
examination demonstrated the complete elimination of the EHC zone (Figure 5.8 
(R)). However, since no cell viability test was performed on the foetal bone 
rudiments, further examination would be required to rule out any cytotoxic effect 
of the inhibitor at the given concentration on the foetal bone tissues. To do this, 
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other feasible viability test technique should be employed on the foetal bone since 
the present method requires the cutting of these bones that would causes a greater 
cell death artifact than earlier discussed for the P7 bones. 
The variation between the skeletal development in foetal and postnatal 
mouse and rat have also been reported in the changes of bone longitudinal growth 
rates (Patton and Kaufman 1995; Wilsman et al., 2008), the first appearance of the 
ossification centre and ossification pattern (Patton and Kaufman 1995); changes in 
hypertrophic volume increase and GPC production/ turnover (Wilsman et al., 
2008), and catch-up growth response following withdrawal of dexamethasone 
treatment (Chagin et al., 2010).  
The different GPC performances at different periods of skeletal 
development could influence the behaviour or the response of the GPC to both 
DIDS and EIPA. The process of skeletal development in foetus and neonatal 
animals by endochondral bone development through chondrogenesis and 
osteogenesis are tightly coordinated in time and space. The histology of the growth 
plate changes: as shown during the second half of human foetal development is 
more cellular, is less organised in columns, and shows less development of the 
matrix than at the end of the period studied. On the other hand, at birth, the growth 
plate, although thinner and less cellular than in foetuses, has well-organised 
hypertrophic cell columns separated from one another by the longitudinal septa of 
the matrix (Rodriguez-Zavala et al., 2005).  
The difference between both bone development stages could be 
demonstrated further by the important contribution of the GPC proliferation in the 
prenatal period to the bone growth in comparison with the postnatal period, in 
where the GPC hypertrophy is relatively more important in the bone length growth 
(Wilsman, et al. 2008). The species difference adds to this variation as for example 
the process of ossification of majority of the mouse skeleton and the growth takes 
places relatively more rapidly when compared with that of the rat (Patton & 
Kaufman, 1995).  
The fact that the inhibitors could bring about various effects in different 
type of cells as shown in the earlier discussion, does raise the possibility that the 
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mode of action of the drugs on the GPC could also be different between different 
species and age of the animal. Beside that, we also could not rule out a possible 
manifold effects of the drugs on the foetal bones such as the inhibition by DIDS of 
DTDST activity that was suggested as an important requirement for chondrocytes 
to grow and crucially important for endochondral bone development (Satoh et al., 
1998). The irregular and abnormal changes in the foetal metatarsal GPC 
differentiation pattern following treatment with the DIDS could imply the 
important effect of the DTDST inhibition on the early age of skeletal bone 
formation. 
In accord with the present results, it can be reasoned that the inconsistent 
findings between the possible existence role of the transporter in the bone 
lengthening (as implied by the present result) and the non increase of NHE mRNA 
expression between PZ cells and HZ cells (Bush et al., 2010), could be due to the 
difference in the expression level of the transporters (e.g. NHE) between different 
stages of the skeletal development i.e. between animals at postnatal age (used in the 
current study) and at the later age (used in the previous microarray analysis study).  
5.5 Conclusion 
In summary, the present findings underscore a possible role for AE and 
NHE in post natal bone longitudinal growth. The inhibition of the AE or NHE by 
DIDS or EIPA respectively, resulted in bone lengthening inhibition in a dose-
dependent manner. The inhibition of both membrane transporters caused a 
significant decrease in the hypertrophic zone over the total growth plate length. 
Whilst the inhibition of the AE resulted in no clear effect on the growth plate 
chondrocyte volume, the NHE inhibition caused a significant decrease in the cell 
volume of the proliferative and hypertrophic chondrocyte cells. It also highlights 
the different response to the DIDS and EIPA between the prenatal and postnatal 
bones that warrants further examination. These findings might imply a possible 
important involvement of the AE and NHE in the growth plate chondrogenesis and 
bone longitudinal growth. 
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6.1 Introduction 
6.1.1 A Possible Role for NHE and AE 
The previous results in Chapter 5 have demonstrated a possible function of NHE 
and AE in post natal mammalian bone growth. The reported data showed dose-
dependent inhibition of bone growth by EIPA or DIDS known to respectively 
block the NHE or AE activity. Histology on the DIDS and EIPA-treated bones 
showed a significant decrease in the percentage height of the growth plate (GP) 
hypertrophic zone (HZ), which could explain how both drugs affect the bone 
longitudinal growth.  Analysis of the GP chondrocytes revealed that the HZ cell 
volume decreased significantly following treatment with a NHE inhibitor, whereas 
AE inhibitor did not result in any cell volume changes at the same zone. The 
present study was designed to further investigate the presence of the transporters by 
examining cellular and tissue localisation of specific NHE and AE isoforms (NHE1 
and AE2) in post natal rat GP using fluorescence immunohistochemistry (FIHC).  
6.1.2 FIHC Technique 
Immunohistochemical staining is the detection of antigens in histological tissue 
sections (frozen or paraffin embedded) through the use of specific antibodies that 
are labeled (e.g. with the use of enzyme or fluorescence) so that the sites of 
antibody become microscopically visible (Haines and Chelack, 1991). The term 
FIHC or immunofluorescence being used in the present study refers to the 
immunostaining technique using a fluorescent label (Renshaw, 2007). It has proved 
an invaluable investigative tool for the visualization of tissue antigens in healthy 
and pathologic tissues. When coupled with high resolution imaging methods (e.g. 
confocal laser scanning microscopy) immunohistochemistry (IHC) has the 
potential to reveal further information about the complex three-dimensional 
composition and organization of cellular and extracellular matrix compartments in 
GP cartilage. These technologies can also be used to quantify signal intensities and 
thereby facilitate numerical computation of image data (Hayes et al., 2008).  
It cannot be overemphasised the importance of every IHC result to be 
consistently accurate and reproducible. A good result could be hampered by the 
type of tissue sections used. For instance, although paraffin embedded sections are 
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preferred to frozen tissue sections as the former offers better morphological 
appearance, the antigen (Ag) preservation in paraffin embedded sections might be 
affected by excessive fixation and processing regime such as Ag masking and 
background autofluorescent problems (Renshaw, 2007). Autofluorescence is the 
ability of a tissue or cellular component to fluoresce naturally, such as the 
fluorescent pigment lipofuscin in mammalian tissue. This occurs independent of 
the binding of immunochemical staining reagents conjugated to fluorochromes. 
Autofluorescence can potentially mask specific fluorescent signals or be mistaken 
for fluorescent labels (Baschong et al., 2001; Renshaw, 2007). In order to 
overcome this, appropriate tissue section pretreatment inevitably should be first 
undertaken prior to FIHC procedure to constantly produce high quality FIHC 
results.  
 
6.1.3 A Review on NHE and AE Isoforms and the Distribution in Other 
Tissues 
Previous research work has studied protein expression and localisation, regulatory 
features and physiological roles for NHE and AE protein in other tissues (Alrefai et 
al., 2001; Malo & Fliegel, 2006). The family of NHE proteins includes 9 isoforms 
(NHE1-9), each with unique tissue and cellular distribution, inhibitor sensitivities, 
regulatory elements, and subsequent physiological roles. NHE1, the first isoform 
identified, is distinct in that it is ubiquitously expressed in all mammalian cells and 
plays a housekeeping role (Malo & Fliegel, 2006). This isoform was the most 
sensitive to amiloride and its derivatives (Masereel et al., 2003).  
NHE2 shared 42% identity in an amino acid sequence with NHE1 (Wang et 
al., 1993) and is expressed in the epithelial tissue of the intestinal tract and kidney, 
skeletal muscle, and the testis (Malakooti et al., 1999). Within the digestive tract, 
NHE2 is quite prominent with strong expression in the jejunum, ileum, and colon 
(Bookstein et al., 1997) and specific expression in renal tissue (Chambrey et al., 
1998; Peti-Peterdi et al., 2000). This isoform has similar inhibition constants for 
both amiloride and nonamiloride compounds as that observed for NHE1 (Yu et al., 
1993). Overall, NHE2 appears to be involved in several secretory processes. 
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NHE isoforms 3 and 4 were both identified to have 39% and 42% amino 
acid identity to NHE1, respectively (Orlowski et al., 1992). Furthermore, both 
NHE3 and NHE4 were identified as having significant levels of expression in the 
kidney and gastrointestinal tract (GIT). In the gastrointestinal tract, NHE3 has 
higher expression in the intestine, whereas NHE4 appears to be localized 
predominantly in the stomach. In renal tissue, NHE3 has been identified as an 
apical membrane protein in the proximal tubule and thick ascending limb 
(Amemiya et al., 1995), whereas the NHE4 isoform has basolateral epithelial 
distribution and is found specifically in the inner medulla of the kidney (Bookstein 
et al., 1997; Pizzonia et al., 1998). More recently, both isoforms have also been 
identified in the submandibular gland in rats, with NHE3 having apical expression 
in duct cells and NHE4 having basolateral expression in acinar and ducts cells 
(Oehlke et al., 2006). Both NHE3 and NHE4 are relatively resistant to amiloride 
and nonamiloride inhibitors (Brant et al., 1995; Yu et al., 1993) and NHE4 requires 
hyperosmolarity for activation (Bookstein et al., 1994; Bookstein et al., 1996).  
Studies on NHE5 have revealed that its expression is restricted to the brain 
in both rats and humans. Sequence analysis demonstrated that NHE5 has 39% 
amino acid identity to NHE1, but also 53% identity to NHE3. In addition to having 
similar primary structure to NHE3, NHE5 also has similar inhibitor sensitivities to 
NHE3 (Attaphitaya et al., 1999; Baird et al., 1999). Overall, NHE5's restricted 
expression in the brain suggests a specialized role for the isoform, but as of yet no 
physiological role has been elucidated. NHE isoforms 6–9 are unique in that they 
are localized to the membranes of the Golgi and post-Golgi endocytic 
compartments. It is likely that these NHE isoforms contribute to pH maintenance 
of these intracellular organelles (Nakamura et al., 2005). 
For AE, there are at least three structurally and functionally related genes 
for AE, termed as AE1, AE2 and AE3 (Alper, 1991). AE1 or band-3 AE of 
erythrocytes was the first described AE and is expressed in greatest abundance in 
the erythrocyte plasma membrane. Outside the erythrocytes the predominant site of 
AE1 expression is the kidney in the basolateral plasma membrane of Type A 
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intercalated cells of the renal cortical and medullary collecting ducts. It is also 
expressed at lower levels in heart, distal colon, and other tissues (Alper, 1991).  
AE2 is the most widely expressed form of AE, and in nearly all epithelial 
cells resides in the basolateral plasma membrane. Membrane localisation studies 
revealed that AE2 polypeptide was present at highest levels in the epithelial cell 
basolateral membrane of choroid plexus, gastric parietal cells, throughout the GI 
tract, and in some cell types of the respiratory and genital tracts. AE2 in exocrine 
glands is expressed in acinar cell basolateral membranes, but minimally in duct 
epithelial cells. It is also expressed throughout the nephron, but most abundantly in 
the medullary thick ascending limb and the inner medullary collecting duct (Alper, 
2006). Whereas AE1 shows little sensitivity to pH over the physiological range, 
intracellular and extracellular acidification both inhibit AE2 (Alper et al., 1991).   
AE3 is expressed at highest level in excitable tissues, throughout the GI 
tract, and at lower levels in other tissues (Kudrycki et al., 1990). The AE3 gene has 
been shown to code at least two transcripts and two protein isoforms, bAE3 (brain 
subtype) and cAE3 (cardiac subtype). Adult hearts of rat, rabbit, chicken and 
human express both bAE3 and cAE3 at almost equal levels (Yannoukakos et al., 
1994).  To date, very little is known about the expression of the AE3 isoforms in 
epithelial tissue (Alrefai et al., 2001). The latest reported AE4 isoform 
(Tsuganezawa et al., 2001) was cloned from kidney and is more closely related in 
sequence to the NBC Na-bicarbonate cotransporters than to AE anion exchangers, 
although it is reported to mediate Na+-independent Cl- /HCO3 - exchange (Alper et 
al., 2001). 
6.1.4 Aim of the Study and Hypothesis 
Having found evidence of functional roles of NHE and AE in longitudinal bone 
growth (Chapter 5), the present study explored further the presence of the NHE1 
and AE2 isoforms in P7 rat GP cartilage using FIHC. These two were the most 
ubiquitously found isoforms in other tissues and cells (Alper 2006; Malo & Fliegel, 
2006). Other isoforms (AE1 and AE3) were also tested but the antibodies used to 
detect these isoforms were found ineffective (see Table 6.1). The study was 
undertaken to test the hypothesis that changes in chondrocyte size during the 
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transition from the proliferative to hypertrophic zones is associated with changes in 
the distribution of NHE and AE expression. Collagen type X distribution in the 
growth plate tissue was also examined in the preliminary FITC staining 
optimization studies as it known to be only produced by GP hypertrophic 
chondrocytes and uniquely present in the extracellular matrix of the hypertrophic 
zone (Kielty et al., 1985; Sasano et al., 1998).  
In this study, proximal tibia growth plates of P7 rats were fixed and 
processed for immunofluorescence microscopy. The pretreatment procedure for the 
FIHC comprising heat-induced antigen (epitope) retrieval (HIAR) and 
autofluorescence quenching was initially optimized. Ag retrieval is defined as an 
enzymatic or high-temperature heating method to recover the antigenicity of tissue 
sections that had been masked by formalin fixation or paraffin-embedding tissue 
processing (Shi et al., 2001). The established FIHC pretreatment technique was 
then used to test for collagen type X distribution in GP sections. Having established 
the methods, the immunostaining study of NHE1 and AE2 within the GP was 
performed. CLSM was used to record high resolution images of the 
immunofluorescent GP sections. A semi-quantitative method was used to measure 
the immunofluorescence intensity in order to determine the tissue and cellular 
localisation of the transporters from the proliferative through to the hypertrophic 
GP zones.  
6.2 Materials and Methods 
6.2.1 Animals and Growth Plate Preparation  
Tibiae from each hind limb of P7 Sprague-Dawley rats were prepared and fixed as 
described previously (Chapter 2). The tibias with intact proximal GP from five 
different animals were used (n=5). Kidney and gastrointestinal tract tissues were 
collected to be used as positive control tissues for the antibodies used in this FIHC 
study. 
For histological sections preparation, tibiae were bisected sagitally and 
placed in fixative solution (4% (w/v) PFA or 2% (v/v) GA with 0.7% (w/v) RHT) 
for 24 hrs at room temperature (RT). Sagital bisection of the GP prior to fixation 
has been shown to significantly reduce the shrinkage artefacts associated with high 
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osmolarity of the conventional fixatives used (Chapter 4). Kidneys and GITs were 
also fixed in the same fixatives. All the fixed tissues were dehydrated though a 
series of graded ethanol solutions prior to paraffin embedding using a standard 
procedure for histological sectioning. Tissue sections (10 µm) were prepared using 
the method described in 2.3.2. 
For in situ GPC imaging, a tibia from a 7-day-old rat pup were bisected 
sagitally and stained with Calcein AM (5 µM) for image scanning using CLSM as 
described previously (2.3.4.1). 
 
6.2.2 Optimization of Pretreatment Method for the FIHC on Growth 
Plate Histological Sections 
For FIHC optimization, techniques comprising heat-induced antigen retrieval 
(HIAR) and autofluorescence quenching (i.e. NaBH4) were assessed. GP 
histological sections were de-waxed in xylene, rehydrated in 100, 95, and then 75% 
ethanol followed by PBS. Four groups of treatment were tested: (i) no treatment 
given (control), (ii) 1% (w/v) sodium borohydride (NaBH4), (iii) HIAR, and (iv) a 
combination of HIAR and 1% NaBH4. For HIAR, histological slides were 
immersed in boiling Tris-EDTA-T80 HIAR buffer for 20 mins and then cooled in 
water for 10 mins (a domestic microwave was used  in the HIAR procedure, and a 
plastic rack vessel was used to hold the slides during the Ag retrieval  process). For 
pretreatment with 1% NaBH4, GP sections were incubated with NaBH4 in 0.1M 
PBS, refreshing 3 times at 20 mins intervals. For combination methods, GP 
sections were first treated with HIAR and followed by treatment with 1% NaBH4. 
For this experiment, the pretreatment steps were then followed by FIHC protocol 
using anti-collagen type X primary antibody (Ab). 
6.2.3 Fluorescence Immunohistochemistry 
FIHC was performed (see details in 2.3.4.2) after pretreatment procedures being 
applied to the GP histological sections. Rabbit polyclonal 1o Ab for the NHE1 and 
AE2 were used at 1:500 and 1:100 dilution respectively. Other antibodies used are 
shown in Table 6.1. For the negative control section, the primary Ab was omitted 
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and replaced with goat serum. FITC-tagged goat anti-rabbit was used as the 2o Ab. 
The experiments were repeated in at least 5 different GP sections of 5 separate 
animals. 
6.2.4 Confocal Laser Scanning Microscopy  
An upright Zeiss Axioskop LSM 510 CLSM was used to acquire fluorescent 
images of GP sections using the protocol that has been described previously (2.4.2)  
A series of high power images were obtained along the GP under examination, 
starting from the osteochondral junction distally to the early proliferative zone cells 
proximally. For immunofluorescence studies, the negative control sections were 
imaged first followed by other respective sections under examination. The same 
confocal settings used were maintained throughout the procedures. 
6.2.5 Semi Quantitative-Measurement of NHE1 and AE2 Cellular 
Localisation 
In order to measure cellular immunofluorescence staining intensity and the 
localisation of the transporters across the GP, the GPCs in high power images were 
recorded using a CLSM. GP images of sequential zones were ‘stitched’ together to 
produce a montage of the whole length of a GP from the proliferative zone (PZ) to 
the hypertrophic zone (PZ). Each imaged growth plate was divided into 8 equal 
sections (S1-S8) as described previously (2.5.1). An average fluorescence labeling 
intensity associated with AE2 or NHE1 in individual GPC was analyzed along GP 
zones in an unbiased semi-quantitative manner using ImageJ Java-based scientific 
image processing software as described before (Bush et al., 2010). The average 
intensity of intracellular and plasma membrane fluorescence were further 
determined for chondrocytes at the PZ (S1) and HZ (S7-8) (Bush et al., 2010; 
Figure 6.6). To achieve this, a line was drawn centrally across a middle optical 
section for each chondrocyte and the peaks of fluorescence intensity at the two 
opposite plasma membrane surfaces (2 selected plasma membrane segments) from 
each individual chondrocyte to give the average of fluorescence intensity on the 






















































Table 6.1 The antibodies against AE and NHE isoforms used in the present IHC study. 
Fluorescent IHC test in the present 
study 
 Antibody Target Isotype Notes on the cross reactivity and other 
remarks provided by the supplying 
company 
Company 
Ab Titre Comments 
1. Band 3 (C-17) goat 
polyclonal antibody against 
a peptide mapping within an 
internal region of band 3 of 
human origin (sc-20559). 
 
AE1 (band 3) IgG Is recommended for detection of band 3 
of mouse, rat and human origin. 
Detection by Western Blotting, 
immunofluorescence (starting dilution 
1:50, dilution range 







Ineffective Ab. No +ve 
immunostaining detected 
when tested on the positive 
control tissue (rat red 
blood cells, kidney). 
2. Rabbit polyclonal to AE2 
(ab42687) 
AE2 IgG Mouse and human. 
Predicted: rat, rabbit, horse, guinea pig, 
cow, orangutan 
 
Abcam, UK 1:500 (see Results in 6.3.2) 
 
 

















































Table 6.1 The antibodies against AE and NHE isoforms used in the present IHC study (cont.) 
Fluorescent IHC test   Antibody Target Isotype Cross reactivity and other remarks 
from the supplying company 
Company 
Ab Titre Comments 





Family 4, Anion 
Exchanger, 
Member 3 
(SLC4A3, AE3)  
IgG Recognizes rat anion exchanger 3 
(bAE3). No significant sequence 
homology is detected with other AE or 
other proteins. Does not recognize 
cardiac AE3. Species sequence 
homology: mouse 100%: human 95%: 
rabbit 90%. 
Does not recognize cardiac isoform of 
AE3. Actual crossreactivity of 
antibodies in various species has not 
been studied.  
Suitable for use in ELISA. Other 




1:100 Ineffective Ab. No +ve 
immunostaining detected 
when tested on the positive 
control tissue (rat kidney). 
4. Rabbit polyclonal to 
Sodium/ Hydrogen 
Exchanger 1 (ab67313) 
NHE1 IgG Mouse, rat, human Abcam, UK 1:100 (see Results in 6.3.2) 
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the graph (Figure 6.6B). Similarly, fluorescence intensity from the cytoplasm of a 
cell could be determined from any peak values between the first 2.5 µm and before 
the last 2.5 µm from the graph depicted (2.5 µm is the consistent approximate 
distant allocated to observe fluorescence intensity at plasma membrane surfaces 
along a line drawn across the chondrocyte optical section). Although the plasma 
membrane thickness is relatively very much less than this, it was chosen for 
reasons of convenience for the present method. The total average fluorescence 
signal of the 2 plasma membrane segments and the central intracellular portion 
gave the average of whole cellular fluorescence intensity for each GPC. The 
fluorescence intensity (in gray value) was expressed as a percentage with the 
highest intensity measured was assigned 100% thus normalizing the staining 
intensity of images from different GPs. Fluorescence signals at the plasma 
membrane were further corrected for cell surface area: volume ratio in light of 
previous studies that showed a relatively large reduction in the cell surface area and 
volume ratio in the late GP hypertrophic zone (see Chapter 4). 
6.3 Results  
6.3 1 Pretreatment Optimization for GPC FIHC Staining 
In order to improve the quality of FIHC staining, a pretreatment technique was 
initially optimized. Two main procedures were tried namely the autofluorescence 
quenching method (using NaBH4) and HIAR technique (see Materials and 
Methods). In this study, FIHC staining with an Ab to collagen type X was tested in 
P7 GPs. Collagen type X was used as it is known to be synthesized in GP only by 
hypertrophic chondrocytes (Kielty et al., 1985; Poole & Pidoux, 1989; Sasano et 
al., 1998). It is also a major component of the matrix and by reducing its 
autofluorescence the background levels could be reduced and the fluorescently-
labeled Ab would be visualised more easily. Figure 6.1A shows none of the FIHC 
pretreatment techniques employed could remove auto-fluorescence background in 
GP tissue sections fixed in 2% GA + 0.7% RHT. No obvious difference in the 
fluorescence staining could be seen between GP sections pretreated with NaBH4, 
HIAR or the combination of both pretreatments with the non-pretreated sections, 
which stained virtually the whole GP sections. There was also no apparent  
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Figure 6.1A FIHC pretreatment did not remove fixative-induced 
autofluorescence in GA-fixed GP tissue sections. FIHC staining of collagen type 
X in P7 rat histological GP sections fixed with 2% GA + 0.7% RHT as observed 
under x20 objective of CLSM using the same settings throughout (see Materials and 
Methods). Sections were subjected to the following pretreatment procedures: (a) 
negative control (goat serum), (b) no pretreatment, (c) autofluorescence quenching 
with NaBH4 and, (d) HIAR and NaBH4. Bar scale in all panels = 50 µm. HZ, 
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Figure 6.1B Effects of antigen retrieval and autofluorescence quenching in 
PFA-fixed GP tissue immunostaining. FIHC staining of collagen type X in P7 rat 
histological GP sections, sagitally bisected before being fixed with 4% PFA as 
observed under x20 objective of CLSM using the same settings throughout (see 
Materials and Methods). The sections were subjected to different pretreatment 
procedures as follows before being stained with collagen type X antibodies: (a) 
negative control (goat serum), (b) no pretreatment, (c) autofluorescence quenching 
with NaBH4, (d) HIAR and NaBH4.  Bar scale in all panels = 50 µm. HZ, 
hypertrophic cells zone; PZ, proliferative cells zone. 
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Figure 6.1C Ag retrieval and fixative-induced autofluorescence quenching in 
PFA-fixed GP hypertrophic cells. FIHC staining of collagen type X in P7 rat 
histological GP sections, sagitally bisected before being fixed with 4% PFA as 
observed under x63 objective of CLSM where the field of view (FOV) was selected 
at hypertrophic cells zone. Each section was subjected to different pretreatment 
procedures: (a) negative control (goat serum), (b) no pretreatment, (c) 
autofluorescence quenching with NaBH4 and, (d) HIAR and NaBH4.  Images are 
presented as single slice optical images (2-D images, left panels) and their 
corresponding stack (3-D, projected) images (right panels). Bar scale in all panels = 
20 µm.  
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Figure 6.1D Ag retrieval and fixative-induced autofluorescence quenching in 
PFA-fixed GP proliferative cells. FIHC staining of collagen type X in P7 rat 
histological GP sections, sagitally bisected before being fixed with 4% PFA as 
observed under x63 objective of CLSM where the FOV was selected at proliferative 
cells zone. Each section was subjected to different pretreatment procedures: (a) 
negative control (goat-serum), (b) no pretreatment, (c) autofluorescence quenching 
with NaBH4, (d) HIAR and NaBH4. Images are presented as single slice optical 
images (2-D images, left panels) and their corresponding stack (3-D, projected) 
images (right panels). Bar scale in all panels = 20 µm.  
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difference with the negative control sections (Figure 6.1A (a)), which suggests that 
the auto-fluorescence background was mainly due to the GA (Renshaw, 2007) that 
was used to fix the GP tissues. When the FIHC staining was performed in GP 
tissue sections fixed in 4% PFA, pretreatment with the combination of NaBH4 and 
HIAR demonstrated an obvious improvement in the fluorescence labeling of 
collagen type X compared to the un-pretreated or singly pre-treated sections 
(Figure 6.1B, 1C and 1D). The sections treated with HIAR alone gave inconsistent 
results (data not shown). The autofluorescence background produced by the PFA 
fixed tissue was relatively lower as shown in the negative control sections (Figure 
6.1B(a), 1C and 1D). The staining of collagen type X was detected mainly around 
the hypertrophic chondrocytes and the surrounding matrix of GP cartilage (Figure 
6.1B (d) and 1C). In GP proliferative zone, the collagen type X staining was 
observed occasionally around the chondrocytes (Figure 6.1D). This study has 
optimized the right pretreatment steps for FIHC staining on GP sections fixed in 
4% PFA. The stepwise procedure was summarized in Figure 6.2. In light of the 
present result, the following FIHC study would avoid using GA-fixed GP tissues 
since the relatively strong autofluorescence background induced by the fixative 
could not be satisfactorily removed by the current established pretreatment method.  
6.3 2. NHE1 and AE2 Positive FIHC Staining in Kidney and GIT 
Having established the optimum FIHC pretreatment steps for the GP, the FIHC 
study was performed for NHE1 and AE2. As a part of quality assurance of the 
FIHC results obtained, the anti-NHE1 and AE2 Ab staining were first tested on 
tissues known for positively expressing the proteins in relatively high levels. For 
NHE1 and AE2, P7 rat kidney and GIT were used as the control tissues 
respectively (Mahnensmith and Aronson, 1985; Alrefai et al., 2001). Figure 6.3A 
shows no fluorescence staining of NHE1 in the negative control kidney section (a-
b) compared to the positively stained section (c-f). Guided by the corresponding 
transmitted light image (d and f), the localisation of the NHE1 based on the 
fluorescence labeling (c and e) was mainly observed in renal corpuscles and renal 
convoluted tubules of the renal cortex region. For the AE2, the localisation of the 
transporters was confined at the mucosa membrane of the GIT (Figure 6.3B (c-f)). 
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Figure 6.2 Summary of Ag retrieval and autofluorescence quenching protocol. 
Optimized techniques for Ag retrieval and fixative-induced autofluorescence 
quenching of GP histological sections (10 µm in thickness) fixed in 4% PFA, as 
pretreatment steps prior to FIHC procedure. pretreatment steps prior to FIHC 
procedure. 
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Figure 6.3A Positive NHE1 FIHC staining in the rat kidney. NHE1 was 
positively labeled by FIHC staining in P7 rat histological kidney sections fixed with 
4% PFA.  Primary Ab at 1:300 dilution was used and the secondary Ab was 
conjugated with FITC for FIHC staining.  The fluorescence images (FITC) were 
shown in the left panels and their corresponding transmitted light images (Tr Light) 
were shown in the right. The negative control sections (a and b) are shown in 
comparison to the positively labeled NHE1sections (c and d) as observed under x10 
objective of CLSM.  The (e) and (f) showed the higher magnification images of 
positively NHE1 labeled sections as observed under x63 objective of CLSM. Bar 
scale = 100 µm and 20 µm in (a-d) and (e-f) respectively. CRTX, cortex; MDULA, 
medulla; RC, renal corpuscle; RCT, renal convoluted tubule; RCOLT, renal 
collecting tubule. 
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Figure 6.3B Positive AE2 FIHC staining in the rat gastrointestinal tract (GIT). 
AE2 was positively labeled by FIHC staining in P7 rat histological GIT sections 
fixed with 4% PFA.  Primary Ab of 1:500 dilution was used and the secondary Ab 
was conjugated with FITC for the FIHC staining. The fluorescence images (FITC) 
were shown in the left and their same scale corresponding transmitted light images 
(Tr Light) were shown in the right panels. The negative control (a and b) are shown 
in comparison to the positively labeled AE2 sections (c and d) as observed under x 
10 objective of CLSM. The (e) and (f) showed the higher magnification images of 
positively AE2 labeled sections observed under x63 objective of CLSM. Bar scale 
= 100 µm and 20 µm in (a, c) and (e) respectively. MM, mucosal membrane; LMN, 
lumen; SM, submucosa. 
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This was confirmed with no fluorescence labeling observed in the negative control 
section (a-b). This result gave assurance that the antibodies of NHE1 and AE2 used 
in the current FIHC study was reliable and validated the next immunochemical 
staining study that identified the presence and distribution of NHE1 and AE2 in GP 
tissues. 
6.3 3 NHE1 and AE2 Positive FIHC Staining in P7 Rat GPC 
This section presents the result of NHE1 and AE2 localisation in P7 rat GP tissues 
using anti NHE1 and AE2 FIHC staining. Low power (x10 objective lens) CLSM 
images showed no NHE1 fluorescence staining in the negative control sections 
(Figure 6.4A (a-b)) in comparison with the tested GP sections, which revealed 
distribution of fluorescence staining along the GP (Figure 6.4A (c-f)). The 
fluorescent signal was less intense at the early PZ but increasing at the late PZ and 
early HZ, before decreasing in the middle to late HZ. Almost the same distribution 
of fluorescence staining could be observed for AE2, with the most intense 
fluorescence staining observed at the late PZ and early hypertrophic GP zone 
(Figure 6.4B (c-f)). As for comparison, no fluorescence signal was observed in the 
negative control sections (Figure 6.4B (a-b)). Further examination in high power 
(x63 objective lens) CLSM images (FITC and transmitted light images) revealed 
the cellular distribution of both NHE1 and AE2 fluorescence labeling in GPCs was 
mainly at S1-S6 of the GP proliferative and hypertrophic zones (Figure 6.5). This 
finding was consistent across proximal tibial GP of all five animals. This finding 
indicates the localisation of both the NHE1 and AE2 in GPC were site-specific 
within the zones of GPC differentiation. 
6.3 4 Localisation of NHE1 and AE2 in GPC Plasma Membrane and 
Intracellular Cytoplasm 
In order to specify the localisation of NHE1 and AE2 in GPC, the cellular 
distribution of immunofluorescence staining was further determined semi-
quantitatively by measuring fluorescence intensity of the plasma membrane and 
intracellular immuno-staining of PZ (S1) and HZ (S7-S8) cells in P7 proximal 
tibial GP (Figure 6.6; see Materials and Methods). For NHE1, the  
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Figure 6.4A Positive NHE1 FIHC staining in rat P7 GPs. NHE1 was positively 
labeled by FIHC staining in P7 rat histological proximal tibia GP sections, sagitally 
bisected before being fixed with 4% PFA.  Primary Ab of 1:100 dilution was used 
and the secondary Ab was conjugated with FITC for the FIHC staining. The 
fluorescence images (FITC) were shown in the left and their corresponding 
transmitted light images (Tr Light) were shown in the right panels. The negative 
control (a and b) were shown in comparison to the positively labeled NHE1 
sections (c and d) as observed under x10 objective of CLSM. The (e) and (f) show 
the higher magnification images of positively NHE1 labeled sections at the 
hypertrophic GPC zones observed under x 63 objective of CLSM. Bar scale = 100 
µm and 20 µm in (a-d) and (e-f) respectively. HZ, hypertrophic cells zone; PZ, 
proliferative cells zone. 
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Figure 6.4B Positive AE2 FIHC staining in rat P7 GPs. AE2 was positively 
labeled by FIHC staining in P7 rat histological proximal tibia GP sections, sagitally 
bisected before being fixed with 4% PFA.  Primary Ab of 1:500 dilution was used 
and the secondary Ab was conjugated with FITC for the FIHC staining. The FITC 
were shown in the left and their corresponding transmitted light images (Tr Light) 
were shown in the right panels. The negative control (a and b) were shown in 
comparison to the positively labeled AE2 sections (c and d) as observed under x10 
objective of CLSM. The (e) and (f) showed the higher magnification images of 
positively AE2 labeled sections at the hypertrophic GPC zones observed under x63 
objective of CLSM. Bar scale = 100 µm and 20 µm in (a-d) and (e-f) respectively. 
HZ, hypertrophic cells zone; PZ, proliferative cells zone.  
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Figure 6.5 Positive fluorescence signal associated with NHE1 and AE2 in the GP 
IHC. Paraffin embedded sections (10 µm-thick) of proximal tibia GP of 7-day old rat 
showed positive fluorescence (FITC) in GPC at different zone sections of 
proliferative zone and hypertrophic zone cells (S1-S8). Tr Light = transmitted light 
image corresponding to the fluorescence images. In situ GPC (figure far left) as 
viewed in unfixed live (calcein-loaded) GP tissue was shown for comparison. Images 
were taken using CLSM (x63 objective lens). Bar = 20 µm. 
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Figure 6.6 Localisation of NHE1 and AE2 in GPC plasma membrane and 
cytoplasm. Localisation of NHE1 and AE2 in GPC plasma membrane (PM) and 
intracellular cytoplasm (IM) by FIHC was measured semi-quantitatively (see 
Materials and Methods). Bar = 20 µm. (A) GPC NHE1 or AE2 localisation is 
shown in typical proliferative (PZ, top) and hypertrophic (HZ, bottom) 
chondrocyte(s) determined from the corresponding transmitted light (Tr Light) 
image. (B) Examples of the intensity profiles of fluorescence associated with NHE1 
and AE2 as determined along a line drawn across an optical section of a 
proliferative (top) and hypertrophic (bottom) chondrocyte using ImageJ. 
Fluorescence intensity is in gray scale value. (C) Table of values (% highest 
intensity) representing cellular localisation of NHE1 (left) and AE2 (right) in GPC 
PM and IC; and in the corresponding PZ (S1) and HZ (S7-8). *Significantly 




Chapter 6: NHE1 and AE2 Growth Plate Immunohistochemistry 
                                                                                                       Page  201 
immunofluorescence intensity in GPC plasma membranes was significantly 5-fold 
higher in PZ cells compared to HZ cells (Student’s unpaired t-test; P<0.05; n=5). 
The intracellular cytoplasm of PZ cells also had significantly higher fluorescence 
intensity (~3-fold) than the HZ cells (P<0.05). However there was no significant 
difference in the fluorescence intensity between the plasma membrane and 
intracellular membrane of the cells from the same zones. For AE2, the fluorescence 
intensity in both plasma membrane and intracellular cytoplasm of the PZ cells was 
significantly higher than the HZ cells (~3-fold; P<0.05). The fluorescence intensity 
between plasma membrane and intracellular cytoplasm within the same zones was 
not significantly different. These results demonstrate that PZ cells had significantly 
higher fluorescent intensity of NHE1 and AE2 immunostaining than in HZ cells. 
However, there was no apparent difference in localisation of NHE1 and AE2 
between plasma membrane and intracellular cytoplasm within a same cell in either 
PZ or HZ. Fluorescence intensity of the plasma membrane and intracellular 
immuno-staining of other zone sections between S1 and S7-S8 were not 
determined due to inconsistent quality of the GPC sections to allow the 
discrimination between the plasma membrane and intracellular cytoplasm 
fluorescent labeling. 
6.3 5 Semi-quantitative Distribution Pattern of NHE1 and AE2 in GPC 
along the GP 
To examine the overall semi-quantitative distribution pattern of NHE1 and AE2 in 
GPCs along P7 proximal tibia GP (S1-S8), the average fluorescence labeling 
intensity associated with membrane transporter localisation was determined as 
described in Materials and Methods. Figure 6.7A shows a relatively high level of 
NHE1 immunofluorescence intensity throughout S1-S5 before decreasing 
dramatically from S6-S8 (One-way ANOVA; P<0.001). The fluorescence intensity 
was significantly lower in S8 compared to the maximum intensity that was reached 
in S5 (Student’s unpaired t-test; P<0.001; 5[15]). Figure 6.7B demonstrates a 
significant increase in immunofluorescence intensity of AE2 throughout S1-S5 
(One-way ANOVA; P<0.001). The peak intensity was observed in S5, which was 
significantly higher than the original intensity recorded in S1 (Student’s unpaired t- 
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Figure 6.7 Localisation of NHE1 and AE2 in GPC along the GP. Overall NHE1 
(A) and AE2 (B) fluorescence labelling intensity (%) pattern are shown as seen at 
the plasma membrane and intracellular compartments of chondrocytes along P7 rat 
proximal tibia GPs. Data pooled from five separate animals and at least 15 cells/ 
section. Section 1 (S1) is nearest to the epiphyseal end and marks the early 
proliferative zone and section 8 (S8) is nearest to the metaphyseal end and denotes 
the late hypertrophic zone of the GP. The inset shows the graphs in (A) and (B) 
were re-plotted together for easier comparison by normalising the data to 100% at 
S5. *Significant difference compared to S1 of AE2 (Student’s unpaired t-test; P< 
0.005, n=5). 
 
test; P<0.001; data from at least 5[15]). After reaching the highest fluorescence 
intensity in S5, there was a significant decrease in the intensity from S6-S8 (One-
way ANOVA; P<0.001). The fluorescence intensity of AE2 in S8 was significantly 
lower than in S1 (Mann-Whitney test; P=0.008; 5[15]). Although 
immunofluorescence labeling of both NHE1 and AE2  shared the highest intensity 
in S5 and the lowest in S8, the intensity of NHE1 in S1 was significantly higher 
than in AE2 (Student’s unpaired t-test; P<0.005; 5[15]). Figure 6.7 (inset) 
demonstrates direct comparison between NHE1 and AE2 immunofluorescent 
intensity along GP after the data from Figure 6.7(A & B) being normalized to 
100% at S5 (peak intensity in both graphs). It shows that while NHE1 was 
maintaining a constantly higher level of immunofluorescent labeling throughout 
S1-S5, the AE2 labeling has initially lower immunofluorescence labeling and was 
gradually increasing toward S5. Both NHE1 and AE2 immunofluorescence 
decreased dramatically after S5 toward S8. 
6.4 Discussion  
6.4 1 The Key Findings 
This study has optimized FIHC staining technique for NHE and AE detection on 
PFA-fixed and paraffin-embedded GP cartilage histological sections. The FIHC 
result identified a consistent distribution pattern of AE2 and NHE1 in postnatal GP 
cartilage. The NHE1 was found at a relatively higher level throughout proliferative 
and early hypertrophic zones, whereas AE2 level was initially lower at early 
proliferative zone but gradually increased toward the late proliferative and early 
hypertrophic zones. Both NHE1 and AE2 levels decreased dramatically from early 
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to late hypertrophic zones. At the cellular level, the NHE1 and AE2 showed almost 
equal distribution within the intracellular and plasma membrane compartments of 
the proliferative and hypertrophic zone, with the overall immunofluorescent 
staining being significantly higher in PZ compared to HZ. 
6.4 2 FIHC Technique 
The basis of IHC comprises three scientific disciplines: immunology, histology, 
and chemistry. The fundamental concept behind IHC is the demonstration of 
antigens within tissue sections by means of specific antibodies. Once antigen–
antibody binding occurs, it can be demonstrated with a coloured histochemical 
reaction visible by light microscopy (enzymatic immunolabeling) or fluorochromes 
with excitation light (fluorescent immunolabeling) (Ramos-Vara, 2005). An 
advantage of using fluorescent-label immunostaining is it is relatively quick and 
easy to perform compared to enzyme-immunolabeled histochemistry, which is 
more complex and time-consuming (Renshaw, 2007). In addition, the present study 
used indirect fluorescent immunostaining method to localize the NHE1 and AE2, 
which is simple and economical to do because the reaction is only a two-step 
process with a secondary Ab conjugated directly with fluorescent label (Renshaw, 
2007). 
6.4 3 Background Staining and Ag Masking Problems in FIHC Study 
However, one setback of the fluorescent immunohistochemistry method is the 
presence of unwanted back-ground fluorescence, which is either due to 
autofluorescence of the tissue of interest, or presents as a fluorescent background 
caused by nonspecific binding of the fluorescent antibody giving a false positive 
staining (Ramos-Vara, 2005). Besides, the indirect immunostaining method used 
provides little amplification of the visible signal, so their use is limited to detection 
of plentiful Ag but lacks sufficient sensitivity for the detection of relatively low 
concentrations of Ag in question.  
Therefore understanding the source of the background staining is the key 
strategy to improve the discrimination of the Ag labeling when using the indirect 
fluorescent immunostaining technique. There are three common types of 
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autofluorescence, which can be categorized as intrinsic or induced by fixation 
media and tissue processing: i) elastin and collagen autofluorescence, ii) lipofuscin 
autofluorescence and iii) aldehyde (fixative)-induced autofluorescence (Renshaw, 
2007). Native fluorescence of elastin and collagen is typically found in blood 
vessel walls and skin; whereas lipofuscin is prominent in neurons, glial cells 
cardiac muscle cells but is also found in a wide range of cell types (Billinton and 
Knight, 2001). For GP sections, the presence of native autofluorescences was less 
problematic compared to the autofluorescence caused by aldehyde fixative during 
FIHC staining. Aldehyde fixative served as a good choice for the preservation of 
GP tissue morphological details for electron microscopy (Paljarvi et al., 1979), or 
for general histology when the fixative was coupled with a cationic dye (Hunziker 
et al., 1983). However the fixative has a major drawback as it may further augment 
background fluorescence when the aldehyde-fixed tissue is destined for 
immunochemical staining. Formaldehyde forms covalent bonds between adjacent 
amine-containing groups through Schiff acid-base reactions. As a consequence, 
fluorescent products are formed, resulting in an intense fluorescent background. 
Moreover, these products may also non-specifically react with antibodies (Vieges 
et al., 2007). Molecules that contribute to the intrinsic and induced 
autofluorescence are responsible for an emission of fluorescence between 450 and 
650 nm that overlaps the emission wavelength of fluorophores widely used in 
immunofluorescence studies such as fluorescein isothiocianate (FITC) (Vieges et 
al., 2007) 
Besides that, background staining could also be contributed by hydrophobic 
protein interactions, and non-specific attachment of conjugated antibodies to free 
aldehyde groups in aldehyde-fixed specimens (Ramos-Vara, 2005). Tissue proteins 
are rendered more hydrophobic by fixation with aldehyde containing fixatives as 
the result of cross-linking of reactive epsilon- and alpha-amino acids, both within 
and between adjacent tissue proteins. The increase hydrophobicity of proteins 
during fixation increases the background staining in immunohistochemical 
procedures (Ramos-Vara, 2005; Renshaw, 2007). The non-specific attachment of 
conjugated antibodies to free aldehyde groups introduced by aldehyde-containing 
Chapter 6: NHE1 and AE2 Growth Plate Immunohistochemistry 
                                                                                                       Page  206 
fixatives present in the tissue is more common when glutaraldehyde is being used, 
but prolonged fixation in formaldehyde can also produce free aldehydes (Ramos-
Vara, 2005).  
Moreover, Ag masking due to cross linking of proteins in aldehyde-fixed 
tissue section has been recognized as one of the major causes for 
immunohistochemical failures in the past (D’Amico et al., 2009). Although 
adequate fixation is an important factor in successful IHC localisation of Ag 
through preservation of tissue morphology and immobilization of the Ag, it could 
adversely affect the preservation of Ag immunoreactivity and hinder adequate 
penetrability of tissue to the immunochemical reagents (Berod et al., 1981). As 
discussed earlier, this Ag masking by cross linking proteins also causes other 
related background staining problems in FITC. 
6.4 4 Pretreatment of FIHC Study 
Having understood the issues related to FIHC method, coping with the Ag masking 
and background staining is therefore particularly important when adopting FIHC 
technique. This study has found that a combination of HIAR technique and the use 
of 1% NaBH4 (Figure 6.2) were effective to improve FIHC staining of PFA-fixed 
GP tissues in pre detection phase. The theory behind HIAR remains unclear 
(Renshaw, 2007), but a possible mechanism of the technique was the loosening or 
breaking of the cross-links (methylene bridges) between proteins induced by 
aldehyde fixation (Shi et al., 1991 & 1992). The breakage of the cross-links allows 
the proteins to take on a more tertiary-like structure, allowing antibodies access to 
the epitope. This technique demonstrates that cross-linking of protein may be a 
reversible chemical reaction under certain conditions, serving to unmask 
antigenicity after aldehyde fixation (Shi et al., 2001).  
Besides that, calcium precipitation (and also that of other divalent metal 
cations) is currently thought to play a significant role in effective Ag retrieval. 
Methylene bridge formation allows bonding of proteins to calcium ions and their 
removal or precipitation is thought to be a critical step in salt-mediated Ag retrieval 
(Renshaw, 2007). Morgan et al. (1997) demonstrated that the chelating effects of 
EDTA to be improved at high pH compared with low pH. The present study 
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showed that to detect NHE1 and AE2 antigens, HIAR solution comprising of with 
0.01 M Tris Base buffer, 0.001 M EDTA (pH 9.0) gave satisfactory FIHC results. 
However, care has to be taken when using the HIAR technique. Tissues 
undergoing this procedure should be on tissue-adhesive-coated slides to improve 
tissue adherence to the glass. Harsh conditions of heat-induced Ag retrieval often 
cause tissue to lift off the slides, and friable tissues are prone to lifting, even on 
coated slides (Renshaw, 2007) 
 The use of sodium borohydrate in the present study reduces aldehyde-
induced autofluorescence by reducing Schiff bases (R1HC=NR2) that are formed 
between the aldehyde and NH2 groups (Renshaw, 2007). This also removes non-
specific attachment of conjugated antibodies to free aldehyde groups introduced by 
the aldehyde-containing fixatives present in the tissue. Other compounds that can 
abolish this binding include ammonium chloride, ammonium carbonate buffer, 
lysine, and glycine (Baschong, 2001). 
For GA-fixed sections, the Ag masking by the proteins cross-linking is a 
major drawback for immunochemical staining due to the excessive and aggressive 
cross-linking compared to PFA or formaldehyde (Renshaw, 2007). In addition, 
there is a relatively higher degree of autofluorescence compounds formed between 
the aldehyde fixatives and proteins or amines. All these could be the reasons why 
antigens in GA-fixed tissue could not be restored by the current FIHC optimization 
method (Figure 6.1A).  
There are a number of other different FIHC pretreatment approaches that 
could be attempted for GA-fixed tissue sections. Baschong et al. (2001) 
summarized different types of strategies to control  autofluorescence that were (a) 
extraction of the autofluorescent constituent by dissolution such as treatment with 
ammonia/ethanol; (b) chemical modification of the fluorochrome such as the use of 
photochemical methods, e.g. photobleaching, through which the molecular 
structure of a fluorophore is changed so that it loses its ability to fluoresce; and (c) 
masking of the autofluorescent structure by appropriate staining. Autofluorescence 
masking can be achieved using Trypan Blue and Sudan Black B by its veiling 
activity on autofluorescence without interfering with the surface fluorescent label 
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resembles the effect of counterstains (Baschong et al. 2001). Other strategies 
involve using instruments, such as optimized filter sets, CLSM and post-
measurement image correction also allow discrimination of autofluorescence 
through the use of mathematical models (Steinkamp and Stewart, 1986; Van de 
Lest et al. 1995).  
A number of workers have reported several methods that combined or 
modified the above mentioned strategies that could be worthwhile on GA-fixed GP 
sections. An example is the use of water-bath heating for 30 mins at 80°C in 10–50 
mM sodium citrate at pH of 8.5–9.0, which considerably enhances the 
immunolabeling that can be obtained in fixed sections without any evident 
deleterious effect of the treatment on tissue integrity at the light microscopy or 
electron microscopy (EM) level (Jiao et al., 1999). Vieges et al. (2007) proposed 
the combined use of high-intensity (30W), short-duration (2 hrs) photobleaching 
and Sudan Black B as the sections pretreatment for FIHC staining, which can be 
used regardless of tissue type as similar results were obtained for highly 
vascularised, lipofuscin-rich tissues, such as kidney and liver, and tissues with 
reduced vascularisation and low lipofuscin content. This approach is even more 
effective when poorly vascularised and low lipofuscin content tissues, such as the 
pancreas. Having discussed the various pretreatment methods, a possible simple 
way to reduce aldehyde-related fluorescence is to use the fixative in low 
concentrations or to avoid it altogether if the tissue is destined for FIHC 
(Tokumasu and Dvorak, 2003). 
6.4 5 Other Pretreatment Techniques Studied 
Other pretreatment methods have been tried in the present study (data not shown) 
in order to improve the signal-to-background noise ratios in FIHC staining. 
However the results were unsatisfactory compared with the combination of HIAR 
and NaBH4. These include the use of thiol-based blocking strategies (Rogers et al., 
2006, and CAS-Block™ (Invitrogen). Thiol-based blocking approach has been 
proposed to inhibit the mechanism of intermolecular disulfide bridge formation 
and/or other thiol linkages between antibodies and substrate chemical side groups, 
whereas CAS-Block™ is used as a universal blocking agent for reducing 
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nonspecific background staining using non species-specific serum. Using 
enzymatic Ag retrieval methods such as trypsin or proteinase K were also 
attempted but gave poor and inconsistent results. 
Allthough there are other wide range of strategies to tackle 
autofluorescence problems as discussed earlier, the results of the present study 
highlight the fact that there is no general methodology available for all antigen 
demasking and the control of autofluorescence. Success in exploiting them was 
found in a tactical approach to choose appropriate reagent(s) by trial and error, 
either individually or in combination, tailored for a specific tissue type and fixation 
medium and other relevant factors such as processing technique, and wavelength of 
excitation light (Baschong et al., 2001). Optimizing FIHC techniques is laborious 
and time consuming, however it is worth endeavouring as it is an indispensable 
step to obtain reliable FITC results where quality assurance is of utmost 
importance. 
6.4 6 FIHC Quality Assurance 
One of quality assurance measures in fluorescence IHC procedure that applied in 
the present works was simultaneous staining of sections of known positive 
(positive control tissue) such as the kidney (Figure 6.3A) and GIT (Figure 6.3B) 
for NHE1 and AE2 antigens, respectively (Mahnensmith and Aronson, 1985; 
Alrefai et al., 2001). The appearance of tissue staining in the positive control tissue 
in an expected distribution corresponding to the Ag under investigation provides 
evidence of the specificity of the antiserum used. Conversely, staining in an 
unexpected location or pattern suggests that the staining may not be specific. Thus 
the reproducibility of the technique is assured because the staining intensity and 
distribution in this tissue should remain consistent. In addition, the control and 
unknown case tissues were sampled, fixed, embedded and stored identically to 
ensure the antigens in the test and control tissues have been equally preserved thus 
avoiding false negative results from occurring. Otherwise, the interpretation of 
negative findings in FIHC result must be made with caution (Haines and Chelack, 
1991). 
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6.4.7 FIHC Result Quantification and Analysis 
Quantification of FIHC staining is not non-straightforward and can only be 
performed subjectively according to a semi-quantitative grading, which can have 
poor reproducibility depending on the skills. Therefore standardisation of the 
quantification method used and consistency in the results from a repeated number 
of studies is important.  
Even though there is a number of automatic image analysis facilities 
available to study FITC results (Renshaw, 2007), some basic technical issues like 
morphological quality of the tissue need to be addressed beforehand. The quality of 
the sections is particularly important to study a specific cellular localisation at sub-
cellular level e.g. antigens distribution to the plasma membrane and cytoplasm 
because this requires good detail of cellular morphology. Based on this study, using 
PFA 4% gave a good trade off between adequate morphological preservation and 
providing acceptable quality of FIHC staining with manageable background 
staining and Ag masking induced by the  fixative. Future work could be attempted 
to optimize FIHC staining technique for GP tissue fixed in 2% GA with 0.7% RHT 
solutions (osmolarity  adjusted to ~280 mOsm) as it has shown to provide superior 
preservation of the original GPC morphology with minimal artifacts compared to 
other conventional fixatives (Chapter 4). 
CLSM allowed a careful morphological observation and analysis at a 
cellular resolution (Paddock, 2000) that make the localisation of the Ag at cellular 
level possible based on the acquired 2D and 3D images. However, because of the 
limitation of the image analysis technique used in the present study, the distribution 
of NHE1 and AE2 fluorescent staining either in the plasma membrane and 
cytoplasm was based on a rather subjective approximation of plasma membrane 
thickness and cytoplasm diameter range.  
In future, improved measurement of cellular localisation of membrane 
transporters could be attained by exploiting the advantage CLSM method that 
permits the determination of the location of multiple fluorescently tagged 
molecules in the same tissue preparation without fear of the signal from one 
molecule contributing to the others (Renshaw, 2007). For instance, the in situ GPC 
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colocalisation of specific membrane transporters and plasma membrane could be 
performed by using a specific antibody for the membrane transporters and 
fluorescent probes for plasma membrane (e.g. 1-43FX fixable analog of FM®, 
Invitrogen) and in situ live cell (e.g. fixable CellTracker™ Blue CMAC (7-amino-
4-chloromethylcoumarin), Invitrogen). Preliminary works on this approach showed 
lack of specificity in the labeling of the plasma membrane (data not shown), but 
warranted further optimization. However, overall observation of  NHE1 and AE2 
immunofluorescence staining in GPCs along P7 proximal tibia GP (S1-S8) in this 
study clearly showed the transporters fluorescent-labeled signals were detected 
specifically from within the chondrocyte compartments (Figures 3, 4 and 5). 
To allow comparison between the result values acquired from different 
animals using semi-quantitative method, normalization of the values based on the 
highest percentage value in each individual GP tissue was performed. 
Alternatively, normalization using a standard reference value based on a universal 
parameter could be utilized similar to the use of loading control in Western blots 
technique (Aldridge et al., 2008). The parameter of reference should be 
consistently present and measurable in cells from different individual animals. For 
example, normalization of immunofluorescent staining of the Ag of interest 
measured in parallel to the immunofluorescence of a high-abundance housekeeping 
protein such as actin and tubulin (Spector et al., 2001; Ferguson et al., 2005; 
Romero-Calvo et al., 2010). This could ensure the reliability of the data that were 
pooled and compared from different samples or animals. However this 
normalization method has its own limitation due to the influence of various 
physiological and pathological factors on the control of gene expression (Ferguson 
et al., 2005), besides extra technical and optimization steps required in the FIHC 
technique compared to the present method used. 
6.4 8 Collagen Type X 
Collagen type X was found mainly in the hypertrophic cartilage zone peri- and 
extracellularly. This finding was in agreement with previous reported studies that 
showed the secretion of collagen type X in hypertrophic chondrocytes of chick GP 
(Poole & Pidoux, 1989), condylar cartilage of fetal mouse mandible (Shibata et al., 
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1997), developing rat trachea (non GP cartilage) (Sasano et al., 1998); and 
newborn rat tibia GP (Sasano et al., 1998); chick embryo epiphysial cartilages 
(Kielty et al., 1985), and human fetal and juvenile articular cartilage-bone 
metamorphosis (Nerlich et al., 1992). Thus this result further supports the notion 
that collagen types X can be utilised as markers of chondrocyte hypertrophy 
(Farquharson & Whitehead, 1995; Shibata et al., 1997) in numerous cartilage cells 
that have been studied.  
6.4 9 NHE1 and AE2 Distribution in Postnatal GP 
Previous work on NHE in rat GP has demonstrated the presence of activity NHE 
activity in the HZ cells but not in the PZ cells, based on pH recovery measurement 
in a HCO3-free medium following intracellular acidification using the ammonium 
rebound technique (Bush et al., 2006b). The subsequent work also showed absolute 
expressions of the AE gene families in PZ and HZ of 6 week rats with the fold 
change between PZ and HZ (Bush et al., 2010). The microarray analysis 
highlighted AE3 alone as changing expression between proliferative and 
hypertrophic zones, with an approximately 14-fold increase compared with no 
change for AE1 or AE2.  
The results appeared to be not fully in agreement with the present 
immunofluorescence staining results that showed the NHE distribution was found 
to be almost consistent along the PZ before decreasing through to the late HZ 
(Figure 6.5 and 6.7A). The current result also specifically demonstrated the 
distribution of AE2 was relatively higher at the late PZ and early HZ compared to 
the rest of GPC differentiation zones (Figure 6.5 and 6.7B). A possible explanation 
for this lies with the fact that there was a difference in a categorical selection of the 
GP PZ and HZ zone for tissue sampling between these studies. For an example the 
microarray analysis to analyze mRNA levels of the membrane transporters was 
based on a group of GP cells that was procured using laser capture microdissection 
(LCM) (Wang et al., 2004) and not the distribution of the protein from stained PZ 
or HZ segments, whereas in FIHC study the fluorescent labelling was examined in 
individual GPC across the different GP zones. In this respect, even though neither 
method is a specific measure of protein activity, FIHC offers a more specific 
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definition of the transporter distribution and localisation along the GP tissue. 
Another possible explanation for the contradictory results was the difference in the 
age of animals studied i.e. day-7 and day-42.  The expression of transporters or 
their subfamily could be affected by the animal age and this was demonstrated by 
alkaline phosphatase, a known HZ marker that showed 4 times greater in the 
enzyme expression from GP PZ to HZ in 6-week-old compared to 7-week-old rats 
(Wang et al., 2004). Further FIHC study of other subfamily AE or NHE 
localisation in GP could give a complete picture of the role of the transporters in 
the bone growth. To achieve this, reliable specific antibodies for FIHC studies are 
essential. 
6.4 10 NHE1 and AE2 Possible Roles in Bone Growth 
The relatively high levels of NHE1 throughout the proliferative (PZ) and early 
hypertrophic zones (Figure 7A) support a ‘housekeeping’ role of this transporter in 
the maintenance of optimal pHi (Schelling & Abu Jawdeh, 2008). However the 
increased levels of AE2 appeared to correspond with early chondrocyte 
enlargement (Fig. 7B). The FIHC results suggested that both transporters were 
localized at the plasma membrane and cytoplasm of both PZ and HZ cells (Fig. 6). 
The increased AE2 labelling along the GP (along with NHE1 activity) might give 
rise to the accumulation of intracellular Cl- and Na+ (leading to the stimulation of 
the 3Na+/2K+ pump), creating an osmotic gradient into the cell resulting in water 
accumulation and subsequent cell enlargement. It is also possible that raised levels 
of AE2 might correspond to the increased requirement for the maintenance of 
steady-state pHi in the face of elevated metabolism of HZ chondrocytes (Brighton 
et al., 1973; Hunziker et al., 1987b). The decreased levels of both transporters in 
S5 to S6 appeared to occur when hypertrophic chondrocytes are maximally 
enlarged (Chapter 3) and this could accelerate cell death thus allowing calcification 
and new bone formation. These results suggest complex changes to levels of these 
transporters along the GP which might be associated with GPC hypertrophy and 
thus bone lengthening. Hypertrophy and survival in other cell types has also been 
associated with changes to levels of these transporters (Schelling & Abu Jawdeh, 
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2008; Hwang et al., 2009) raising the possibility that they play similar roles in the 
GP.  
6.4 11 Comparison of Growth Plate Chondrocyte Hypertrophy 
Mechanisms with Other Cell Types 
 Hypertrophy in cell types other than chondrocytes was usually observed in 
pathological conditions. For examples, cardiac hypertrophy (Geisterfer et al., 1988; 
Shubeita et al., 1990; Wang et al., 1998; Colella et al., 2008), systemic and 
pulmonary hypertension (Tseng and Berk, 1992; Tajsic and Morrell, 2011) and 
compensatory renal hypertrophy (Johnson and Vera Roman, 1966; Bonvalet et al., 
1972; Liu and Preisig, 2002; Chen et al., 2005). The pathological cell hypertrophy 
is controlled by paracrine factors, as also occurs in normal cell growth and 
differentiation (Shubeita et al., 1990; Wolf and Nelson, 1990; Wolf et al., 1993; 
Franch et al., 1997; Flyvbjerg et al., 1999; Huet et al., 2001; Colella et al., 2008). 
 Hypertrophy of non-chondrocytes is predominantly associated with influx 
of water and ions into the intracellular spaces via alteration of plasmalemmal ion 
channel and transporter proteins expression to maintain the increase in cells 
volume (Tseng and Berk, 1992; Tajsic and Morrell, 2011). Other mechanisms have 
also been suggested, which include cell-cycle-dependent or independent 
mechanisms that mediate the increase in RNA and cellular protein synthesis 
(Bonvalet et al., 1972; Ouellette et al., 1987; Liu and Preisig, 2002; Chen et al., 
2005), and endoreduplication process that increases the DNA content (Soonpaa and 
Field, 1994; Lippin and Roth., 1997; Larkins et al., 2001). 
 The hypertrophic cells could increase their volume without DNA synthesis, 
but instead through the synthesis of RNA and cellular protein. This could be 
achieved with or without cell cycle activation. The cell cycle-dependent 
mechanism of cell hypertrophy involves entry of cells into the G1 phase of the cell 
cycle, initiating G1 -related events, followed by arrest of cell cycle progression 
prior to the G1 /S checkpoint (Liu and Preisig, 2002) as a result of coordinated 
effects of a mitogen and antiproliferative agent (Wolf and Nelson, 1990; Liu and 
Preisig, 2002). These agents block progression of the cell cycle before entry into S 
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phase so cells do not divide but continue to synthesize protein, yielding 
hypertrophy (Franch et al., 1997). This mechanism was shown to mediate renal 
tubular cell hypertrophy following unilateral nephrectomy (Liu and Preisig, 2002).  
 On the other hand, cell-independent mechanism involves an imbalance 
between rates of cellular protein synthesis and degradation by lysosomal enzymes 
(Liu and Preisig, 2002). This form of hypertrophy is induced by alkalinization of 
acidic intracellular vesicles (e.g. lysosomes) by certain compounds that inhibit the 
activity of lysosomal enzymes in protein degradation (Liu and Preisig, 2002), or by 
suppression of lysosomal proteolysis under influence of growth factors such as 
epidermal growth factor (EGF) and transforming growth factor- β (TGF-β) (Franch 
et al., 1997).  
 Hypertrophy of cells is irreversible if it is coupled with increase in the DNA 
content via endoreduplication, as observed in vascular smooth muscle cells (Tajsic 
and Morrell, 2011). Endoreduplication is a form of nuclear polyploidization that 
results in multiple, uniform copies of chromosomes. This process is common in 
plants and animals, especially in tissues with high metabolic activity, and generally 
in cells that are terminally differentiated. During this process, cells amplify their 
genome without chromatin condensation, segregation or cytokinesis, resulting in 
what appears to be multiple, uniform copies of the nuclear DNA. Clearly, some of 
the mechanisms that direct sequential progression of the G1-, S-, G2- and M-phases 
of the cell cycle are modified in this an 'alternative' cell cycle to allow the 
chromosomes to replicate without consequent nuclei and cells division. Typically, 
cells that have undergone endoreduplication are larger than comparable cells that 
have not. Being bigger and having a larger number of organelles (mitochondria or 
plastids in plants) would potentially confer the cells with greater transcriptional and 
translational capacities, manifested functionally by high cellular metabolic 
activities (Larkins et al., 2001). It was suggested the large cells have the capacity to 
increase their volume faster than smaller cells, and this could be advantageous in 
the case of rapidly growing tissues, as observed in some species of fruits and seeds 
(Grime and Mowforth, 1982).  
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 However, the characterization of the mechanisms involved in the 
development of hypertrophy in the other cell types than chondrocytes was only 
demonstrated in in vitro (Iwaki et al., 1990; Shubeita et al., 1990; Wolf and 
Nelson, 1990; Tseng and Berk, 1992; Wolf et al., 1993; Franch et al., 1997; Chu et 
al., 2008). Nonetheless from those studies and the present results, there are a 
number of common features shared between chondrocytes and other cell types with 
regards to cell hypertrophy. These include regulatory functions of paracrine factors 
in the cell enlargement process and potential roles of membrane transporters in 
mediating cell volume increase associated with the hypertrophy.  
6.4 12 Future Study 
Previous studies have shown roles of growth factors and hormone in controlling 
membrane transporters activity in AE regulation in rat ventricular myocytes (Malo 
& Fliegel, 2006). This and the fact that growth hormone has been known for many 
years to be an important regulator of longitudinal bone growth (Nilsson et al., 
2005) raises an intriguing question whether growth hormone has any contributory 
effects on the GPC membrane transporters activity  and sets an interesting direction 
of future study on the current topic. 
6.4 13 Summary 
This study suggests that the NHE1 presence in the GP could be associated with its 
maintenance role in chondrocytes survival from the onset of chondrocyte 
proliferation through to the early stage of chondrocyte hypertrophy, whereas AE2 
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7.1 General Discussion and Conclusions 
The study highlighted the importance of the well-coordinated chondrogenesis as a 
‘making space’ mechanism model that allow the normal growth plate development 
in a mammalian. The study has also emphasised the importance of GPC 
hypertrophy in longitudinal bone growth and a possible involvement of plasma 
membrane transporters in the GPC enlargement. Based on the hypothesis that 
plasma membrane transporters have a role in driving the cell swelling associated 
with chondrocyte hypertrophy, the focus of the investigations were centered on the 
NHE and AE - two membrane transporters ubiquitously found in mammalian cells. 
The functions and distributions of these membrane transporters in the growth plate 
of a mammalian species were studied by using tissue culture and 
immunohistochemistry coupled with the powerful micro-imaging tools of CLSM. 
The experimental findings of this project are presented under four broad 
headings: (i) characterization of in situ living GPC in the rat GP, (ii) GPC fixation 
and shrinkage artifact incurred by conventional fixatives, (iii) possible roles for 
NHE and AE in longitudinal bone growth, and (iv) expression of NHE1 and AE2 
within hypertrophic GPC hypertrophy in the rat GP. 
(i) Characterization of in situ living GPC in the rat GP 
Studying GPC volume changes within GP cartilage without artefacts caused by GP 
tissue fixation was essential. Therefore this work initially studied unfixed 
fluorescently labeled living GPCs in situ by using high resolution confocal 
scanning microscopy.  
This study identified a number of important observations of live in situ 
GPC in the different maturational zones. All GPs exhibited the cell differentiation 
cascade characteristic of GPs. The final hypertrophic GPC volume varied markedly 
depending on the bone under investigation although the cell volume at the 
proliferative zone was not significantly different between different GPs. In other 
words, all of these bones start with the same sort of growth plate chondrocytes. The 
hypertrophic GPC volume to some extent was influenced by the rate of cell volume 
changes between the proliferative zone and hypertrophic zone. 
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Interestingly, there was no obvious relationship between the final 
hypertrophic GPC volumes and bone length based on a single time point (i.e. post 
natal) cell volume measurement. It could be reasoned that the final hypertrophic 
GPC volume changes dynamically during the bone growth phase to attain specific 
final bone lengths for different bones. This result highlighted differential growth 
(Wilsman et al., 1996b, 2008) among different growth plates of postnatal rats that 
signify the complex regulatory mechanism involved in longitudinal bone growth. 
(ii) GPC shrinkage artifact incurred by conventional fixative solutions. Having 
characterized living in situ GPCs, the second scope of study examined was the 
effect of conventional fixatives on GPC morphology. Optimal fixation methods 
that maintain the original morphology of the GPCs are vital when fixed GP tissues 
are used to study the tissue and cellular distribution of plasma membrane 
transporters in GP using the immunohistochemistry technique. 
This study demonstrated that the osmolarity of fixative solutions was 
important for maintaining the normal morphology of hypertrophic chondrocytes 
within the mammalian growth plate following chemical fixation. The shrinkage 
artifact incurred by conventional fixatives, was abolished when the osmolarity of 
the medium was reduced close to that of normal physiological solutions or 
markedly reduced when the bones were sagitally bisected prior to fixation. These 
results raised important issues in relation to the accurate preservation of cell 
morphology by widely-used conventional fixative solutions. The subsequent works 
in the thesis took a careful note of this finding e.g. when fixed GP sections were 
prepared for FIHC studies. 
(iii) A possible role for NHE and AE in longitudinal bone growth. The third 
part of the present study determined if plasma membrane transporters have a role in 
growth plate chondrocyte enlargement and subsequent longitudinal bone growth  
This study identified an essential role of AE and NHE in postnatal 
longitudinal bone growth as shown by dose-response relationship of the inhibitors 
to the two transporters with bone growth in an ex vivo bone growth model (Figure 
5.3). The results indicated that both NHE and AE are implicated in the postnatal 
GPC enlargement mechanism. However, the role of the transporters in prenatal 
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bone growth appeared more complicated and warranted further examination with 
additional number of samples, and adjustment of the inhibitor drugs concentration 
to avoid drug-induced cytotoxicity of the relatively smaller and delicate embryonic 
bones.  
(iv) Changes to sodium hydrogen 1 (NHE1) and anion exchanger (AE2) 
expression levels with GPC hypertrophy in the postnatal rat GP. In light of the 
ex vivo results indicating a possible functions of NHE and AE in GPC enlargement 
and longitudinal bone growth, the subsequent study was undertaken to investigate 
the GP tissue distribution and cellular localisation of NHE1 and AE2 along the 
GPC differentiation cascade using optimized FIHC staining technique. 
FIHC examination described the expression and distribution pattern of 
NHE1 and AE2 in postnatal GP cartilage. These findings highlighted a distinct 
relationship between NHE1 and AE2 expression levels and GPC hypertrophy in rat 
postnatal GPs. The transporter GP and cellular localisation suggested that the role 
of NHE1 in the GP was associated with maintenance of chondrocyte survival from 
the onset of chondrocyte proliferation through to the early stage of chondrocyte 
hypertrophy. In contrast, AE2 appeared to be specifically involved in the transition 
of cells from the proliferative to hypertrophic zones. 
 While GPC hypertrophy of bone growth could be considered physiological, 
hypertrophy in other cell types is usually pathological. For examples hypertrophy 
of smooth muscle cells (Geisterfer et al.1988; Tseng and Berk, 1992; Tajsic and 
Morrell, 2011), cardiomyocytes (Iwaki et al., 1990; Shubeita et al., 1990; Wang et 
al., 1998; Colella et al., 2008), neurons (De Souza et al., 2000) and nephrons 
(Johnson and Vera Roman, 1966; Liu and Preisig, 2002; Chen et al., 2005). These 
cells hypertrophy is controlled by paracrine factors as in normal cell growth and 
differentiation (Shubeita et al., 1990; Huet et al., 2001; Colella et al., 2008) 
dominantly associated with activities of channel and transporter systems to 
maintain the cell volume increase (Tseng and Berk, 1992; De Souza et al., 2000; 
Tajsic and Morrell, 2011). However other mechanisms have been implicated in the 
pathological cell hypertrophy including cell hypertrophy attributable to the increase 
in RNA, cellular protein and DNA content (Soonpaa and Field, 1994; Lippin and 
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Roth., 1997). Even though the hypertrophy mechanisms of these cells have been 
only characterized using in vitro systems (Iwaki et al., 1990; Shubeita et al., 1990; 
Wolf and Nelson, 1990; Tseng and Berk, 1992; Wolf et al., 1993; Franch et al., 
1997), those previous studies and the present results, chondrocytes and other cell 
types shared a number of common characteristics with regards to cell hypertrophy 
mechanisms. These include regulatory functions of paracrine factors in the cell 
enlargement process and potential roles of membrane transporters in mediating cell 
volume increase associated with the hypertrophy.  
Taken together, the ex vivo experiment and IHC results provided important 
evidence to support the hypothesis proposed in the thesis that plasma membrane 
transporters are important for GPC enlargement and longitudinal bone growth.  
7.2 Future Studies 
Future areas of research, based on the data from this studentship have been outlined 
in the discussion sections of Chapter 3, 4, 5 and 6. However for clarity, they are 
summarized below: 
(i) In view of the present findings that show differential growth (Wilsman et al., 
1996b, 2008) among various growth plates and a role of plasma membrane 
transporters in the GPC hypertrophy (Bush et al., 2010), future studies could 
examine whether membrane transporter(s) are temporally expressed within a 
particular GPC zone during the active phase of bone growth. 
(ii) The roles of growth factors and hormones in controlling membrane transporter 
activity have been shown in AE regulation of rat ventricular myocytes (Malo & 
Fliegel, 2006). This and the fact that GH has been known to be an important 
regulator of longitudinal bone growth (Nilsson et al., 2005) raises an intriguing 
question whether GH modifies GPC membrane transporters activity and 
expression, and sets an interesting direction of future study on the current topic. 
The fetal murine growth bone culture model (Mushtaq et al., 2004) could be used 
to examine the effect of specific bone regulatory factors (e.g. IGF or 
glucocorticoid) on the expression of the transporters at different time points.  
(iii) In addition, future studies could examine the cellular mechanism of 
chondrocyte hypertrophy in an established chondrocyte cell line. This study would 
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offer some basic understanding of membrane transporters involvement in 
chondrocyte hypertrophy without the presence of other confounding factors e.g. 
circulating growth hormones or local factors found in in vivo GP.  
The current work has undertaken preliminary studies using ATDC5 cells 
(Atsumi et al., 1990) as a model system to study the cellular process of 
chondrocyte hypertrophy (data not shown). The finding showed that the ATDC5 
cells became hypertrophic only at the centre of cartilage nodules, which formed 
after 24 days of culture (Shukunami et al. 1997). Suspension of cells derived from 
the monolayer cells comprised mixed cell population of various sizes (see 
Appendix 2), which made it technically difficult to study hypertrophic cells without 
parallel biochemical evaluation using specific hypertrophic cell markers (e.g. 
collagen type X expression and ALPase activity; Shukunami et al. 1997). Further 
work is required to optimize the technique so that quantitative evaluation can be 
made to study the function of membrane transporters in the cellular enlargement 
process. 
(iv) As discussed earlier (6.4.11), pathological hypertrophy in other cell types has 
been shown to involve cell cycle mechanisms and endoreduplication. Although the 
current study suggest the role of plasma membrane transporters in GPC 
hypertrophy, the involvement of cell cycle mechanisms and endoreduplication are 
still largely unknown. Therefore it is interesting to know whether the cell cycle and 
endoreduplication mechanisms have any alternative or complementary role to 
plasma membrane transport regulation in GPC hypertrophy complex mechanisms - 
an interesting area to be explored in future study. Furthermore, better insight into 
physiological mechanism(s) of cell hypertrophy in GPCs could increase the 
understanding of the principles in pathophysiology of cell hypertrophy at cellular 
levels of other organs under diseased conditions. 
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ABSTRACT
The mechanisms that underlie growth plate chondrocyte volume increase and hence bone lengthening are poorly understood. Many
cell types activate the Na-K-Cl cotransporter (NKCC) to bring about volume increase. We hypothesised that NKCC may be responsible for
the volume expansion of hypertrophic chondrocytes. Metatarsals/metacarpals from 16 rat pups (P7) were incubated in the presence/
absence of the specific NKCC inhibitor bumetanide and measurement of whole-bone lengths and histologic analysis of the growth plate
were done after 24 hours. Fluorescent NKCC immunohistochemistry was visualised using a confocal laser scanning microscopy on seven
rat tibial growth plates (P7). Microarray analysis was performed on mRNA isolated from proliferative and hypertrophic zone cells of tibial
growth plates from five rats of each of three ages (P49/53/58). Exposure to bumetanide resulted in approximately 35% reduction (paired
Student’s t test, p< .05) of bone growth in a dose-dependent manner; histologic analysis showed that a reduction in hypertrophic zone
height was responsible. Quantification of fluorescence immunohistochemistry revealed a significant (paired Student’s t test, p< .05)
change in NKCC from the intracellular space of proliferative cells to the cytosolic membrane of hypertrophic zone cells. Further,
microarray analysis illustrated an increase in NKCC1mRNA between proliferative and hypertrophic cells. The increase in NKCC1mRNA in
hypertrophic zone cells, its cellular localization, and reduced bone growth in the presence of the NKCC inhibitor bumetanide implicate
NKCC in growth plate hypertrophic chondrocyte volume increase. Further investigation is warranted to determine the regulatory control
of NKCC in the mammalian growth plate and the possible detrimental effect on bone growth with chronic exposure to loop diuretics.
 2010 American Society for Bone and Mineral Research.
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Introduction
The growth plate is comprised of a thin layer of columnarchondrocytes lying perpendicular to and responsible for
new bone formation during longitudinal skeletal growth. Cells
within the column are highly organized, with a ‘‘reserve’’ zone
preceding proliferative zone chondrocytes (PZCs). After a regu-
lated period of time, a marked differentiation occurs, signified
by a dramatic increase in volume, resulting in the formation of
hypertrophic zone chondrocytes (HZCs). This volume increase is
predominantly in the longitudinal axis, which accounts for
approximately 80% of bone lengthening.(1) The volume of a
typical cell increases from approximately 1000mm3 in the PZC to
approximately 15,000mm3 in the HZC.(2) It has been postulated
that this cell volume increase occurs through a combination
of classic ‘‘hypertrophy’’(2) and ‘‘swelling.’’(3) However, the mech-
anisms that drive growth plate HZC volume expansion are
unknown.
Cell swelling describes the process arising from the net
movement of water into the cell, and in biologic systems, this
process relies solely on an osmotic gradient. This can result from
a reduction in extracellular osmolarity, an increase in intracellular
osmolarity, or a combination of the two. Studies measuring the
effect of hypoosmotic challenge on in situ growth plate
chondrocytes suggest that for cell swelling to be entirely
mediated by a reduction in extracellular osmolarity, these cells
would need to be exposed to an approximately 280mOsmol
reduction in osmolarity(2) to approximately 120mOsmol. Plasma
osmolarity therefore would need to be reduced from approxi-
mately 300mOsmol to near 20mOsmol, which is clearly
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implausible. Therefore, osmotic gradient–driven water accumu-
lation is more likely to be due to an increase in intracellular
osmolarity in the transition of a PZC to an HZC.
Intracellular osmolarity can be raised by the catabolism of
intracellular macromolecules (eg, proteins and/or complex
carbohydrates) into osmotically active components (eg, amino
acids and/or simple sugars).(4) However, intracellular organic
osmolytes do not account for the volume increase between PZC
and HZC.(5) Therefore, the ‘‘active’’ movement of osmolytes
across the plasma membrane into the cell is the most probable
mechanism. Previous studies suggest that the accumulation of
organic solutes (eg, simple sugars and amino acids) is res-
ponsible for approximately 9% of the osmolytes required.(5) This
strongly suggests other osmolytes are involved, and the activity
and/or number of inorganic solute transporters also may be
increased in order for cells to amass appropriate quantities of
osmolytes to drive such a volume increase.
The intracellular sodium concentration ([Naþ]i) plays a key
role in determining cell volume, and Naþ is moved across the
cytoplasmic membrane through a range of transport proteins
(see ref. (6)). One of these, the Na-K-2Cl cotransporter (NKCC), is
an obvious candidate for HZC expansion owing to its ability
to increase cell volume in other cell types.(7) NKCC mediates
electroneutral ion transport and is characterized by its sensitivity
to loop diuretics (eg, bumetanide and furosemide).(8) In many
cell types, activation of NKCC (eg, by exposure to hypertonicity)
results in an increase in cell volume, termed regulatory volume
increase (RVI).(6,7) Typically, RVI describes volume recovery after
cell shrinkage, returning a cell to its ‘‘normal’’ volume. In contrast,
growth plate chondrocytes require a coordinated, continual
volume increase as they progress from PZC to terminal HZC
phenotypes. Increased activity of NKCCmay be able to drive such
cell swelling.
Two NKCC isoforms are known, the near-ubiquitous NKCC1
and NKCC2, which appears to be localized exclusively in the
kidney.(7–10) Although considered to be present in all tissues, to
our knowledge, only mRNA for NKCC1 has been reported in
growth plates, where it demonstrates increased expression from
PZCs to HZCs.(11)
In this study, we tested the hypothesis that NKCC1 was involved
with HZC volume increase and longitudinal bone growth using
a variety of methodologies. First, whole-metatarsal/metacarpal
rudiments were incubated with the loop diuretic bumetanide,
a specific NKCC inhibitor, which inhibited bone elongation by
approximately 35%. Histologic analysis of growth plates from
bumetanide-exposed metatarsal rudiments showed a reduction
in HZ height, suggesting an inhibition of NKCC-mediated HZC
volume increase. For bumetanide to be acting on NKCC in the
hypertrophic zone, NKCC has to be associatedwith the HZC plasma
membrane. To elucidate NKCC tissue and cellular distribution,
immunohistochemistry was performed on growth plate sections.
While NKCC immunofluorescence was present throughout the
growth plate, it was most prevalent in HZCs. Further examination
of NKCC cellular distribution revealed a dramatic change from a
predominantly intracellular location in PZCs to the cytoplasmic
membrane in HZCs. NKCC1-specific antibodies are not available,
but gene array microanalysis confirmed the upregulation of
NKCC1 mRNA, with negligible signal for NKCC2 mRNA.
Materials and Methods
Biochemicals and solutions
Unless otherwise stated, all biochemicals and solutions were
obtained from Sigma Chemical Company (Poole, UK). Bone
rudiment dissection media consisted of phosphate-buffered
saline (PBS) containing a-medium (7.5% v/v; Invitrogen, Ltd.,
Paisey, UK) and bovine serum albumin V (1mM). Standard
culture medium (a-medium) was supplemented with Na2
glycerol biphosphate (1mM), bovine serum albumin V (1mM),
and L-ascorbic acid (5mg/mL). Bumetanide was prepared as a
20mM stock solution in ethanol. 4,4’-Diisothiocyanatostilbene-
2,2’-disulfonic acid (DIDS) was prepared as a 0.1M stock solution
in 0.1M potassium bicarbonate.
Animal preparation
For immunohistochemistry and bone rudiment culture, 19
Sprague-Dawley rat pups (7 days old, P7) were humanely killed
by decapitation following UK Home Office guidelines for other
experiments. The three middle metatarsals of each hind limb,
three middle metacarpals from 14 of the animals, and tibias from
6 animals were dissected out while immersed in dissection
medium and carefully cleaned of soft tissue.
Fifteen Sprague-Dawley rats were also used, aged 49, 53, and
58 days old (5 animals in each set). These older animals with
larger growth plates were used to obtain sufficient material for
microarray analysis studies. Animals were killed by carbon
dioxide asphyxiation following procedures reviewed and
approved by the Institutional Use and Care of Animals
Committee. For the purpose of this study, the left proximal
tibial bone including the growth plate then was harvested and
immediately frozen in liquid nitrogen and stored at 808C.
Whole-metatarsal rudiment preparation and
measurement
In order to prepare duplicate samples for determination of
the effects of six bumetanide concentrations (0 to 200mM) on
bone lengthening, metatarsals and metacarpals of four animals
were used (12 bones per animal). Each duplicate consisted of one
metatarsal and onemetacarpal. Bones were cultured individually
in 1mL of standard culture medium andmaintained at 378C [CO2
(5%):air (95%), pH 7.4]. Rudiment pairs were randomly selected
for either bumetanide (12.5 to 200mM) or vehicle control
(ethanol alone) addition to the medium. Owing to the slower
growth rate of metacarpals, further experiments were performed
(100mM of bumetanide or vehicle controls) on metatarsals alone
from a further 15 animals. A bumetanide concentration of
100mM was chosen because it resulted in maximal inhibition of
bone lengthening (Fig. 1), but it was still below the concentration
known to disrupt the activity of other membrane-transport
proteins.(12–14) Similarly, metatarsals and metacarpals were
dissected from 10 animals and randomly selected for a range
of DIDS concentrations (0 to 1mM) in the presence of 100mM of
bumetanide. A minimum of four animals was used for each DIDS
concentration.
Images (640 320 pixels) of rudiments were acquired imme-
diately after dissection and after 24hours in the presence/absence
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of inhibitor using an eyepiece camera (DCM35, BrunelMicroscopes,
Chippenham, UK) fitted to a dissecting stereomicroscope (Wild M3,
Heerbrugg, Switzerland). An image of a rule was acquired to
provide calibration, and bone lengths were measured using
ImageJ (National Institute of Health, Bethesda, MD, USA).
After 24 hours of incubation in the presence/absence of
bumetanide, metatarsals were fixed with 4% paraformaldehyde
in 0.1M phosphate buffer, pH 7.4, overnight. After dehydration
through a graded series of ethanol solutions, tibias were
embedded in paraffin wax, cut into longitudinal 10mm serial
sections (Reichert-Jung 1130/Biocut microtome, Leica Biosys-
tems Nussloch GmbH, Nussloch, Germany), and mounted onto
polylysine-coated glass slides. Section wax was dissolved in
xylene, followed by rehydration through a series of ethanol
grades to PBS. Images of both proximal and distal growth plates
were taken using the transmitted light detector of an upright
confocal laser scanning microscope (Zeiss LSM510, Welwyn
Garden City, UK) fitted with a 10 dry objective lens. Zone
heights were determined by eye using a line drawn freehand
along the top of proliferating cells, the clear demarcation of cell
enlargement between proliferative and hypertrophic regions,
and the zone of mineralization at the base of the hypertrophic
zone. The distance was measured from a point in the center of
the image, and the length between each was recorded using
ImageJ (NIH; Fig. 2). The total number of cells between the zone
of mineralization and hypertrophy was counted by eye.
Growth plate immunohistochemistry
Dissected tibias were fixed and embedded, and sections were
cut as described earlier for metatarsals. Sections were dewaxed
and rehydrated to PBS, and nonspecific antigen sites were
blocked using donkey serum (1:5 dilution). Sections were
incubated with a 1:100 dilution of the mouse monoclonal
anti–human NKCC antibody T4(14) (affinity for both NKCC1 and
NKCC2). Sections then were exposed to a 1:50 dilution of
AlexaFluor 488 donkey anti-mouse (Invitrogen, Ltd.) secondary
antibody for 1 hour at 378C. Omission of the primary antibody
served as a control.
Immunohistochemically stained growth plate sections were
imaged using a Zeiss LSM510 upright confocal laser scanning
microscope (CLSM) at low power [10 dry objective, numerical
aperture (NA)¼ 0.3] and high power (63 oil immersion objec-
tive, NA¼ 1.4). Emitted light, following excitation of AlexaFluor
488 (excitation/emission maximum 495/519 nm) with a 488-nm
argon laser, was collected through a long-pass 505-nm filter.
Transmitted light also was collected to aid cell/zone identif-
ication. High-resolution (1024 1024) images were acquired
representing a field of view 920 and 206mm2 and using
sequential optical Z-steps of either 10 or 1mm for low- or high-
power lenses, respectively. Detector sensitivity was adjusted to
Fig. 1. The effect of NKCC inhibition on rat metatarsal bone rudiment
growth by the NKCC inhibitor bumetanide. Each data point contains
paired metatarsals, and metacarpals from each animal (main graph) or
metatarsals alone (inset) were cultured for 24 hours and measured as
described in ‘‘Materials and Methods.’’ There was a dose-dependent
relationship for bumetanide inhibition; individual points were signifi-
cantly different from control (no bumetanide, open circle) with bumeta-
nide concentrations of 12.5, 100, and 200mM (ap< .05; bp< .01, paired t
test). The inset chart shows the significant reduction (cp< .002, paired t
test) of bone lengthening by 100mM of bumetanide (pattern fill) on
metatarsals alone (n¼ 19). Data expressed as means with errors bars
representing SEM.
Fig. 2. Lightmicrograph of rat metatarsal growth plate in the absence (A)
and presence (B) of 100mM of bumetanide. The irregular horizontal lines
were traced by eye along the beginning of late HZCs that exhibited an
unambiguous volume enlargement and the bottom at the zone of
calcification. The black-and-white vertical bars indicate the average
height of the late hypertrophic and remaining growth plate, respectively.
Scale bar¼ 100mm.
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provide maximum contrast without pixel saturation and exc-
essive dye bleaching. Adjacent fields of view were acquired
comprising the entire depth of the growth plate.
In order to identify intracellular and cytoplasmic membrane-
associated immunofluorescence in an unbiased manner, the
cell membrane was visualised using high-power images obt-
ained with transmitted light images. A line was plotted through
the central axis of the middle optical section for each cell. The
average fluorescent signal between the two cytoplasmic
membrane segments and the central intracellular portion were
recorded. To correct for variations in sectioning angle between
metatarsals, the growth plate was partitioned into eight
equidistant sections.(2) The top of section 1 (S1) was taken as
the top of the proliferating zone, with the bottom of section 8 (S8)
at the zone of mineralization. Section average intracellular
and cytoplasmic membrane fluorescence was determined
from all cells within each section. The fluorescence intensity
was expressed as a percentage; the most intense intracellular
or cytoplasmic membrane section measurement was assig-
ned 100%, thereby normalizing images from different growth
plates.
Microarray analysis
The transcriptional analysis of cDNA by microarray used here has
been described previously in detail.(11) Briefly, serial 6-mm sections
of snap frozen tibia were cut using a Leica CM3050 cryostat onto
Leica polyethylennaphtalae slides (PEN, Leica Microsystems,
Bannockburn, IL, USA) and kept on dry ice immediately prior to
laser capture microdissection (LCM). A Leica Application Solution
Laser Microdissection instrument (Leica Microsystems) with either
a 10 or 20 objective lens was used to cut freehand-traced
areas. The morphology of PZC and HZC was easily identified by
eye. Each growth plate fragment fell directly into an RNase-free
microfuge tube containing RLT lysis buffer (Qiagen, Valencia, CA,
USA). Approximately three regions of PZ and HZ were collected
from each slide, with each zone harvested into separate tubes.
Total RNA was extracted using the RNeasy RNA isolation kit
(Qiagen). Pooled samples contained between 30 and 50ng of RNA
(RNA Pico Labchip, Agilent Technology Bioanalyzer, Santa Clara,
CA, USA). After purification and quantification of mRNA,(11) 15mg
of biotinylated cRNAwas hydrolyzed to 35 to 200 nucleotides, and
known concentrations of positive control genes were added
(50 pM Oligo B2 and 1.5, 5, 25, and 100 pM of Escherichia coli bioB,
bioC, bioD, and cre). The hybridization solution was heated (458C
for 5 minutes) and centrifuged (5 minutes) before each sample
was injected into an individual RAE230 2.0 GeneChip (Affymetrix,
Santa Clara, CA, USA). Chips were hybridized at 458C for 16 hours
with constant rotation (60 rpm) and then were washed and
stained on the Fluidics station (Affymetrix) according to the
EukGE-WS2v4 protocol. Fluorescent images were acquired using
the Agilent G2500A Gene Array Scanner. Affymetrix software
(MicroArray Suite 5.0) was used to process the raw images into Cel
images files, which were loaded into GeneSpring (Agilent
Technologies, Pale Alto, CA, USA) and normalized using the
robust multiarray averaging (RMA) method. Differential gene
expression ratios were considered significant at the 95%
confidence interval (CI).(15)
Real-time RT-PCR
cDNA was produced from the pooled RNA samples used for the
arrays by reverse transcription (RT) of 1mg of total RNA with M-
MLV reverse transcriptase and oligo-(dT)15 primers (Promega,
Madison, WI, USA). Total RNA from a neonatal (3-day-old) rat
kidney was similarly reverse transcribed to generate a positive
control for all primer sets, which were run in duplicate. Negative
controls included an RT-null control (no RT enzyme), cDNA-null
for each primer set, and a template/primer null reaction.
Primers were synthesized by MWG Biosciences (Huntsville, AL,
USA): 50GTCTAAGGACCTGCCACCAA30 (NKCC1), 50CGGGTCGTCTA
GATCCAAAA30 (NKCC2), and 50AGCCATGTACGTAGCCATCC30 (b-
actin, a housekeeping gene sequence, was used for normalization)
and antisense primers 50TGCTGACGATCCAGTCACTC30, 50ATGGA
CTTGGAAACGACTGG30, and 50CTCTCAGCTGTGGTGGTGAA30, re-
spectively. Prior to performing the real-time assay, the annealing
temperature was optimized by gradient PCR using HotStartTaq
(Qiagen). Probe specificity was assumed from visualization of a
single band at the expected molecular size by agarose gel (2%)
electrophoresis.
PCR was performed with Quantitect SYBR Green PCR master
mix (Qiagen). The total reaction volume was 25mL with 12.5mL
of the master mix, primers at 0.3mM (0.075mL), and 0.5mL of the
RT product cDNA and brought to balance with nuclease-free
water. The reactions were run in duplicate for 40 cycles using an
ABI Prism7000 Sequence Detection System (PE Applied
Biosystems, Foster City, CA, USA). The reaction parameters were
958C for 15 minutes (hot start), denatured at 948C for 15 seconds,
annealed at 588C for 15 seconds, and extension/read at 728C for
30 seconds. After the fortieth cycle, dissociation data were
collected from 66.4 to 91.78C in 0.98C increments.
Data analysis
Data were expressed as means SEM obtained from a number
of individual animals (n). Differences between means were
determined by paired Student’s t test, with p< .05, p< .01, and
p< .001 considered to be significant, highly significant, and
extremely significant, respectively. Statistical analysis was
performed using SigmaStat (Systat, Chicago, IL, USA).
Results
Bumetanide bone rudiment culture
Duplicate paired metatarsal and metacarpal bones from P7 rat
pups exhibited a dose-dependent inhibition of bone lengthen-
ing by bumetanide (Fig. 1). Bone lengthening was significantly
reduced with bumetanide concentrations of 12.5, 100, and
200mM (p< .05, t test) compared with controls. A curve fit of the
bumetanide dose-response data was best fitted by a three-
parameter hyperbolic decay curve (r2¼ 0.9656, correlation
coefficient), with predicted maximal longitudinal growth of
1.725% as [bumetanide] ! 1 compared with growth in control
bones of 3.69% after 24 hours of incubation. Owing to the
differing growth rates of metacarpals and metatarsals,(16) further
experiments were performed using faster-growing metatarsals
alone (Fig. 1, inset). Control metatarsals increased in length by
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approximately 6% after 24 hours in culture. When incubated
with 100mM bumetanide, bone lengthening was significantly
reduced (p< .01, Students t test) by approximately 35%.
Measurement of the growth plate of the metatarsals, from
uppermost PZC to the zone of mineralization, is shown in Fig. 2.
There was no overall difference in total growth plate length
between control and bumetanide-treated samples (Table 1),
although these measurements were associated with a large SEM.
However, there was a significant reduction (p< .05, Student’s
paired t test) in the hypertrophic zone of approximately 50mm.
When the data were normalized with the HZ expressed as a
percentage of the total growth plate height, a highly significant
reduction of nearly 50% was observed in the bumetanide-
exposed specimens (Table 1, p< .01, Student’s t test).
HZ cell counts of each micrograph were almost identical
(p¼ .937, Student’s t test), with 193 11.3 cells for the control
group and 192 13.6 cells for the bumetanide-treated group.
When corrected for the section area, no significant difference
(p¼ .953, Student’s t test) existed between the cell densities
of control and bumetanide-treated groups (1400 125 and
1377 350 cells/mm2, respectively), showing that the number of
HZCs did not change with exposure to bumetanide.
Fluorescence immunohistochemistry
Immunohistochemistry was used to determine both the tissue
and cellular localization of NKCC in the mammalian growth plate.
The T4monoclonal anti-NKCC antibody exhibited strong staining
for chondrocytes throughout proximal tibial growth plate
cartilage from P7 animals, although the pattern of fluorescence
staining was heterogeneous. Low-power (10 objective lens)
CLSM images of NKCC immunohistochemistry (Fig. 3) showed
the distribution of staining along the growth plate. It can be seen
that the fluorescent signal was strong in the early proliferative
zone, decreasing through the late proliferative and early
hypertrophic regions, before increasing again in the middle to
late hypertrophic zones. This observation was consistent across
proximal tibial growth plates of all seven animals.
High-power (63 objective lens) images allowed the
observation of cellular localization, which differed as cells
transitioned from early PZCs to late HZCs. Figure 4A, D shows
typical PZCs and an HZC with a predominantly intracellular and
cytoplasmic membrane-associated fluorescence, respectively.
Quantification of immunofluorescence (Fig. 5) confirmed that
qualitative assessment of intracellular fluorescence was highest
in the PZC, with S1 to S5 being significantly higher than S6 to S8
(p< .05, paired Student’s t test). In contrast, cytoplasmic
membrane–associated fluorescence was lowest in S1 to S4 PZCs,







636 150 689 130 .655
Late HZ (mm) 204 25.6 151 15.0 .015	
HZ (% of total) 33.8 1.57 22.7 0.814 .008		
Note: Growth plate measurements of three P7 rat metatarsals (proximal
and distal) cultured for 24 hours in the absence/presence of 100mM
bumetanide. Bones were fixed, prepared, and visualized (Fig. 2) as
described in ‘‘Materials and Methods.’’ The average height of growth
plates was not significantly different (paired Student’s t test) between
control and bumetanide-treated bones, whereas there was a significant
(	p< .05, paired Student’s t test) decrease by approximately 50mm in the
late hypertrophic zone (HZ). When normalized and presented as a
percentage of total growth plate height, the reduction in growth was
highly significant (		p< .01, Student’s paired t test). Data shown as
means SEM.
Fig. 3. Growth plate NKCC distribution. Low-power (10 objective)
confocal microscope images (projected) of proximal tibial growth plate
stained for NKCC (T4 antibody). Rat proximal tibias were removed and
fixed, and transverse sections were prepared for immunohistochemistry
as described in ‘‘Materials and Methods.’’ (A) AlexaFluor 488 secondary
antibody fluorescence, (B) transmitted light image of the same field of
view, and (C) as for panel A but with primary antibody omitted. The
proliferative zone showed some fluorescence that appeared to reduce to
the upper edge of the HZ. Cells in the HZ exhibited strong fluorescence,
which even at this low magnification appeared to be localized to the
plasma membrane. Scale bar¼ 200mm.
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increasing significantly in S6 to S8 (p< .05, paired Student’s t
test). Within each growth plate section S1 through S8, there was a
significant difference (p< .05, paired Student’s t test) between
intracellular and cytoplasmic membrane–associated fluores-
cence with the exception of cells from S5.
Gene microarray and RT-PCR analysis
Good-quality antibodies raised against the different isoforms of
NKCC (1 and 2) were not available for immunohistochemistry,
and hence an alternative approach of gene microarray analysis
was required to confirm the presence of NKCC1 over NKCC2. Of
the 161 genes examined as part of a wider study into membrane-
transport proteins, the majority (approximately 90%) showed
low expression levels [<10 arbitrary expression units (AEUs)].
Indeed, the average raw expression levels for the 161 transport-
protein genes across both PZCs and HZCs at all time points
studied was 8.997 (ranging from 3.15 to 308 AEUs). As expected,
the kidney-specific NKCC2 gene showed background (<10 AEUs)
expression levels, whereas the ubiquitous NKCC1 gene expres-
sion levels were above background (Table 2). The positive control
proteins for PZC and HZC (procollagen type II and matrix
metalloprotease 13 [MMP13], respectively) exhibited high
expression levels.
Statistical significance was determined at the 95% confidence
interval (CI) with a two-tailed cutoff of 1.96 SD. Log2 values are
shown in Table 3 for the ratios (HZC:PZC) of NKCC1, NKCC2,
MMP13, and procollagen type II on rats aged 49, 53, and 58 days.
With log2 values that exceed the 95% CI, it would be expected
that there would be a less than 5% risk of false-positive results.
For MMP13, since the log2 ratios exceed the 95% CI by at least 8
SDs in one time point, we should expect no false-positive results.
However, of the NKCC transport proteins, only NKCC1 expression
on day 49 exceeded the 95% limit. A twofold HZC:PZC ratio was
considered relevant(13); as expected, MMP13 exhibited a large
increase between PZCs and HZCs (Table 3), and NKCC1 showed a
greater than twofold change on days 49 and 58. There was little
change from unity for NKCC2 expression between PZCs and
HZCs, near background in both zones across the three animal
ages studied.
Owing to the temporal variation in NKCC1 expression by
microarray, confirmation was obtained by RT-PCR (Table 4). Log2
ratios and fold increase in expression between PZ and HZ were
identical to those obtained by microarray; indeed, plotting both
sets of results by linear regression produced a coefficient of
determination (r2) of 0.986. Similar analysis of NKCC2 revealed a
poor correlation (r2¼ 0.116), which was more indicative of the
levels below threshold associated with NKCC2.
DIDS bone rudiment culture
Metatarsal and metacarpal bones from P7 rat pups exhibited a
dose-dependent inhibition of bone lengthening by DIDS in the
presence of 100mM bumetanide (Fig. 6). Bone lengthening was
significantly further reduced by DIDS concentrations of 175mM
Fig. 5. Quantification of cellular NKCC distribution along the growth
plate. The fluorescence associated with the plasma membrane or intra-
cellular space was obtained from images of cells along the entire length
of the growth plate (see ‘‘Materials and Methods’’ and Fig. 4). Owing to
the variability in section position, angle, and inherent differences in
growth plate dimensions, cell positions within the growth plate were
expressed in eight equidistant sections; sections 1 to 3 PZC and 5 to 8
HZC. Significant differences (ap< .05, Student’s t test) between the
fluorescent signal of the intracellular space (solid line, &) and mem-
brane-associated fluorescence (broken line, *). Similarly, significant
differences (p< .05, Student’s t test) between PZC and HZC intracellular
fluorescence (b) and between PZC and HZC membrane-associated
fluorescence (c) are shown. An overlay (gray line, ~) of cell volumes
(right axis) has been included to highlight the appearance of NKCC in the
plasma membrane immediately preceding a volume increase (data
replotted from ref. (2)). Data points are for the mean of a minimum of
four animals (421 cells) with bars denoting SEM.
Fig. 4. Growth plate chondrocyte NKCC localization in typical prolifera-
tive (A–C) and hypertrophic (D–F) zone chondrocytes. Rat proximal tibias
were prepared for and subjected to immunohistochemical procedures,
and then images were acquired as described in ‘‘Materials and Methods.’’
NKCC immunofluorescence from a single optical section is shown in
panels A and D, with the corresponding transmitted light images (B) and
(E) for PZCs and HZCs, respectively. The intensity profile along a line
drawn through the center of a cell (gray line in A and D) is shown (C, F).
The overlaid transparent vertical bars in C and F indicate the approximate
position of the cytoplasmic membrane determined from the transmitted
light image (B, E). Fluorescence intensity is in arbitrary units (AUs). For all
panels, scale bar¼ 5mm.
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to 1mM (p< .05, t test) compared with 100mM of bumetanide
alone. Rudiment culture for 24 hours in the presence of 500mM
of DIDS resulted in a maximal inhibition of approximately 80%
over and above bumetanide alone (p< .001, t test).
Discussion
This study set out to examine the involvement of NKCC1 in the
coordinated volume increase of growth plate HZCs. Using a
variety of techniques, we provide evidence that implicates
NKCC1 in growth plate chondrocyte hypertrophy and hence
longitudinal bone growth. The optimization of different
techniques required the use of different bones from differently
aged animals. Measurable increases in bone length were
possible only with small bones from young animals, but the
growth plate chondrocytes of these bones do not withstand
crushing injury caused by the bisection required for cell volume
determination by CLSM. Hence larger tibias were used from P7
animals to directly compare the relationship between cell
volume and NKCC immunohistochemistry. Although the
metatarsals, metacarpals, and tibias used for immunohistochem-
istry were from age-matched animals (P7), their relatively small
growth plates make extracting sufficient mRNA for microarray
analysis technically demanding. Hence older animals with larger
growth plates were used, a temporal effect partially checked by
examining tibias from P49, P53, and P58 animals.
Table 2. Microarray mRNA Expression of NKCC1, NKCC2, MMP13, and Col II in Rat Growth Plate Chondrocytes
Gene
Expression (AEUs)
Day 49 Day 53 Day 58
PZC HZC PZC HZC PZC HZC
NKCC1 19.4 56.9 16.1 14.1 79.8 189.4
NKCC2 3.21 4.23 3.31 4.31 4.36 3.15
MMP13 5.72 1019 9.34 676 39.6 5241
Col II 6999 5762 4838 2275 8478 6617
Note: Mean raw levels (AEUs) from five animals each, shown for kidney-specific NKCC2 and ubiquitous NKCC1 transport proteins and the HZC and PZC
markers MMP13 and procollagen type II, respectively. The NKCC2 isoform showed no expression above background levels (<10 AEUs), whereas NKCC1
exhibited expression well above average for the 161 transport protein/carrier genes analyzed (
9.0 AEUs). The high expression levels of the standard
markers MMP13 and procollagen type II highlight the low levels associated with NKCC1 and NKCC2 isoforms.
Table 3. Microarray Analysis of Growth Plate NKCC1, NKCC2, MMP13, and Pro-Col II
Gene
Log 2 ratio (HZ/PZ) Ratio (HZ/PZ) fold change
Day 49 Day 53 Day 58 Day 49 Day 53 Day 58
NKCC1 1.55 0.20 1.25 2.93 1.15 2.37
NKCC2 0.40 0.38 0.47 1.32 1.30 1.38
MMP13 7.48 6.18 7.05 178.3 72.5 132.3
Col II 0.28 1.09 0.36 0.823 0.470 0.780
Note: Log2 HZC/PZC ratios and expression ratio fold changes (HPZ/PZC) frommicroarray analysis (see ‘‘Material and Methods’’) of NKCC1 and NKCC2 and
the HZC and PZC positive controls MMP13 and Procollagen Type II, respectively. Only the log2 of NKCC1 ratio on day 49 (double-scored boundary) was
greater than the 95% confidence level (1.20), whereas both day 49 and day 58 exhibited greater than twofold changes in the HZC/PZC ratios. All MMP13
data showed relevant increases in expression between PZC and HZC and Procollagen Type II on day 53.
Fig. 6. The effect of the AE inhibitor DIDS (in the presence of 100mM of
bumetanide) on rat metatarsal/metacarpal bone rudiment growth. Each
data point represents a metatarsal and metacarpal from of each of at
least four animals, cultured for 24 hours, and measured as described in
‘‘Materials and Methods.’’ There was a dose-dependent relationship of
DIDS inhibition, significantly reduced (ap< .05, t test) from control at DIDS
concentrations of 175mM or greater with maximal inhibition at 500mM.
Data points are for the mean of a minimum of four animals with bars
denoting SEM.
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Microarray analysis of raw data (Table 2) indicated a
substantial increase for P49 and P58 animals but no increase
at P53. This may be an indication of temporal changes in NKCC
activity, but when compared with MMP13 and Pro-Col II data, it is
more likely due to a general suppression of hypertrophy-related
genes in this experimental set. Further analysis revealed that
while both P49 and P58 animals showed a greater than twofold
increase in NKCC1 expression between PZCs and HZCs, only the
data from P49 animals exceeded the 95% confidence limit. Some
confusion therefore exists with the microarray data; however,
subsequent RT-PCR analysis of the samples provided confirma-
tion of these results. It must be remembered that the primary
role for this technique was to confirm the presence of NKCC1
over NKCC2, albeit not from P7 rats. The negligible signal for
NKCC2mRNA gives confidence that we were able to associate T4
antibody immunohistochemistry to NKCC1 alone.
The T4 monoclonal antibody used for NKCC immunohisto-
chemistry has been used previously in mammalian tissue for
successful tissue immunolocalization of NKCC in rat hippocam-
pus,(17) gerbil inner ear,(18) rabbit parotid and kidney,(19) and
human airway smooth muscle.(20) Similarly, T4 resulted in clear
CLSM images of NKCC distribution in growth plate sections
(Figs. 3 and 4). Quantification of NKCC immunohistochemistry
cellular localization (Fig. 5) showed that NKCC was present along
the entire growth plate, but with a change in immunolocalization
of NKCC from intracellular regions to the cytoplasmic membrane
with transition from PZCs to HZCs. Localization of NKCC to the
cell membrane is essential for its involvement in HZC volume
increase.
While not of primary concern to the role of HZC volume
increase, the intracellular localization of NKCC in PZCs is
intriguing. PZC NKCC appeared to be adjacent to the nucleus,
suggesting an association with endoplasmic reticulum and/or
the Golgi apparatus. This could represent the synthesis of NKCC
pools ready for translocation to the plasma membrane for future
cell volume increases. Such a redistribution of the cotransporter
to the cell surface is a mechanism for NKCC upregulation in other
cell types.(21) Similar differences in NKCC distribution between
PZCs and HZCs are also observed with human cytomegalovirus
infection of a fibroblast cell line.(22) Infection inhibits transloca-
tion of NKCC to the plasma membrane, resulting in similar
perinuclear distribution as shown here, with abolition of cell
NKCC activity.
The tissue distribution and cellular localization of NKCC were
consistent with its role in HZC volume increase, but it is the
bumetanide inhibition of NKCC that provides direct evidence for
a role in bone lengthening. The precise bumetanide dose
required to inhibit bone lengthening is difficult to determine
because in situ the cells would experience less than that added
to the culture medium, but it may be similar to the bumetanide
concentration required for maximal inhibition of NKCC in
isolated cells (20mM). Conversely, the maximum concentration
of bumetanide used (200mM) would ensure that in situ chond-
rocytes were not exposed to levels associated with nonspecific
inhibition of bicarbonate exchanger,(12) chloride channels,(13)
and potassium chloride cotransport.(14)
Approximately 80% of bone lengthening has been attributed
to HZC volume increase.(1) Therefore, the inhibition of metatarsal
longitudinal growth by bumetanide accounts for less than half, if
one assumes that NKCC inhibition by bumetanide was limited to
HZCs. PZC cell division contributes to approximately 10% of
bone lengthening(1) and may be inhibited by bumetanide.(23–25)
However, NKCC distribution suggests only low levels of NKCC
in the cytoplasmic membrane of PZCs, and histologic analysis
(Fig. 2) of bumetanide-treated metatarsals does suggest that
inhibition was restricted to HZCs.
The partial inhibition of bone lengthening by bumetanide
would suggest the presence of other mechanisms to drive HZC
volume increase. Inorganic ion transporters also known to be
involved in RVI may be implicated, such as increased activity of
sodium hydrogen exchange (NHE), anion exchange (AE), and
sodium chloride cotransport (NCC) or decreased activity of
ion-transport proteins known to bring about a decrease in
cell volume, including potassium-driven transporters and the
Naþ/Kþ pump.(6) Of all these membrane proteins, microarray
analysis highlighted AE3 (Slc4a3) alone as changing expression
between proliferative and hypertrophic zones, with an approxi-
mately 14-fold increase (absolute expression values of 217 to
3122) compared with no change for AE1 (Slc4a1; 255 to 216,
1.18-fold change) or AE2 (Slc4a2; 105 to 109, 1.04-fold change).
Metatarsal culture experiments in the presence of 100mM
bumetanide and the AE inhibitor DIDS (0 to 1mM) resulted in a
dose-dependent inhibition of bone lengthening greater than
bumetanide alone (Fig. 6), inhibiting bone lengthening by a
maximum of 80% compared with control bones.
Growth plate chondrocyte AE3 would appear to be a
candidate for driving the major portion of growth plate chond-
rocyte volume increase; however, a number of concerns with this
hypothesis exist. First, DIDS is a relatively nonspecific inhibitor of
carrier-mediated anion transport.(26) Indeed, in HZ growth plate
chondrocytes, DIDS has been shown to completely abolish
diastrophic dysplasia sulfate transport (DTDST)–mediated sulfate
Table 4. Real-Time RT-PCR Analysis of NKCC1 and NKCC2
Gene
Log 2 ratio (HZ/PZ) Ratio (HZ/PZ) fold change
Day 49 Day 53 Day 58 Day 49 Day 53 Day 58
NKCC1 1.7 0.175 1.12 3.25 1.13 2.17
NKCC2 0.305 0.8 0.305 1.24 1.74 1.24
Note: Log2 HZC/PZC ratios and expression ratio fold changes (HPZ/PZC) from real-time RT-PCR (see ‘‘Material and Methods’’) of NKCC1 and NKCC2. The
results for NKCC1 mimic those obtained in the microarray analysis, with both day 49 and day 58 animals exhibiting greater than twofold changes in the
HZC/PZC ratios. The coefficient of determination (r2) for the linear regression between RT-PCR and microarray analysis was 0.986 for NKCC1 and 0.116 for
NKCC2.
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uptake critical for proteoglycan synthesis.(27) Second, AE must be
coupled with other transport proteins to elicit a volume-
regulatory increase, typically sodium hydrogen exchange,(6) but
these transport proteins show no increase in mRNA expression
between PZCs and HZCs. Finally, we cannot be certain that DIDS
inhibition of anion transport does not exert its inhibition of
bone lengthening through modulation of intracellular pH. Unlike
NKCC, with its specific inhibitors (ie, bumetanide and furose-
mide), the role of AE3 cannot be ascertained because it has no
analogous specific inhibitors, but its role clearly warrants further
investigation.
The putative presence of transporters other than NKCC1 and/
or redundancy in the system to drive HZC volume increase may
explain the reduced size of NKCC1 knockout mice over the first
2 weeks, a period of maximal growth rate,(16) but their ability to
recover to the size of wild-type animals as they reachmaturity.(28)
This ability of NKCC1 knockouts to recover may explain why there
are limited reports of skeletal growth retardation in children
exposed to loop diuretics (eg, bumetanide and furosemide).
Reduced bone growth also may go unreported owing to the
conditions that required prescription of loop diuretics. Pediatric
furosemide therapy is used in the treatment of chronic lung
disease, nephritic syndrome, renal failure, congestive heart
failure, and hydrocephalus fluid shunts (see ref. [29]), conditions
that might be expected to result in poor growth outcome and
therefore not subsequently associated with loop diuretics.
A study of four children prescribed the NKCC inhibitor furos-
emide(30) described bone demineralization, but no mention was
made of reduced longitudinal bone growth. However, anecdotal
clinical reports led to a study by Koo and colleagues,(31) who
subjected 4-day-old rats to furosemide for 24 days and observed
a significant reduction in tibial length that was not associated
with abnormal calcium, sodium, magnesium, potassium, or para-
thyroid hormone in plasma or bone. This suggested that bone
growth and not subsequent demineralization was responsible.
Although no explanation was provided for the bone growth
retardation observed, the present findings could implicate direct
NKCC1 inhibition of HZCs in vivo.
If NKCC plays the major role of HZC volume increase, it would
be expected to be under the same hormonal control that
regulates bone growth. NKCC has been shown to be regulated
by hormones in other tissues.(32) Future work is required to
elucidate this, as well as to study NKCC1 regulation through
control of protein synthesis, translocation to the cytoplasmic
membrane, and activation through phosphorylation/depho-
sphorylation events(22,33,34) to provide an insight into the control
of HZC volume increase mediated by NKCC1. The regulated
activation of NKCC1 within the mammalian growth plate also
could provide an ideal model for the study of general NKCC1
physiology.
In summary, we hypothesised that NKCC activity may play a
role in the coordinated volume increase seen in HZCs of the
growth plate. Using multiple methodologies, we have provided
evidence for the role of NKCC1 in growth plate HZC volume
increase: the inhibition of bone lengthening (through reduction
in HZ height) with the NKCC-specific inhibitor bumetanide,
appropriate cellular localization of NKCC in HZCs to the cyto-
plasmic membrane, and an increase of NKCC1 mRNA in HZCs
with negligible NKCC2 signal. The involvement of NKCC in bone
lengthening warrants further investigation, with special atten-
tion to the detrimental therapeutic effects possible with NKCC1
inhibitors (loop diuretics) in children.
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Abstract
The remarkable increase in chondrocyte volume is a major
determinant in the longitudinal growth of mammalian
bones. To permit a detailed morphological study of
hypertrophic chondrocytes using standard histological
techniques, the preservation of normal chondrocyte
morphology is essential. We noticed that during fixation of
growth plates with conventional fixative solutions, there
was a marked morphological (shrinkage) artifact, and we
postulated that this arose from the hyper-osmotic nature of
these solutions.  To test this, we fixed proximal tibia growth
plates of 7-day-old rat bones in either (a) paraformaldehyde
(PFA; 4%), (b) glutaraldehyde (GA; 2%) with PFA (2%)
with ruthenium hexamine trichloride (RHT; 0.7%), (c) GA
(2%) with RHT (0.7%), or (d) GA (1.3%) with RHT (0.5%)
and osmolarity adjusted to a ‘physiological’ level of
~280mOsm. Using conventional histological methods,
confocal microscopy, and image analysis on fluorescently-
labelled fixed and living chondrocytes, we then quantified
the extent of cell shrinkage and volume change. Our data
showed that the high osmolarity of conventional fixatives
caused a shrinkage artefact to chondrocytes. This was
particularly evident when whole bones were fixed, but could
be markedly reduced if bones were sagittally bisected prior
to fixation. The shrinkage artefact could be avoided by
adjusting the osmolarity of the fixatives to the osmotic
pressure of normal extracellular fluids (~280mOsm). These
results emphasize the importance of fixative osmolarity, in
order to accurately preserve the normal volume/morphology
of cells within tissues.
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Introduction
The accurate study of the morphology of living cells as
they appear within tissues is difficult but fundamental for
an understanding of normal cell biology, and the changes
that occur in disease states.  Accordingly a vast amount
of research has been performed on chemically-fixed cells
and tissues. The intention has been to retain the fine
morphology and constituents of living in situ cells so that
they can be studied without the complications of
deleterious changes to cell metabolism and loss of viability
during the investigation (see Hopwood, 1985). In addition,
tissue fixation should protect against cell autolysis, attack
by bacteria, and changes to cell volume and shape
especially during subsequent preparative treatment
(Baker, 1960) when tissue dehydration is frequently
performed. Thus, fixative solutions should serve to
stabilize the specimen and protect it from rigorous physical
tissue processing and staining as required for study
(Hopwood, 1969). Our particular research emphasis has
been on the cellular mechanisms underlying the structure
and function of the mammalian growth plate. There has
been extensive study on chemically-fixed growth plates,
and particular interest in the remarkable increase in
chondrocyte volume which is a major determinant of bone
growth (Breur et al., 1991). The large volumes of growth
plate chondrocytes (typically ranging from 1,000 to
10,000μm3; Bush et al., 2008) potentially makes them
extremely sensitive to osmotic artefacts during fixation.
Para-formaldehyde (PFA) and glutaraldehyde (GA)
and their combinations have long been used as fixative
solutions (Fox et al., 1985; Hopwood, 1969) to retain the
properties of cells and tissues (Kiernan, 1999; Renshaw,
2007). Perhaps the most widely used fixative for histology
and histopathology is 10% neutral buffered formalin
however this is not usually used for studies on the growth
plate. Examples of more conventional aldehyde
preparations used for this tissue are (a) 4% (w/v) PFA
(Fox et al., 1985; Hosoya et al., 2005; solution A, Table
1) which has the same formaldehyde concentration (4%)
as 10% Formalin (Kiernan, 1999), (b) 2% (w/v) GA &
RHT (ruthenium hexamine trichloride) combined with 2%
(w/v) PFA (Farnum et al., 2002; solution B, Table 1) and
(c) 2% GA (w/v) with 0.7% (w/v) RHT (Hunziker et al.,
1983; solution C see Table 1). Although the fixative
properties have been widely known, less appreciated is
the fact that the osmolarity of these solutions is markedly
greater than that of typical physiological extracellular
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Mohamad Y. Loqman1, Peter G. Bush2, Colin Farquharson3, and Andrew C. Hall1
1Centre for Integrative Physiology, School of Biomedical Sciences, George Square, University of Edinburgh,
Edinburgh EH8 9XD, Scotland, UK
2School of Pharmacy and Biomolecular Sciences, University of Brighton, Lewes Road, Brighton, BN2 4GJ,
England, UK
3The Roslin Institute, R(D)SVS, Developmental Biology, University of Edinburgh, Roslin EH25 9PS, Scotland, UK
215 www.ecmjournal.org
MY Loqman et al.                                                                                          Shrinkage artifact with conventional fixatives
solutions (Table 1). The osmolarity of the fixative solutions
and their effects on cell and tissue morphology have
received relatively little attention recently – indeed often
appear ignored – despite the fact that there are studies in
the literature highlighting this issue. For example, Schultz
and Karlsson (1965) observed that hypertonic fixative
solutions perfused into the central nervous system caused
cellular shrinkage and increased extracellular spaces,
whereas isotonic (300-320mOsm) and hypotonic fixatives
could result in cell swelling. Mathieu et al. (1978) have
reported the importance of both the % of GA and the
molarity of the vehicle used for the fixative solution for
the preservation of lung tissue. Even with these early
studies, there are recent examples of investigators using
hyper-osmolar fixative solutions (Farnum  et al., 2002;
Hosoya  et al., 2005) but little if any comment on the
morphology of the fixed cells which frequently appear
shrunken/distorted (Erben, 1997; Kouri  et al., 1996; Ross
and  Reith, 1985; Sanchez  et al., 2000; Van der Eerden  et
al., 2000) and little or no attempt at quantification of the
shrinkage artefact. We wished therefore (a) to re-visit this
issue and emphasize the importance of osmotic correction
to fixative solutions in order to retain cell morphology and
(b) provide quantitative data on the extent of cell shrinkage
and specifically report on the influence of fixative
osmolarity on connective tissue cells.
During preliminary experiments attempting to optimize
the fixation protocols for mammalian growth plates, we
noticed that for the same standard fixative, the appearance
of hypertrophic zone cells in histological sections from
whole bones were markedly different compared to those
from sagittally sectioned bones. The morphology of the
cells in the whole bone fixed samples appeared
considerably mis-shapen and shrunken, whereas in the
bisected bone, morphology was relatively normal. From
our previous studies on the shape/volume of chondrocytes
exposed to osmotic challenge (Bush and Hall, 2001) we
suspected that an artefact of the relatively high osmotic
pressure of the fixative solutions might account for the
abnormal chondrocyte morphology.
Thus, in the present study, we further examined using
standard and modified fixative solutions, these shrinkage
artefacts. By quantifying the osmotic shrinkage effect on
hypertrophic growth plate chondrocytes, the data
confirmed our preliminary observations that whole bones
were particularly sensitive compared to those sagittally
bisected prior to fixation. We also demonstrate that
adjusting the fixative solution to an osmolarity close to
that of typical extracellular solutions (approx. 280mOsm;
solution D, Table 1) abolishes this artefact.
Materials and Methods
Biochemicals and solutions
Unless otherwise stated, all biochemicals and solutions
were purchased from Sigma-Aldrich (Poole, U.K.) RHT
was purchased from Polysciences Inc. (Warrington, PA,
U.S.A.). Glutaraldehyde was of a grade suitable for
electron microscopy. Paraformaldehyde solution was
prepared from paraformaldehyde powder (purity of ≥95%).
The fluorescent cytoplasmic labelling dye,
chloromethylfluorescein diacetate CMFDA (CellTrackerTM
Green) and calcein AM were obtained from Invitrogen
(Paisley, U.K.) and the mounting medium, FluorSaveTM
was purchased from Calbiochem (Nottingham, U.K.)
Sodium cacodylate buffer was prepared by dissolving
sodium cacodylate trihydrate powder (assay, approx. 98%)
in distilled water, and the pH was corrected to 7.4 by
addition of HCl.
Animals and growth plate preparation
Sprague-Dawley rats (7-day-old; P7) were humanely killed
for other experiments following U.K. Home Office
guidelines. The tibia of each hind limb with intact proximal
growth plate cartilage was dissected and temporarily placed
in medium (phosphate buffered saline; PBS; approx.
293mOsm) containing alpha modified essential medium
(α-MEM; 7.5% v/v; Invitrogen) and bovine serum albumin
V (1mM), prior to fixation.
For the preparation of samples for histology, 2 tibia
from each animal were used and placed in fixative solutions
of differing composition as follows: (a) conventional
fixative solutions (Table 1), (b) fixatives with GA
concentration maintained constant, but with various
osmolarities similar to those used for conventional fixative
solutions (Table 2), and (c) fixatives with various
concentrations of GA but with osmolarity maintained at
approx. 550mOsm (Table 3). The growth plates were fixed
for 24hrs at room temperature for subsequent paraffin-
Solution 




pH Osmolarity (mOsm) References 
A PFA 4% None 7.11 1148 ± 2 Hosoya et al., 2005 
B PFA 2% + GA 2%  + RHT 0.7% 100 7.06 1135 ± 32 Farnum et al., 2002 
C GA 2%  + RHT 0.7% 50 6.72 420 ± 20 Hunziker et al., 1983 
D GA 1.3% + RHT 0.5% 30 5.67 270 ± 10 (present study) 
Table 1. Composition of fixative solutions used in the study.
Fixative solutions were prepared as described in the references cited which reported the morphology of growth plate
chondrocytes following fixation. For solution A, distilled water was used instead of cacodylate buffer. Fixative solution
D was prepared by diluting solution C with distilled water. [Concentrations are given as % (v/v) for GA= glutaraldehyde
and PFA= paraformaldehyde, and as % (w/v) for RHT= ruthenium hexamine trichloride].
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embedding for histological sectioning. For group (a) three
intact tibias and 3 bisected tibias were fixed in each fixative
solution, whereas in group (b) and (c), three and five intact
tibias were used in each fixative solution respectively.
For the preparation of growth plates for the analysis of
in situ growth plate chondrocyte (GPC) volume, tibias from
eight P7 rat pups were grouped into: (i) five bones
maintained intact, and (ii) ten bones that were bisected
sagittally. Bones were incubated with either CMFDA-green
for 60mins (if the bones were subsequently fixed) or calcein
AM (for non-fixed bones). Then, all bones from group (i)
and four bones from group (ii) were fixed in solution A.
Three bones from group (ii) were fixed in osmotically-
corrected fixative solution (solution D, Table 1). When
appropriate, bones were fixed for 24hrs at room
temperature. The remaining 3 bones from group (ii) were
maintained unfixed for in situ living cell imaging. The
osmolarity of all solutions was determined using a freezing
point micro-osmometer (Model 3300, Vitech Scientific
Ltd., Partridge Green, U.K.) with solid NaCl or distilled
water added to adjust the osmolarity to the required range.
The pH of all solutions was measured at room temperature
using a SevenEasyTM pH meter (Mettler Toledo, UK) with
the pH of fixative solutions altered by adding either HCl
or NaOH.
Histology of the growth plate
Bones were embedded in paraffin wax using a standard
procedure (Kiernan, 1999) and tissue sections (10μm) cut
using a microtome (Reichert-Jung Microtome 2050
Supercut, Arnsberg, Germany). The sections were then
mounted on poly-l-lysine-coated microscope slides
(PolysineTM, VWR International, Leicestershire, UK) and
dried overnight. After de-paraffinisation with xylene and
rehydration with a series of ethanol solutions (100%, 90%,
75%), the sections were stained with 0.1% (w/v) Toluidine
blue O in PBS buffer (pH 5.5; 30secs at room temperature)
using the technique adapted from Bancroft and Cook
(1994). The sections were then rinsed briefly in distilled
water and allowed to air dry prior to mounting in
FluorSaveTM with cover slips.
Measurement of growth plate chondrocyte shrinkage
Histological sections of fixed hypertrophic GPC stained
with 0.1% Toluidine blue O were observed under an x63
(oil-immersion) objective lens. Several histological views
of chondrocytes within sections S5 and S6 of the
hypertrophic zone (see details in the section ‘In situ volume
measurement’ (below), and Figure 1(A)) were randomly
selected and the images recorded using a mounted digital
camera (Coolpix 4500, Nikon, Tokyo, Japan) with Coolpix
MDC2 Relay lens (MXA 2900, Nikon). The captured
images were then transferred to a computer for further
image analysis. Java-based scientific image processing
software (ImageJ, NIH, Bethesda, MD, U.S.A.) was then
used to measure the cell shrinkage from the images of the
histological sections.
In order to determine the extent of chondrocyte
shrinkage it was necessary to identify the area of individual
chondrocytes and that of their lacuna – i.e., the ‘cavity’ in
which the cell resided. It was in fact relatively
straightforward to do this as the outermost edge of the cell
area stained distinctly with Toluidine blue O, and the
perimeter of the corresponding lacuna was identified as
the edge of the extracellular matrix that demarcated the
border between the stained area of the matrix and the
‘space’ of the lacuna which was relatively unstained. It
was noted that the area of the lacuna could only be observed
if there was cell shrinkage. For each group of treatments,
4 fields of view from each growth plate section were
selected and up to 11 cells and their corresponding lacunae
randomly taken for area measurement. The area of each
Solution 
ID 
Fixative Solution Cacodylate buffer 
(mM)  pH 7.4 
pH Osmolarity 
(mOsm) 
280 0.7% RHT + 1% GA 50 6.76 273 ± 13 
480 0.7% RHT + 1% GA 50 6.60 467 ± 28 
640 0.7% RHT + 1% GA 50 6.55 637 ± 20 
1200 0.7% RHT + 1% GA 50 6.49 1141 ± 116 
 Fixative solutions were prepared with the constituents at the concentrations indicated (see Materials and Methods),
with the osmolarities and pH of the resulting solutions as shown. Concentrations are given as % (w/v) for RHT,
and % (v/v) for GA. Data expressed as means ± S.E.M. from at least 3 independent determinations.







(mM), pH 7.4 
pH Osmolarity 
(mOsm) 
0.5GA 0.7% RHT + GA 0.5 50 6.81 543 ± 1 
1GA 0.7% RHT + GA 1.0 50 6.73 542 ± 4 
2GA 0.7% RHT + GA 2.0 50 6.72 556 ± 18 
4GA 0.7% RHT + GA 4.0 50 6.35 577 ± 11 
Table 3. Modified fixative solutions with varying GA concentration, but with similar final osmolarity.
Fixative solutions were prepared with the constituents including different GA concentrations (% v/v) as indicated (see
Materials and Methods), with the osmolarities of the resulting solutions as shown. Concentrations of RHT are given
as % (v/v). Data expressed as means ± S.E.M from at least 3 independent determinations.
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cell and that of its associated lacuna were selected by
outlining their perimeters using the freehand selection tool
(see Fig. 2A, panel a). The total area of the cell and its
lacuna were then determined using the ‘analyze’ and
‘measure’ toolbar in the software.  Cell shrinkage was
calculated as {100 – [(cell area/lacuna area) x 100]} and
expressed as a percentage of the initial volume (see Fig.
2A, panel a). When the cell and its corresponding lacuna
shared the same perimeter, the value of cell shrinkage was
zero as defined above.
Confocal laser scanning microscopy (CLSM)
An upright Zeiss Axioskop LSM 510 (Carl Zeiss Ltd.,
Welwyn Garden City, Herts., U.K.) CLSM was used to
acquire fluorescent images of in situ hypertrophic growth
plate chondrocytes. Cells were visualized using a Plan-
Fig. 1. Overview of the rat growth plate, and division of in situ living rat chondrocytes (GPC) into sections from
proliferative to hypertrophic zones. Living chondrocytes in a bisected proximal tibia of a 7-day-old rat pup were
labelled with calcein AM, and sequential CLSM images taken with a x63 water-dipping objective (see Materials and
Methods). Panel (A) demonstrates the projected image of a section of the growth plate showing the increase in
chondrocyte volume from proliferative to hypertrophic zone. The zones were divided into eight equal sections (labelled
S1-S8) from early proliferative zone to late hypertrophic zone. Panel (B) shows the changes in the volume along the
growth plate sections as measured using Volocity® software on living in situ growth plate chondrocyte images
captured with CLSM. Also shown is an inset where the same data points were transformed to log10. (Data shown are
means ± S.E.M. or S.D. as appropriate, with n = 2 for S1-S4 and S7-S8, and n = 3 for S5-S6; and at least N=15 cells
measured at each section).
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Fig. 2A. Conventional fixatives cause considerable shrinkage of hypertrophic growth plate chondrocytes when
applied to whole (intact) bones. Intact proximal tibias of 7-day-old rat pups were fixed using various standard
fixative solutions (Table 1) and sections prepared and stained with 0.1% Toluidine blue O (see Materials and
Methods). The method used to calculate the extent of chondrocyte shrinkage was illustrated in Panel (a). The thick
white line was drawn free-hand around the perimeter of the lacuna and the black broken line drawn around the
membrane edge of its resident chondrocyte (see details in Materials and Methods). The gap between the cells and
the border of the lacuna is illustrated by double headed arrows. Cell shrinkage was observed in all conventional
fixatives (panels a - c) but not when the osmolarity of the fixative was adjusted to a ‘physiological’ osmolarity
(panel d). For pooled data see Figure 3. The scale bar of 20μm in this and the following Figure applied to all
panels.
Neofluar x10/0.3 numerical aperture (NA) dry objective
for a low power overview and an Achroplan x 63/0.95 NA
ceramic water-dipping lens for high power views.
Intracellular CMFDA was excited using an Argon laser
(Ex = 488nm) and emitted fluorescence (Em = 517nm)
detected using a 500-550nm band pass filter. The confocal
detection pinhole was set at 1.00 Airy Unit. Laser power
and detector sensitivity were adjusted to provide optimum
image quality. The scanning speed was typically 0.6Hz
with 2 frame integration of a 512 x 512 pixel image, with
serial 1 μm z-step optical sections (see Bush and Hall,
2001; Bush et al., 2007 for further details).
In situ volume measurement
Whole growth plates imaged from the proliferative to
hypertrophic zones were divided into eight equal parts and
labeled S1 to S8 (Fig. 1A). This was done so that a
comparative analysis could be made between
corresponding sections from different individuals
irrespective of variations in section cutting angle (Bush et
al., 2008). Since the greatest number of hypertrophic cells
that was consistently found to be intact was in S5 and S6,
the in situ growth plate cell volume analysis was performed
only at these sections. Chondrocytes in S7-S8 often
appeared to be in poor condition, possibly as a result of
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cutting trauma during the preparation of the tissue (Huntley
et al., 2005). Volume analysis was performed using high
performance 3D imaging software (Volocity®,
Improvision, Coventry, U.K.) on scanned CLSM images
using the calibrated cell volume method as previously
described (Bush and Hall, 2001).
Statistical analysis
Data were expressed as means ± standard error of the mean
(S.E.M), obtained from a minimum of 3 separate animals
(n), and (N) chondrocytes at each condition with the data
shown as (n[N]). Statistical significance was evaluated
using two-tailed Student’s unpaired t-tests, or ANOVA tests
as appropriate, with the P value considered significant
when P<0.05. Statistical tests were performed using
Microsoft Office Excel (Microsoft, Redmond, WA, U.S.A.)
or SigmaPlot® statistical software (Systat Software,
Chicago, IL, U.S.A.).
Results
Volume and morphology of rat growth plate
chondrocytes (GPC)
Initially, to determine live cell volumes and the morphology
of in situ, unfixed chondrocytes, we labelled in situ growth
plate chondrocytes with calcein as shown (Fig. 1). Imaging
of the fluorescently-labelled in situ living growth plate
chondrocytes demonstrated a clear increase in the size of
GPC from the proliferative through to hypertrophic zones
(Fig. 1a). Chondrocytes within the proliferative zone
(between the reserve and hypertrophic zone) appeared
Fig. 2B. Reduced cell shrinkage in GPC of bones sagittally-bisected before fixation. Bisected sections prepared
and stained with 0.1% Toluidine blue O (see Materials and Methods). With these bisected bones the extent of cell
shrinkage was markedly less compared to the intact bones (Fig. 2A) and shrunken chondrocytes were only
occasionally observed as illustrated by the double headed arrows (panel a). The morphology of chondrocytes
within the three other fixative solutions (panels b to d) was relatively normal (see pooled data in Fig. 3).
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Fig. 3A. Growth plate chondrocyte shrinkage in
histological sections from intact bones fixed in four
different solutions.  Cell shrinkage of in situ
chondrocytes fixed in solutions A, B, C or D (for
composition see Table 1) in intact tibias from 7 day-old
rats were measured as described (see Materials and
Methods). Data in this and the subsequent Figure were
from at least (3[44]) for each condition. In this and the
following Figure, P values for unpaired Student’s t-tests
are shown. (Data are given as means ± S.E.M.).
Fig. 3B. Growth plate chondrocyte shrinkage in
histological sections from bisected bones fixed in four
different solutions.  Cell shrinkage of in situ
chondrocytes fixed in solutions A, B, C or D (Table 1)
in sagittally-bisected tibias from 7 day-old rats were
measured as described (see Materials and Methods). A
single asterisk (*) denoted a significant difference when
the two-way ANOVA tested the trend of cell shrinkage
between intact and bisected bones in various fixative
solutions.  A double asterisk (**) denoted a significant
difference compared to the intact bone fixed in solution
A (Student’s unpaired t-test).
ellipsoidal and usually arranged in columns of at least three
to eight cells. In the hypertrophic zone (between the
proliferative zone and the zone of calcification) the cells
were larger and frequently more rounded although there
were cells with a height greater than the cell’s width
(Buckwalter et al., 1985; Farnum and Wilsman, 1986).
In accordance with the visual appearance of
chondrocytes along the growth plate, the quantified volume
of in situ cells increased although it was clearly not a linear
process as there was a relatively poor fit to a linear
regression (correlation coefficient r2 = 0.793). The volume
increase was initially gradual through to S5, but then
became more rapid from S5-S8 similar to an exponential
growth relationship (Fig. 1b). When the volume data were
transformed to log10 and plotted semi-logarithmically (see
inset to Fig. 1b) there was a much better fit to the data (r2
= 0.955) supporting the notion of a logarithmic increase
in chondrocyte volume associated with hypertrophy. In the
present study we focused on chondrocytes within these
latter sections of the growth plate. Although the shrinkage
artefact was apparent in the smaller cells, it was very
difficult to quantify the phenomenon using our imaging
methods (see Materials and Methods). This was because
the distinction between the perimeter of the lacuna and
the cell edges of smaller (shrunken) cells was difficult to
determine accurately, resulting in large variations.
Therefore, we decided to study the phenomenon only on
chondrocytes in the hypertrophic zone to ensure accurate
measurements, and the cells within S5-S6 were chosen
because an adequate number of intact cells from these
segments could consistently be observed.
Measurement of cell shrinkage
The accuracy of the method used for assessing chondrocyte
shrinkage in histological sections as described in Materials
& Methods (Fig. 2A panel a) was initially determined by
measuring the area of GPC cells that had distinct and well-
defined perimeters. The cell measurement was made
independently using the free-hand selection tool on the
same cell twice and the difference between the two
readings compared. The mean difference between the two
measurements was 2.7±1.9 % (mean ± standard deviation
(S.D.), for 11 cells) indicating the measurement method
had an appropriate level of accuracy.
Morphology of growth plate chondrocytes fixed
using conventional solutions
An ideal fixative should successfully preserve tissue for
subsequent staining procedures, but it is important to
accurately retain the original morphology of the living cells
in the tissue, free from artefacts occurring during the
fixation process. To demonstrate the morphology of GPC
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fixed with conventional fixatives (Farnum et al., 2002;
Hosoya et al., 2005; Hunziker et al., 1983), we used three
standard and widely-used solutions (Table 1). These
fixative solutions were all hyper-osmotic (Table 1), and
therefore for comparison an iso-osmotic fixative with
osmolarity adjusted to close to that of typical extracellular
physiological solutions (280mOsm; Table 1), was also
included.
In whole (non-bisected) bone samples, fixed and
processed as described for histology (see Materials and
Methods), there was a clear cell shrinkage artefact observed
in tissue fixed with the three conventional fixatives
(solutions A, B & C; Table 1; Fig. 2A panels a-c)). Among
the three fixatives, chondrocyte shrinkage assessed visually
was most marked for solutions A and B and least for
solution C (Fig. 2A(c)). When osmotically corrected
solution D (~280mOsm) was used, we observed no
apparent cell shrinkage (Fig. 2A panel d). Quantitatively,
solution A caused the highest cell shrinkage (44 ± 3 %
(3[44])), followed by tissue fixed in solution B (31 ± 4%
(3[44]), then cells in solution C 17 ± 5% (3[44]) and finally
for the osmotically-corrected fixative solution D, there was
no significant change in cell volume (5.5 ± 0.8% (3[44])).
When analysing the extent of the shrinkage from solutions
A to D (lowering osmolarity, Table 1), there was a
significantly decreasing trend (one-way ANOVA test;
P=0.010) however only the shrinkage for cells in solutions
A and B were significantly different (unpaired Student’s
t-test, P<0.05) from the osmotically-corrected fixative
solution D. Note that although shrunken cells were
routinely observed microscopically in cells fixed in
solution C (Fig. 2A panel c) the pooled data did not show
a significant difference and this was mainly because of
the range in the magnitude of the shrinkage effect.
In bisected bones (Fig. 2B), microscopic inspection
showed clearly that the extent of the chondrocyte shrinking
artefact was considerably reduced with the four fixatives
when compared to the cells within fixed whole bones (Fig.
2A panels a-d). When the shrinkage was quantified (Fig.
3B), the same decreasing trend in cell shrinkage with the
four fixatives was also observed and the trend significant
over the whole range (one-way ANOVA test; P=0.024).
The absolute level of shrinkage and the trend with
decreasing osmolarity, was less compared to the data for
intact bones (Fig. 3A). When the data sets for intact and
bisected bones over the range of fixatives were compared
using a two-way ANOVA, the difference was significant
(P=0.004). In solution A cell shrinkage in bisected bones
was 22 ± 2.6%, which was significantly less than the
shrinkage of chondrocytes fixed in intact tibias (P=0.030).
Fixative solution B caused 17 ± 1.4% (3[44]) shrinkage
whereas solution C caused 9 ± 0.4% (3[44]) cell shrinkage
Fig. 4A. Chondrocyte shrinkage increased with elevated
osmolarity of the fixative solution.  Whole bones were
fixed in solutions composed of 1% GA and 0.7% RHT,
with osmolarity varied over the range 273 to 1141 mOsm
by the addition of NaCl (see Table 2). Shrinkage of GPC
was determined as described (see Materials and
Methods, and Fig. 2A panel a). Data were from at least
(3[44]) for each condition and are presented as means
± S.E.M.
Fig. 4B. There was no difference in cell shrinkage with
an increase of fixative concentration if osmolarity was
kept constant. Whole bones were fixed in fixative
solutions with the GA concentration varied over the
range 0.5 to 4%, but with the osmolarity maintained
constant at ~550 mOsm (see Table 3 for composition
of solutions). Shrinkage of GPC was determined as
described (see Materials and Methods, and Fig. 2A
panel a). There was no significant difference between
any pairs of data (Student’s unpaired t-test). Data were
from at least (5[44]) for each condition and presented
as means ± S.E.M.
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and these values were less than for intact bones but did
not reach the level of significance (P>0.05). Cell shrinkage
in the iso-osmotic fixative solution D for GPC in bisected
bones was only 4 ± 0.4% (3[44]; Fig. 3) and this was not
significantly different from the data in intact bones (see
above). These results showed that the shrinkage artefact
was considerably reduced if the bones were bisected prior
to fixation, and with osmotic correction, there was no
significant shrinkage artefact of GPC in either intact or
bisected bones.
As noted in Table 1, the pH of the fixatives varied over
the range 5.67 to 7.11, which was the result of different
types and concentration of fixative agents and buffer
concentration. We conducted a further experiment to
examine whether pH contributed significantly to the quality
of tissue preservation. We tested two pH values (i.e., 5.6
and 7.2) using the same fixative solution (solution D) to
fix two groups of growth plate tissue from proximal tibia
of P7 rats (n=3). Using the same method to quantify the
cell shrinkage as described previously, the result showed
that at pH 5.7 there was 8 ± 0.6 % (mean ± S.E.M.) cell
shrinkage, whereas at pH 7.2 there was 7 ± 1.5 % of cell
shrinkage. These were not significantly different (P<0.05)
and so we concluded that pH over this range had a
Fig. 5. Reduced volume and altered morphology of in situ GPC fixed within intact bone compared to those within
bisected bones. Panels (a-c) showed the typical appearance of fluorescently (CMFDA-green)-labelled chondrocytes
within intact (panel a) or bisected (panels b, c) bones, and fixed under the various conditions indicated. The
shrinkage of some cells was observed in the fixed in situ cells (examples indicated with white arrows, panels a, b)
but not in the osmotically-corrected fixative solution D (panel c). Panel (d) shows the appearance of unfixed (i.e.,
living) in situ hypertrophic GPCs labelled with calcein. All images were taken by CLSM using a x63 water-dipping
objective. Cell volume measurements were performed as described (see Materials and Methods) with pooled data
given in Table 4. Details of the composition of fixative solutions are given in Table 1. Scale bar = 20mm.
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negligible effect on cell shrinkage compared to the
osmolarity of the fixative solutions.
Fixation of GPC using different concentrations and
osmolarities of glutaraldehyde (GA) solution
To test whether the osmolarity or concentration of fixative
was responsible for the shrinkage artefact, whole bones
were immersed in solutions with varying osmolarity (273-
1141mOsm) and standard fixative concentrations (GA 1%,
RHT 0.7%; Table 2), or in solutions varying fixative
concentration (GA 0.5-4%) whilst maintaining osmolarity
relatively constant (555± 8mOsm; Table 3). At the lowest
osmolarity (273 ± 13 mOsm), cell shrinkage was minimal
(13 ± 0.6% (3[44])), but as it was raised, there was a
progressive and significant increase (ANOVA, P<0.001)
in the extent of cell shrinkage (Fig. 4(A)). At the highest
osmolarity studied (1141mOsm) cell shrinkage was 52 ±
1.6% (3[44]) and significantly greater (unpaired Student’s
t-test, P<0.001 for both) than the shrinkage observed in
273 and 467 mOsm solutions. When the GA concentration
was varied over the range 0.5 to 4%, but with the osmolarity
of all solutions maintained constant, the shrinkage of GPC
fixed in intact bones with 1%, 2% and 4% GA was 15 ±
2.4%, 12 ± 0.5%, and 16 ± 2.1% respectively, and not
significantly different (P>0.05; data from at least (5[44]);
Fig. 4B). It was notable that GA at 0.5% showed an
apparent slightly higher cell shrinkage (25 ± 4.1% (5[44]))
compared to 1% GA, but this was not significantly different
from the lowest cell shrinkage produced by GA at 2%
(P>0.05). The morphology of a noticeable number of these
cells was abnormal, suggesting that they were not properly
fixed, and thus it was possible that the cells were
susceptible to the post-fixation dehydration protocols
(Mohamad Yusof Loqman, unpublished observations).
Taken together, these data suggest that the shrinkage and
morphological changes of GPC fixed using standard
solutions could be accounted for by the osmolarity of the
fixative solutions and not by the concentration of the
fixative.
In situ growth plate chondrocyte volume following
fixation with solution A in intact and bisected bones
The volume of in situ GPC within intact or sagittally-
bisected bones and fixed under various conditions was also
assessed using another method.  Solution A was chosen as
it had the highest osmolarity among the different
conventional fixative solutions used in the present study,
resulted in the greatest shrinkage artefact (which was easily
measured), and has been used previously in the study of
growth plate chondrocytes (see Table 1). Images of
fluorescently-labelled in situ chondrocytes taken by CLSM
showed the majority of cells with abnormal shrunken
morphology in intact bone fixed with this solution (Fig.
5a). When the bone was sagittally bisected and then fixed
using the same solution, the proportion of shrunken
chondrocytes was markedly less (Fig. 5b), and similarly
when these bones were fixed in the osmotically-corrected
solution (solution D, Table 1) there were almost no
shrunken cells observed (Fig. 5c) with the cells appearing
morphologically normal. The volume of GPC fixed in the
intact bone had a significantly reduced cell volume of
almost two and half-fold less compared to the cells in the
bisected bone (Table 4; unpaired t-test: P = 0.016, n=5).
For comparison, GPC volume of living non-fixed bone
and of bisected bones fixed in solution D were not
significantly different from the GPC volume of bisected
bone fixed in solution A (unpaired t-tests, P>0.05).
However, the volume of GPC fixed in solution A showed
no significant decrease compared to the volume of GPCs
fixed in solution D and non-fixed GPC as expected due to
cell shrinkage, as shown previously (Figure 3B). The
reason for this was not immediately obvious, although it
should be noted that the errors associated with the
measurement of in situ GPC volume were relatively large
(Table 4). In summary, the reduction in cell volume was
significantly greater for GPC within intact bones compared
to bisected bones when fixed in a conventional fixative
solution (Table 4).
Discussion
This study demonstrated that the osmolarity of fixative
solutions was of critical importance for maintaining the
normal morphology of in situ hypertrophic chondrocytes
within the mammalian growth plate following chemical
fixation. The shrinkage artefact evident when using
conventional fixatives, was abolished when the osmolarity
of the medium was reduced to close to that of normal
physiological solutions or markedly reduced when the
bones were sagittally bisected prior to fixation. These
results raise important issues in relation to the accurate
preservation of cell morphology by these widely-used
chemical fixative solutions.
The first point to consider is the identification of a
fixative concentration that ensured proper fixation of the
CMFDA-labelled in situ chondrocytes were fixed under the conditions shown (see Figure 5), their volume determined
as described (see Materials and Methods) and the pooled data presented. Data (as means ± S.E.M.) are from n = 5
animals with 5-29 chondrocytes measured from each animal. *Denotes a significant difference (P<0.05; Student’s
unpaired t-test) between the data for the intact bone and each of the data sets for the bisected bone sections.
Nature of the 
bone specimen Fixatives 
In situ GPC 
volume (µm3) 
Intact PFA 4% (solution A) 1698 ± 166* 
Bisected PFA 4% (solution A) 4064 ± 571 
Bisected GA 1.3% + RHT 0.5% (solution D) 3389 ± 659 
Bisected No fixative 3411 ± 1148 
Table 4. Reduction of in situ GPC volume in fixed intact bones compared to bisected bones.
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cells/tissue without the osmolarity being too high to cause
a shrinkage artefact and our data suggest that solution D
was optimal (Table 1; Fig. 3). This osmolarity would be
close to that normally present in physiological extracellular
solutions meaning that the osmolarity of the cells within
the extracellular matrix of the growth plate would similarly
be optimal for normal chondrocyte morphology. (Note
however that the exact extracellular osmolarity around the
GPC will most likely be higher due to the presence of
glycosaminoglycans present in the extracellular matrix
(Urban et al., 1993)). A lower concentration of GA (0.5%)
produced what appeared to be a shrinkage artefact (Fig.
4B) but although individual shrunken cells were present
on visual examination, statistical analysis of pooled data
showed this was not significant. However we would
caution against using such a low concentration as the fine
appearance of the cells suggested that there were cells that
were not properly fixed, resulting in morphological
changes/distortions during post-fixation protocols
(Mohamad Yusof Loqman, unpublished observations).
Previous studies have, however, successfully utilized low
fixative concentrations. For example Maunsbach (1966)
investigating the kidney and Hopwood (1967) studying
the brain noted that GA was an effective fixative down to
0.25% (Hopwood, 1967; Maunsbach, 1966). It is possible
that low fixative concentrations could be used successfully
in these studies because of the different physical nature of
hard tissues compared to soft tissues, as in the latter the
diffusion rate and thus penetration of the fixative would
be expected to be considerably greater. Our findings were
in general agreement with a previous report that identified
the importance of fixative osmolarity to produce correct
soft tissue preservation. Mathieu et al., (1978) reported
both the GA percentage and molarity of the fixative vehicle
were of importance for the preservation of lung tissue. In
this study, they noted the shrinkage was induced by the
osmolarity of buffer and fixative combined, as evidenced
by shape changes of erythrocytes in capillaries and small
vessels of the trachea, and a reduction in the air-blood tissue
barrier of the trachea with different fixative osmolarities.
Higher fixative concentrations (e.g. 2-4% GA) could of
course be used for some applications where cell shrinkage
is not a concern (e.g. for tissue perfusion fixation
(Santoreneos et al., 1998) or biomaterial fixation (Nuss et
al., 2006)), but clearly the results from the present study
emphasize the importance of researchers being aware of
the potential for an osmotic shrinkage artefact to cell shape.
In the present study we included RHT (ruthenium
hexamine trichloride) in most of the fixative solutions
(Table 1). Hunziker et al., (1982) have proposed that this
cationic dye stabilized the GPC plasma membrane within
the lacuna by establishing electrostatic cross-linkage
between anionic components within the plasma membrane
and the proteoglycans of the pericellular matrix which
surrounds chondrocytes. They suggested that this could
prevent the rupture or detachment of the plasma membrane
from the pericellular matrix when conventional aldehyde
solutions were used simultaneously (Hunziker et al., 1982,
1992) (Fixative solutions B and C; Table 1). In our hands
however, the presence of RHT could not prevent the
shrinkage artefact (see Fig. 3). Thus, although the %
shrinkage was not significantly different from the
osmotically-corrected fixative solution (solution D) it was
still clearly greater than the solution B & C. In addition,
we routinely observed abnormal/shrunken cells (Fig. 2A
panels b and c) as also observed in the original Hunziker
et al. (1983) study. Therefore, although it is possible that
RHT does protect against the shrinkage effect to some
extent by stabilizing the cell membrane against the
pericellular matrix, we feel that osmotic correction is the
preferred procedure to eliminate the artefact (Fig. 3) and
the presence of any abnormal cells (Fig. 2A panel d).
The nature of the chemical fixative is also an issue of
importance as there is not one fixative suitable for all
applications. For example, GA has been associated with
antigen masking due to its excessive and aggressive cross-
linking of proteins, and is therefore normally considered
unsuitable for tissues intended for immunochemical
staining (Renshaw, 2007). GA is usually used as a mixture
with PFA termed Karnovsky’s fixative (Karnovsky, 1965)
so as to take advantage of the latter which has rapid tissue
penetration although the fixation rate is not as rapid as
that of GA (Kiernan, 1999). Our view is that PFA (4%)
alone, probably gives the best compromise between good
cytological preservation and immunolocalization, while
at the same time maintaining antigen masking to a
minimum. However, as it is a fixative solution with high
osmolarity (Table 1), tissues should be bisected beforehand
to maximize rapid fixative access to limit undesirable cell
shrinkage artefacts although it should be noted that they
were still clearly apparent (Fig. 2B panel a) and still
significant (~20% shrinkage, Fig. 3). We note that although
10% neutral buffered formalin is rarely used in growth
plate studies, it is a widely used fixative for routine
histology and histopathology (Renshaw, 2007). However
it should be noted that its osmolarity (measured at approx.
1700mOsm; Mohamad Yusof Loqman, unpublished
observations) is even higher than the fixatives used here
and thus we would expect that the artefactual shrinkage
would be even more marked than reported for solution A
(4% PFA).
The finding that the shrinkage artefact was significantly
reduced in bisected compared to whole bones, strongly
suggested that the rate of penetration of the fixative
compared to the osmotic changes to chondrocytes resulting
from the high osmolarity of the fixative solutions are
important. In the whole bone, the large shrinkage artefact
suggested that osmotically-induced cell shrinkage occurred
before the tissue was fixed. Thus when the bone was placed
in the fixative solution, water movement out of the bones
to the hyper-osmolar fixative solution occurred rapidly,
and before the fixative fully penetrated the bone/cartilage
matrix to fix the cells throughout the sample. Dempster
(1960) has shown that fixatives obeyed the diffusion laws,
that is, the depth penetrated (d) was proportional to the
square root of time and the coefficient of diffusibility of
the fixative, which was specific for each fixative. As the
diffusion is directly proportional to the concentration
gradient based on Fick’s Law (Mehrer, 2007), the
diffusibility of the fixative molecules (PFA, FA, GA)
through the extracellular matrix of the tissue will
undoubtedly be less than that for water molecules because
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of their different molecular shape and molecular weight.
Thus, the diffusibility of the fixatives will be markedly
less than that of water, leading to a greater shrinkage effect
in thicker and denser tissues such as bone/cartilage,
compared to ‘soft’ tissues such as brain and kidney. For
thick tissues where preservation of cell morphology deep
in the tissue is of importance, osmotic adjustment with
lower fixation concentrations and longer fixation times
would be advisable. Most workers set the fixation period
using conventional fixatives of between 1- 4 hrs, or even
longer (Hopwood, 1969). The optimum time will depend
on several factors including the physical properties of the
tissue (e.g. bone/cartilage vs. brain) concentration of the
fixative and thickness of tissue sections. Higher fixative
concentration requires shorter fixation times (Monis et al.,
1965) whereas thicker blocks and harder tissues will
necessitate longer fixation times as the penetration of the
fixative will be slower.
Our results demonstrated that the shrinkage artefact
could also be significantly reduced – although not
abolished – when the bone was bisected before being fixed
in standard (high osmolarity) fixative solutions (Fig. 3).
Bone bisection would markedly reduce the physical
obstacles and diffusional distances thereby providing a
more direct and far more rapid exposure of the GPC that
were being visualized to the fixative solutions. The rate of
fixation would thus be much more rapid compared to GPC
within intact bone, although the fact that the shrinkage
artefact was still present indicated that despite the increased
access provided to the fixative, significant cell shrinkage
still occurred before the tissue was effectively fixed (Fig.
3). However, the drawback with bone bisection as a
manoeuvre to reduce the fixation artefact would be that it
could cause physical trauma/death to the cells at the cut
edge (Huntley et al., 2005) and unless care was taken with
imaging protocols by optically sectioning deeper into the
tissue, the damaged surface cells would be the ones that
are visualized. Bone bisection would also release internal
(physiological) pressures within the bone and result in the
loss/damage to matrix constituents (loss of proteoglycans,
damage to the collagenous network, altered ionic/osmotic
environment) potentially leading to changes to the in vivo
properties (volume/morphology) of chondrocytes prior to
fixation (Guilak  and  Mow, 2000).
Our measurements of cell shrinkage by a histological
method (Fig. 2A,B; Fig. 3) were supported to some extent
by volume analysis of fluorescently-labelled living in situ
GPC images taken by CLSM (Fig.5 and Table 4). Although
the latter technique was more time-consuming, it served
as a useful additional and direct measure of cell volume to
confirm the cell shrinkage due to hyper-osmolar fixatives.
The results from this method clearly showed the reduction
in the cell volume of chondrocytes fixed with PFA (4%)
in intact bone compared to bisected bone (Table 4). We
would have expected that in parallel with the histological
shrinkage measurements (Fig. 3A, B), the volume of cells
within the bisected bone samples would not have been
reduced in the PFA solution to the same extent as cells
fixed with the osmotically-corrected fixative solution. At
present we do not have an explanation for this finding, but
note that we did not find the volume method was as
sensitive for detecting the chondrocyte shrinkage compared
to the histological method.
Both of these approaches provided us with more
accurate quantitative measurements of the cell shrinkage
artefact, compared to previous indirect methods e.g.
counting the number of cell nuclei per unit area of tissue
(Fox et al., 1985).  Previous studies had suggested fixation
artefacts arose from subsequent steps in tissue processing
e.g. during ethanol-induced dehydration and embedding
(Hopwood, 1969). However our data suggested that before
it was possible to determine these secondary artefacts
resulting from further preparation of tissue for histological
analysis, it was essential that as far as possible the fixed
tissue was close to its native state by abolishing the osmotic
shrinkage artefact reported here.
In summary, our study demonstrated that the high
osmolarity of conventional fixatives caused a shrinkage
artefact to chondrocytes within the hypertrophic zone of
the mammalian growth plate. This was particularly
noticeable when whole bones were fixed, but was still
present when the bones were bisected prior to fixation.
This problem could be avoided by adjusting the osmolarity
of the fixatives to the osmotic pressure of normal
extracellular fluids (~280mOsm). In conclusion, in order
to preserve the normal volume/morphology of cells within
tissue samples, careful consideration should be given to
the osmotic pressure of the fixative solution.
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Discussion with Reviewer
Reviewer I: 10% Neutral Buffered Formalin is probably
the most widely used fixative for routine histology and
histopathology. Was this fixative tested at all? Did the
authors simply concentrate on fixatives considered specific
for growth plates?
Authors: While 10% Neutral Buffered Formalin (also
referred to as 4% formaldehyde (Renshaw, 2007)) is widely
used for processing tissues for routine histology, its use in
growth plate tissue fixation is rather uncommon compared
to other conventional fixatives as tested in the present study.
Accordingly we have not focussed on this fixative. We
note that the osmolarity of the 10% neutral phosphate
buffered formaldehyde solution measured in our laboratory
was ~1700mOsm, and thus much higher than the
osmolarity of the fixatives used in the present investigation.
We would expect that the artefactual shrinkage produced
by this fixative would be much more marked, and have
included a comment on the use of this commonly used
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Appendix 1 
 
Skeletal anatomy of a rat. Some of the anatomical features of a growing rat 
(>3wks) as observed in the whole-body dorso-ventral view of radiograph (inset). 
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Confocal laser scanning microscope 
(CLSM)  
 




Coolpix MDC2 relay lens  
 




Digital Eyepiece Camera  
 
 
Dissecting stereomicroscope  
 








Analytical Plus, Ohaus 
 
Zeiss Axioskop LSM 510, Carl Zeiss 
Ltd., Welwyn Garden City, Herts., U.K. 
 
Loctite®, Cheshire, U.K. 
 
Cellstar®, Greiner Bio One, U.K. 
 
MXA 2900, Nikon, Japan 
 
Leica DFC 490, Peterbrough, U.K. 
Coolpix 4500, Nikon, Japan 
COHU, San Diego, California 
 
DCM 35 350K, Brunel Microscopes, 
U.K. 
 
Wild M3, Switzerland 
 
Clean Air Ltd., Bolton  
 
Magnetic Immuno Staining Tray, 
MIST, Cellpath, Hempstead 
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Incubator 
 
Inverted microscope  
 
Microbiological safety cabinet (Class II) 
 














Poly-l-lysine-coated microscope slides 
 
 








37° C: Biohit 
 
Eclipse T300, Nikon, Surrey, U.K. 
 
Bio 2+, Envair Ltd., Lancahire 
 
SkyScan 1172 instrument, Kontich, 
Belgium  
 
Model 3300, Vitech Scientific Ltd., 




Leica DMR, Peterbrough, U.K. 
Labophot 2, Nikon 
 
Reichert-Jung Microtome 2050 
Supercut, Arnsberg, Germany 
 
PolysineTM, VWR International, 
Leicestershire, UK 
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Swan-Morton, Sheffield, U.K. 
 
Magnetic Stirrer Hotplate, Stuart 
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